Citrus Sinensis ID: 016311
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 391 | 2.2.26 [Sep-21-2011] | |||||||
| Q9S7T8 | 391 | Serpin-ZX OS=Arabidopsis | yes | no | 0.992 | 0.992 | 0.636 | 1e-144 | |
| Q75H81 | 396 | Serpin-ZXA OS=Oryza sativ | yes | no | 0.984 | 0.972 | 0.580 | 1e-121 | |
| Q40066 | 398 | Serpin-ZX OS=Hordeum vulg | N/A | no | 0.982 | 0.964 | 0.562 | 1e-120 | |
| Q10GX0 | 405 | Serpin-ZXB OS=Oryza sativ | yes | no | 0.984 | 0.950 | 0.541 | 1e-115 | |
| P93692 | 398 | Serpin-Z2B OS=Triticum ae | N/A | no | 0.989 | 0.972 | 0.539 | 1e-115 | |
| Q9ST58 | 398 | Serpin-Z1C OS=Triticum ae | N/A | no | 0.989 | 0.972 | 0.521 | 1e-114 | |
| Q9M1T7 | 393 | Serpin-Z4 OS=Arabidopsis | no | no | 0.974 | 0.969 | 0.523 | 1e-113 | |
| Q9ST57 | 398 | Serpin-Z2A OS=Triticum ae | N/A | no | 0.989 | 0.972 | 0.526 | 1e-113 | |
| P93693 | 399 | Serpin-Z1B OS=Triticum ae | N/A | no | 0.989 | 0.969 | 0.515 | 1e-112 | |
| Q41593 | 398 | Serpin-Z1A OS=Triticum ae | N/A | no | 0.989 | 0.972 | 0.508 | 1e-111 |
| >sp|Q9S7T8|SPZX_ARATH Serpin-ZX OS=Arabidopsis thaliana GN=At1g47710 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 513 bits (1321), Expect = e-144, Method: Compositional matrix adjust.
Identities = 249/391 (63%), Positives = 319/391 (81%), Gaps = 3/391 (0%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
MDVRESIS Q V+++L KHV T +++SN++FSP+SI+V+LS+I+AGS G T DQ+LSF
Sbjct: 1 MDVRESISLQNQVSMNLAKHVITTVSQNSNVIFSPASINVVLSIIAAGSAGATKDQILSF 60
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
LK S DQLN+F+SE+V+ V ADGS +GGP+LSVANG WID+SLS K +FKQ++++ YKA
Sbjct: 61 LKFSSTDQLNSFSSEIVSAVLADGSANGGPKLSVANGAWIDKSLSFKPSFKQLLEDSYKA 120
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
ASNQ DFQ+KA EV EVN WAEKETNGL+ EVLP GS D+ T+LIFANALYFKG WNE
Sbjct: 121 ASNQADFQSKAVEVIAEVNSWAEKETNGLITEVLPEGSADSMTKLIFANALYFKGTWNEK 180
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
FD S T++ +FHLL+G + PFMTSKK Q+VSA+DGFKVLGLPY QG+DKR+FSMYF+L
Sbjct: 181 FDESLTQEGEFHLLDGNKVTAPFMTSKKKQYVSAYDGFKVLGLPYLQGQDKRQFSMYFYL 240
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
PDA +GL LL+K+ S FLD+H+P ++V+V +F+IP+FK SFG + S VLKGLGL P
Sbjct: 241 PDANNGLSDLLDKIVSTPGFLDNHIPRRQVKVREFKIPKFKFSFGFDASNVLKGLGLTSP 300
Query: 301 FSGEGGGLAEMVDSP-VGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVL-SDK 358
FSGE GL EMV+SP +GKNL VS+IF K+ IEVNEEGTEAAAASA + LR +++ D+
Sbjct: 301 FSGE-EGLTEMVESPEMGKNLCVSNIFHKACIEVNEEGTEAAAASAGVIKLRGLLMEEDE 359
Query: 359 IDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389
IDFVADHPF+ ++ E++TG+V+F G V++PL
Sbjct: 360 IDFVADHPFLLVVTENITGVVLFIGQVVDPL 390
|
Inhibits metacaspase-9 cysteine protease. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q75H81|SPZXA_ORYSJ Serpin-ZXA OS=Oryza sativa subsp. japonica GN=Os03g0610650 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1120), Expect = e-121, Method: Compositional matrix adjust.
Identities = 228/393 (58%), Positives = 299/393 (76%), Gaps = 8/393 (2%)
Query: 2 DVRESISNQTDVALSLTKHVALTE----AKDSNLVFSPSSIHVLLSLISAGSKGPTLDQL 57
D+R SI++QT AL L ++ N+ FSP S+HV LSL++AG+ G T DQL
Sbjct: 4 DLRVSIAHQTSFALRLAAALSSPAHPAGGAGRNVAFSPLSLHVALSLVAAGAGGATRDQL 63
Query: 58 LSFLKSK-SNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDN 116
S L S + L+AFA +LV +V AD S +GGPR++ A+GV++D SLSLK TF V
Sbjct: 64 ASALGGPGSAEGLHAFAEQLVQLVLADASGAGGPRVAFADGVFVDASLSLKKTFGDVAVG 123
Query: 117 VYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGA 176
YKA ++ VDFQTKAAEV+ +VN W EK T+GL+KE+LPPGSVD++TRL+ NALYFKGA
Sbjct: 124 KYKAETHSVDFQTKAAEVASQVNSWVEKVTSGLIKEILPPGSVDHTTRLVLGNALYFKGA 183
Query: 177 WNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSM 236
W E FD+SKTKD +FHLL+G S++ PFM++ K Q++ ++D KVL LPY+QG DKR+FSM
Sbjct: 184 WTEKFDASKTKDGEFHLLDGKSVQAPFMSTSKKQYILSYDNLKVLKLPYQQGGDKRQFSM 243
Query: 237 YFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLG 296
Y LP+A+DGL +L EK+ SE +FL+ H+P+++V VG F++P+FKISFG E S +LK LG
Sbjct: 244 YILLPEAQDGLWSLAEKLNSEPEFLEKHIPTRQVTVGQFKLPKFKISFGFEASDLLKSLG 303
Query: 297 LVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLS 356
L LPFS E L EMVDSP GKNL+VSS+F KSF+EVNEEGTEAAAA+AA + LRS ++
Sbjct: 304 LHLPFSSE-ADLTEMVDSPEGKNLFVSSVFHKSFVEVNEEGTEAAAATAAVITLRSAPIA 362
Query: 357 DKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389
+ DFVADHPF+F+I+EDMTG+V+F GHV+NPL
Sbjct: 363 E--DFVADHPFLFLIQEDMTGVVLFVGHVVNPL 393
|
Probable serine protease inhibitor. Oryza sativa subsp. japonica (taxid: 39947) |
| >sp|Q40066|SPZX_HORVU Serpin-ZX OS=Hordeum vulgare GN=PAZX PE=1 SV=1 | Back alignment and function description |
|---|
Score = 432 bits (1110), Expect = e-120, Method: Compositional matrix adjust.
Identities = 222/395 (56%), Positives = 290/395 (73%), Gaps = 11/395 (2%)
Query: 2 DVRESISNQTDVALSLTKHVAL-TEAKDS--NLVFSPSSIHVLLSLISAGSKGPTLDQLL 58
D+R SI++QT A+ L ++ + AK S N FSP S+HV LSL++AG+ T DQL
Sbjct: 5 DIRLSIAHQTRFAVRLASAISSPSHAKGSSGNAAFSPLSLHVALSLVAAGAAA-TRDQLA 63
Query: 59 SFLKSKSN---DQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVD 115
+ L + + L+A A ++V VV AD S +GGPR S AN V++D SL LK +FK +V
Sbjct: 64 ATLGAAEKGDAEGLHALAEQVVQVVLADASGAGGPR-SFAN-VFVDSSLKLKPSFKDLVV 121
Query: 116 NVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKG 175
YK + VDFQTKA EV+ +VN W EK T GL+KE+LP GSVD++TRL+ NALYFKG
Sbjct: 122 GKYKGETQSVDFQTKAPEVAGQVNSWVEKITTGLIKEILPAGSVDSTTRLVLGNALYFKG 181
Query: 176 AWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFS 235
+W E FD+SKTKD FHLL+G S++ PFM+S K Q++S++D KVL LPY+QG DKR+FS
Sbjct: 182 SWTEKFDASKTKDEKFHLLDGSSVQTPFMSSTKKQYISSYDSLKVLKLPYQQGGDKRQFS 241
Query: 236 MYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGL 295
MY LP+A+DGL L K+ +E +F++ H+P Q+V VG F++P+FKISFG E S +LKGL
Sbjct: 242 MYILLPEAQDGLWNLANKLSTEPEFMEKHMPMQKVPVGQFKLPKFKISFGFEASDMLKGL 301
Query: 296 GLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSI-V 354
GL LPFS E L+EMVDSP ++LYVSS+F KSF+EVNEEGTEAAA +A V LRS+ V
Sbjct: 302 GLQLPFSSE-ADLSEMVDSPAARSLYVSSVFHKSFVEVNEEGTEAAARTARVVTLRSLPV 360
Query: 355 LSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389
K+DFVADHPF+F+IRED+TG+V+F GHV NPL
Sbjct: 361 EPVKVDFVADHPFLFLIREDLTGVVLFVGHVFNPL 395
|
Inhibits chymotrypsin, cathepsin G and trypsin in vitro. Hordeum vulgare (taxid: 4513) |
| >sp|Q10GX0|SPZXB_ORYSJ Serpin-ZXB OS=Oryza sativa subsp. japonica GN=Os03g0610800 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 415 bits (1066), Expect = e-115, Method: Compositional matrix adjust.
Identities = 217/401 (54%), Positives = 293/401 (73%), Gaps = 16/401 (3%)
Query: 2 DVRESISNQTDVALSLTKHVALTEAK----------DSNLVFSPSSIHVLLSLISAGSKG 51
D+R SI++QT A L ++ A SN+ FSP S+HV LSL++AG+ G
Sbjct: 7 DLRVSIAHQTRFAFRLAAALSSPRAHPAAGGAAGAGGSNVAFSPLSLHVALSLVAAGAGG 66
Query: 52 PTLDQLLSFLK---SKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKN 108
T DQL+S L + + L+AFA ++V +V AD SP+GGPR++ A+GV+ID SLSL
Sbjct: 67 ATRDQLVSLLGVPGRGTAEGLHAFAEQVVQLVLADSSPAGGPRVAFADGVFIDSSLSLMK 126
Query: 109 TFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFA 168
+FK V YKA ++ VDFQTKAAEV+ +VN W ++ T+GL+KE+LPPGSVD++TRL+
Sbjct: 127 SFKDVAVGKYKAETHSVDFQTKAAEVASQVNSWVDRVTSGLIKEILPPGSVDHTTRLVLG 186
Query: 169 NALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQG 228
NALYFKGAW E FD+SKTKD +F LL+G S+ PFM++ K Q++S++D KVL LPY++G
Sbjct: 187 NALYFKGAWTEKFDASKTKDGEFRLLDGKSVLAPFMSTSKKQYLSSYDSLKVLKLPYQKG 246
Query: 229 EDKRRFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEV 288
D R+FSMY LP+A+DGL +L K+ SE +FL+ +P+++V VG F++P+FKISFG E
Sbjct: 247 RDLRQFSMYILLPEAQDGLWSLAAKLNSEPEFLEKRIPTRQVTVGKFKLPKFKISFGFEA 306
Query: 289 SKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATV 348
S +LK LGL LPFS + L MV SP NL+VSS+F KSF++V+EEGTEAAAASAA V
Sbjct: 307 SDLLKILGLQLPFSSK-ADLTGMVGSPERHNLFVSSLFHKSFVQVDEEGTEAAAASAAVV 365
Query: 349 VLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389
RS ++ +DFVADHPF+F+IREDMTG+V+F GHV+NPL
Sbjct: 366 SFRSAPVT--VDFVADHPFLFLIREDMTGVVLFIGHVVNPL 404
|
Probable serine protease inhibitor. Oryza sativa subsp. japonica (taxid: 39947) |
| >sp|P93692|SPZ2B_WHEAT Serpin-Z2B OS=Triticum aestivum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 414 bits (1063), Expect = e-115, Method: Compositional matrix adjust.
Identities = 210/389 (53%), Positives = 281/389 (72%), Gaps = 2/389 (0%)
Query: 2 DVRESISNQTDVALSLTKHVALT-EAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
DVR SI++QT A L ++ E+ +N FSP S+HV LSLI+AG+ G T +QL +
Sbjct: 8 DVRLSIAHQTRFAFRLASAISSNPESTVNNAAFSPVSLHVALSLITAGAGGATRNQLAAT 67
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
L + L+A A ++V V AD S GGPR++ ANGV++D SL LK +F+++ YKA
Sbjct: 68 LGEGEVEGLHALAEQVVQFVLADASNIGGPRVAFANGVFVDASLQLKPSFQELAVCKYKA 127
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
+ VDFQTKAAEV+ +VN W EK T GL+K++LP GS+DN+TRL+ NALYFKGAW +
Sbjct: 128 EAQSVDFQTKAAEVTAQVNSWVEKVTTGLIKDILPAGSIDNTTRLVLGNALYFKGAWTDQ 187
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
FD T+ DF+LL+G SI+ PFM S + Q++S+ DG KVL LPYKQG DKR+FSMY L
Sbjct: 188 FDPRATQSDDFYLLDGSSIQTPFMYSSEEQYISSSDGLKVLKLPYKQGGDKRQFSMYILL 247
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
P+A GL +L EK+ +E +FL+ H+P Q+V + F++P+FKIS GIE S +LKGLGL+LP
Sbjct: 248 PEALSGLWSLAEKLSAEPEFLEQHIPRQKVALRQFKLPKFKISLGIEASDLLKGLGLLLP 307
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKID 360
F E L+EMVDSP+ +NLY+SSIF K+F+EVNE GTEAAA + A VVLR +D
Sbjct: 308 FGAE-ADLSEMVDSPMAQNLYISSIFHKAFVEVNETGTEAAATTIAKVVLRQAPPPSVLD 366
Query: 361 FVADHPFVFMIREDMTGLVMFTGHVLNPL 389
F+ DHPF+F+IRED +G+V+F GHV+NPL
Sbjct: 367 FIVDHPFLFLIREDTSGVVLFIGHVVNPL 395
|
Inhibits chymotrypsin, cathepsin G and trypsin in vitro. Triticum aestivum (taxid: 4565) |
| >sp|Q9ST58|SPZ1C_WHEAT Serpin-Z1C OS=Triticum aestivum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 412 bits (1058), Expect = e-114, Method: Compositional matrix adjust.
Identities = 203/389 (52%), Positives = 281/389 (72%), Gaps = 2/389 (0%)
Query: 2 DVRESISNQTDVALSLTKHVALT-EAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
DVR SI++QT AL L ++ ++ SN VFSP S+HV LSL++AG+ T DQL++
Sbjct: 8 DVRLSIAHQTRFALRLASTISSNPKSAASNAVFSPVSLHVALSLLAAGAGSATRDQLVAT 67
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
L + + L+A A ++V V AD S +GGP ++ ANGV++D SL LK +F+++ YKA
Sbjct: 68 LGTGEVEGLHALAEQVVQFVLADASSAGGPHVAFANGVFVDASLPLKPSFQELAVCKYKA 127
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
+ VDFQTKAAEV+ +VN W EK T+G +K++LP GSVDN+T+L+ ANALYFKGAW +
Sbjct: 128 DTQSVDFQTKAAEVATQVNSWVEKVTSGRIKDILPSGSVDNTTKLVLANALYFKGAWTDQ 187
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
FDSS TK+ F+L +G S++ PFM+S +Q++S+ DG KVL LPYKQG DKR+FSMY L
Sbjct: 188 FDSSGTKNDYFYLPDGSSVQTPFMSSMDDQYLSSSDGLKVLKLPYKQGGDKRQFSMYILL 247
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
P+A GL L EK+ +E FL+ H+P QRV + F++P+FKISF E S +LK LGL LP
Sbjct: 248 PEAPGGLSNLAEKLSAEPDFLERHIPRQRVALRQFKLPKFKISFETEASDLLKCLGLQLP 307
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKID 360
FS E +EMVDSP+ L VSS+F ++F+EVNE+GTEAAA++A + L +D
Sbjct: 308 FSNE-ADFSEMVDSPMAHGLRVSSVFHQAFVEVNEQGTEAAASTAIKMALLQARPPSVMD 366
Query: 361 FVADHPFVFMIREDMTGLVMFTGHVLNPL 389
F+ADHPF+F++RED++G+V+F GHV+NPL
Sbjct: 367 FIADHPFLFLLREDISGVVLFMGHVVNPL 395
|
Inhibits chymotrypsin and cathepsin G in vitro. Triticum aestivum (taxid: 4565) |
| >sp|Q9M1T7|SPZ4_ARATH Serpin-Z4 OS=Arabidopsis thaliana GN=At3g45220 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 407 bits (1047), Expect = e-113, Method: Compositional matrix adjust.
Identities = 208/397 (52%), Positives = 279/397 (70%), Gaps = 16/397 (4%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
M++ +S+ NQTDV + L KHV T A SNLVFSP SI+VLL LI+AGS T +Q+LSF
Sbjct: 1 MELGKSMENQTDVMVLLAKHVIPTVANGSNLVFSPMSINVLLCLIAAGSNCVTKEQILSF 60
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
+ S+D LNA ++ V+V DG LS A GVWID+SLS K +FK +++N Y A
Sbjct: 61 IMLPSSDYLNAVLAKTVSVALNDGMERSDLHLSTAYGVWIDKSLSFKPSFKDLLENSYNA 120
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDN--STRLIFANALYFKGAWN 178
NQVDF TK AEV EVN WAE TNGL+KE+L S+ + LI ANA+YFKGAW+
Sbjct: 121 TCNQVDFATKPAEVINEVNAWAEVHTNGLIKEILSDDSIKTIRESMLILANAVYFKGAWS 180
Query: 179 ETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYF 238
+ FD+ TK YDFHLL+G +KVPFMT+ K Q++ +DGFKVL LPY ED+R+F+MY
Sbjct: 181 KKFDAKLTKSYDFHLLDGTMVKVPFMTNYKKQYLEYYDGFKVLRLPYV--EDQRQFAMYI 238
Query: 239 FLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLV 298
+LP+ +DGLPTLLE++ S+ +FLD+H+P QR+ F+IP+FK SF + S VLK +GL
Sbjct: 239 YLPNDRDGLPTLLEEISSKPRFLDNHIPRQRILTEAFKIPKFKFSFEFKASDVLKEMGLT 298
Query: 299 LPFSGEGGGLAEMVDSP-------VGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLR 351
LPF+ G L EMV+SP V +NL+VS++F K+ IEV+EEGTEAAA S A++
Sbjct: 299 LPFT--HGSLTEMVESPSIPENLCVAENLFVSNVFHKACIEVDEEGTEAAAVSVASMTKD 356
Query: 352 SIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
+++ DFVADHPF+F +RE+ +G+++F G VL+P
Sbjct: 357 MLLMG---DFVADHPFLFTVREEKSGVILFMGQVLDP 390
|
Probable serine protease inhibitor. Arabidopsis thaliana (taxid: 3702) |
| >sp|Q9ST57|SPZ2A_WHEAT Serpin-Z2A OS=Triticum aestivum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 407 bits (1046), Expect = e-113, Method: Compositional matrix adjust.
Identities = 205/389 (52%), Positives = 279/389 (71%), Gaps = 2/389 (0%)
Query: 2 DVRESISNQTDVALSLTKHVALT-EAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
DVR SI++QT L ++ E+ +N+ FSP S+HV LSLI+AG+ G T DQL++
Sbjct: 8 DVRLSIAHQTRFGFRLASTISSNPESTANNVAFSPVSLHVALSLITAGAGGATRDQLVAT 67
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
L ++L+A A ++V V AD S + PR++ ANGV++D SL LK +F+++ YKA
Sbjct: 68 LGEGEAERLHALAEQVVQFVLADASYADSPRVTFANGVFVDASLPLKPSFQELAVCKYKA 127
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
+ VDFQTKAAEV+ +VN W EK T GL+K++LP GS+ N+TRL+ NALYFKGAW +
Sbjct: 128 EAQSVDFQTKAAEVTAQVNSWVEKVTTGLIKDILPAGSISNTTRLVLGNALYFKGAWTDQ 187
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
FDS TK F+LL+G SI+ PFM S + Q++S+ DG KVL LPYKQG DKR+FSMY L
Sbjct: 188 FDSRVTKSDYFYLLDGSSIQTPFMYSSEEQYISSSDGLKVLKLPYKQGGDKRQFSMYILL 247
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
P+A G+ +L EK+ +E + L+ H+P Q+V + F++P+FKISFGIE S +LK LGL LP
Sbjct: 248 PEAPSGIWSLAEKLSAEPELLERHIPRQKVALRQFKLPKFKISFGIEASDLLKHLGLQLP 307
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKID 360
FS E L+EMVDSP+ + L +SS+F K+F+EVNE GTEAAAA+ A VL S +D
Sbjct: 308 FSDE-ADLSEMVDSPMPQGLRISSVFHKTFVEVNETGTEAAAATIAKAVLLSASPPSDMD 366
Query: 361 FVADHPFVFMIREDMTGLVMFTGHVLNPL 389
F+ADHPF+F+IRED +G+V+F GHV+NPL
Sbjct: 367 FIADHPFLFLIREDTSGVVLFIGHVVNPL 395
|
Inhibits chymotrypsin and cathepsin G in vitro. Triticum aestivum (taxid: 4565) |
| >sp|P93693|SPZ1B_WHEAT Serpin-Z1B OS=Triticum aestivum PE=1 SV=1 | Back alignment and function description |
|---|
Score = 406 bits (1044), Expect = e-112, Method: Compositional matrix adjust.
Identities = 201/390 (51%), Positives = 282/390 (72%), Gaps = 3/390 (0%)
Query: 2 DVRESISNQTDVALSLTKHVALT-EAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
DVR SI++QT AL L ++ ++ SN FSP S+H LSL++AG+ T DQL++
Sbjct: 8 DVRLSIAHQTRFALRLASTISSNPKSAASNAAFSPVSLHSALSLLAAGAGSATRDQLVAT 67
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
L + + +A A ++V V AD S +GGPR++ ANGV++D SL LK +F+++ YKA
Sbjct: 68 LGTGEVEGGHALAEQVVQFVLADASSAGGPRVAFANGVFVDASLLLKPSFQELAVCKYKA 127
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
+ VDFQTKAAEV+ +VN W EK T+G +K +LP GSVDN+T+L+ ANALYFKGAW +
Sbjct: 128 ETQSVDFQTKAAEVTTQVNSWVEKVTSGRIKNILPSGSVDNTTKLVLANALYFKGAWTDQ 187
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTS-KKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFF 239
FDS TK+ F+LL+G S++ PFM+S +Q++S+ DG KVL LPYKQG D R+FSMY
Sbjct: 188 FDSYGTKNDYFYLLDGSSVQTPFMSSMDDDQYISSSDGLKVLKLPYKQGGDNRQFSMYIL 247
Query: 240 LPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVL 299
LP+A GL +L EK+ +E FL+ H+P QRV + F++P+FKISFG+E S +LK LGL L
Sbjct: 248 LPEAPGGLSSLAEKLSAEPDFLERHIPRQRVAIRQFKLPKFKISFGMEASDLLKCLGLQL 307
Query: 300 PFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKI 359
PFS E +EMVDSP+ + L VSS+F ++F+EVNE+GTEAAA++A +V + +
Sbjct: 308 PFSDE-ADFSEMVDSPMPQGLRVSSVFHQAFVEVNEQGTEAAASTAIKMVPQQARPPSVM 366
Query: 360 DFVADHPFVFMIREDMTGLVMFTGHVLNPL 389
DF+ADHPF+F++RED++G+V+F GHV+NPL
Sbjct: 367 DFIADHPFLFLLREDISGVVLFMGHVVNPL 396
|
Inhibits chymotrypsin and cathepsin G in vitro. Triticum aestivum (taxid: 4565) |
| >sp|Q41593|SPZ1A_WHEAT Serpin-Z1A OS=Triticum aestivum GN=WZCI PE=1 SV=1 | Back alignment and function description |
|---|
Score = 403 bits (1035), Expect = e-111, Method: Compositional matrix adjust.
Identities = 198/389 (50%), Positives = 279/389 (71%), Gaps = 2/389 (0%)
Query: 2 DVRESISNQTDVALSLTKHVALT-EAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
DVR SI++QT AL L ++ ++ SN FSP S++ LSL++AG+ T DQL++
Sbjct: 8 DVRLSIAHQTRFALRLASTISSNPKSAASNAAFSPVSLYSALSLLAAGAGSATRDQLVAT 67
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
L + + L+A A ++V V AD S +GG ANGV++D SL LK +F+++ YKA
Sbjct: 68 LGTGKVEGLHALAEQVVQFVLADASSTGGSACRFANGVFVDASLLLKPSFQEIAVCKYKA 127
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
+ VDFQTKAAEV+ +VN W EK T+G +K++LPPGS+DN+T+L+ ANALYFKGAW E
Sbjct: 128 ETQSVDFQTKAAEVTTQVNSWVEKVTSGRIKDILPPGSIDNTTKLVLANALYFKGAWTEQ 187
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
FDS TK+ F+LL+G S++ PFM+S +Q++ + DG KVL LPYKQG D R+F MY L
Sbjct: 188 FDSYGTKNDYFYLLDGSSVQTPFMSSMDDQYLLSSDGLKVLKLPYKQGGDNRQFFMYILL 247
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
P+A GL +L EK+ +E FL+ H+P QRV + F++P+FKISFGIE S +LK LGL LP
Sbjct: 248 PEAPGGLSSLAEKLSAEPDFLERHIPRQRVALRQFKLPKFKISFGIEASDLLKCLGLQLP 307
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKID 360
F G+ +EMVDS + + L VSS+F ++F+EVNE+GTEAAA++A +VL+ +D
Sbjct: 308 F-GDEADFSEMVDSLMPQGLRVSSVFHQAFVEVNEQGTEAAASTAIKMVLQQARPPSVMD 366
Query: 361 FVADHPFVFMIREDMTGLVMFTGHVLNPL 389
F+ADHPF+F++RED++G+V+F GHV+NPL
Sbjct: 367 FIADHPFLFLVREDISGVVLFMGHVVNPL 395
|
Inhibits chymotrypsin and cathepsin G in vitro. Triticum aestivum (taxid: 4565) |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 391 | ||||||
| 26224736 | 389 | serpin-like protein, partial [Citrus x p | 0.994 | 1.0 | 0.982 | 0.0 | |
| 255538432 | 391 | Protein Z, putative [Ricinus communis] g | 0.989 | 0.989 | 0.780 | 1e-177 | |
| 147810055 | 389 | hypothetical protein VITISV_021647 [Viti | 0.994 | 1.0 | 0.759 | 1e-172 | |
| 359492076 | 445 | PREDICTED: serpin-ZX [Vitis vinifera] | 0.984 | 0.865 | 0.759 | 1e-169 | |
| 356510338 | 389 | PREDICTED: serpin-ZX-like [Glycine max] | 0.994 | 1.0 | 0.741 | 1e-162 | |
| 224136672 | 391 | predicted protein [Populus trichocarpa] | 0.989 | 0.989 | 0.737 | 1e-156 | |
| 356519136 | 389 | PREDICTED: serpin-ZX-like [Glycine max] | 0.992 | 0.997 | 0.723 | 1e-154 | |
| 58416137 | 389 | serpin [Cucumis sativus] | 0.989 | 0.994 | 0.673 | 1e-149 | |
| 449470035 | 389 | PREDICTED: serpin-ZX-like [Cucumis sativ | 0.989 | 0.994 | 0.673 | 1e-148 | |
| 357465383 | 389 | Serpin-like protein [Medicago truncatula | 0.992 | 0.997 | 0.668 | 1e-146 |
| >gi|26224736|gb|AAN76362.1| serpin-like protein, partial [Citrus x paradisi] | Back alignment and taxonomy information |
|---|
Score = 770 bits (1989), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 382/389 (98%), Positives = 385/389 (98%)
Query: 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK 62
VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK
Sbjct: 1 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK 60
Query: 63 SKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAAS 122
SKS+DQLN FASELVAVVFADGSPSGGPRLSVANGVWID+SLSLKNTFKQVVDNVYKAAS
Sbjct: 61 SKSDDQLNTFASELVAVVFADGSPSGGPRLSVANGVWIDKSLSLKNTFKQVVDNVYKAAS 120
Query: 123 NQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFD 182
NQVD QTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFD
Sbjct: 121 NQVDSQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFD 180
Query: 183 SSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPD 242
SSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPD
Sbjct: 181 SSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPD 240
Query: 243 AKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFS 302
AKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFS
Sbjct: 241 AKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFS 300
Query: 303 GEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFV 362
GEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSI+L DKIDFV
Sbjct: 301 GEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSILLLDKIDFV 360
Query: 363 ADHPFVFMIREDMTGLVMFTGHVLNPLAG 391
ADHPFVFMIREDMTGLVMF GHVLNPLAG
Sbjct: 361 ADHPFVFMIREDMTGLVMFIGHVLNPLAG 389
|
Source: Citrus x paradisi Species: Citrus x paradisi Genus: Citrus Family: Rutaceae Order: Sapindales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255538432|ref|XP_002510281.1| Protein Z, putative [Ricinus communis] gi|223550982|gb|EEF52468.1| Protein Z, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 626 bits (1615), Expect = e-177, Method: Compositional matrix adjust.
Identities = 303/388 (78%), Positives = 342/388 (88%), Gaps = 1/388 (0%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
MD+RESI NQ DVAL+L+KHV L EAK SN VFSP SI V+L +I+AGSKG TLDQLLSF
Sbjct: 1 MDLRESIKNQIDVALTLSKHVLLGEAKSSNSVFSPLSIQVVLGIIAAGSKGATLDQLLSF 60
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
LKSKSNDQL++F+SELVAV FADGS +GGPRLS ANGVW+D++LSLK++FKQVVDNVYKA
Sbjct: 61 LKSKSNDQLSSFSSELVAVAFADGSAAGGPRLSFANGVWVDKALSLKHSFKQVVDNVYKA 120
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
ASN VDFQTKA EV+ EVN WAEKET+GL+KEVLP GSVDNSTRL+FANALYFKGAW E
Sbjct: 121 ASNNVDFQTKAVEVANEVNAWAEKETDGLIKEVLPSGSVDNSTRLVFANALYFKGAWTEK 180
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
FD+S TKD+DF+LLNG S+ PFMTSKK QF+ AF+GFKVLGLPY QG+DKR+FSMYFFL
Sbjct: 181 FDASITKDHDFYLLNGSSVHAPFMTSKKKQFIRAFEGFKVLGLPYYQGQDKRQFSMYFFL 240
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
PDAKDGLP L+EK+GSES FLDHHLP Q+VEVGDFRIPRF+ISFG E S+ LKGLGLVLP
Sbjct: 241 PDAKDGLPALVEKVGSESGFLDHHLPRQQVEVGDFRIPRFRISFGFEASEALKGLGLVLP 300
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKID 360
FSGE G L EMVDS VG+ LYVSSIF KSFIEVNEEGTEAAAASA + LRS+ SDKID
Sbjct: 301 FSGE-GDLTEMVDSSVGQKLYVSSIFHKSFIEVNEEGTEAAAASAGVIKLRSLAFSDKID 359
Query: 361 FVADHPFVFMIREDMTGLVMFTGHVLNP 388
FVADHPF+F+IRE+MTGLV+F GHVL P
Sbjct: 360 FVADHPFLFLIRENMTGLVLFIGHVLEP 387
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147810055|emb|CAN78278.1| hypothetical protein VITISV_021647 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 611 bits (1575), Expect = e-172, Method: Compositional matrix adjust.
Identities = 297/391 (75%), Positives = 337/391 (86%), Gaps = 2/391 (0%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
MD+R+ I NQ DVAL + KHVALTE+KDSNLV SP SIHV+LSL++AGSKG TLDQLLSF
Sbjct: 1 MDLRQCIGNQNDVALGIAKHVALTESKDSNLVLSPLSIHVVLSLVAAGSKGATLDQLLSF 60
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
LKSK++ LNAFASELV++VFADGSPSGGP LS ANGVWID++L LK +FKQ+VD YKA
Sbjct: 61 LKSKASGDLNAFASELVSLVFADGSPSGGPCLSFANGVWIDKTLPLKPSFKQIVDTAYKA 120
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
A +Q DF+ KAAEV+ E N WAEKETNGL+KEVLPPGSVD+STRLIFANALYFKGAWNE
Sbjct: 121 AVHQADFRIKAAEVTSEANSWAEKETNGLIKEVLPPGSVDSSTRLIFANALYFKGAWNEK 180
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
FD+S TKDYDFHLLNG S++VPFMTSKK Q +S FD FKVLGL YKQG DKR FSMYFFL
Sbjct: 181 FDASATKDYDFHLLNGSSVQVPFMTSKKKQLISTFDDFKVLGLSYKQGGDKRSFSMYFFL 240
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
PDAKDGL L++K+GS+S FLD HLPS V VGDFRIPRFKISFG E SKVLKGLGLVLP
Sbjct: 241 PDAKDGLQALIDKVGSDSAFLDRHLPSMPVPVGDFRIPRFKISFGFEASKVLKGLGLVLP 300
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKID 360
F+ GGL EMVDSP+G++LYVSSIF KSFIEVNEEGTEAAAAS V LR ++ +D ID
Sbjct: 301 FT--EGGLTEMVDSPMGQDLYVSSIFHKSFIEVNEEGTEAAAASVGVVKLRGMLSTDNID 358
Query: 361 FVADHPFVFMIREDMTGLVMFTGHVLNPLAG 391
F+ADHPF+F+IREDMTG+V+F GHVLNPLAG
Sbjct: 359 FIADHPFLFVIREDMTGVVLFIGHVLNPLAG 389
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359492076|ref|XP_002284126.2| PREDICTED: serpin-ZX [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 602 bits (1551), Expect = e-169, Method: Compositional matrix adjust.
Identities = 294/387 (75%), Positives = 333/387 (86%), Gaps = 2/387 (0%)
Query: 5 ESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSK 64
+ I NQ DVAL + KHVALTE+KDSNLV SP SIHV+LSL++AGSKG TLDQLLSFLKSK
Sbjct: 61 KCIGNQNDVALGIAKHVALTESKDSNLVLSPLSIHVVLSLVAAGSKGATLDQLLSFLKSK 120
Query: 65 SNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQ 124
++ LNAFASELV++VFADGSPSGGP LS ANGVWID++L LK +FKQ+VD YKAA +Q
Sbjct: 121 ASGDLNAFASELVSLVFADGSPSGGPCLSFANGVWIDKTLPLKPSFKQIVDTAYKAAVHQ 180
Query: 125 VDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSS 184
DF+ KAAEV+ E N WAEKETNGL+KEVLPPGSVD+STRLIFANALYFKGAWNE FD+S
Sbjct: 181 ADFRIKAAEVTSEANSWAEKETNGLIKEVLPPGSVDSSTRLIFANALYFKGAWNEKFDAS 240
Query: 185 KTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPDAK 244
TKDYDFHLLNG S++VPFMTSKK Q +S FD FKVLGL YKQG DKR FSMYFFLPDAK
Sbjct: 241 ATKDYDFHLLNGSSVQVPFMTSKKKQLISTFDDFKVLGLSYKQGGDKRSFSMYFFLPDAK 300
Query: 245 DGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGE 304
DGL L++K+GS+S FLD HLPS V VGDFRIPRFKISFG E SKVLKGLGLVLPF+
Sbjct: 301 DGLQALIDKVGSDSAFLDRHLPSMPVPVGDFRIPRFKISFGFEASKVLKGLGLVLPFT-- 358
Query: 305 GGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVAD 364
GGL EMVDSP+G++LYVSSIF KSFIEVNEEGTEAAAAS V LR ++ +D IDF+AD
Sbjct: 359 EGGLTEMVDSPMGQDLYVSSIFHKSFIEVNEEGTEAAAASVGVVKLRGMLSTDNIDFIAD 418
Query: 365 HPFVFMIREDMTGLVMFTGHVLNPLAG 391
HPF+F+IREDMTG+V+F GHVLNPLAG
Sbjct: 419 HPFLFVIREDMTGVVLFIGHVLNPLAG 445
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356510338|ref|XP_003523896.1| PREDICTED: serpin-ZX-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1489), Expect = e-162, Method: Compositional matrix adjust.
Identities = 290/391 (74%), Positives = 337/391 (86%), Gaps = 2/391 (0%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
MD+RESISNQTDVALS+TK + A+DSNLV+SP S+HV+LS+I++GSKGPTLDQLLSF
Sbjct: 1 MDLRESISNQTDVALSITKLLLSKNARDSNLVYSPLSLHVVLSIIASGSKGPTLDQLLSF 60
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
L+SKS D LN+FAS+LVAVV +D +P+GGPRLS A+GVW+++SLSL +FKQ+V YKA
Sbjct: 61 LRSKSTDHLNSFASQLVAVVLSDAAPAGGPRLSFADGVWVEQSLSLHPSFKQLVSAQYKA 120
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
VDFQTKA EV+ EVN WAEKETNGLVK++LPPGSVDNSTRLIFANALYFKGAWNE
Sbjct: 121 TLASVDFQTKAVEVTNEVNSWAEKETNGLVKDLLPPGSVDNSTRLIFANALYFKGAWNEK 180
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
FD+S TKDYDFHLLNG S+KVPFMTSKK QF+ AFD FKVLGLPYKQGEDKR+F+MYFFL
Sbjct: 181 FDASITKDYDFHLLNGSSVKVPFMTSKKKQFIMAFDSFKVLGLPYKQGEDKRQFTMYFFL 240
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
P+ KDGL L EK+ SES FL+ LP+Q+VEVGDFRIPRFKISFG EVS VLK LG+VLP
Sbjct: 241 PETKDGLLALAEKLASESGFLERKLPNQKVEVGDFRIPRFKISFGFEVSNVLKELGVVLP 300
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKID 360
FS GGL EMVDSPVG+NL VS+IF KSFIEVNEEGTEAAAA++AT+ LRS +L KID
Sbjct: 301 FS--VGGLTEMVDSPVGQNLCVSNIFHKSFIEVNEEGTEAAAATSATIRLRSAMLPTKID 358
Query: 361 FVADHPFVFMIREDMTGLVMFTGHVLNPLAG 391
FVADHPF+F+IRED+TG V+F G VL+P AG
Sbjct: 359 FVADHPFLFLIREDLTGTVLFIGQVLDPRAG 389
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224136672|ref|XP_002326917.1| predicted protein [Populus trichocarpa] gi|222835232|gb|EEE73667.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 556 bits (1433), Expect = e-156, Method: Compositional matrix adjust.
Identities = 286/388 (73%), Positives = 326/388 (84%), Gaps = 1/388 (0%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
MD+R+SI NQTDVALSL+K + LTE+ +SNLVFSP SI VLLSLI++GSKG TL+QLLSF
Sbjct: 1 MDLRDSIGNQTDVALSLSKQILLTESNNSNLVFSPLSIEVLLSLIASGSKGSTLEQLLSF 60
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
LKSKS+D L++F+S+L+AVV DGS SGGP+L ANGVW+D SLSLK +FKQVV + YKA
Sbjct: 61 LKSKSSDHLSSFSSQLLAVVLTDGSASGGPQLKFANGVWVDNSLSLKPSFKQVVGSTYKA 120
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
A+NQVDFQTKA EV+ EVN WAE ETNGL+KEVLP GSVD +TRLI NALYFKGAWNE
Sbjct: 121 ATNQVDFQTKAVEVTNEVNTWAENETNGLIKEVLPSGSVDRTTRLILTNALYFKGAWNEK 180
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
FD+S TKD DF+LLNGGS++VPFMTSKK QFV FDGFKVL LPYKQGEDKR+FSMYF+L
Sbjct: 181 FDASTTKDDDFYLLNGGSVRVPFMTSKKKQFVCDFDGFKVLALPYKQGEDKRKFSMYFYL 240
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
PDAKDGL L+EKM SES FLD HLP ++V+V DFRIPRFKISFG E S LKGLGLV P
Sbjct: 241 PDAKDGLQALVEKMVSESGFLDRHLPPKQVKVDDFRIPRFKISFGFEASNALKGLGLVSP 300
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKID 360
FS E L EMVDS G+ L VSSIF KSFIEVNEEGTEAAAASA + LR I + KID
Sbjct: 301 FSNE-ADLTEMVDSSAGQGLCVSSIFHKSFIEVNEEGTEAAAASAGVIALRGIDIPTKID 359
Query: 361 FVADHPFVFMIREDMTGLVMFTGHVLNP 388
FVADHPF+F+IREDMTG+VMF GHVL+P
Sbjct: 360 FVADHPFLFLIREDMTGVVMFVGHVLDP 387
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356519136|ref|XP_003528230.1| PREDICTED: serpin-ZX-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 551 bits (1420), Expect = e-154, Method: Compositional matrix adjust.
Identities = 282/390 (72%), Positives = 330/390 (84%), Gaps = 2/390 (0%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
MD+RESISNQTDVALS++K + EA+D NLV+SP S+HV+LS+I+AGSKGPTLDQLLSF
Sbjct: 1 MDLRESISNQTDVALSISKLLLSKEARDKNLVYSPLSLHVVLSIIAAGSKGPTLDQLLSF 60
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
L+SKS D LN+FAS+L AVV +D SP+GGPRLS A+GVW+++SLSL +FKQ+V YKA
Sbjct: 61 LRSKSTDHLNSFASQLFAVVLSDASPAGGPRLSFADGVWVEQSLSLLPSFKQLVSADYKA 120
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
VDFQTKA EV+ EVN WAEKETNGLVK++LPPGSVD+STRLIFANALYFKGAWNE
Sbjct: 121 TLASVDFQTKAVEVANEVNSWAEKETNGLVKDLLPPGSVDSSTRLIFANALYFKGAWNEK 180
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
FDSS TKDYDFHLL+G SI+VPFMTS+KNQF+ AFDGFKVLGLPYKQGEDKR+F+MYFFL
Sbjct: 181 FDSSITKDYDFHLLDGRSIRVPFMTSRKNQFIRAFDGFKVLGLPYKQGEDKRQFTMYFFL 240
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
P+ KDGL L EK+ SES FL+ LP+ ++EVGDFRIPRFKISFG E S VLK LG+VLP
Sbjct: 241 PETKDGLLALAEKLASESGFLERKLPNNKLEVGDFRIPRFKISFGFEASNVLKELGVVLP 300
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKID 360
FS GGL EMVDS VG+NL+VS IF KSFIEVNEEGTEAAAA+AAT+ + +ID
Sbjct: 301 FS--VGGLTEMVDSAVGQNLFVSDIFHKSFIEVNEEGTEAAAATAATIQFGCAMFPTEID 358
Query: 361 FVADHPFVFMIREDMTGLVMFTGHVLNPLA 390
FVADHPF+F+IRED+TG V+F G VLNP A
Sbjct: 359 FVADHPFLFLIREDLTGTVLFIGQVLNPQA 388
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|58416137|emb|CAI43280.1| serpin [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 533 bits (1372), Expect = e-149, Method: Compositional matrix adjust.
Identities = 262/389 (67%), Positives = 322/389 (82%), Gaps = 2/389 (0%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
MD+ E+I + +VA+++TKH+ L EAK SN+V SP SIHV+LSLI++GSKGP LDQLLSF
Sbjct: 1 MDIMETIRSHGEVAIAITKHLLLNEAKASNVVLSPLSIHVVLSLIASGSKGPPLDQLLSF 60
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
LKS S D LN+FAS++VA VFAD SPSGGPRLS ANGVW+D+SL LK++FKQVVD +YKA
Sbjct: 61 LKSNSTDNLNSFASQIVATVFADASPSGGPRLSFANGVWVDQSLPLKSSFKQVVDTLYKA 120
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
+Q DF+TKAAEV+ EVN WAEK+TNGL+ EVLPPGSVD+ ++LI ANALYFKG W E
Sbjct: 121 KLSQADFKTKAAEVTSEVNSWAEKQTNGLITEVLPPGSVDSLSKLILANALYFKGEWEEK 180
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
FD+SKTK DF+LL+G S++VPFMTSK Q ++AFDGFKVLGL YKQG D R FSMY FL
Sbjct: 181 FDASKTKKQDFYLLDGSSVEVPFMTSKNKQHIAAFDGFKVLGLSYKQGSDPRHFSMYIFL 240
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
PD++DGLP+L+E++ S+S F+D H+P ++++VG+F+IP+FKISFGIEVS VLKGLGLVLP
Sbjct: 241 PDSRDGLPSLIERLDSQSNFIDRHIPYEKLKVGEFKIPKFKISFGIEVSNVLKGLGLVLP 300
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKID 360
FS GGL EMV+S +NL+VS IF KSFIEVNEEGTEAAAASAA + LR + D ID
Sbjct: 301 FS--EGGLTEMVESQTAQNLHVSKIFHKSFIEVNEEGTEAAAASAAVIKLRGLPSMDIID 358
Query: 361 FVADHPFVFMIREDMTGLVMFTGHVLNPL 389
FVAD PF++ IRED TG ++F G VLNPL
Sbjct: 359 FVADRPFLYAIREDKTGSLLFIGQVLNPL 387
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449470035|ref|XP_004152724.1| PREDICTED: serpin-ZX-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 532 bits (1371), Expect = e-148, Method: Compositional matrix adjust.
Identities = 262/389 (67%), Positives = 322/389 (82%), Gaps = 2/389 (0%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
MD+ E+I + +VA+++TKH+ L EAK SN+V SP SIHV+LSLI++GSKGP LDQLLSF
Sbjct: 1 MDIMETIRSHGEVAIAITKHLLLNEAKASNVVLSPLSIHVVLSLIASGSKGPPLDQLLSF 60
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
LKS S D LN+FAS++VA VFAD SPSGGPRLS ANGVW+D+SL LK++FKQVVD +YKA
Sbjct: 61 LKSNSTDNLNSFASQIVATVFADASPSGGPRLSFANGVWVDQSLPLKSSFKQVVDTLYKA 120
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
+Q DF+TKAAEV+ EVN WAEK+TNGL+ EVLPPGSVD+ ++LI ANALYFKG W E
Sbjct: 121 KLSQADFKTKAAEVTSEVNSWAEKQTNGLITEVLPPGSVDSLSKLILANALYFKGEWEEK 180
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
FD+SKTK DF+LL+G S++VPFMTSK Q ++AFDGFKVLGL YKQG D R FSMY FL
Sbjct: 181 FDASKTKKQDFYLLDGSSVEVPFMTSKNKQRIAAFDGFKVLGLSYKQGSDPRHFSMYIFL 240
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
PD++DGLP+L+E++ S+S F+D H+P ++++VG+F+IP+FKISFGIEVS VLKGLGLVLP
Sbjct: 241 PDSRDGLPSLIERLDSQSNFIDRHIPYEKLKVGEFKIPKFKISFGIEVSNVLKGLGLVLP 300
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKID 360
FS GGL EMV+S +NL+VS IF KSFIEVNEEGTEAAAASAA + LR + D ID
Sbjct: 301 FS--EGGLTEMVESQTAQNLHVSKIFHKSFIEVNEEGTEAAAASAAVIKLRGLPSMDIID 358
Query: 361 FVADHPFVFMIREDMTGLVMFTGHVLNPL 389
FVAD PF++ IRED TG ++F G VLNPL
Sbjct: 359 FVADRPFLYAIREDKTGSLLFIGQVLNPL 387
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357465383|ref|XP_003602973.1| Serpin-like protein [Medicago truncatula] gi|355492021|gb|AES73224.1| Serpin-like protein [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 523 bits (1346), Expect = e-146, Method: Compositional matrix adjust.
Identities = 262/392 (66%), Positives = 332/392 (84%), Gaps = 4/392 (1%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
MD+RESI+NQT+V+LS+ KH+ ++ D+N+VFSP S+ V+LS+I++GS+GPT QL +F
Sbjct: 1 MDLRESIANQTNVSLSVAKHL-FSKESDNNIVFSPLSLQVVLSIIASGSEGPTQQQLFNF 59
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
L+SKS D LN FAS+LV+V+ +D SP+GGP LS +GVW+D++LSL+ +F+Q+V +KA
Sbjct: 60 LQSKSTDHLNYFASQLVSVILSDASPAGGPLLSFVDGVWVDQTLSLQPSFQQIVSTHFKA 119
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
A + VDFQ KA EV+ EVN WAEKETNGL+KE+LP GSV+N+TRLIFANALYFKGAWN+
Sbjct: 120 ALSSVDFQNKAVEVTNEVNSWAEKETNGLIKELLPLGSVNNATRLIFANALYFKGAWNDK 179
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
FD+SKT+DY+FHLLNG +KVPFMTSKK QF+ AFDGFKVLGLPYKQGEDKR+F+MYFFL
Sbjct: 180 FDASKTEDYEFHLLNGSPVKVPFMTSKKKQFIRAFDGFKVLGLPYKQGEDKRQFTMYFFL 239
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
P+AKDGL L+EK+ SES+ L H LP +VEVGDFRIP+F ISFG+E S +LK LG+VLP
Sbjct: 240 PNAKDGLAALVEKVASESELLQHKLPFGKVEVGDFRIPKFNISFGLETSDMLKELGVVLP 299
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIV-LSDKI 359
FS GGGL +MV+S V +NL VS+IF KSFIEVNEEGTEAAAA+AAT++LRS + + ++
Sbjct: 300 FS--GGGLTKMVNSSVSQNLCVSNIFHKSFIEVNEEGTEAAAATAATILLRSAMSIPPRL 357
Query: 360 DFVADHPFVFMIREDMTGLVMFTGHVLNPLAG 391
DFVADHPF+FMIRED+TG ++F G VLNPLAG
Sbjct: 358 DFVADHPFLFMIREDLTGTIIFVGQVLNPLAG 389
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 391 | ||||||
| TAIR|locus:2015443 | 391 | SERPIN1 "AT1G47710" [Arabidops | 0.992 | 0.992 | 0.603 | 1.6e-125 | |
| UNIPROTKB|Q10GX0 | 405 | LOC_Os03g41438 "Serpin-ZXB" [O | 0.984 | 0.950 | 0.513 | 2.6e-102 | |
| TAIR|locus:2059585 | 385 | CCP3 "AT2G25240" [Arabidopsis | 0.969 | 0.984 | 0.516 | 4.1e-97 | |
| TAIR|locus:2096910 | 393 | AT3G45220 "AT3G45220" [Arabido | 0.974 | 0.969 | 0.496 | 1.1e-96 | |
| TAIR|locus:2055185 | 407 | SRP2 "AT2G14540" [Arabidopsis | 0.739 | 0.710 | 0.517 | 1.3e-92 | |
| TAIR|locus:2024532 | 385 | SRP3 "AT1G64030" [Arabidopsis | 0.739 | 0.750 | 0.523 | 8e-91 | |
| TAIR|locus:2066316 | 389 | AT2G26390 "AT2G26390" [Arabido | 0.964 | 0.969 | 0.488 | 5.9e-89 | |
| TAIR|locus:2062400 | 374 | AT2G35580 "AT2G35580" [Arabido | 0.764 | 0.799 | 0.456 | 5.2e-77 | |
| UNIPROTKB|Q94DW6 | 411 | LOC_Os01g56010 "Serpin-Z1" [Or | 0.992 | 0.944 | 0.393 | 1.2e-74 | |
| UNIPROTKB|Q2R8P2 | 439 | LOC_Os11g11500 "Probable non-i | 0.943 | 0.840 | 0.382 | 1.2e-63 |
| TAIR|locus:2015443 SERPIN1 "AT1G47710" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1233 (439.1 bits), Expect = 1.6e-125, P = 1.6e-125
Identities = 236/391 (60%), Positives = 306/391 (78%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
MDVRESIS Q V+++L KHV T +++SN++FSP+SI+V+LS+I+AGS G T DQ+LSF
Sbjct: 1 MDVRESISLQNQVSMNLAKHVITTVSQNSNVIFSPASINVVLSIIAAGSAGATKDQILSF 60
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
LK S DQLN+F+SE+V+ V ADGS +GGP+LSVANG WID+SLS K +FKQ++++ YKA
Sbjct: 61 LKFSSTDQLNSFSSEIVSAVLADGSANGGPKLSVANGAWIDKSLSFKPSFKQLLEDSYKA 120
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
ASNQ DFQ+KA EV EVN WAEKETNGL+ EVLP GS D+ T+LIFANALYFKG WNE
Sbjct: 121 ASNQADFQSKAVEVIAEVNSWAEKETNGLITEVLPEGSADSMTKLIFANALYFKGTWNEK 180
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
FD S T++ +FHLL+G + PFMTSKK Q+VSA+DGFKVLGLPY QG+DKR+FSMYF+L
Sbjct: 181 FDESLTQEGEFHLLDGNKVTAPFMTSKKKQYVSAYDGFKVLGLPYLQGQDKRQFSMYFYL 240
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSXXXXXXXXXXP 300
PDA +GL LL+K+ S FLD+H+P ++V+V +F+IP+FK SFG + S P
Sbjct: 241 PDANNGLSDLLDKIVSTPGFLDNHIPRRQVKVREFKIPKFKFSFGFDASNVLKGLGLTSP 300
Query: 301 FSGEGGGLAEMVDSP-VGKNLYVSSIFQKSFIEVNEEGTEXXXXXXXTVVLRSIVLS-DK 358
FSGE G L EMV+SP +GKNL VS+IF K+ IEVNEEGTE + LR +++ D+
Sbjct: 301 FSGEEG-LTEMVESPEMGKNLCVSNIFHKACIEVNEEGTEAAAASAGVIKLRGLLMEEDE 359
Query: 359 IDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389
IDFVADHPF+ ++ E++TG+V+F G V++PL
Sbjct: 360 IDFVADHPFLLVVTENITGVVLFIGQVVDPL 390
|
|
| UNIPROTKB|Q10GX0 LOC_Os03g41438 "Serpin-ZXB" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 1014 (362.0 bits), Expect = 2.6e-102, P = 2.6e-102
Identities = 206/401 (51%), Positives = 278/401 (69%)
Query: 2 DVRESISNQTDVALSLTK-------HVAL---TEAKDSNLVFSPSSIHVLLSLISAGSKG 51
D+R SI++QT A L H A A SN+ FSP S+HV LSL++AG+ G
Sbjct: 7 DLRVSIAHQTRFAFRLAAALSSPRAHPAAGGAAGAGGSNVAFSPLSLHVALSLVAAGAGG 66
Query: 52 PTLDQLLSFLKSKSN---DQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKN 108
T DQL+S L + L+AFA ++V +V AD SP+GGPR++ A+GV+ID SLSL
Sbjct: 67 ATRDQLVSLLGVPGRGTAEGLHAFAEQVVQLVLADSSPAGGPRVAFADGVFIDSSLSLMK 126
Query: 109 TFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFA 168
+FK V YKA ++ VDFQTKAAEV+ +VN W ++ T+GL+KE+LPPGSVD++TRL+
Sbjct: 127 SFKDVAVGKYKAETHSVDFQTKAAEVASQVNSWVDRVTSGLIKEILPPGSVDHTTRLVLG 186
Query: 169 NALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQG 228
NALYFKGAW E FD+SKTKD +F LL+G S+ PFM++ K Q++S++D KVL LPY++G
Sbjct: 187 NALYFKGAWTEKFDASKTKDGEFRLLDGKSVLAPFMSTSKKQYLSSYDSLKVLKLPYQKG 246
Query: 229 EDKRRFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEV 288
D R+FSMY LP+A+DGL +L K+ SE +FL+ +P+++V VG F++P+FKISFG E
Sbjct: 247 RDLRQFSMYILLPEAQDGLWSLAAKLNSEPEFLEKRIPTRQVTVGKFKLPKFKISFGFEA 306
Query: 289 SXXXXXXXXXXPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEXXXXXXXTV 348
S PFS + L MV SP NL+VSS+F KSF++V+EEGTE V
Sbjct: 307 SDLLKILGLQLPFSSKAD-LTGMVGSPERHNLFVSSLFHKSFVQVDEEGTEAAAASAAVV 365
Query: 349 VLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389
RS ++ +DFVADHPF+F+IREDMTG+V+F GHV+NPL
Sbjct: 366 SFRSAPVT--VDFVADHPFLFLIREDMTGVVLFIGHVVNPL 404
|
|
| TAIR|locus:2059585 CCP3 "AT2G25240" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 965 (344.8 bits), Expect = 4.1e-97, P = 4.1e-97
Identities = 202/391 (51%), Positives = 264/391 (67%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
M++ +SI N DV + LTKHV T A SNLVFSP SI+VLLSLI+AGS T +Q+LSF
Sbjct: 1 MELGKSIENHNDVVVRLTKHVIATVANGSNLVFSPISINVLLSLIAAGSCSVTKEQILSF 60
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
L S D LN ++A + G+ RLS+ANGVWID+ SLK +FK +++N YKA
Sbjct: 61 LMLPSTDHLNL----VLAQIIDGGTEKSDLRLSIANGVWIDKFFSLKLSFKDLLENSYKA 116
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDN--STRLIFANALYFKGAWN 178
+QVDF +K +EV EVN WAE TNGL+K++L S+D S+ L+ ANA+YFKGAW+
Sbjct: 117 TCSQVDFASKPSEVIDEVNTWAEVHTNGLIKQILSRDSIDTIRSSTLVLANAVYFKGAWS 176
Query: 179 ETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYF 238
FD++ TK DFHLL+G S+KVPFMT+ ++Q++ ++DGFKVL LPY ED+R+FSMY
Sbjct: 177 SKFDANMTKKNDFHLLDGTSVKVPFMTNYEDQYLRSYDGFKVLRLPYI--EDQRQFSMYI 234
Query: 239 FLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSXXXXXXXXX 298
+LP+ K+GL LLEK+GSE F D+H+P + VG FRIP+FK SF S
Sbjct: 235 YLPNDKEGLAPLLEKIGSEPSFFDNHIPLHCISVGAFRIPKFKFSFEFNASEVLKDMGLT 294
Query: 299 XPFSGEGGGLAEMVDSPV-GKNLYVSSIFQKSFIEVNEEGTEXXXXXXXTVVLRSIVLSD 357
PF+ GGGL EMVDSP G +LYVSSI K+ IEV+EEGTE V S +
Sbjct: 295 SPFNN-GGGLTEMVDSPSNGDDLYVSSILHKACIEVDEEGTEAAAVSVGVVSCTSFRRNP 353
Query: 358 KIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
DFVAD PF+F +RED +G+++F G VL+P
Sbjct: 354 --DFVADRPFLFTVREDKSGVILFMGQVLDP 382
|
|
| TAIR|locus:2096910 AT3G45220 "AT3G45220" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 961 (343.3 bits), Expect = 1.1e-96, P = 1.1e-96
Identities = 197/397 (49%), Positives = 267/397 (67%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
M++ +S+ NQTDV + L KHV T A SNLVFSP SI+VLL LI+AGS T +Q+LSF
Sbjct: 1 MELGKSMENQTDVMVLLAKHVIPTVANGSNLVFSPMSINVLLCLIAAGSNCVTKEQILSF 60
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
+ S+D LNA ++ V+V DG LS A GVWID+SLS K +FK +++N Y A
Sbjct: 61 IMLPSSDYLNAVLAKTVSVALNDGMERSDLHLSTAYGVWIDKSLSFKPSFKDLLENSYNA 120
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDN--STRLIFANALYFKGAWN 178
NQVDF TK AEV EVN WAE TNGL+KE+L S+ + LI ANA+YFKGAW+
Sbjct: 121 TCNQVDFATKPAEVINEVNAWAEVHTNGLIKEILSDDSIKTIRESMLILANAVYFKGAWS 180
Query: 179 ETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYF 238
+ FD+ TK YDFHLL+G +KVPFMT+ K Q++ +DGFKVL LPY ED+R+F+MY
Sbjct: 181 KKFDAKLTKSYDFHLLDGTMVKVPFMTNYKKQYLEYYDGFKVLRLPYV--EDQRQFAMYI 238
Query: 239 FLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSXXXXXXXXX 298
+LP+ +DGLPTLLE++ S+ +FLD+H+P QR+ F+IP+FK SF + S
Sbjct: 239 YLPNDRDGLPTLLEEISSKPRFLDNHIPRQRILTEAFKIPKFKFSFEFKASDVLKEMGLT 298
Query: 299 XPFSGEGGGLAEMVDSP-------VGKNLYVSSIFQKSFIEVNEEGTEXXXXXXXTVVLR 351
PF+ G L EMV+SP V +NL+VS++F K+ IEV+EEGTE ++
Sbjct: 299 LPFTH--GSLTEMVESPSIPENLCVAENLFVSNVFHKACIEVDEEGTEAAAVSVASMTKD 356
Query: 352 SIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
+++ D FVADHPF+F +RE+ +G+++F G VL+P
Sbjct: 357 MLLMGD---FVADHPFLFTVREEKSGVILFMGQVLDP 390
|
|
| TAIR|locus:2055185 SRP2 "AT2G14540" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 773 (277.2 bits), Expect = 1.3e-92, Sum P(2) = 1.3e-92
Identities = 151/292 (51%), Positives = 203/292 (69%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQ-LLS 59
+D++E++ NQ +V+L L V AK+SN VFSP+SI+ +L++ +A + TL +LS
Sbjct: 29 IDMQEAMKNQNEVSLLLVGKVISAVAKNSNCVFSPASINAVLTVTAANTDNKTLRSFILS 88
Query: 60 FLKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYK 119
FLKS S ++ NA EL +VVF DGS +GGP+++ NGVW+++SLS ++ + N +K
Sbjct: 89 FLKSSSTEETNAIFHELASVVFKDGSETGGPKIAAVNGVWMEQSLSCNPDWEDLFLNFFK 148
Query: 120 AASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNE 179
A+ +VDF+ KA EV +VN WA + TN L+KE+LP GSV + T I+ NALYFKGAW +
Sbjct: 149 ASFAKVDFRHKAEEVRLDVNTWASRHTNDLIKEILPRGSVTSLTNWIYGNALYFKGAWEK 208
Query: 180 TFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGED--KRRFSMY 237
FD S T+D FHLLNG S+ VPFM S + QF+ A+DGFKVL LPY+QG D R FSMY
Sbjct: 209 AFDKSMTRDKPFHLLNGKSVSVPFMRSYEKQFIEAYDGFKVLRLPYRQGRDDTNREFSMY 268
Query: 238 FFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVS 289
+LPD K L LLE++ S FLD H+P RV+VGDFRIP+FKI FG E S
Sbjct: 269 LYLPDKKGELDNLLERITSNPGFLDSHIPEYRVDVGDFRIPKFKIEFGFEAS 320
|
|
| TAIR|locus:2024532 SRP3 "AT1G64030" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 784 (281.0 bits), Expect = 8.0e-91, Sum P(2) = 8.0e-91
Identities = 153/292 (52%), Positives = 208/292 (71%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLD-QLLS 59
MDVRE++ NQT VA+ L+ HV + KDSN++FSP+SI+ +++ +AG G + Q+LS
Sbjct: 1 MDVREAMKNQTHVAMILSGHVLSSAPKDSNVIFSPASINSAITMHAAGPGGDLVSGQILS 60
Query: 60 FLKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYK 119
FL+S S D+L EL +VV+AD S +GGP+++ ANG+WID+SL FK + +N +K
Sbjct: 61 FLRSSSIDELKTVFRELASVVYADRSATGGPKITAANGLWIDKSLPTDPKFKDLFENFFK 120
Query: 120 AASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNE 179
A VDF+++A EV +EVN W E TN L+K++LP GSV + T I+ANAL FKGAW
Sbjct: 121 AVYVPVDFRSEAEEVRKEVNSWVEHHTNNLIKDLLPDGSVTSLTNKIYANALSFKGAWKR 180
Query: 180 TFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGED--KRRFSMY 237
F+ T+D DF+L+NG S+ VPFM+S +NQ+V A+DGFKVL LPY++G D R+FSMY
Sbjct: 181 PFEKYYTRDNDFYLVNGTSVSVPFMSSYENQYVRAYDGFKVLRLPYQRGSDDTNRKFSMY 240
Query: 238 FFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVS 289
F+LPD KDGL LLEKM S FLD H+P+ R E+ FRIP+FKI FG V+
Sbjct: 241 FYLPDKKDGLDDLLEKMASTPGFLDSHIPTYRDELEKFRIPKFKIEFGFSVT 292
|
|
| TAIR|locus:2066316 AT2G26390 "AT2G26390" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 888 (317.7 bits), Expect = 5.9e-89, P = 5.9e-89
Identities = 194/397 (48%), Positives = 258/397 (64%)
Query: 1 MDVRESISNQTDVALSLTKHVALTE-AKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLS 59
M++ +SI NQ +V L K V T+ A SN+VFSP SI+VLLSLI+AGS T +++LS
Sbjct: 1 MELGKSIENQNNVVARLAKKVIETDVANGSNVVFSPMSINVLLSLIAAGSNPVTKEEILS 60
Query: 60 FLKSKSNDQLNAFASELVAVVFADGSPSGGPR-LSVANGVWIDESLSLKNTFKQVVDNVY 118
FL S S D LNA +++ ADG LS A+GVWID+S LK +FK++++N Y
Sbjct: 61 FLMSPSTDHLNAVLAKI-----ADGGTERSDLCLSTAHGVWIDKSSYLKPSFKELLENSY 115
Query: 119 KAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVD------NSTRLIFANALY 172
KA+ +QVDF TK EV EVN+WA+ TNGL+K++L D NST LI ANA+Y
Sbjct: 116 KASCSQVDFATKPVEVIDEVNIWADVHTNGLIKQILSRDCTDTIKEIRNST-LILANAVY 174
Query: 173 FKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKR 232
FK AW+ FD+ TKD DFHLL+G ++KVPFM S K+Q++ +DGF+VL LPY EDKR
Sbjct: 175 FKAAWSRKFDAKLTKDNDFHLLDGNTVKVPFMMSYKDQYLRGYDGFQVLRLPYV--EDKR 232
Query: 233 RFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSXXX 292
FSMY +LP+ KDGL LLEK+ +E FLD H+P R V RIP+ SF + S
Sbjct: 233 HFSMYIYLPNDKDGLAALLEKISTEPGFLDSHIPLHRTPVDALRIPKLNFSFEFKASEVL 292
Query: 293 XXXXXXXPFSGEGGGLAEMVDSPV-GKNLYVSSIFQKSFIEVNEEGTEXXXXXXXTVVLR 351
PF+ +G L EMVDSP G L+VSSI K+ IEV+EEGTE ++ +
Sbjct: 293 KDMGLTSPFTSKGN-LTEMVDSPSNGDKLHVSSIIHKACIEVDEEGTEAAAVSVAIMMPQ 351
Query: 352 SIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
++ + DFVADHPF+F +RED +G+++F G VL+P
Sbjct: 352 CLMRNP--DFVADHPFLFTVREDNSGVILFIGQVLDP 386
|
|
| TAIR|locus:2062400 AT2G35580 "AT2G35580" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 666 (239.5 bits), Expect = 5.2e-77, Sum P(2) = 5.2e-77
Identities = 141/309 (45%), Positives = 197/309 (63%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPT--LDQLL 58
MD+ ESI Q + L + V D L + I+V+LS+I+A S G T D+++
Sbjct: 1 MDLEESIEKQYKAMMDLKESVG--NQNDIVLRLTAPLINVILSIIAASSPGDTDTADKIV 58
Query: 59 SFLKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVY 118
S L++ S D+L+A +SE+V V AD + SGGP +S ANG+WI+++L+++ +FK ++ N Y
Sbjct: 59 SLLQASSTDKLHAVSSEIVTTVLADSTASGGPTISAANGLWIEKTLNVEPSFKDLLLNSY 118
Query: 119 KAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLP--PGSVDNSTRLIFANALYFKGA 176
KAA N+VDF+TKA EV+REVN W EK+TNGL+ +LP P S T IFANAL+F G
Sbjct: 119 KAAFNRVDFRTKADEVNREVNSWVEKQTNGLITNLLPSNPKSAP-LTDHIFANALFFNGR 177
Query: 177 WNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQG-EDKRRFS 235
W+ FD S TKD DFHLL+G ++VPFMT ++ ++GFKV+ L Y++G ED R FS
Sbjct: 178 WDSQFDPSLTKDSDFHLLDGTKVRVPFMTGASCRYTHVYEGFKVINLQYRRGREDSRSFS 237
Query: 236 MYFFLPDAKDGLPTLLEKMGSESKFL-DHH-LPSQRVEVGDFRIPRFKISFGIEVSXXXX 293
M +LPD KDGLP++LE++ S FL D+ LPS + + +IPRFK F E S
Sbjct: 238 MQIYLPDEKDGLPSMLERLASTRGFLKDNEVLPSHSAVIKELKIPRFKFDFAFEASEALK 297
Query: 294 XXXXXXPFS 302
P S
Sbjct: 298 GFGLVVPLS 306
|
|
| UNIPROTKB|Q94DW6 LOC_Os01g56010 "Serpin-Z1" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 753 (270.1 bits), Expect = 1.2e-74, P = 1.2e-74
Identities = 160/407 (39%), Positives = 234/407 (57%)
Query: 1 MDVRESISNQTDVALSLTKHVALTE---AKDSNLVFSPSSIHVLLSLISAGSKGPTLDQL 57
M++ E++ ++T +A+ L H+A D NL SP S+H L+L+ AG++G TLDQ+
Sbjct: 1 MELAEAVRDETAMAMRLLGHLARAPRGGGGDKNLAVSPLSLHAALALLGAGARGETLDQI 60
Query: 58 LSFLKSKSNDQLNAFASELVAVVFAD----GSPSGGPRLSVANGVWIDESLSLKNTFKQV 113
++FL A AS + AD G GGP++ ANGVW+D +L LK + +V
Sbjct: 61 IAFLGPAGGPAHAALASHVALCSLADDSGPGDDRGGPKVRFANGVWVDAALRLKAAYARV 120
Query: 114 VDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYF 173
V + Y+A + V F+ K E RE+N W E T G +K+ LP +VD +T + NALYF
Sbjct: 121 VADKYRAEARPVSFRDKLEEARREINEWFESATAGRIKDFLPKDAVDRATPAVLGNALYF 180
Query: 174 KGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQG----- 228
KG W FD+ T D F+L +GG + PFM+S K Q+++ G+KVL LPY +G
Sbjct: 181 KGDWESKFDARSTSDDVFYLPDGGHVSAPFMSSGKWQYIACRAGYKVLRLPYARGGRGRG 240
Query: 229 -EDKRRFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPS--QRVEVGDFRIPRFKISFG 285
+ R FSMY +LPD + GLP +L K+ S+ L + ++V VG F +PRF +S+
Sbjct: 241 RDTGRLFSMYIYLPDERHGLPDMLRKLCSDPAALIESSAALTEKVPVGAFMVPRFTLSYK 300
Query: 286 IEVSXXXXXXXXXXPFSGEGGGLAEMVDS-PVGKNLYVSSIFQKSFIEVNEEGTEXXXXX 344
+ PF G L+EMV+S P + + VS+++ +SF+EVNEEGTE
Sbjct: 301 TNAAETLRQLGLRLPFEYPGADLSEMVESSPEAEKIVVSAVYHESFVEVNEEGTEAAAAT 360
Query: 345 XXTVVLRSIVLSDKI---DFVADHPFVFMIREDMTGLVMFTGHVLNP 388
+ L S + DFVADHPF+F+I+ED+TG+V+F G V NP
Sbjct: 361 AVVMTLGCAAPSAPVHVVDFVADHPFMFLIKEDLTGVVVFAGQVTNP 407
|
|
| UNIPROTKB|Q2R8P2 LOC_Os11g11500 "Probable non-inhibitory serpin-Z9" [Oryza sativa Japonica Group (taxid:39947)] | Back alignment and assigned GO terms |
|---|
Score = 649 (233.5 bits), Expect = 1.2e-63, P = 1.2e-63
Identities = 148/387 (38%), Positives = 219/387 (56%)
Query: 10 QTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFL------KS 63
Q L L V L A N S ++HV L+L + G++G T Q+L L +
Sbjct: 59 QRAFCLPLAGRV-LAAAGTGNAAVSAPAVHVSLALAAGGARGATRRQVLQALGCGGGGRG 117
Query: 64 KSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASN 123
+ D N AS +V V D S SGGPRL+ A GVW D S SL F + NVY +A+
Sbjct: 118 GAADAANV-ASRVVKRVLRDRSTSGGPRLAFAGGVWADASRSLSPEFVGLAGNVYGSAAK 176
Query: 124 QVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDS 183
+ DF+ K + ++N W + T G V +LP G++D +T L+ +ALYF+G W + D
Sbjct: 177 KADFKNKPEDAPDQINSWVKDSTKGTVTTLLPAGTIDQNTGLVLGSALYFRGRWLDRDDL 236
Query: 184 SKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPDA 243
+T + F+ L+G S++VPF+ + + + D FKV+ LPYKQG+++R+FSMY FLPD
Sbjct: 237 RRTTEQKFYCLDGTSVEVPFVEYDRTRLFAVHDNFKVIKLPYKQGKNERKFSMYIFLPDD 296
Query: 244 KDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSXXXXXXXXXXPFSG 303
DGL L +K+ SE FL+ HLP+++ VG +P FKISF I+V PF
Sbjct: 297 HDGLFELTQKIFSEPMFLEQHLPTEKCHVG-ISVPNFKISFQIDVKDFLKDMGLELPFLR 355
Query: 304 EGGGLAEMV--DSPVGKNLYVSSIFQKSFIEVNEEGTEXXXXXXXTVVLRSIVLSDKIDF 361
E ++M+ D G L++S + K+ +EV+++G E ++ L + + F
Sbjct: 356 EAE-FSDMIKEDDSSGP-LFLSDVLHKAVLEVDQKGIEETSV---SMGLGKPLPAQH--F 408
Query: 362 VADHPFVFMIREDMTGLVMFTGHVLNP 388
ADHPF FMIRE+++G V+F GHVL+P
Sbjct: 409 KADHPFFFMIREEVSGTVIFMGHVLDP 435
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| P93693 | SPZ1B_WHEAT | No assigned EC number | 0.5153 | 0.9897 | 0.9699 | N/A | no |
| P93692 | SPZ2B_WHEAT | No assigned EC number | 0.5398 | 0.9897 | 0.9723 | N/A | no |
| Q9S7T8 | SPZX_ARATH | No assigned EC number | 0.6368 | 0.9923 | 0.9923 | yes | no |
| Q41593 | SPZ1A_WHEAT | No assigned EC number | 0.5089 | 0.9897 | 0.9723 | N/A | no |
| P06293 | SPZ4_HORVU | No assigned EC number | 0.5190 | 0.9820 | 0.9624 | N/A | no |
| Q40066 | SPZX_HORVU | No assigned EC number | 0.5620 | 0.9820 | 0.9648 | N/A | no |
| Q9ST57 | SPZ2A_WHEAT | No assigned EC number | 0.5269 | 0.9897 | 0.9723 | N/A | no |
| Q9ST58 | SPZ1C_WHEAT | No assigned EC number | 0.5218 | 0.9897 | 0.9723 | N/A | no |
| Q75H81 | SPZXA_ORYSJ | No assigned EC number | 0.5801 | 0.9846 | 0.9722 | yes | no |
| Q90935 | NEUS_CHICK | No assigned EC number | 0.3164 | 0.9309 | 0.8878 | yes | no |
| Q10GX0 | SPZXB_ORYSJ | No assigned EC number | 0.5411 | 0.9846 | 0.9506 | yes | no |
| Q43492 | BSZ7_HORVU | No assigned EC number | 0.5012 | 0.9769 | 0.9622 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
No EC number assignment, probably not an enzyme!
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00014745001 | SubName- Full=Putative uncharacterized protein (Chromosome chr18 scaffold_1, whole genome shotgun sequence); (389 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 391 | |||
| cd02043 | 381 | cd02043, plant_SERPIN, SERine Proteinase INhibitor | 0.0 | |
| pfam00079 | 369 | pfam00079, Serpin, Serpin (serine protease inhibit | 1e-115 | |
| cd00172 | 364 | cd00172, SERPIN, SERine Proteinase INhibitors (ser | 1e-101 | |
| smart00093 | 359 | smart00093, SERPIN, SERine Proteinase INhibitors | 1e-88 | |
| cd02059 | 389 | cd02059, ovalbumin_like, The ovalbumin_like group | 2e-67 | |
| cd02049 | 364 | cd02049, bacterial_SERPIN, SERine Proteinase INhib | 6e-67 | |
| cd02058 | 380 | cd02058, PAI-2, Plasminogen Activator Inhibitor-2 | 8e-65 | |
| cd02048 | 388 | cd02048, neuroserpin, Neuroserpin is a inhibitory | 6e-63 | |
| COG4826 | 410 | COG4826, COG4826, Serine protease inhibitor [Postt | 7e-63 | |
| cd02045 | 381 | cd02045, antithrombin-III_like, Antithrombin is a | 8e-59 | |
| cd02044 | 370 | cd02044, ov-serpin, ovalbumin family of serpins (o | 2e-54 | |
| cd02056 | 361 | cd02056, alpha-1-antitrypsin_like, alpha-1-antitry | 7e-46 | |
| cd02051 | 377 | cd02051, PAI-1_nexin-1, Plasminogen activator inhi | 7e-45 | |
| cd02047 | 436 | cd02047, HCII, Heparin cofactor II (HCII) inhibits | 3e-36 | |
| cd02057 | 372 | cd02057, maspin_like, Maspin (mammary serine prote | 5e-35 | |
| cd02055 | 365 | cd02055, PZI, Protein Z-dependent protease inhibit | 2e-31 | |
| cd02052 | 374 | cd02052, PEDF, Pigment epithelium-derived factor ( | 2e-31 | |
| cd02050 | 352 | cd02050, C1_inh, C1 inhibitor (C1-Inh) is a protea | 2e-26 | |
| cd02053 | 351 | cd02053, alpha2AP, Alpha2-antiplasmin (alpha2AP) i | 6e-26 | |
| cd02046 | 366 | cd02046, hsp47, Heat shock protein 47 (Hsp47), als | 7e-21 | |
| PHA02948 | 373 | PHA02948, PHA02948, serine protease inhibitor-like | 2e-19 | |
| PHA02660 | 364 | PHA02660, PHA02660, serpin-like protein; Provision | 2e-10 | |
| cd02054 | 372 | cd02054, angiotensinogen, Angiotensinogen is part | 7e-07 |
| >gnl|CDD|238998 cd02043, plant_SERPIN, SERine Proteinase INhibitors (serpins), plant specific subgroup | Back alignment and domain information |
|---|
Score = 541 bits (1396), Expect = 0.0
Identities = 233/383 (60%), Positives = 293/383 (76%), Gaps = 4/383 (1%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSND 67
NQ VA+ L+ HVA K SN++FSP SI+V LSL++AG++G TLDQLLSFL S S D
Sbjct: 1 KNQCLVAMRLSGHVAAAAGKGSNVIFSPLSINVALSLVAAGARGETLDQLLSFLGSPSTD 60
Query: 68 QLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDF 127
+L+A A+ +V +V AD S SGGPRLS ANGVW+D+SLSLK +FK + N YKA + VDF
Sbjct: 61 ELHAVAASIVDLVLADASASGGPRLSFANGVWVDKSLSLKPSFKDLAANSYKAEARPVDF 120
Query: 128 QTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTK 187
+TKA EV REVN W EK TNGL+K++LPPGSVD+ST+L+ ANALYFKGAW+ FD+S TK
Sbjct: 121 RTKAEEVRREVNSWVEKATNGLIKDILPPGSVDSSTKLVLANALYFKGAWSSKFDASDTK 180
Query: 188 DYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQG--EDKRRFSMYFFLPDAKD 245
D DFHLL+G S++VPFM+S+K+Q+V+AFDGFKVL LPYK+G +D R+FSMY +LPD KD
Sbjct: 181 DRDFHLLDGTSVRVPFMSSEKDQYVAAFDGFKVLRLPYKRGGHDDARQFSMYIYLPDKKD 240
Query: 246 GLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEG 305
GL LLEK+ SE FLD H+P+ EVG F IP+FK SFG E S+VLK LGL LPF G
Sbjct: 241 GLADLLEKLVSEPGFLDRHIPASEQEVGAFMIPKFKFSFGFEASEVLKKLGLTLPFDPGG 300
Query: 306 GGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADH 365
L + SP G+NLYVSS++ K+ +EV+EEGTEAAAA+A + S +DFVADH
Sbjct: 301 ALL--SMSSPEGENLYVSSVYHKACVEVDEEGTEAAAATAVVMSGTSSPPPRPVDFVADH 358
Query: 366 PFVFMIREDMTGLVMFTGHVLNP 388
PF+F+IRED TG+V+F G V+NP
Sbjct: 359 PFLFLIREDKTGVVLFLGQVMNP 381
|
It has been suggested that plant serpins play a role in defense against insect predators. This subgroup corresponds to clade P of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 381 |
| >gnl|CDD|215699 pfam00079, Serpin, Serpin (serine protease inhibitor) | Back alignment and domain information |
|---|
Score = 340 bits (874), Expect = e-115
Identities = 148/388 (38%), Positives = 219/388 (56%), Gaps = 26/388 (6%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK--SKS 65
D A L K ++ E+ D N+ FSP SI L+++ G++G T +QLLS L
Sbjct: 1 EANNDFAFDLYKQLSK-ESPDKNIFFSPLSISTALAMLYLGARGETAEQLLSVLGFPELD 59
Query: 66 NDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQV 125
+++++ L++ + P G L +AN +++D+ L LK F Q++ Y A V
Sbjct: 60 DEEIHEGFQSLLSSLN---KPDKGYTLKIANRLFVDKGLKLKPDFLQLLKKYYGAEVESV 116
Query: 126 DFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSK 185
DF A E +++N W EK+TNG +K++LP GS+D TRL+ NA+YFKG W FD
Sbjct: 117 DFSDPA-EARKQINSWVEKKTNGKIKDLLPEGSLDPDTRLVLVNAIYFKGKWKTPFDPEL 175
Query: 186 TKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFLPD 242
TK+ FH+ NG ++KVP M S++ F A D G KVL LPY K SM LPD
Sbjct: 176 TKEEPFHVDNGTTVKVPMM-SQEGTFRYAEDEELGCKVLELPY-----KGNLSMLIILPD 229
Query: 243 AKDGLPTLLEKMGSE--SKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
GL L + + +E ++L P + E + +P+FKI ++ +VLK LG+
Sbjct: 230 EGGGLEELEKSLTAELLEEWLSSLKPRKVRE--ELYLPKFKIESSYDLKEVLKKLGITDA 287
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKID 360
FS + + + S + LYVS + K+FIEVNEEGTEAAAA+ +V R+ +
Sbjct: 288 FSSK-ADFSGISSS---EPLYVSKVVHKAFIEVNEEGTEAAAATGVVIVPRA--PPPPPE 341
Query: 361 FVADHPFVFMIREDMTGLVMFTGHVLNP 388
FVAD PF+F+IR++ TG ++F G V+NP
Sbjct: 342 FVADRPFLFLIRDNSTGSILFMGRVVNP 369
|
Structure is a multi-domain fold containing a bundle of helices and a beta sandwich. Length = 369 |
| >gnl|CDD|238101 cd00172, SERPIN, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms | Back alignment and domain information |
|---|
Score = 304 bits (782), Expect = e-101
Identities = 139/386 (36%), Positives = 198/386 (51%), Gaps = 31/386 (8%)
Query: 9 NQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQ 68
D AL L K +A D N+VFSP SI L+L+ G+ G T +QL L
Sbjct: 1 ANNDFALDLYKQLAK-SEPDENVVFSPLSIASALALLYLGAGGETREQLRKVL------G 53
Query: 69 LNAFASELVAVVFAD-----GSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASN 123
L + E V F G L +AN +++ + L++K F + Y A
Sbjct: 54 LPSLDDEDVHQAFKSLLSSLKDSEKGVELKLANRLFVQKGLTVKEDFLDLAKKYYDAEVE 113
Query: 124 QVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDS 183
VDF + ++N W E++TNG +K++L P ++D TRL+ NA+YFKG W FD
Sbjct: 114 SVDFANPE-AAAAQINNWVEEKTNGKIKDLLSPDALDPDTRLVLVNAIYFKGKWKTPFDP 172
Query: 184 SKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFL 240
T+ F++ G S++VP M + +F A D +VL LPYK SM L
Sbjct: 173 ELTRKRPFYVSEGESVQVPMM-YQTGKFRYAEDEELDAQVLELPYK----GSDLSMLIIL 227
Query: 241 PDAKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVL 299
P GL L EK+ +E L +L + VEV +P+FKI +++ +VL+ LG+
Sbjct: 228 PKEVTGLAELEEKLSAEKLDDLLSNLKEREVEV---TLPKFKIESSLDLKEVLQALGITD 284
Query: 300 PFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKI 359
FS + D P LYVS + K+FIEVNEEGTEAAAA+A V + S +
Sbjct: 285 LFSPSADLSSISSDEP----LYVSKVIHKAFIEVNEEGTEAAAATA--VSIVPRRPSPPV 338
Query: 360 DFVADHPFVFMIREDMTGLVMFTGHV 385
+F AD PF+F+IR+D TG ++F G V
Sbjct: 339 EFKADRPFLFLIRDDTTGTILFLGRV 364
|
Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 364 |
| >gnl|CDD|214513 smart00093, SERPIN, SERine Proteinase INhibitors | Back alignment and domain information |
|---|
Score = 271 bits (696), Expect = 1e-88
Identities = 133/381 (34%), Positives = 203/381 (53%), Gaps = 29/381 (7%)
Query: 15 LSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK----SKSNDQLN 70
L K +A E+ D N+ FSP SI L+++S G+KG T Q+L L S ++
Sbjct: 1 FDLYKELAK-ESPDKNIFFSPVSISSALAMLSLGAKGSTATQILEVLGFNLTETSEADIH 59
Query: 71 AFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTK 130
L+ ++ P L AN +++D+SL LK++F + + +Y A VDF K
Sbjct: 60 QGFQHLLHLLNR---PDSQLELKTANALFVDKSLKLKDSFLEDIKKLYGAEVQSVDFSDK 116
Query: 131 AAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYD 190
A E +++N W EK+T G +K++L +D+ TRL+ NA+YFKG W FD T++ D
Sbjct: 117 AEEAKKQINDWVEKKTQGKIKDLLSD--LDSDTRLVLVNAIYFKGKWKTPFDPELTREED 174
Query: 191 FHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFLPDAKDGL 247
FH+ ++KVP M+ F D +VL LPY K SM LPD + GL
Sbjct: 175 FHVDETTTVKVPMMSQTGRTFNYGHDEELNCQVLELPY-----KGNASMLIILPD-EGGL 228
Query: 248 PTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGG 307
L + + E L + S + +P+FKI ++ VL+ LG+ FS +
Sbjct: 229 EKLEKALTPE--TLKKWMKSLTKRSVELYLPKFKIEGTYDLKDVLEKLGITDLFSNK-AD 285
Query: 308 LAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPF 367
L+ + + K+L VS + K+ +EVNEEGTEAAAA+ V RS+ +F A+ PF
Sbjct: 286 LSGISED---KDLKVSKVLHKAVLEVNEEGTEAAAATGVIAVPRSLPP----EFKANRPF 338
Query: 368 VFMIREDMTGLVMFTGHVLNP 388
+F+IR++ TG ++F G V+NP
Sbjct: 339 LFLIRDNKTGSILFMGKVVNP 359
|
Length = 359 |
| >gnl|CDD|239014 cd02059, ovalbumin_like, The ovalbumin_like group of serpins contains ovalbumin, the squamous cell carcinoma antigen 1 (SCCA1) and other closely related serpins of clade B of the serpin superfamily | Back alignment and domain information |
|---|
Score = 218 bits (557), Expect = 2e-67
Identities = 126/384 (32%), Positives = 189/384 (49%), Gaps = 35/384 (9%)
Query: 26 AKDSNLVFSPSSIHVLLSLISAGSKGPTL---------DQLLSFLKSKSNDQLNAFASEL 76
K+ N+ FSP SI L ++ G++ T D SK S
Sbjct: 20 HKNKNIFFSPLSISSALGMVLLGARDDTAAQIEKVLHFDHASGSGSSKPAASAQCNQSGG 79
Query: 77 VAVVFAD-----GSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKA 131
V F D P+ LS+AN ++ +++ + V+ +Y+A VDFQ A
Sbjct: 80 VHSQFKDLLSQINKPNDDYELSIANRLYGEKTYPFHQEYLDCVEKLYRAKLEPVDFQNAA 139
Query: 132 AEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDF 191
+++N W E +TNG +K + G++D+ST L+ NA+YFKG W + F+ T D F
Sbjct: 140 EASRKKINSWVESQTNGKIKNLFGKGTIDSSTVLVLVNAIYFKGKWEKKFEKENTVDAPF 199
Query: 192 HLLNGGSIKVPFMTSKKNQFVSAF---DGFKVLGLPYKQGEDKRRFSMYFFLPDAKDGLP 248
LN K M + +F A K+L LPY G SM LPD GL
Sbjct: 200 K-LNENENKPVQMMYQIGKFKLASIEEPKMKILELPYAGG----GLSMIVLLPDEISGLE 254
Query: 249 TLLEKMGSESKFLD----HHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGE 304
L K+ E K ++ ++ ++VEV +PRFK+ + VLK +G+ FS
Sbjct: 255 QLESKLTYE-KLMEWTSSENMRERKVEV---YLPRFKLEEKYNLKSVLKAMGMTDIFSES 310
Query: 305 GGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVAD 364
L+ + S K+LY+S KS++EVNEEGTEAAAA+ A +V +S+ +S+ +F AD
Sbjct: 311 KADLSGISSS---KSLYLSKAIHKSYVEVNEEGTEAAAATGAGIVEKSLPVSE--EFRAD 365
Query: 365 HPFVFMIREDMTGLVMFTGHVLNP 388
HPF+F IR + T ++F G +P
Sbjct: 366 HPFLFFIRHNKTNTILFFGRFSSP 389
|
Ovalbumin, the major protein component of avian egg white, is a non-inhibitory member of SERine Proteinase INhibitorS (serpins). In contrast, SCCA1 inhibits cysteine proteinases such as cathepsin S, K, L, and papain, a so called cross-class serpin. Length = 389 |
| >gnl|CDD|239004 cd02049, bacterial_SERPIN, SERine Proteinase INhibitors (serpins), prokaryotic subgroup | Back alignment and domain information |
|---|
Score = 216 bits (551), Expect = 6e-67
Identities = 121/379 (31%), Positives = 192/379 (50%), Gaps = 16/379 (4%)
Query: 7 ISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN 66
T L + E + N+ SP SI + LS+ G+ G T ++L L N
Sbjct: 2 NDANTRFGFKLFSELN-KEDVEKNIFISPLSIALALSMTYNGADGTTRKEMLKALG-LDN 59
Query: 67 DQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVD 126
L S L ++ + L +AN +WI+ +LK F Q + + Y+A ++D
Sbjct: 60 IDLEDLNSALATLMDQLNTHDKTVELIIANSIWIEPGFTLKPDFLQTIKDYYQAYVLELD 119
Query: 127 FQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKT 186
FQ+ AA + E+N W +++T G + +++ +D + NA+YFKG W E FD T
Sbjct: 120 FQSPAA--AEEINRWVKEKTKGKIDKIVDK--IDPDDVMFLINAVYFKGDWQEPFDKQST 175
Query: 187 KDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPDAKDG 246
+ F+L +G + +VPFM+ N GF+ + LPY G R SMY FLP
Sbjct: 176 YEAPFYLPDGSTKEVPFMSRTGNFRYLETPGFQAVRLPYGDG----RLSMYVFLPKENVS 231
Query: 247 LPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGG 306
L ++ + +E K+ + R+ G +PRF++ + IE+ LK LG+ F+ +
Sbjct: 232 LREFVKTLTAE-KWRKW-IEQFRMREGSLSLPRFQLEYEIELRDALKALGMEEAFTPDAA 289
Query: 307 GLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHP 366
+++ NLY+S + K+FIEVNEEGTEAAAA++ + S + VAD P
Sbjct: 290 DFSKLG----EGNLYISKVIHKTFIEVNEEGTEAAAATSVEITETSAPAGEPFTMVADRP 345
Query: 367 FVFMIREDMTGLVMFTGHV 385
F+F IR++ TG ++F G V
Sbjct: 346 FLFAIRDNRTGSILFMGAV 364
|
Little information about specific functions is available for this subgroup, most likely they are inhibitory members of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors. Length = 364 |
| >gnl|CDD|239013 cd02058, PAI-2, Plasminogen Activator Inhibitor-2 (PAI-2) | Back alignment and domain information |
|---|
Score = 211 bits (538), Expect = 8e-65
Identities = 128/390 (32%), Positives = 202/390 (51%), Gaps = 27/390 (6%)
Query: 11 TDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQL---LSFLKSKSN- 66
T AL+L K +A + N+ FSP SI L+++ G+KG T Q+ L F + N
Sbjct: 6 TSFALNLFKKLA-ESSPTKNIFFSPWSISSALAMVYLGAKGNTAAQMAKVLQFNEVGGNS 64
Query: 67 DQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVD 126
+ +++ L++ + G+ L AN ++ +++ F Q+ Y+A VD
Sbjct: 65 EDIHSGFQSLLSEINKPGTNY---LLKSANRLYGEKTYPFLEKFLQLTQKYYQAEPQAVD 121
Query: 127 FQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKT 186
F A + +E+N W E++T G ++ +LPPGSVD+ TRL+ NA+YFKG W E F T
Sbjct: 122 FVEAAEQARKEINSWVERQTEGKIQNLLPPGSVDSLTRLVLVNAIYFKGNWEEKFLKENT 181
Query: 187 KDYDFHLLNGGSIKVPFMTSKKNQFVSAFDG---FKVLGLPYKQGEDKRRFSMYFFLPDA 243
++ F L + V M K +F + +VL LPY E SM+ LPD
Sbjct: 182 RERPFRLNKNTTKPVQMM-FLKKKFPITYIEELKAQVLELPYVGKE----LSMFILLPDE 236
Query: 244 KDGLPTLLEKMGSE---SKFLDHHLPS--QRVEVGDFRIPRFKISFGIEVSKVLKGLGLV 298
+ + T LEK+ E K + P + EV + +P+FK+ ++ L +G+
Sbjct: 237 IEDVTTGLEKLEKELTYEKLNEWTSPEMMEEYEV-EVYLPKFKLEESYDLKSTLSSMGME 295
Query: 299 LPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDK 358
F + M + +L++S +F K+F+EVNEEGTEAAAA+AA ++LR ++ S
Sbjct: 296 DAFDPGKADFSGMSSA---NDLFLSKVFHKAFVEVNEEGTEAAAATAAIMMLRCLMPS-- 350
Query: 359 IDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
F ADHPF+F IR + T ++F G +P
Sbjct: 351 PRFNADHPFLFFIRHNKTNTILFFGRFCSP 380
|
PAI-2 is a serine protease inhibitor that belongs to the ov-serpin branch of the serpin superfamily. It is is an effective inhibitor of urinary plasminogen activator (urokinase or uPA) and is involved in cell differentiation, tissue growth and regeneration. Length = 380 |
| >gnl|CDD|239003 cd02048, neuroserpin, Neuroserpin is a inhibitory member of the SERine Proteinase INhibitor (serpin) family that reacts preferentially with tissue-type plasminogen activator (tPA) | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 6e-63
Identities = 119/390 (30%), Positives = 189/390 (48%), Gaps = 31/390 (7%)
Query: 11 TDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLN 70
++++ L + ++ +D N++FSP S + L ++ G+KG L ++ L
Sbjct: 5 AELSVDLYNALRASK-EDENIIFSPLSTALALGMVELGAKGSALKEIRHSLGYDGLKNGE 63
Query: 71 AFA--SELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQ 128
F+ +L +++ A ++AN +++ +K F Q + AA VDF
Sbjct: 64 EFSFLKDLSSMITAKEKEY---VFNLANSLYLQNGFHVKEKFLQSNKKYFNAAVKLVDFS 120
Query: 129 TKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKD 188
A V+ +N W E TN +K++ TRL+ NALYFKG W F T+
Sbjct: 121 QVKA-VAEHINKWVENHTNNKIKDMFSSRDFTPLTRLVLVNALYFKGNWKSQFRPENTRT 179
Query: 189 YDFHLLNGGSIKVPFMT--------SKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
+ F + +++P M + A ++VL LPY+ E S+ L
Sbjct: 180 FSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLELPYEGDE----ISLMIIL 235
Query: 241 PDAKDGLPTLLEKMGSES--KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLV 298
+ L T LE + + + + Q+VEV +PRFK+ I++ VLK LG+
Sbjct: 236 SRQEVPLAT-LEPLVKAPLIEEWANSVKKQKVEV---YLPRFKVEQKIDLKDVLKNLGIT 291
Query: 299 LPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDK 358
FSG G L+ + DS K LYVS +F K F+EVNEEG+EAAA+S + R VL +
Sbjct: 292 EIFSG-GADLSGISDS---KELYVSKVFHKVFLEVNEEGSEAAASSGMIAISRMAVLYPQ 347
Query: 359 IDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
+ DHPF F+IR TG ++F G V++P
Sbjct: 348 --VIVDHPFFFLIRNRRTGSILFMGRVMHP 375
|
It is located in neurons in regions of the brain where tPA is also found, suggesting that neuroserpin is the selective inhibitor of tPA in the central nervous system (CNS). This subgroup corresponds to clade I of the serpin superfamily. Length = 388 |
| >gnl|CDD|227163 COG4826, COG4826, Serine protease inhibitor [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Score = 206 bits (526), Expect = 7e-63
Identities = 113/378 (29%), Positives = 177/378 (46%), Gaps = 20/378 (5%)
Query: 14 ALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLS-FLKSKSNDQLNAF 72
A L +A E + N++FSP S+ +++ G++G T +Q+ + F + L
Sbjct: 46 AFDLYSELAKQEGEAENILFSPYSVSAAMAMCYEGAEGSTKEQMSNVFYFPINKTVLKVR 105
Query: 73 ASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAA 132
L + SP+ L AN +W+ E LK + V N Y A +DF K
Sbjct: 106 EKSLNDKIN---SPNDSYELETANALWVQEDYPLKENYVNNVRNYYDAEVTNLDFVNKPD 162
Query: 133 EVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFH 192
+N W E++TNG +K+++P + TRL+ NA+YF G W FD T F+
Sbjct: 163 ASRDTINKWVEEKTNGKIKDLVPEDYIGPDTRLVLTNAIYFNGKWWPEFDKQMTGKRTFY 222
Query: 193 LLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPDAKDGLPTLLE 252
G V M+ + K++ LPYK + SMY LP KD T E
Sbjct: 223 PAKGEDKSVDMMSICGDFNYGETSKAKIVELPYKGDD----LSMYIVLP--KDNNITEFE 276
Query: 253 KMGSESKF--LDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAE 310
+ K+ L ++ Q + + IP+FK E+ L +G+V F +
Sbjct: 277 NNFTLEKYTELKSNMEDQ--DEVEVEIPKFKFETKTELKDALIEMGVVDAFENT-ANFSG 333
Query: 311 MVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFM 370
+ D L +S +F ++FI+V+EEGTEAAAA+A ++FV DHPF+F+
Sbjct: 334 ISDRR----LEISDVFHQAFIDVDEEGTEAAAATAVVFKAVCAKGG-WVEFVVDHPFLFV 388
Query: 371 IREDMTGLVMFTGHVLNP 388
I + +G ++F G V+NP
Sbjct: 389 IEDRRSGCILFIGKVVNP 406
|
Length = 410 |
| >gnl|CDD|239000 cd02045, antithrombin-III_like, Antithrombin is a serine proteinase inhibitor (serpin) which controls the process of coagulation | Back alignment and domain information |
|---|
Score = 195 bits (497), Expect = 8e-59
Identities = 125/381 (32%), Positives = 201/381 (52%), Gaps = 21/381 (5%)
Query: 14 ALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF-----LKSKSNDQ 68
AL+ KH+A +++ D N+ SP SI ++ G+ TL+QL+ + K++DQ
Sbjct: 13 ALAFYKHLADSKSNDENIFLSPLSISTAFAMTKLGACNNTLEQLMEVFQFDTISEKTSDQ 72
Query: 69 LNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQ 128
++ F ++L ++ + S L AN ++ D+SL+ T++ + + VY A +DF+
Sbjct: 73 VHFFFAKLNCRLYRKANKSS--ELISANRLFGDKSLTFNETYQDISEIVYGAKLWPLDFK 130
Query: 129 TKAAEVSRE-VNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTK 187
K E+SR +N W +T + +V+P G++D +T L+ NA+YFKG W FD T+
Sbjct: 131 EKP-ELSRITINEWIANKTENRITDVIPEGAIDTNTVLVLVNAIYFKGLWKSKFDKENTR 189
Query: 188 DYDFHLLNGGSIKVPFMTSKKNQFVSAF---DGFKVLGLPYKQGEDKRRFSMYFFLPDAK 244
FH G VP M + +F A D +VL LPYK G+D +M LP
Sbjct: 190 KDLFHKAPGEKCPVPMMYQES-KFRYAKIPEDKVQVLELPYK-GDD---ITMVLILPKEG 244
Query: 245 DGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGE 304
L + + + + L L + + +IPRF++ V + L+ +GL FS E
Sbjct: 245 TTLSEVEQNLTLDK--LQGWLDAMKETTLAVQIPRFRVEDSFSVKEQLQKMGLEDLFSPE 302
Query: 305 GGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVAD 364
L +V +LYVS F K+F+EVNEEG+EA+AA+A + RS+ + ++I FVA+
Sbjct: 303 NAKLPGIVAGG-RTDLYVSDAFHKAFLEVNEEGSEASAATAVVITGRSLNI-NRIIFVAN 360
Query: 365 HPFVFMIREDMTGLVMFTGHV 385
PF+ IRE ++F G V
Sbjct: 361 RPFLLFIREVAINAIIFMGRV 381
|
It is the most important anticoagulant molecule in mammalian circulation systems, controlled by its interaction with the co-factor, heparin, which accelerates its interaction with target proteases, such as thrombin and factor Xa. This subgroup corresponds to clade C of the serpin superfamily. Length = 381 |
| >gnl|CDD|238999 cd02044, ov-serpin, ovalbumin family of serpins (ov-serpins) | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 2e-54
Identities = 106/380 (27%), Positives = 185/380 (48%), Gaps = 23/380 (6%)
Query: 14 ALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFA 73
A+ + K ++ A N+ FSP +I L+++ G+KG T +Q+ L D +
Sbjct: 9 AVDVFKELSKKSA-LQNVFFSPIAIMSSLAMVYLGAKGSTANQIGKVLHF---DNVKDVH 64
Query: 74 SELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAE 133
S ++ + L + N ++ ++ + F Y VDF+ KA E
Sbjct: 65 SSFQTLLSDINKLNSFYSLKLVNRLYGEKRYNFLPEFLSSTKKPYAKELETVDFKDKAEE 124
Query: 134 VSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHL 193
++N W + +T G ++ +LP SVD+ T ++ NA YFKG W + F +TK+ F +
Sbjct: 125 TRGQINSWIKDQTKGKIENLLPENSVDSQTAMVVVNAAYFKGKWMKKFSEEETKESPFRV 184
Query: 194 LNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGEDKRRFSMYFFLPDAKDGLPTLL 251
+ V M + + + K+L LP+ + SM+ LPD GL L
Sbjct: 185 NKTETKPVQMMYMEATFNMGNIESLKMKILELPFANKD----LSMFILLPDEVTGLEKLE 240
Query: 252 EKMGSE--SKFLDHHLPSQR-VEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGL 308
++ E +K+ ++ V+V +PRFK+ ++ VL+ LG+ FS
Sbjct: 241 SEINYEKLNKWTSPSTMAEAKVKV---YLPRFKMEKMYDLKSVLESLGMKDAFSEGRANF 297
Query: 309 AEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFV 368
+ M ++ K L +S++ K+ +E+NE+GTEAA + A ++ RS+ K +F ADHPF+
Sbjct: 298 SGMSET---KGLALSNVIHKASLEINEDGTEAAEVTGAVMLQRSV----KEEFNADHPFL 350
Query: 369 FMIREDMTGLVMFTGHVLNP 388
F+IR + T ++F G +P
Sbjct: 351 FIIRHNKTNCILFFGKFSSP 370
|
Family of closely related proteins, whose members can be secreted (ovalbumin), cytosolic (leukocyte elastase inhibitor, LEI), or targeted to both compartments (plasminogen activator inhibitor 2, PAI-2). This subgroup corresponds to clade B of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants can cause blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 370 |
| >gnl|CDD|239011 cd02056, alpha-1-antitrypsin_like, alpha-1-antitrypsin_like | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 7e-46
Identities = 107/388 (27%), Positives = 195/388 (50%), Gaps = 42/388 (10%)
Query: 11 TDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLS---F-LKSKSN 66
D A L + +A +E+ N+ FSP SI L+++S G++ TL Q+L F L S
Sbjct: 3 ADFAFRLYRQLA-SESPSKNIFFSPVSISTALAMLSLGARSSTLAQILEGLGFNLTEISE 61
Query: 67 DQLN-AFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQV 125
++++ F L + P G +L++ N +++D+ L + F + V ++Y++ +
Sbjct: 62 EEIHQGFQHLLHLL----NQPDSGLQLNMGNALFLDKRLKPLDKFLEDVKHLYESEAFST 117
Query: 126 DFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSK 185
DFQ +AE +++N + EK+T+G + +++ +D+ T ++ N +YFKG W + FD
Sbjct: 118 DFQ-DSAEAKKQINDYVEKKTHGKIVDLVK--DLDSDTVMVLVNYIYFKGKWEKPFDPEL 174
Query: 186 TKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFLPD 242
T++ DF + ++KVP M + ++ D V+ +PYK + +F LPD
Sbjct: 175 TQEEDFFVDEKTTVKVPMM-HQTGRYDYLHDSELSCTVVQMPYKGN-----ATAFFVLPD 228
Query: 243 AKDGLPTLLEKMGSE---SKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVL 299
+G +E S K+ L + V++ +P+F IS + +L +G+
Sbjct: 229 --EGKMKQVEAALSRDTLKKWSK-LLSKRSVDL---YLPKFSISGTYNLKDILPKMGITD 282
Query: 300 PFSGEG--GGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSD 357
FS + G+ E NL VS K+ ++V+E+GTEAAAA+ + S +
Sbjct: 283 VFSDKADLSGITE------QPNLKVSKAVHKAVLDVDEKGTEAAAATGVEITPMSALPPI 336
Query: 358 KIDFVADHPFVFMIREDMTGLVMFTGHV 385
+ F + PF+ +I + T ++F G V
Sbjct: 337 -LKF--NRPFLLLIFDRTTESILFLGKV 361
|
This family contains a variety of different members of clade A of the serpin superfamily. They include the classical serine proteinase inhibitors, alpha-1-antitrypsin and alpha-1-antichymotrypsin, protein C inhibitor, kallistatin, and noninhibitory serpins, like corticosteroid and thyroxin binding globulins. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. Length = 361 |
| >gnl|CDD|239006 cd02051, PAI-1_nexin-1, Plasminogen activator inhibitor-1_like | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 7e-45
Identities = 111/390 (28%), Positives = 176/390 (45%), Gaps = 36/390 (9%)
Query: 11 TDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLN 70
+D + + VA N+V SP I +L ++ G+ G T QL + ++ K N
Sbjct: 12 SDFGIQVFNQVAQAR-PQENVVVSPHGIASVLGMLQLGADGKTKKQLQTVMRYKINGVAK 70
Query: 71 AFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTK 130
A A+V S ++ AN V+ ++ F V++ VDF
Sbjct: 71 ALKKLNKAIV----SKKNKDIVTTANAVFAQSGFKMEVPFVPRNKEVFQCEVKSVDFSDP 126
Query: 131 AAEVSREVNMWAEKETNGLVKEVLPPGSVDNS-TRLIFANALYFKGAWNETFDSSKTKDY 189
+ +N W + ET G++ +L P D++ TRL+ NALYFKG W F TK
Sbjct: 127 ET-AAFSINDWVKNETKGMIDNLLSPDLADDALTRLVLVNALYFKGLWKSRFQPESTKKR 185
Query: 190 DFHLLNGGSIKVPFMTSKKNQF----VSAFDG--FKVLGLPYKQGEDKRRFSMYFFLPDA 243
FH +G + +VP M ++ + F S +G + ++ LPY GE SM LP
Sbjct: 186 TFHAGDGKTYQVP-MLAQLSVFRSGSASTPNGLWYNIIELPY-HGES---ISMLIALPTE 240
Query: 244 KDG-----LPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLV 298
K +P + K Q V +P+F + ++ + LK LG+
Sbjct: 241 KSTPLSAIIPHISTKTIQSWMGTMVPKRMQLV------LPKFTVEAETDLKEPLKALGIT 294
Query: 299 LPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDK 358
F ++ S ++L+VS QK+ IEVNE+GT+A+AA+ A ++ R S
Sbjct: 295 DMFDQSKANFTKISRS---ESLHVSHALQKAKIEVNEDGTKASAATTAILIAR----SSP 347
Query: 359 IDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
F+ D PF+F IR + TG ++F G + P
Sbjct: 348 PWFIVDRPFLFFIRHNPTGTILFMGQINKP 377
|
Plasminogen activator inhibitor-1 (PAI-1) is the primary, fast-acting inhibitor of plasminogen activators. It is often bound to vitronectin, an abundant component of the extracellular matrix in many tissues. Protease nexin-1 is a potent serpin able to inhibit thrombin, plasmin, and plasminogen activators. PAI-1 and nexin-1 are members of the serpin superfamily and represent clade E. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 377 |
| >gnl|CDD|239002 cd02047, HCII, Heparin cofactor II (HCII) inhibits thrombin, the final protease of the coagulation cascade | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 3e-36
Identities = 111/370 (30%), Positives = 177/370 (47%), Gaps = 34/370 (9%)
Query: 30 NLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFAS-ELVAV--VFADGS- 85
N++ +P I + +IS G KG T +Q+LS L K D +NA + E+ V +F +
Sbjct: 89 NILLAPVGISTAMGMISLGLKGQTQEQVLSTLGFK--DFVNASSKYEITTVHNLFRKLTH 146
Query: 86 ----PSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMW 141
+ G L N ++I + + FK V Y A + DF A + N
Sbjct: 147 RLFRRNFGYTLRSVNDLYIKKDFPILLDFKNNVKTYYFAEAQIADFSDPAFIT--KTNNR 204
Query: 142 AEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKV 201
+K T GL+KE L +VD +T ++ N +YFKG W F T + +F L +KV
Sbjct: 205 IQKLTKGLIKEALE--NVDPATLMMILNCIYFKGTWENKFPVEMTHNRNFRLNEKEVVKV 262
Query: 202 PFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFLPDAKDGLPTLLEKMGSES 258
P M +K N F++A D +L LPY SM +P G+ TL +++
Sbjct: 263 PMMQTKGN-FLAAADPELDCDILQLPYVGN-----ISMLIVVPHKLSGMKTLEKQI--TP 314
Query: 259 KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGK 318
+ ++ S + +P+FK+ + + LK +G+ F+ E G +A + D +
Sbjct: 315 QVVERWQKSMTNRTREVVLPKFKLEKNYNLIESLKLMGITDLFT-EKGNMAGVSDEKIAI 373
Query: 319 NLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGL 378
+L+ + I VNEEGTEAAA + + + LS ++ F+ D PF+F+I E T
Sbjct: 374 DLFK----HQGTITVNEEGTEAAAVT----TVGFMPLSTQVRFIVDRPFLFLIYEHRTNC 425
Query: 379 VMFTGHVLNP 388
++F G V NP
Sbjct: 426 LLFMGRVANP 435
|
HCII is allosterically activated by binding to cell surface glycosaminoglycans (GAGs). The specificity of HCII for thrombin is conferred by a highly acidic hirudin-like N-terminal tail, which becomes available after GAG binding for interaction with the anion-binding exosite I of thrombin. This subgroup corresponds to clade D of the serpin superfamily. Length = 436 |
| >gnl|CDD|239012 cd02057, maspin_like, Maspin (mammary serine proteinase inhibitor), a member of the serpin superfamily, with a multitude of effects on cells and tissues at an assortment of developmental stages | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 5e-35
Identities = 109/392 (27%), Positives = 182/392 (46%), Gaps = 39/392 (9%)
Query: 11 TDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQL---LSFLKSKSND 67
T A+ L K + E N+VFSP + L+L G+KG T +++ L F K
Sbjct: 6 TAFAVDLFKKLCEKEPTG-NVVFSPICLSTSLALAQVGAKGDTANEIGKVLHFENVKDVP 64
Query: 68 QLNAFASELVAVVFADGSP-SGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVD 126
F + V +D S S L + +++D+SL+L F Y VD
Sbjct: 65 ----FGFQTVT---SDVSKLSSFYSLKLIKRLYVDKSLNLSTDFINSTKRPYPKELETVD 117
Query: 127 FQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKT 186
F+ K E ++N ++ T+G + +L SV++ T+++ NA YF G W + F S+T
Sbjct: 118 FKDKLEETRGQINNSIKELTDGHFENILNENSVNDQTKILVVNAAYFVGNWMKKFPESET 177
Query: 187 KDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFK--VLGLPYKQGEDKRRFSMYFFLP--- 241
K+ F + + V M + + D +L LP++ + SM LP
Sbjct: 178 KECPFRVNKTETKPVQMMNLEATFSMGYIDELNTKILELPFQN----KHLSMLILLPKDI 233
Query: 242 -DAKDGLPTLLEKMGSESKFLDHHLPS----QRVEVGDFRIPRFKISFGIEVSKVLKGLG 296
D GL L +++ SE PS +V+V +P+FK+ I++ +L+ LG
Sbjct: 234 EDESTGLEKLEKQLTSE-SLSQWTNPSMMANAKVKV---SLPKFKVEKMIDLKAMLESLG 289
Query: 297 LVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLS 356
L F+ + + M ++ K + +S++ K +EVNE+G E+ A +L
Sbjct: 290 LKHIFNEDASDFSGMSET---KGVALSNVIHKVCLEVNEDGGESIEVPGAR------ILQ 340
Query: 357 DKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
K +F ADHPF+F+IR + T ++F G +P
Sbjct: 341 HKDEFNADHPFIFIIRHNKTRNIIFFGRFCSP 372
|
Maspin has tumor suppressing activity against breast and prostate cancer. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 372 |
| >gnl|CDD|239010 cd02055, PZI, Protein Z-dependent protease inhibitor (ZPI) is a member of the serpin superfamily of proteinase inhibitors (clade A10) | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 108/377 (28%), Positives = 173/377 (45%), Gaps = 52/377 (13%)
Query: 28 DSNLVFSPSSIHVLLSLISAGSKGPTLDQL-----LSFLKSKSNDQLNAFASELVAVVFA 82
D N++FSP + + ++ + ++G T Q+ L LK + L A L +
Sbjct: 22 DGNIIFSPFGMSLAMAGLLLAAEGETERQIAKALHLHALKDRDPGLLPALFKGLKDNI-- 79
Query: 83 DGSPSGGPRLSVANGV--WIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNM 140
S L G+ +I + +K F + + +DFQ A++ +N
Sbjct: 80 ----SRNEELGFTQGIFAFIHKDFDVKEAFFNLSKQYFDMECLCMDFQN-ASQAKFLINH 134
Query: 141 WAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIK 200
+KET G + E+ +D ++LI + ++FKG W FD T+ FH+ SIK
Sbjct: 135 NIKKETKGKIPELFD--EIDPESKLILLDYIFFKGKWLTPFDPEFTEIDTFHIDKYKSIK 192
Query: 201 VPFMTSKKNQFVSAFD-GFK--VLGLPYKQGEDKRRFSMYFFLPDAKDGLPTLLEKMGSE 257
VP M ++F S FD F+ V+ LPYK + +M + EK
Sbjct: 193 VPMMF-GADKFASTFDENFRCHVIKLPYKG-----KATMLIVIM----------EKGEDH 236
Query: 258 SKFLDHHLPSQRVEVG---------DFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGL 308
L+ HL VE D P+FK+ E+ ++L+ LG+ F+ L
Sbjct: 237 LA-LEDHLTMDLVESWLANMKSRNMDIFFPKFKLDQKYEMHELLRALGIKNIFA-PFADL 294
Query: 309 AEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFV 368
+E+ GK+L VS + QK+ IEV+E+GTEAAAA + ++ S+ K+ D PF
Sbjct: 295 SEL--LADGKHLQVSQVLQKAVIEVDEKGTEAAAAIGSEIIAFSMPPVIKV----DRPFH 348
Query: 369 FMIREDMTGLVMFTGHV 385
FMI E+ G+++F G V
Sbjct: 349 FMIFEETFGMLLFIGRV 365
|
ZPI inhibits coagulation factor Xa , dependent on protein Z (PZ), a vitamin K-dependent plasma protein. ZPI also inhibits factor XIa in a process that does not require PZ. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Length = 365 |
| >gnl|CDD|239007 cd02052, PEDF, Pigment epithelium-derived factor (PEDF)_like | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 97/378 (25%), Positives = 165/378 (43%), Gaps = 58/378 (15%)
Query: 29 SNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSK--SNDQLNAFASELVAVVFADGSP 86
+N+ SP SI LS +S G+ T Q+ L ++ +L+ +L+A + A
Sbjct: 37 ANVFLSPLSIATALSQLSLGAGERTESQIHRALYYDLLNDPELHDTYKDLLASLTAPAK- 95
Query: 87 SGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA-----ASNQVDFQTKAAEVSREVNMW 141
L A+ + ++ L L+ F V+ Y A N +D Q E+N W
Sbjct: 96 ----GLKSASRILLERKLRLRLEFVNQVEKSYGERPRILAGNALDLQ--------EINDW 143
Query: 142 AEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKV 201
+++T G V + + + ++ + YFKG W FD T DFHL ++ V
Sbjct: 144 VQQQTGGKVDRFVK--EIPRNVSILLLGSAYFKGQWITKFDKRNTVLTDFHLDEQRTVVV 201
Query: 202 PFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFLPDAKDGLPTLLEKMGSES 258
P M+ D K+ LP G S+ FFLPD TL+E+ S
Sbjct: 202 PMMSDPNAPVRYGLDSDLNCKIAQLPLTGG-----VSIMFFLPDKVTQNLTLIEE-SLTS 255
Query: 259 KF---LDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSP 315
+F +D L + + +P+ K+S+ E+ L+ L L + SP
Sbjct: 256 EFVHDIDRELKTVKA---VLTLPKLKLSYETELLPSLQEL-----------KLQSLFASP 301
Query: 316 -----VGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFM 370
K + +S + K+ +E+NE+G E A + + L+ +++ D PF+F+
Sbjct: 302 DFTKITSKPIKLSHVHHKAVLELNEDGAETAPTPGS-----ATALTFPLEYHVDRPFLFV 356
Query: 371 IREDMTGLVMFTGHVLNP 388
+R++ TG ++F G VL+P
Sbjct: 357 LRDEDTGALLFIGKVLDP 374
|
PEDF is non-inhibitory member of the Serpin superfamily. It exhibits neurotrophic, neuroprotective and antiangiogenic properties and is widely expressed in the developing and adult nervous systems. This subgroup corresponds to clade F1 of the serpin superfamily. Length = 374 |
| >gnl|CDD|239005 cd02050, C1_inh, C1 inhibitor (C1-Inh) is a protease inhibitor of the serpin family | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-26
Identities = 99/384 (25%), Positives = 170/384 (44%), Gaps = 45/384 (11%)
Query: 12 DVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNA 71
+ +L L +H++ + D+NL+FSP SI +LLS + G++G T +L S L +
Sbjct: 4 EFSLKLYQHLSESAKPDTNLLFSPVSIALLLSHLLLGARGKTQRRLESIL---------S 54
Query: 72 FASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKA 131
+ + V A L A+ ++ L L+ +F YKA ++ +
Sbjct: 55 YPHDFACVHSALKKLKNKLGLLSASQIFHHPDLHLRESFTNESWQFYKARPREL---SNN 111
Query: 132 AEVSRE-VNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYD 190
+E++ E +N W K TN + +L S+ + TRL+ NA+YF+ W + FD+ T
Sbjct: 112 SELNLEMINSWVAKATNNKIPRLL--DSLPSETRLVLLNAVYFQAQWKKKFDTKHTVLLP 169
Query: 191 FHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFLPDAKDGL 247
F NG +KVP M SKK S D +V L G S+ +P G
Sbjct: 170 FK-RNGDPVKVPVMYSKKYPVASFTDPRLKAQVGRLELSGG-----LSLVVLVP---RGP 220
Query: 248 PTLLEKMG---SESKFLD--HHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLV-LPF 301
LE + + FL + + + + +PR K+ +++ ++ LGL L
Sbjct: 221 KEDLEAVERALTPPAFLAMLEKMAANTPQRTEVTLPRIKLDLAVDMVALMHKLGLFGLFL 280
Query: 302 SGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDF 361
GL + L V + ++ + + E+G EAAAA+A + ++
Sbjct: 281 DANLCGLYQ------DPELAVDAAQHRAVLTLTEKGVEAAAATATSFARTALSFE----- 329
Query: 362 VADHPFVFMIREDMTGLVMFTGHV 385
A PF+F++ +D + +F G V
Sbjct: 330 -ALQPFLFVLWDDQAKVPLFMGRV 352
|
It plays a pivotal role in regulating the activation of the classical complement pathway and of the contact system, via regulating bradykinin formation, inhibiting factor XII and kallikrein of the contact system, and via acting on factor XI in the coagulation cascade. This subgroup corresponds to clade G of the serpin superfamily. Length = 352 |
| >gnl|CDD|239008 cd02053, alpha2AP, Alpha2-antiplasmin (alpha2AP) is the primary inhibitor of plasmin, a proteinase that digests fibrin, the main component of blood clots | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 6e-26
Identities = 95/366 (25%), Positives = 165/366 (45%), Gaps = 38/366 (10%)
Query: 25 EAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFADG 84
E+ NL+ SP SI + LS ++ G++ T +LL L ++S L+ S L +
Sbjct: 19 ESTKPNLILSPLSIALALSHLALGAQNETEQRLLKTLHAESLPCLHHLLSRLRQDL---- 74
Query: 85 SPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEK 144
G L +A +++ + +K +F + + +Y + V + +N W ++
Sbjct: 75 ---GPGALRLATRMYLQKGFEIKESFLEESEKLY--GAKPVSLTGTKEDDLANINKWVKE 129
Query: 145 ETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFM 204
T G + L + + T L+ NA++FKG W FD S T+ FHL + ++ V M
Sbjct: 130 ATEGQIPNFL--SDLPHDTVLLLLNAIHFKGFWRNKFDPSLTQRDAFHLDDDFTVSVEMM 187
Query: 205 TSKKNQF----VSAFDGFKVLGLPYKQGEDKRRFSMYFFLPDAKDG-LPTLLEKMGSESK 259
+ + + +V P+K S +P + +L +
Sbjct: 188 QASTYPLRWFHLEQPEI-QVAKFPFKGN-----MSFVVLMPTPFTWNVSQVLANL----N 237
Query: 260 FLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKN 319
+ D + + ++P+ K+ + +E+++ L LGL F L+ + D P
Sbjct: 238 WDDLYRRLPKERPTKVKLPKLKLDYQLELNEALSQLGLQELFQAP--DLSGISDEP---- 291
Query: 320 LYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLV 379
L+VSS+ +S +E++E+G E ASAAT V S LS F + PF+F I ED GL
Sbjct: 292 LFVSSVQHQSTLELSEKGVE---ASAATSVATSRSLS---SFSVNRPFLFFIFEDTMGLP 345
Query: 380 MFTGHV 385
+F G V
Sbjct: 346 LFMGSV 351
|
Alpha2-Antiplasmin forms an inactive 1 : 1 stoichiometric complex with plasmin. It also rapidly crosslinks to fibrin during blood clotting by activated coagulation factor XIII, and as a consequence fibrin becomes more resistant to fibrinolysis. Therefore alpha2AP is important in modulating the effectiveness and persistence of fibrin with respect to its susceptibility to digestion and removal by plasmin. This subgroup corresponds to clade F2 of the serpin superfamily. Length = 351 |
| >gnl|CDD|239001 cd02046, hsp47, Heat shock protein 47 (Hsp47), also called colligin, because of its collagen binding ability, is a chaperone specific for procollagen | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 7e-21
Identities = 83/378 (21%), Positives = 164/378 (43%), Gaps = 26/378 (6%)
Query: 11 TDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSK--SNDQ 68
+A +L H + N++ SP + L L+S G K T Q + L + ++
Sbjct: 8 AGLAFNLY-HAMAKDKGVENILLSPVVVASSLGLVSMGGKASTASQAKAVLSADKLKDEH 66
Query: 69 LNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQ 128
++ SEL+ V S + + N ++ S+S + F + Y ++++F+
Sbjct: 67 VHTGLSELLNEV--SNSTARNVTWKIGNRLYGPSSVSFADDFVKNSKKHYNYEHSKINFR 124
Query: 129 TKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKD 188
K + + +N WA + T+G + EV V+ + + NA++FK W+E F +
Sbjct: 125 DKRSAL-NSINEWAAQTTDGKLPEVTK--DVEKTDGALIVNAMFFKPHWDEKFHHKMVDN 181
Query: 189 YDFHLLNGGSIKVPFM--TSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPDAKDG 246
F + ++ VP M T + + +++ +P + SM F +P +
Sbjct: 182 RGFMVTRSYTVSVPMMHRTGLYGYYDDEENKLQIVEMPLAH----KLSSMIFIMPYHVEP 237
Query: 247 LPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEG 305
L L + + E K + + V + +P+ + ++ K L LGL
Sbjct: 238 LERLEKLLTREQLKTWISKMKKRAVAIS---LPKVSLEVSHDLQKHLGDLGLTEAIDKSK 294
Query: 306 GGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADH 365
L+++ K+LY+S++F + +E + EG +R+ L F ADH
Sbjct: 295 ADLSKISGK---KDLYLSNVFHAAALEWDTEGNPFDPDIYGREEMRNPKL-----FYADH 346
Query: 366 PFVFMIREDMTGLVMFTG 383
PF+F+++++ T ++F G
Sbjct: 347 PFIFLVKDNKTNSILFIG 364
|
It has been shown to be essential for collagen biosynthesis, but its exact function is still unclear. Hsp47 is a non-inhibitory member of the SERPIN superfamily and corresponds to clade H. Length = 366 |
| >gnl|CDD|165258 PHA02948, PHA02948, serine protease inhibitor-like protein; Provisional | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-19
Identities = 92/368 (25%), Positives = 171/368 (46%), Gaps = 37/368 (10%)
Query: 27 KDSNLVFSP--SSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFADG 84
+D N+VFSP S + +SL+ A G T +LL + + D AF +EL++ + A
Sbjct: 37 EDDNIVFSPFGYSFSMFMSLLPA--SGNTRVELLKTMDLRKRDLGPAF-TELISGL-AKL 92
Query: 85 SPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEK 144
S + ++D ++ +K ++ Q ++ +++F+ A ++N E+
Sbjct: 93 KTSKYTYTDLTYQSFVDNTVCIKPSYYQ---QYHRFGLYRLNFRRDAVN---KINSIVER 146
Query: 145 ETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFM 204
+ + V+ +DN+T N +YFKG W FD +KT + F G+ VP M
Sbjct: 147 RSG--MSNVVDSTMLDNNTLWAIINTIYFKGTWQYPFDITKTHNASF-TNKYGTKTVPMM 203
Query: 205 TS----KKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPDAKDGLPTLLEKMGSESKF 260
+ N + + ++ LPYK SMY + D + ++ +
Sbjct: 204 NVVTKLQGNTITIDDEEYDMVRLPYKDAN----ISMYLAIGDNMTHFTDSI--TAAKLDY 257
Query: 261 LDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNL 320
L ++ V + ++PRF I ++ + + + + F+ + M P L
Sbjct: 258 WSSQLGNK---VYNLKLPRFSIENKRDIKSIAEMMAPSM-FNPDNASFKHMTRDP----L 309
Query: 321 YVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVM 380
Y+ +FQ + I+V+E+GT A A++ RS ++++F + PFVF+IR D+TG ++
Sbjct: 310 YIYKMFQNAKIDVDEQGTVAEASTIMVATARSS--PEELEF--NTPFVFIIRHDITGFIL 365
Query: 381 FTGHVLNP 388
F G V +P
Sbjct: 366 FMGKVESP 373
|
Length = 373 |
| >gnl|CDD|165039 PHA02660, PHA02660, serpin-like protein; Provisional | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 2e-10
Identities = 83/373 (22%), Positives = 147/373 (39%), Gaps = 52/373 (13%)
Query: 30 NLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFADGSPSGG 89
N+VFSP S+ L ++ GS+ T ++L ++ SP
Sbjct: 30 NIVFSPESLKAFLHVLYLGSERETKNELSKYIGHAY-------------------SPIRK 70
Query: 90 PRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGL 149
+ V++D L + + F ++++ D A + R +N W ++TN +
Sbjct: 71 NHIHNITKVYVDSHLPIHSAFVASMNDMGIDVILA-DLANHAEPIRRSINEWVYEKTNII 129
Query: 150 -VKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKK 208
+P T ++ NA+ F G W F KT F++ V MT+K
Sbjct: 130 NFLHYMP------DTSILIINAVQFNGLWKYPFLRKKTTMDIFNIDKVSFKYVNMMTTKG 183
Query: 209 NQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPDA--KDGLPTLLEKM-GSESKFLDHHL 265
+ ++ +PY ++ R M+ PDA D L L M G K H
Sbjct: 184 IFNAGRYHQSNIIEIPY---DNCSRSHMWIVFPDAISNDQLNQLENMMHGDTLKAFKH-- 238
Query: 266 PSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMV-DSPVGKNLYV-- 322
+ R + + IP+F+I +L G+ F+ L+ M+ +LY
Sbjct: 239 -ASRKKYLEISIPKFRIEHSFNAEHLLPSAGIKTLFTNP--NLSRMITQGDKEDDLYPLP 295
Query: 323 SSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFV-------ADHPFVFMIREDM 375
S++QK +E++EEGT + A + R+ D + + PF+F+I +
Sbjct: 296 PSLYQKIILEIDEEGTN--TKNIAKKMRRNPQDEDTQQHLFRIESIYVNRPFIFII--EY 351
Query: 376 TGLVMFTGHVLNP 388
++F G + P
Sbjct: 352 ENEILFIGRISIP 364
|
Length = 364 |
| >gnl|CDD|239009 cd02054, angiotensinogen, Angiotensinogen is part of the renin-angiotensin system (RAS), which plays an important role in blood pressure regulation, renal haemodynamics, fluid and electrolyte homeostasis | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 7e-07
Identities = 55/271 (20%), Positives = 109/271 (40%), Gaps = 35/271 (12%)
Query: 125 VDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSS 184
VDF T+ ++N + + ++G VK L + + L+FA +++F+G W
Sbjct: 130 VDF-TEPDVAEEKINNFVQATSDGKVKSSLK--GLSPDSDLLFATSVHFQGNWKTASQLE 186
Query: 185 KTKDYDFHLLNGGSIKVPFM--TSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPD 242
+ +++ N S+ VP + T D F + LP +R + P
Sbjct: 187 EPQEFWVD--NNTSVSVPMLSHTGTFKYLSDIQDNFSITQLPL-----SKRACLLLVQPH 239
Query: 243 AKDGLPTLLEKMGSESKFLD--HHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
L +E + + +L + +E+ +P+F + ++ +L + L
Sbjct: 240 EGSDLDK-VEGKLPQQNSSNWLKNLSPRTIEL---TLPKFSLQGSYDLQDLLAQMELP-A 294
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGT---EAAAASAATVVLRSIVLSD 357
G L+++ + V + K F E++E+GT E+ VL
Sbjct: 295 LLGSEANLSKLSN----DRFTVGKVLNKVFFELSEDGTEVQESTQQLNKPEVL------- 343
Query: 358 KIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
++ + PF+F + E + ++F G V NP
Sbjct: 344 EVTL--NRPFLFAVYEANSNAILFLGRVTNP 372
|
It is also involved in normal and abnormal growth processes. The growth promoting actions of angiotensin have been shown in a variety of cells and tissues. This subgroup represents clade A8 of the serpin superfamily. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Length = 372 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 391 | |||
| COG4826 | 410 | Serine protease inhibitor [Posttranslational modif | 100.0 | |
| cd02044 | 370 | ov-serpin ovalbumin family of serpins (ov-serpins) | 100.0 | |
| cd02043 | 381 | plant_SERPIN SERine Proteinase INhibitors (serpins | 100.0 | |
| KOG2392 | 380 | consensus Serpin [Defense mechanisms] | 100.0 | |
| cd02054 | 372 | angiotensinogen Angiotensinogen is part of the ren | 100.0 | |
| cd02048 | 388 | neuroserpin Neuroserpin is a inhibitory member of | 100.0 | |
| cd02059 | 389 | ovalbumin_like The ovalbumin_like group of serpins | 100.0 | |
| cd02057 | 372 | maspin_like Maspin (mammary serine proteinase inhi | 100.0 | |
| cd02045 | 381 | antithrombin-III_like Antithrombin is a serine pro | 100.0 | |
| cd02058 | 380 | PAI-2 Plasminogen Activator Inhibitor-2 (PAI-2). P | 100.0 | |
| cd02051 | 377 | PAI-1_nexin-1 Plasminogen activator inhibitor-1_li | 100.0 | |
| cd00172 | 364 | SERPIN SERine Proteinase INhibitors (serpins) exhi | 100.0 | |
| cd02049 | 364 | bacterial_SERPIN SERine Proteinase INhibitors (ser | 100.0 | |
| cd02046 | 366 | hsp47 Heat shock protein 47 (Hsp47), also called c | 100.0 | |
| cd02047 | 436 | HCII Heparin cofactor II (HCII) inhibits thrombin, | 100.0 | |
| cd02056 | 361 | alpha-1-antitrypsin_like alpha-1-antitrypsin_like. | 100.0 | |
| smart00093 | 359 | SERPIN SERine Proteinase INhibitors. | 100.0 | |
| cd02052 | 374 | PEDF Pigment epithelium-derived factor (PEDF)_like | 100.0 | |
| PF00079 | 371 | Serpin: Serpin (serine protease inhibitor); InterP | 100.0 | |
| cd02055 | 365 | PZI Protein Z-dependent protease inhibitor (ZPI) i | 100.0 | |
| cd02053 | 351 | alpha2AP Alpha2-antiplasmin (alpha2AP) is the prim | 100.0 | |
| PHA02948 | 373 | serine protease inhibitor-like protein; Provisiona | 100.0 | |
| cd02050 | 352 | C1_inh C1 inhibitor (C1-Inh) is a protease inhibit | 100.0 | |
| PHA02660 | 364 | serpin-like protein; Provisional | 100.0 |
| >COG4826 Serine protease inhibitor [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-83 Score=566.16 Aligned_cols=370 Identities=29% Similarity=0.495 Sum_probs=337.7
Q ss_pred hhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh-hHHHHHHHHHHHHHhh
Q 016311 4 RESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN-DQLNAFASELVAVVFA 82 (391)
Q Consensus 4 ~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~-~~~~~~~~~l~~~l~~ 82 (391)
...+.++|.|+++||..+++.....+|+.|||.||+.+|||-|.||.|.|++||..+++++-+ ..+....+.+...+.
T Consensus 36 y~ia~ANNaF~FdlyS~~~~~~~~~~Ni~fSPySV~~AmAmcY~GaeGsTkeqmsnvfyfp~n~~vl~~~~~~~nd~i~- 114 (410)
T COG4826 36 YDIAAANNAFAFDLYSELAKQEGEAENILFSPYSVSAAMAMCYEGAEGSTKEQMSNVFYFPINKTVLKVREKSLNDKIN- 114 (410)
T ss_pred cchhhcccchhHHHHHHHHhhcccccceeeccHHHHHHHHHHhcccCcchHHHHHhheeccccchHhhhhHHhhccccc-
Confidence 356789999999999999864457899999999999999999999999999999999999955 456666666665554
Q ss_pred CCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCc
Q 016311 83 DGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNS 162 (391)
Q Consensus 83 ~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~ 162 (391)
++..+..|..+|++|+++++++++.|+..++.+|.+++..+||.++|+.++..||+|++++|+|+|.++++++.+.++
T Consensus 115 --sp~~~y~le~AnalWvqedyplke~yv~n~r~yy~aevtnlDF~~~p~~s~dtINkWvEekT~gkIkdlVp~~~i~~d 192 (410)
T COG4826 115 --SPNDSYELETANALWVQEDYPLKENYVNNVRNYYDAEVTNLDFVNKPDASRDTINKWVEEKTNGKIKDLVPEDYIGPD 192 (410)
T ss_pred --CCccchhhhhhhhHHHhcCCCCCHHHHHHHHhhhhcceeecccccCchHHHHHHHHHHHHhhcchHhhcCCccccCCc
Confidence 456778999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccCCeEEEEeecCCCCCCceEEEEEEecC
Q 016311 163 TRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPD 242 (391)
Q Consensus 163 t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~~~~vveLp~~~~~~~~~~sm~iilP~ 242 (391)
++++|+||+||+|+|...||+..|.++.|+...|....|+||.+.+.|+|.+..++++|||||++. ++||+|+||+
T Consensus 193 ~rlvltnAiYFnGkW~~efDk~~t~krtFy~a~~~d~sv~mMs~~g~fny~et~kakiveLPy~gd----~lSmYIvLPk 268 (410)
T COG4826 193 TRLVLTNAIYFNGKWWPEFDKQMTGKRTFYPAKGEDKSVDMMSICGDFNYGETSKAKIVELPYKGD----DLSMYIVLPK 268 (410)
T ss_pred eeEEEEeeEEEcCeeccccchhhccceeeecCChhhhcchhHHhcCCCCcccCcCceEEEcccCCC----ceEEEEEeeC
Confidence 999999999999999999999999999999999999999999999999999999999999999998 8999999999
Q ss_pred CCCChHHHHHHhcCchHHHhhcCCCCcee-eeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCee
Q 016311 243 AKDGLPTLLEKMGSESKFLDHHLPSQRVE-VGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLY 321 (391)
Q Consensus 243 ~~~~l~~l~~~L~~~~~~l~~~~~~~~~~-~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~ 321 (391)
+. .+.++++.|+ ...++++...++.. .+++.||||+.+++..|++.|.+||+.++|+. .||||||++ .+|.
T Consensus 269 ~n-Ni~~Fe~nft--~e~y~elk~~m~~~~~v~v~iPkFkfetk~el~~aLieMGvvdAF~n-~AnFSgI~~----~~L~ 340 (410)
T COG4826 269 DN-NITEFENNFT--LEKYTELKSNMEDQDEVEVEIPKFKFETKTELKDALIEMGVVDAFEN-TANFSGISD----RRLE 340 (410)
T ss_pred CC-ChHHHHhhcc--HHHHHHHHhcCCccceEEEEecceeeeehhhhhHHHHHhhHHHHhhc-ccCcccccC----Cccc
Confidence 87 7999999998 33455554443333 67999999999999999999999999999996 899999998 4699
Q ss_pred EeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCC
Q 016311 322 VSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389 (391)
Q Consensus 322 v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~ 389 (391)
|++++|++.|+|+|+|++|+|+|++.+...++..+ -.+|++||||+|+|.|+.||.|||||+|.+|.
T Consensus 341 Is~V~Hqa~idv~EeGteAaAAT~v~~~a~~~~~~-~~e~~vD~PFlf~i~D~~s~~IlFiG~Vv~P~ 407 (410)
T COG4826 341 ISDVFHQAFIDVDEEGTEAAAATAVVFKAVCAKGG-WVEFVVDHPFLFVIEDRRSGCILFIGKVVNPE 407 (410)
T ss_pred HHHHhhhhheeccccchhhhhhceeeeeeeeeccc-ceEEEecCceEEEEecCCcceEEEEeeecCCC
Confidence 99999999999999999999999988887777554 35999999999999999999999999999996
|
|
| >cd02044 ov-serpin ovalbumin family of serpins (ov-serpins) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-79 Score=592.54 Aligned_cols=364 Identities=28% Similarity=0.465 Sum_probs=326.8
Q ss_pred hhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHHhhCCCCC
Q 016311 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFADGSPS 87 (391)
Q Consensus 8 ~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~~~ 87 (391)
.++++||++||+++. ...+++|+||||+||+.+|+||+.||+|+|++||.++||++...+++..++.+...+.+ ..
T Consensus 3 ~~~~~F~~~l~~~~~-~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~---~~ 78 (370)
T cd02044 3 LANSAFAVDVFKELS-KKSALQNVFFSPIAIMSSLAMVYLGAKGSTANQIGKVLHFDNVKDVHSSFQTLLSDINK---LN 78 (370)
T ss_pred chhhHHHHHHHHHHh-hcCCCCcEEECHHHHHHHHHHHhhhcCCcHHHHHHHHhCCCCHHHHHHHHHHHHHHHhc---CC
Confidence 578899999999998 45788999999999999999999999999999999999998767888888888877653 23
Q ss_pred CCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCeEEE
Q 016311 88 GGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIF 167 (391)
Q Consensus 88 ~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~l~l 167 (391)
.+..++++|++|++++++++++|.+.++++|++++..+||+++++.+++.||+||+++|+|+|++++++.+++++|.+++
T Consensus 79 ~~~~l~~a~~~~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~lv~~~~l~~~t~lvl 158 (370)
T cd02044 79 SFYSLKLVNRLYGEKRYNFLPEFLSSTKKPYAKELETVDFKDKAEETRGQINSWIKDQTKGKIENLLPENSVDSQTAMVV 158 (370)
T ss_pred CCceEeeeeehhhcCCCcccHHHHHHHHHhhccceEeccccCCHHHHHHHHHHHHHHhcCCchhhcCCCCCCCcchhhee
Confidence 45689999999999999999999999999999999999999877788999999999999999999999889999999999
Q ss_pred EEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccc--cCCeEEEEeecCCCCCCceEEEEEEecCCCC
Q 016311 168 ANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSA--FDGFKVLGLPYKQGEDKRRFSMYFFLPDAKD 245 (391)
Q Consensus 168 vna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLp~~~~~~~~~~sm~iilP~~~~ 245 (391)
+||+||+|.|+.||++..|..++|+..+|+++.||||++.+.++|.. ..++++|+|||+++ +++|+||||++..
T Consensus 159 vnai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vv~LPy~~~----~~sm~iiLP~~~~ 234 (370)
T cd02044 159 VNAAYFKGKWMKKFSEEETKESPFRVNKTETKPVQMMYMEATFNMGNIESLKMKILELPFANK----DLSMFILLPDEVT 234 (370)
T ss_pred eeeeeEcccccCCCChhhCccCcCCcCCCcEEEeeCccccCceeeEEcCCCCeEEEEcccCCC----ceEEEEEcCCCCC
Confidence 99999999999999999999999999999999999999888776654 45889999999987 7999999999999
Q ss_pred ChHHHHHHhcCchHHHhhcCC--CCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCeeEe
Q 016311 246 GLPTLLEKMGSESKFLDHHLP--SQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVS 323 (391)
Q Consensus 246 ~l~~l~~~L~~~~~~l~~~~~--~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~v~ 323 (391)
+|.++++.|+ ...+..+.. ..+...++|+||||++++.+||+++|++||++++|++..|||++|++ ..+++|+
T Consensus 235 ~l~~l~~~l~--~~~l~~~~~~~~~~~~~v~l~lPkF~i~~~~~l~~~L~~mGl~~~F~~~~Adfs~ms~---~~~l~vs 309 (370)
T cd02044 235 GLEKLESEIN--YEKLNKWTSPSTMAEAKVKVYLPRFKMEKMYDLKSVLESLGMKDAFSEGRANFSGMSE---TKGLALS 309 (370)
T ss_pred cHHHHHHHhC--HHHHHHhhccccceeeEEEEEeeEEEEeeEEccHHHHHHcCchhhCCCCCCChhhcCC---CCCeeEe
Confidence 9999999997 334555542 34445679999999999999999999999999999985699999987 4679999
Q ss_pred eeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 324 SIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 324 ~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
+++|++.|+|||+|++|+|+|......++. +.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus 310 ~v~qka~ievdE~Gt~aaa~t~~~~~~~~~----~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P 370 (370)
T cd02044 310 NVIHKASLEINEDGTEAAEVTGAVMLQRSV----KEEFNADHPFLFIIRHNKTNCILFFGKFSSP 370 (370)
T ss_pred eeeEeeEEEECCCccccccccceeeeccCC----CCeEEeeCCEEEEEEECCCCeEEEEEEecCC
Confidence 999999999999999999999854433332 3589999999999999999999999999998
|
Family of closely related proteins, whose members can be secreted (ovalbumin), cytosolic (leukocyte elastase inhibitor, LEI), or targeted to both compartments (plasminogen activator inhibitor 2, PAI-2). This subgroup corresponds to clade B of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants can cause blood clotting disorders, emphysema, cirrhosis, and dementia. |
| >cd02043 plant_SERPIN SERine Proteinase INhibitors (serpins), plant specific subgroup | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-79 Score=593.10 Aligned_cols=378 Identities=61% Similarity=0.999 Sum_probs=328.5
Q ss_pred hhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHHhhCCCCCC
Q 016311 9 NQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFADGSPSG 88 (391)
Q Consensus 9 ~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~~~~ 88 (391)
.+++||++||+++.....+++|+||||++|+.+|+||++||+|+|++||.++||++..++++..++.+...+..+....+
T Consensus 2 ~~~~~~~~l~~~~~~~~~~~~N~v~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~l~~~~~~~~~~~~ 81 (381)
T cd02043 2 NQCLVAMRLSGHVAAAAGKGSNVIFSPLSINVALSLVAAGARGETLDQLLSFLGSPSTDELHAVAASIVDLVLADASASG 81 (381)
T ss_pred chHHHHHHHHHHHhccCCCCCcEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCCCChHHHHHHHHHHHHHHhhhcccCC
Confidence 46899999999998432378999999999999999999999999999999999998767778888888766543221234
Q ss_pred CCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCeEEEE
Q 016311 89 GPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFA 168 (391)
Q Consensus 89 ~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~l~lv 168 (391)
+..++++|+||++++++++++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|++++++.+++++|+++++
T Consensus 82 ~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~i~~~t~l~lv 161 (381)
T cd02043 82 GPRLSFANGVWVDKSLSLKPSFKDLAANSYKAEARPVDFRTKAEEVRREVNSWVEKATNGLIKDILPPGSVDSSTKLVLA 161 (381)
T ss_pred CcEEehhhhHHHhCCCCcCHHHHHHHHhhhhccceeecCCCCHHHHHHHHHHHHHHHhcChHHhhCCCCCcCCCceEEEE
Confidence 56899999999999999999999999999999999999987778899999999999999999999988899999999999
Q ss_pred EeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccCCeEEEEeecCCCCCC--ceEEEEEEecCCCCC
Q 016311 169 NALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDK--RRFSMYFFLPDAKDG 246 (391)
Q Consensus 169 na~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~~~~vveLp~~~~~~~--~~~sm~iilP~~~~~ 246 (391)
||+||+|.|+.||++..|..++||..+|+++.||||++.+.++|...+++++|+|||++++++ +++||+||||++..+
T Consensus 162 nai~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~~~~~~~~~veLPy~~~~~~~~~~~sm~iiLP~~~~~ 241 (381)
T cd02043 162 NALYFKGAWSSKFDASDTKDRDFHLLDGTSVRVPFMSSEKDQYVAAFDGFKVLRLPYKRGGHDDARQFSMYIYLPDKKDG 241 (381)
T ss_pred eeeEEeeeeccCCccccCccccceeCCCCeEEeeeeeccCcccccccCCCEEEEcCCCCCCCCCCCcEEEEEEccCCCCC
Confidence 999999999999999999999999999999999999988776676667899999999875211 149999999999999
Q ss_pred hHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCeeEeeee
Q 016311 247 LPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIF 326 (391)
Q Consensus 247 l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~v~~~~ 326 (391)
|.+++++|......+..+....+...++|.||||++++++||+++|++||++++|++ .+++++++... +++++|++++
T Consensus 242 L~~l~~~l~~~~~~~~~~~~~~~~~~v~l~lPKF~i~~~~dl~~~L~~mGl~~~F~~-~~~~~~~~~~~-~~~l~vs~v~ 319 (381)
T cd02043 242 LADLLEKLVSEPGFLDRHIPASEQEVGAFMIPKFKFSFGFEASEVLKKLGLTLPFDP-GGALLSMSSPE-GENLYVSSVY 319 (381)
T ss_pred HHHHHHhhccChhhhhhhcccceeeEEEEEcccEEEEeecchHHHHHHCCCccccCC-ccccccCccCC-CCCeeEEeee
Confidence 999999997543445556666666667999999999999999999999999999997 66666664311 3679999999
Q ss_pred eeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 327 QKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 327 q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
|++.|+|||+|++|+|+|.+....++.+.+++++|+|||||+|+|+|+.||.|||+|||.+|
T Consensus 320 hka~ieVdE~Gt~aaa~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P 381 (381)
T cd02043 320 HKACVEVDEEGTEAAAATAVVMSGTSSPPPRPVDFVADHPFLFLIREDKTGVVLFLGQVMNP 381 (381)
T ss_pred eEEEEEECCCcceehhccceeeccccCCCCCCceEEecCCEEEEEEECCCCcEEEEEEecCC
Confidence 99999999999999999985444444333445689999999999999999999999999998
|
It has been suggested that plant serpins play a role in defense against insect predators. This subgroup corresponds to clade P of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. |
| >KOG2392 consensus Serpin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-78 Score=582.70 Aligned_cols=369 Identities=40% Similarity=0.663 Sum_probs=333.2
Q ss_pred hhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh---hHHHHHHHHHHHHHh
Q 016311 5 ESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN---DQLNAFASELVAVVF 81 (391)
Q Consensus 5 ~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~---~~~~~~~~~l~~~l~ 81 (391)
.......+|+++||+.++ ...+++|++|||+||..+|+|+++||+|+|++||+++|+++.. ..++..++.+...+.
T Consensus 6 ~~~~~~~~f~~~l~~~~~-~~~~~~Ni~fSP~SI~~aL~m~~lGa~g~T~~qi~~~L~~~~~~~~~~~~~~~~~~~~~~~ 84 (380)
T KOG2392|consen 6 SLSQSEADFALDLYRQLA-KSAPDENVVFSPLSISSALAMVSLGAKGETADQILKALHFNSTDEENEVHESFQSLLLLLN 84 (380)
T ss_pred hhhhhhhHHHHHHHHHHH-hhCCCCCEEEChHHHHHHHHHHHhcCCccHHHHHHHHhCCCCCcchHHHHHHHHHHHHHhc
Confidence 445678999999999998 4678999999999999999999999999999999999999854 457777777765222
Q ss_pred hCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCC
Q 016311 82 ADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDN 161 (391)
Q Consensus 82 ~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~ 161 (391)
....+..++++|++|+++.+.+.+.|.+.++++|++++..+||.++++.+++.||.|++++|+|+|.+++++.++++
T Consensus 85 ---~~~~~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~a~~~~~dF~~~~e~~~~~IN~wv~~~T~gkI~~ll~~~~~~~ 161 (380)
T KOG2392|consen 85 ---STESGYELKLANRLFVSKSLKLLQKFLELVKKLYKAEAESLDFSNDTEEAAKEINEWVEEHTNGKIKDLLSPDSIDS 161 (380)
T ss_pred ---cccCCceEEEeeeheecCCccccHHHHHHHHHHHhCcceeecCccChHHHHHHHHHHHHHHcCCchhhhcCCCCCCc
Confidence 23566899999999999999999999999999999999999999657899999999999999999999999999999
Q ss_pred cCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccc--cCCeEEEEeecCCCCCCceEEEEEE
Q 016311 162 STRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSA--FDGFKVLGLPYKQGEDKRRFSMYFF 239 (391)
Q Consensus 162 ~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLp~~~~~~~~~~sm~ii 239 (391)
.|.++|+||+||+|.|+.+|+++.|..++|+..+++.+.||||++.+.++|.. +..+++++|||.+. +++|+|+
T Consensus 162 ~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~VpmM~~~~~f~~~~~~~l~~~vl~LpY~~~----~~sm~i~ 237 (380)
T KOG2392|consen 162 LTVLVLVNAIYFKGKWEKKFDKELTKESDFFLSEGTSVKVPMMHQEGSFRYAEDEDLFAVVLELPYKGS----NLSMLIL 237 (380)
T ss_pred chhheeeehheeehhhcCCCChhhccccccEECCCeEEEeechhccCccceEEeCCcceEEEECccCCC----CeEEEEE
Confidence 99999999999999999999999999999999999999999999999876544 45899999999996 7999999
Q ss_pred ecCCCCChHHHHHHhcCchHHHhhcC-CCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCC
Q 016311 240 LPDAKDGLPTLLEKMGSESKFLDHHL-PSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGK 318 (391)
Q Consensus 240 lP~~~~~l~~l~~~L~~~~~~l~~~~-~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~ 318 (391)
||++..+|.+++++|+. ..+..|. +......++|.||||+++..+||+++|++|||+++|++..|||++|++ ..
T Consensus 238 LP~~~~gL~~le~~L~~--~~~~~~~~~~~~~~~v~v~lPKfkie~~~dL~~~L~~lGi~~~F~~~~adls~ls~---~~ 312 (380)
T KOG2392|consen 238 LPDERDGLKELEKKLTS--ETLVEWLFSRMSEKVVEVSLPKFKIEFDYDLKEVLKQLGITDIFSESKADLSGLSE---SS 312 (380)
T ss_pred eCCCCCCHHHHHHHhCh--hhHHHhhhhhhhceeEEEECCCEEEEEEechHHHHHHcCChhccCCCccccccCcc---CC
Confidence 99999999999999984 3455555 556667789999999999999999999999999999986699999999 35
Q ss_pred CeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 319 NLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 319 ~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
+++|++++||+.|||||+|++|+|+|.+.+..++.+. +.+|+|||||+|+|+|+.|+.|||+|+|.||
T Consensus 313 ~l~vs~v~Hka~ieV~E~GteAaaat~~~~~~~~~~~--~~~f~adhPFlF~I~~~~t~~iLF~G~v~~P 380 (380)
T KOG2392|consen 313 NLYISKVIHKAFIEVDEEGTEAAAATAVEIVLRSLPP--PEEFVADHPFLFVIRDNKTGSILFLGRVVDP 380 (380)
T ss_pred CeeeeeeeEEEEEEECCCCchhhhhhhhHHhhccCCC--CCeEECCCCEEEEEEECCCCcEEEEEEccCC
Confidence 8999999999999999999999999997666665533 5699999999999999999999999999999
|
|
| >cd02054 angiotensinogen Angiotensinogen is part of the renin-angiotensin system (RAS), which plays an important role in blood pressure regulation, renal haemodynamics, fluid and electrolyte homeostasis | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-78 Score=579.91 Aligned_cols=356 Identities=19% Similarity=0.331 Sum_probs=309.6
Q ss_pred hhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh------------hHHHHHH
Q 016311 6 SISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN------------DQLNAFA 73 (391)
Q Consensus 6 ~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~------------~~~~~~~ 73 (391)
++.++++||++||++++ ...+++|+||||+||+.+|+|+++||+|+|++||.++||++.. .++...+
T Consensus 2 ~~~~~~~f~~~l~~~l~-~~~~~~N~v~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~ 80 (372)
T cd02054 2 LAMLVNVLGLRMYGMLS-ELWVHTNTLLSPTSVFGTLASLYLGASKKTADSLQALLGLPWKSKNSDCTSRVDGHKVLSTL 80 (372)
T ss_pred hHHHHHHHHHHHHHHHH-hhCCCCCEEEChHHHHHHHHHHHcCCCccHHHHHHHHhCCCcccccccccccccHHHHHHHH
Confidence 35678999999999998 4467889999999999999999999999999999999999742 2344455
Q ss_pred HHHHHHHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCe-eEEecCCCChHHHHHHHHHHHHHHhCCcccc
Q 016311 74 SELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAA-SNQVDFQTKAAEVSREVNMWAEKETNGLVKE 152 (391)
Q Consensus 74 ~~l~~~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~-~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~ 152 (391)
+.+...+.. ...+..+..+|++|++++++++++|++.++++|+++ ++.+||.+ ++.+++.||+||+++|+|+|++
T Consensus 81 ~~~~~~~~~---~~~~~~l~~a~~i~~~~~~~l~~~f~~~~~~~y~a~~~~~vdF~~-~~~a~~~IN~WV~~~T~g~I~~ 156 (372)
T cd02054 81 QAIQSLVDA---QGRQLLLSTVVWTFTAPGIHLSQPFVQGLADFSDASFPRSVDFTE-PDVAEEKINNFVQATSDGKVKS 156 (372)
T ss_pred HHHHHHHcC---CCCccEEEEEEEEEecCCCCccHHHHHHHHHHhCcccceeecCCC-hHHHHHHHHHHHHHHhcCchhh
Confidence 555544431 234567999999999999999999999999999997 99999986 6788999999999999999999
Q ss_pred cCCCCCCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc--CCeEEEEeecCCCCC
Q 016311 153 VLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF--DGFKVLGLPYKQGED 230 (391)
Q Consensus 153 ~l~~~~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLp~~~~~~ 230 (391)
+++ +++++|+++|+||+||+|.|+.+|++..|. +|+..+|..++||||++.+.++|.+. .++++++|||++
T Consensus 157 ll~--~~~~~t~lvLvNaiyFkg~W~~~F~~~~T~--~f~~~~~~~~~V~mM~~~~~~~y~~~~~~~~~vleLPy~~--- 229 (372)
T cd02054 157 SLK--GLSPDSDLLFATSVHFQGNWKTASQLEEPQ--EFWVDNNTSVSVPMLSHTGTFKYLSDIQDNFSITQLPLSK--- 229 (372)
T ss_pred hcc--CCCCCCeEEEEEEEEEEHhhcCCCCcccce--eEEeCCCCEEEEeeeeccCcEEEEEecCCCcEEEEEeeCC---
Confidence 995 688999999999999999999999999986 68888899999999999988877664 478999999985
Q ss_pred CceEEEEEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcC
Q 016311 231 KRRFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAE 310 (391)
Q Consensus 231 ~~~~sm~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~ 310 (391)
+++|+||||++..+|.++++.|+. ..+..+....+...++|.||||++++++||+++|++||++++|+. .||||+
T Consensus 230 --~~sm~iiLP~~~~~l~~l~~~L~~--~~l~~~~~~~~~~~v~v~lPkF~i~~~~~L~~~L~~lGi~~~F~~-~Adfs~ 304 (372)
T cd02054 230 --RACLLLVQPHEGSDLDKVEGKLPQ--QNSSNWLKNLSPRTIELTLPKFSLQGSYDLQDLLAQMELPALLGS-EANLSK 304 (372)
T ss_pred --CeEEEEEeCCCCCCHHHHHHhhCH--HHHHHHHHhCCceEEEEECCeEEEEEEeccHHHHHHcCCcccccC-cccccc
Confidence 499999999998899999999973 345555444445567999999999999999999999999999986 899999
Q ss_pred CCCCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 311 MVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 311 is~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
|++ .+++|++++|++.|||||+|++|+|+|.+.. . +.+.+|+|||||+|+|+|+.||.|||+|+|.+|
T Consensus 305 i~~----~~l~vs~v~hka~ieVdE~GteAaaat~~~~----~--~~~~~f~~drPF~f~I~d~~t~~iLF~G~v~~P 372 (372)
T cd02054 305 LSN----DRFTVGKVLNKVFFELSEDGTEVQESTQQLN----K--PEVLEVTLNRPFLFAVYEANSNAILFLGRVTNP 372 (372)
T ss_pred ccC----CCceeeeeeeeEEEEEccCceeccccccccc----C--CCCceEEecCCEEEEEEECCCCcEEEEEEecCC
Confidence 985 4799999999999999999999999997421 1 224589999999999999999999999999998
|
It is also involved in normal and abnormal growth processes. The growth promoting actions of angiotensin have been shown in a variety of cells and tissues. This subgroup represents clade A8 of the serpin superfamily. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. |
| >cd02048 neuroserpin Neuroserpin is a inhibitory member of the SERine Proteinase INhibitor (serpin) family that reacts preferentially with tissue-type plasminogen activator (tPA) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-79 Score=591.00 Aligned_cols=366 Identities=30% Similarity=0.547 Sum_probs=324.0
Q ss_pred hhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh--hHHHHHHHHHHHHHhhCCC
Q 016311 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN--DQLNAFASELVAVVFADGS 85 (391)
Q Consensus 8 ~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~--~~~~~~~~~l~~~l~~~~~ 85 (391)
++.++||++||+++. ..++++|+|+||+||+.+|+||++||+|+|++||.++||++.. .+....++.+...+..
T Consensus 2 ~~~~~Fa~~l~~~~~-~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~--- 77 (388)
T cd02048 2 EAIAELSVDLYNALR-ASKEDENIIFSPLSTALALGMVELGAKGSALKEIRHSLGYDGLKNGEEFSFLKDLSSMITA--- 77 (388)
T ss_pred chhhHHHHHHHHHhh-ccCCCCcEEEChHHHHHHHHHHhhhcCCcHHHHHHHHhCCCCCChHHHHHHHHHHHHHhcc---
Confidence 467899999999997 4568899999999999999999999999999999999999854 3444456666655532
Q ss_pred CCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCeE
Q 016311 86 PSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRL 165 (391)
Q Consensus 86 ~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~l 165 (391)
...+..++++|++|++++++++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|++++++.+++++|++
T Consensus 78 ~~~~~~l~~an~i~v~~~~~l~~~f~~~~~~~f~~~~~~vdF~~-~~~~~~~IN~wv~~~T~g~I~~l~~~~~l~~~t~l 156 (388)
T cd02048 78 KEKEYVFNLANSLYLQNGFHVKEKFLQSNKKYFNAAVKLVDFSQ-VKAVAEHINKWVENHTNNKIKDMFSSRDFTPLTRL 156 (388)
T ss_pred CCCccchHHhhhhHhhcCCCccHHHHHHHHHHhcCeeEEECCCC-hHHHHHHHHHHHHHhccCchhhcCCCccCCHHHHH
Confidence 23456799999999999999999999999999999999999987 57899999999999999999999988899999999
Q ss_pred EEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC--------CeEEEEeecCCCCCCceEEEE
Q 016311 166 IFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--------GFKVLGLPYKQGEDKRRFSMY 237 (391)
Q Consensus 166 ~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--------~~~vveLp~~~~~~~~~~sm~ 237 (391)
+|+||+||+|.|+.+|++..|..++|+..+|++++||||++.+.++|++.+ ++++|+|||+++ +++|+
T Consensus 157 vlvNai~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~y~~~~~~~~~~~~~~~vv~LPy~~~----~~sm~ 232 (388)
T cd02048 157 VLVNALYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLELPYEGD----EISLM 232 (388)
T ss_pred HhhheEEEeeeccCCCCHHHCeeccEEECCCceEEeehhcccCcEEEEeccccccccccCcEEEEEecCCC----ceEEE
Confidence 999999999999999999999999999999999999999999888887653 489999999987 79999
Q ss_pred EEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCC
Q 016311 238 FFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVG 317 (391)
Q Consensus 238 iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~ 317 (391)
||||++..+|.+++++|+. ..+..+....+...++|.||||++++++||.++|++||++++|++ .|||++|++ +
T Consensus 233 iiLP~~~~~l~~l~~~l~~--~~l~~~~~~~~~~~v~l~lPkF~i~~~~~l~~~L~~lGi~~~F~~-~adfs~i~~---~ 306 (388)
T cd02048 233 IILSRQEVPLATLEPLVKA--PLIEEWANSVKKQKVEVYLPRFKVEQKIDLKDVLKNLGITEIFSG-GADLSGISD---S 306 (388)
T ss_pred EEccCCCCCHHHHHHHhCh--HHHHHHHHhCceeEEEEEccEEEEEEEechHHHHHHcCCchhhcC-ccCcccccC---C
Confidence 9999999999999999973 345556555566678999999999999999999999999999997 899999987 4
Q ss_pred CCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 318 KNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 318 ~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
.+++|++++|++.|+|||+|++|+|+|......++. +.+.+|+|||||+|+|+|+.||.|||+|||.+|..
T Consensus 307 ~~l~vs~v~hka~ieV~E~Gt~a~a~t~~~~~~~~~--~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v~~P~~ 377 (388)
T cd02048 307 KELYVSKVFHKVFLEVNEEGSEAAASSGMIAISRMA--VLYPQVIVDHPFFFLIRNRRTGSILFMGRVMHPET 377 (388)
T ss_pred CCeEEEEEEeeeEEEECCCcceehhhcccccccccC--CCCceEEecCCEEEEEEECCCCeEEEEEEecCCCc
Confidence 679999999999999999999999999754333333 22348999999999999999999999999999974
|
It is located in neurons in regions of the brain where tPA is also found, suggesting that neuroserpin is the selective inhibitor of tPA in the central nervous system (CNS). This subgroup corresponds to clade I of the serpin superfamily. |
| >cd02059 ovalbumin_like The ovalbumin_like group of serpins contains ovalbumin, the squamous cell carcinoma antigen 1 (SCCA1) and other closely related serpins of clade B of the serpin superfamily | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-78 Score=586.15 Aligned_cols=366 Identities=32% Similarity=0.535 Sum_probs=324.9
Q ss_pred hhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh-----------------hHHH
Q 016311 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN-----------------DQLN 70 (391)
Q Consensus 8 ~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~-----------------~~~~ 70 (391)
.++++||++||+++. ...+++|+|+||++|+.+|+||+.||+|+|+.||.++|+++.. .+++
T Consensus 3 ~~~~~Fa~~l~~~~~-~~~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~ 81 (389)
T cd02059 3 AANTEFCFDLFKELK-KNHKNKNIFFSPLSISSALGMVLLGARDDTAAQIEKVLHFDHASGSGSSKPAASAQCNQSGGVH 81 (389)
T ss_pred chhhHHHHHHHHHHh-hcCCCCCEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCCCccccccccccccccccccHHHHH
Confidence 578999999999998 4567899999999999999999999999999999999999632 3567
Q ss_pred HHHHHHHHHHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcc
Q 016311 71 AFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLV 150 (391)
Q Consensus 71 ~~~~~l~~~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i 150 (391)
..++.+...+.+ +..+..++++|+||++++++++++|++.++++|+++++.+||.+.++.+++.||+||+++|+|+|
T Consensus 82 ~~~~~l~~~~~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~~~~~IN~wv~~~T~g~I 158 (389)
T cd02059 82 SQFKDLLSQINK---PNDDYELSIANRLYGEKTYPFHQEYLDCVEKLYRAKLEPVDFQNAAEASRKKINSWVESQTNGKI 158 (389)
T ss_pred HHHHHHHHHHcC---CCCCcEEEEeeehhhhCCCCccHHHHHHHHHHhcCeeEEEcCCCCHHHHHHHHHHHHHHhccchh
Confidence 778888776643 23557899999999999999999999999999999999999998666788899999999999999
Q ss_pred cccCCCCCCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccc--ccCCeEEEEeecCCC
Q 016311 151 KEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVS--AFDGFKVLGLPYKQG 228 (391)
Q Consensus 151 ~~~l~~~~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~--~~~~~~vveLp~~~~ 228 (391)
++++++.+++++|+++++||+||+|.|+.+|++..|..++|+..+|+.++||||++.+.++|. ++.++++|+|||+++
T Consensus 159 ~~~~~~~~i~~~t~lvlvna~~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~~~~~~~~~~vl~LPy~~~ 238 (389)
T cd02059 159 KNLFGKGTIDSSTVLVLVNAIYFKGKWEKKFEKENTVDAPFKLNENENKPVQMMYQIGKFKLASIEEPKMKILELPYAGG 238 (389)
T ss_pred hhcCCCCCCCcccceeeEeeeEEeeeccCCCCcccCccCccEeCCCceEEeehhcccCcEEEEEeCCCCcEEEEeecCCC
Confidence 999998899999999999999999999999999999999999999999999999998876654 456899999999987
Q ss_pred CCCceEEEEEEecCCCCChHHHHHHhcCchHHHhhcC--CCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCC
Q 016311 229 EDKRRFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHL--PSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGG 306 (391)
Q Consensus 229 ~~~~~~sm~iilP~~~~~l~~l~~~L~~~~~~l~~~~--~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~a 306 (391)
+++|+||||++..+|.+++++|+. ..+..+. ...+...++|.||||++++++||.++|++||++++|++..|
T Consensus 239 ----~~sm~iiLP~~~~~L~~l~~~l~~--~~l~~~~~~~~~~~~~v~l~lPkF~i~~~~dl~~~L~~mGi~~~F~~~~a 312 (389)
T cd02059 239 ----GLSMIVLLPDEISGLEQLESKLTY--EKLMEWTSSENMRERKVEVYLPRFKLEEKYNLKSVLKAMGMTDIFSESKA 312 (389)
T ss_pred ----ceEEEEEccCCCCCHHHHHHHhCH--HHHHHhhhhhcceeeEEEEECCCEEeeeeecHHHHHHHcCCccccCCccc
Confidence 799999999998899999999973 2344443 23445667999999999999999999999999999998569
Q ss_pred CCcCCCCCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEec
Q 016311 307 GLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVL 386 (391)
Q Consensus 307 dfs~is~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~ 386 (391)
||++|++ +.+++|++++|++.|||||+|++|+++|......++. +++.+|+|||||+|+|+|+.||.|||+|+|.
T Consensus 313 dfs~~~~---~~~l~v~~v~hka~ieV~E~G~~a~a~t~~~~~~~~~--~~~~~f~~nrPF~f~I~~~~t~~iLF~G~v~ 387 (389)
T cd02059 313 DLSGISS---SKSLYLSKAIHKSYVEVNEEGTEAAAATGAGIVEKSL--PVSEEFRADHPFLFFIRHNKTNTILFFGRFS 387 (389)
T ss_pred cccccCC---CCCceEeeeeeeEEEEECCCceeecccccceeeecCC--CCCceEEecCCEEEEEEECCCCeEEEEEEec
Confidence 9999997 4689999999999999999999999999854444443 3356899999999999999999999999999
Q ss_pred CC
Q 016311 387 NP 388 (391)
Q Consensus 387 ~P 388 (391)
+|
T Consensus 388 ~P 389 (389)
T cd02059 388 SP 389 (389)
T ss_pred CC
Confidence 98
|
Ovalbumin, the major protein component of avian egg white, is a non-inhibitory member of SERine Proteinase INhibitorS (serpins). In contrast, SCCA1 inhibits cysteine proteinases such as cathepsin S, K, L, and papain, a so called cross-class serpin. |
| >cd02057 maspin_like Maspin (mammary serine proteinase inhibitor), a member of the serpin superfamily, with a multitude of effects on cells and tissues at an assortment of developmental stages | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-78 Score=583.70 Aligned_cols=362 Identities=27% Similarity=0.433 Sum_probs=319.4
Q ss_pred hhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHHhhCCCCC
Q 016311 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFADGSPS 87 (391)
Q Consensus 8 ~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~~~ 87 (391)
.++++||++||+++. ..++++|+|+||+||+.+|+|+++||+|+|++||.++||++...+++..++.+...+.+ ..
T Consensus 3 ~~~~~F~~~l~~~~~-~~~~~~Nvv~SP~si~~aL~ml~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~---~~ 78 (372)
T cd02057 3 LANTAFAVDLFKKLC-EKEPTGNVVFSPICLSTSLALAQVGAKGDTANEIGKVLHFENVKDVPFGFQTVTSDVSK---LS 78 (372)
T ss_pred chhhHHHHHHHHHHh-ccCCCCcEEECHHHHHHHHHHHHhhcCCcHHHHHHHHhCCCChhHHHHHHHHHHHHHhc---CC
Confidence 468999999999998 45678999999999999999999999999999999999998766677777777766532 12
Q ss_pred CCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCeEEE
Q 016311 88 GGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIF 167 (391)
Q Consensus 88 ~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~l~l 167 (391)
....++++|++|++++++++++|.+.++++|++++..+||.+++..+++.||+||+++|+|+|++++++.+++++|++++
T Consensus 79 ~~~~l~~an~l~v~~~~~~~~~f~~~~~~~y~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~l~~~~~i~~~t~l~l 158 (372)
T cd02057 79 SFYSLKLIKRLYVDKSLNLSTDFINSTKRPYPKELETVDFKDKLEETRGQINNSIKELTDGHFENILNENSVNDQTKILV 158 (372)
T ss_pred ccchhHhhhhhhhhCCCCccHHHHHHHHHHhcCeeEEecCCCCHHHHHHHHHHHHHHhccChhhhcCCCCCCCCCCceee
Confidence 34579999999999999999999999999999999999998866789999999999999999999998889999999999
Q ss_pred EEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccc--ccCCeEEEEeecCCCCCCceEEEEEEecCC--
Q 016311 168 ANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVS--AFDGFKVLGLPYKQGEDKRRFSMYFFLPDA-- 243 (391)
Q Consensus 168 vna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~--~~~~~~vveLp~~~~~~~~~~sm~iilP~~-- 243 (391)
+||+||+|.|+.+|++..|.+++|+..+|+.+.||||++.+.++|. +..++++|+|||+++ +++|+||||++
T Consensus 159 vNa~yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vv~LPy~~~----~~sm~iiLP~~~~ 234 (372)
T cd02057 159 VNAAYFVGNWMKKFPESETKECPFRVNKTETKPVQMMNLEATFSMGYIDELNTKILELPFQNK----HLSMLILLPKDIE 234 (372)
T ss_pred eehheeccccCCCCCccccccCCCEECCCceEeeEhhheeceEEeEEeCCcCceEEEeecCCC----CEEEEEEecCccc
Confidence 9999999999999999999999999999999999999988766654 455889999999987 79999999985
Q ss_pred --CCChHHHHHHhcCchHHHhhcC--CCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCC
Q 016311 244 --KDGLPTLLEKMGSESKFLDHHL--PSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKN 319 (391)
Q Consensus 244 --~~~l~~l~~~L~~~~~~l~~~~--~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~ 319 (391)
..+|.++++.|+. ..+..+. ...+...++|+||||++++++||+++|++||++++|++..|||++|++ +.+
T Consensus 235 ~~~~~L~~l~~~l~~--~~l~~~~~~~~~~~~~v~l~lPKF~i~~~~~l~~~L~~lGi~~~F~~~~adfs~i~~---~~~ 309 (372)
T cd02057 235 DESTGLEKLEKQLTS--ESLSQWTNPSMMANAKVKVSLPKFKVEKMIDLKAMLESLGLKHIFNEDASDFSGMSE---TKG 309 (372)
T ss_pred cccccHHHHHHhcCh--hHHHHhhchhcceeEEEEEECCcEEEEEEechHHHHHHcCChhhcCCcccccccccC---CCc
Confidence 4689999999973 3355443 233445679999999999999999999999999999986799999987 467
Q ss_pred eeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 320 LYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 320 l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
++|++++|++.|||||+|++|+++|.... . +.+..|+|||||+|+|+|+.|+.|||+|+|.+|
T Consensus 310 l~vs~v~hk~~ieVdE~Gt~a~a~t~~~~----~--~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v~~p 372 (372)
T cd02057 310 VALSNVIHKVCLEVNEDGGESIEVPGARI----L--QHKDEFNADHPFIFIIRHNKTRNIIFFGRFCSP 372 (372)
T ss_pred eEEEeeeeeeEEEECCCCeecchhcceec----c--CCCCeEEeeCCEEEEEEECCCCeEEEEEEecCC
Confidence 99999999999999999999999987421 1 123579999999999999999999999999998
|
Maspin has tumor suppressing activity against breast and prostate cancer. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. |
| >cd02045 antithrombin-III_like Antithrombin is a serine proteinase inhibitor (serpin) which controls the process of coagulation | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-78 Score=584.70 Aligned_cols=371 Identities=32% Similarity=0.522 Sum_probs=324.6
Q ss_pred hhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC-----hhHHHHHHHHHHHH
Q 016311 5 ESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS-----NDQLNAFASELVAV 79 (391)
Q Consensus 5 ~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~-----~~~~~~~~~~l~~~ 79 (391)
.+..++++||++||+++.....+++|+++||+||+.+|+||+.||+|.|++||.++|+++. .++++..++.+...
T Consensus 4 ~~~~~~~~Fa~~l~~~l~~~~~~~~Niv~SP~si~~aL~ml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~l~~~ 83 (381)
T cd02045 4 ELSKANSRFALAFYKHLADSKSNDENIFLSPLSISTAFAMTKLGACNNTLEQLMEVFQFDTISEKTSDQVHFFFAKLNCR 83 (381)
T ss_pred hhhhhhhHHHHHHHHHHhcccCCCCCEEECcHHHHHHHHHHhhhcCCcHHHHHHHHhCCCccccccHHHHHHHHHHHHHH
Confidence 3456789999999999973224789999999999999999999999999999999999963 24677778887766
Q ss_pred HhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCC
Q 016311 80 VFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSV 159 (391)
Q Consensus 80 l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~ 159 (391)
+... ...+..+.++|++|+++++.++++|.+.++++|+++++.+||.+++..+++.||+||+++|+|+|++++++.++
T Consensus 84 ~~~~--~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~~~~~~vdF~~~~~~~~~~IN~wv~~~T~g~I~~ll~~~~l 161 (381)
T cd02045 84 LYRK--ANKSSELISANRLFGDKSLTFNETYQDISEIVYGAKLWPLDFKEKPELSRITINEWIANKTENRITDVIPEGAI 161 (381)
T ss_pred Hhcc--cCCcchhhhhhhhhhcCCCchhHHHHHHHHHhhcCeeEEecCCCCHHHHHHHHHHHHHHHHhhHHHhhCCCCCC
Confidence 6421 13456799999999999999999999999999999999999987677788999999999999999999988899
Q ss_pred CCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccc--cCCeEEEEeecCCCCCCceEEEE
Q 016311 160 DNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSA--FDGFKVLGLPYKQGEDKRRFSMY 237 (391)
Q Consensus 160 ~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLp~~~~~~~~~~sm~ 237 (391)
+++|+++++||+||+|.|+.+|++..|..++||..+|++++||||++.+.++|.. ..++++|+|||+++ +++|+
T Consensus 162 ~~~t~lvlvna~~Fkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~y~~~~~~~~~~l~LPy~~~----~~sm~ 237 (381)
T cd02045 162 DTNTVLVLVNAIYFKGLWKSKFDKENTRKDLFHKAPGEKCPVPMMYQESKFRYAKIPEDKVQVLELPYKGD----DITMV 237 (381)
T ss_pred CCccceeeEeeeEEeccccCCCCcccCcccccCcCCCcEEEEeccCccceeeeEecCCCCcEEEEeecCCC----ceEEE
Confidence 9999999999999999999999999999999999999999999999988887765 44889999999987 79999
Q ss_pred EEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCC
Q 016311 238 FFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVG 317 (391)
Q Consensus 238 iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~ 317 (391)
||||++..+|.+++++|+. ..+..+....+...++|.||||++++++||.++|++||++++|++..||||+|+... .
T Consensus 238 iilP~~~~~l~~l~~~l~~--~~l~~~~~~~~~~~v~v~lPkF~i~~~~~l~~~L~~lGi~~~F~~~~Adfs~i~~~~-~ 314 (381)
T cd02045 238 LILPKEGTTLSEVEQNLTL--DKLQGWLDAMKETTLAVQIPRFRVEDSFSVKEQLQKMGLEDLFSPENAKLPGIVAGG-R 314 (381)
T ss_pred EEeCCCCCCHHHHHHhcCH--HHHHHHHHhCcCcEEEEECCCEEEeeEecHHHHHHHcCCcccCCCCCCCccccccCC-C
Confidence 9999998899999999973 345555544445567899999999999999999999999999998679999998521 2
Q ss_pred CCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEe
Q 016311 318 KNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHV 385 (391)
Q Consensus 318 ~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v 385 (391)
.+++|++++|++.|+|||+|++|+|+|.+.+..++.+ .++++|++||||+|+|+|+.|+.|||+|||
T Consensus 315 ~~l~vs~v~hka~ieV~E~GteAaaat~~~~~~~s~~-~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v 381 (381)
T cd02045 315 TDLYVSDAFHKAFLEVNEEGSEASAATAVVITGRSLN-INRIIFVANRPFLLFIREVAINAIIFMGRV 381 (381)
T ss_pred CCceeeccceeeEEEECCCCeehhhhhhhhhhhccCC-CCCCEEEeeCCEEEEEEECCCCcEEEEEeC
Confidence 5799999999999999999999999998544445442 234689999999999999999999999996
|
It is the most important anticoagulant molecule in mammalian circulation systems, controlled by its interaction with the co-factor, heparin, which accelerates its interaction with target proteases, such as thrombin and factor Xa. This subgroup corresponds to clade C of the serpin superfamily. |
| >cd02058 PAI-2 Plasminogen Activator Inhibitor-2 (PAI-2) | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-78 Score=584.06 Aligned_cols=366 Identities=33% Similarity=0.542 Sum_probs=325.1
Q ss_pred hhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh----hHHHHHHHHHHHHHhhC
Q 016311 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN----DQLNAFASELVAVVFAD 83 (391)
Q Consensus 8 ~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~----~~~~~~~~~l~~~l~~~ 83 (391)
.++++||++||+++. ...+++|+|+||++|+.+|+||+.||+|+|++||.++||++.. .+++..++.+...+.+
T Consensus 3 ~~~~~F~~~l~~~~~-~~~~~~N~v~SP~si~~aL~~l~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~~~~- 80 (380)
T cd02058 3 AANTSFALNLFKKLA-ESSPTKNIFFSPWSISSALAMVYLGAKGNTAAQMAKVLQFNEVGGNSEDIHSGFQSLLSEINK- 80 (380)
T ss_pred hhhhHHHHHHHHHHh-hcCCCCcEEECHHHHHHHHHHHhcccCCcHHHHHHHHhCcCccccchHHHHHHHHHHHHHHhC-
Confidence 578999999999998 4567899999999999999999999999999999999999754 5788888888877653
Q ss_pred CCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcC
Q 016311 84 GSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNST 163 (391)
Q Consensus 84 ~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t 163 (391)
+..+..++++|+||++++++++++|.+.++++|++++..+||.+++..+++.||+||+++|+|+|++++++.++++++
T Consensus 81 --~~~~~~l~~~n~l~~~~~~~l~~~f~~~~~~~~~~~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~i~~~t 158 (380)
T cd02058 81 --PGTNYLLKSANRLYGEKTYPFLEKFLQLTQKYYQAEPQAVDFVEAAEQARKEINSWVERQTEGKIQNLLPPGSVDSLT 158 (380)
T ss_pred --CCCccEeehhhhhhhcCCCcHhHHHHHHHHhhhcCceEEecCCCCHHHHHHHHHHHHHHhcccchhhcCCcCCCChhH
Confidence 234568999999999999999999999999999999999999876678999999999999999999999888999999
Q ss_pred eEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccc--cCCeEEEEeecCCCCCCceEEEEEEec
Q 016311 164 RLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSA--FDGFKVLGLPYKQGEDKRRFSMYFFLP 241 (391)
Q Consensus 164 ~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLp~~~~~~~~~~sm~iilP 241 (391)
.++++||+||+|.|+.+|++..|..++|+..+|+++.||||++.+.++|.. ..++++|+|||+++ ++||+||||
T Consensus 159 ~lvlvna~~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vv~LPy~~~----~~sm~iiLP 234 (380)
T cd02058 159 RLVLVNAIYFKGNWEEKFLKENTRERPFRLNKNTTKPVQMMFLKKKFPITYIEELKAQVLELPYVGK----ELSMFILLP 234 (380)
T ss_pred HhHhhheeEEccccCCCCCcccCCcccccCCCCceEEeechhhcCceeeEEcCCCCcEEEEccCCCC----ceEEEEEec
Confidence 999999999999999999999999999999999999999999988666544 45889999999987 799999999
Q ss_pred CCC----CChHHHHHHhcCchHHHhhcC--CCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCC
Q 016311 242 DAK----DGLPTLLEKMGSESKFLDHHL--PSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSP 315 (391)
Q Consensus 242 ~~~----~~l~~l~~~L~~~~~~l~~~~--~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~ 315 (391)
++. .+|.+++++|+. ..+..+. +..+...++|.||||++++++||.++|++||++++|++..|||++|+.
T Consensus 235 ~~~~~~~~~L~~l~~~l~~--~~l~~~~~~~~~~~~~v~l~lPKF~i~~~~~l~~~L~~lGl~~~F~~~~adfs~i~~-- 310 (380)
T cd02058 235 DEIEDVTTGLEKLEKELTY--EKLNEWTSPEMMEEYEVEVYLPKFKLEESYDLKSTLSSMGMEDAFDPGKADFSGMSS-- 310 (380)
T ss_pred cccccccchHHHHHHHhCH--HHHHHhhhhhcceeeEEEEEeeEEEEeeeeccHHHHHHcCccccCCcccccccCCCC--
Confidence 987 789999999973 3455443 234456679999999999999999999999999999985699999987
Q ss_pred CCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 316 VGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 316 ~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
+.+++|++++|++.|||||+|++|+++|......++. +++++|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 311 -~~~l~vs~v~hk~~ieV~E~G~~a~a~t~~~~~~~~~--~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v~~P 380 (380)
T cd02058 311 -ANDLFLSKVFHKAFVEVNEEGTEAAAATAAIMMLRCL--MPSPRFNADHPFLFFIRHNKTNTILFFGRFCSP 380 (380)
T ss_pred -CCCCcccccceeeEEEECCCCcccccccchheeeccC--CCCCeEEEECCEEEEEEECCCCeEEEEEEecCC
Confidence 4689999999999999999999999999754433332 234689999999999999999999999999998
|
PAI-2 is a serine protease inhibitor that belongs to the ov-serpin branch of the serpin superfamily. It is is an effective inhibitor of urinary plasminogen activator (urokinase or uPA) and is involved in cell differentiation, tissue growth and regeneration. |
| >cd02051 PAI-1_nexin-1 Plasminogen activator inhibitor-1_like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-77 Score=579.27 Aligned_cols=366 Identities=27% Similarity=0.475 Sum_probs=323.1
Q ss_pred hhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHHhhC
Q 016311 4 RESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFAD 83 (391)
Q Consensus 4 ~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l~~~ 83 (391)
.....+.++||++||+++. ...+++|+|+||+||+.+|+||+.||+|+|+.||.++||++. .++...++.+.+.+..
T Consensus 5 ~~~~~~~~~F~~~l~~~~~-~~~~~~N~v~SP~si~~~L~~l~~GA~g~T~~el~~~L~~~~-~~~~~~~~~l~~~l~~- 81 (377)
T cd02051 5 SSLEELGSDFGIQVFNQVA-QARPQENVVVSPHGIASVLGMLQLGADGKTKKQLQTVMRYKI-NGVAKALKKLNKAIVS- 81 (377)
T ss_pred HHHHHHHhHHHHHHHHHHH-hcCCCCcEEECcHHHHHHHHHHHhhcCCcHHHHHHHHhCCCh-hHHHHHHHHHHHHHhc-
Confidence 3456789999999999998 457899999999999999999999999999999999999975 4566667777766532
Q ss_pred CCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCC-CCCCc
Q 016311 84 GSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPG-SVDNS 162 (391)
Q Consensus 84 ~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~-~~~~~ 162 (391)
..++..++++|++|++++++++++|++.++++|+++++.+||++ ++.+++.||+|++++|+|+|++++.+. .++++
T Consensus 82 --~~~~~~l~~an~i~~~~~~~l~~~f~~~~~~~f~a~~~~vdF~~-~~~a~~~IN~Wv~~~T~g~I~~~l~~~~~i~~~ 158 (377)
T cd02051 82 --KKNKDIVTTANAVFAQSGFKMEVPFVPRNKEVFQCEVKSVDFSD-PETAAFSINDWVKNETKGMIDNLLSPDLADDAL 158 (377)
T ss_pred --cCCccchHHHHHHHhcCCCchhHHHHHHHHHHhcCeeEEECCCC-HHHHHHHHHHHHHHhcCCCccccCCCCCCCCcc
Confidence 23445799999999999999999999999999999999999986 678999999999999999999999876 78889
Q ss_pred CeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc-----CCeEEEEeecCCCCCCceEEEE
Q 016311 163 TRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF-----DGFKVLGLPYKQGEDKRRFSMY 237 (391)
Q Consensus 163 t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~-----~~~~vveLp~~~~~~~~~~sm~ 237 (391)
|.++++||+||+|.|+.+|++..|.+++|+..+|+.+.|+||++.+.++|+.. .++++|+|||+++ ++||+
T Consensus 159 t~l~lvnai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~~~~vv~LPy~~~----~~sm~ 234 (377)
T cd02051 159 TRLVLVNALYFKGLWKSRFQPESTKKRTFHAGDGKTYQVPMLAQLSVFRSGSASTPNGLWYNIIELPYHGE----SISML 234 (377)
T ss_pred ceEEEEeeeEeeeeecCCCChhhCcccccCcCCCcEEeehhhcccCceeeEeeccccccccEEEEEecCCC----eEEEE
Confidence 99999999999999999999999999999999999999999999887777643 2479999999887 89999
Q ss_pred EEecCCC-CChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCC
Q 016311 238 FFLPDAK-DGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPV 316 (391)
Q Consensus 238 iilP~~~-~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~ 316 (391)
|+||++. .+|.+++++|+ ...+..+.+..+...++|.||||++++++||.++|++||++++|++..|||++|++
T Consensus 235 iiLP~~~~~~L~~l~~~l~--~~~l~~~~~~~~~~~v~v~lPkF~i~~~~~L~~~L~~lGl~~~F~~~~Adfs~i~~--- 309 (377)
T cd02051 235 IALPTEKSTPLSAIIPHIS--TKTIQSWMGTMVPKRMQLVLPKFTVEAETDLKEPLKALGITDMFDQSKANFTKISR--- 309 (377)
T ss_pred EEeccccCCCHHHHHHhcC--HHHHHHHHHhCCceEEEEEccCEEEEEecChHHHHHHCCCcccccCCCCCcccccC---
Confidence 9999865 47999999997 34455555555566789999999999999999999999999999976799999987
Q ss_pred CCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 317 GKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 317 ~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
.++++|++++|++.|+|||+|++|+|+|.+....++. +.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus 310 ~~~l~v~~v~hka~iev~E~Gt~aaa~t~~~~~~~~~----~~~f~~drPF~f~I~~~~t~~~LF~G~v~~P 377 (377)
T cd02051 310 SESLHVSHALQKAKIEVNEDGTKASAATTAILIARSS----PPWFIVDRPFLFFIRHNPTGTILFMGQINKP 377 (377)
T ss_pred CCCEEEEeEEEEEEEEECCCccchhhhcceeeeccCC----CCeEEeeCCEEEEEEeCCCCcEEEEEEecCC
Confidence 4689999999999999999999999999854444443 3479999999999999999999999999998
|
Plasminogen activator inhibitor-1 (PAI-1) is the primary, fast-acting inhibitor of plasminogen activators. It is often bound to vitronectin, an abundant component of the extracellular matrix in many tissues. Protease nexin-1 is a potent serpin able to inhibit thrombin, plasmin, and plasminogen activators. PAI-1 and nexin-1 are members of the serpin superfamily and represent clade E. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. |
| >cd00172 SERPIN SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-77 Score=573.59 Aligned_cols=360 Identities=36% Similarity=0.616 Sum_probs=324.4
Q ss_pred hhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC--hhHHHHHHHHHHHHHhhCCCC
Q 016311 9 NQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS--NDQLNAFASELVAVVFADGSP 86 (391)
Q Consensus 9 ~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~--~~~~~~~~~~l~~~l~~~~~~ 86 (391)
++++||++||+++. ...+++|+|+||+||+.+|+||++||+|+|++||.++|+++. ..+++..++.+.+.+.+ .
T Consensus 1 ~~~~Fa~~l~~~~~-~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~l~~---~ 76 (364)
T cd00172 1 ANNDFALDLYKQLA-KSEPDENVVFSPLSIASALALLYLGAGGETREQLRKVLGLPSLDDEDVHQAFKSLLSSLKD---S 76 (364)
T ss_pred CcchHHHHHHHHHh-hcCCCCCEEEcHHHHHHHHHHHhhhcCchHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHhC---C
Confidence 36899999999998 445789999999999999999999999999999999999984 46788888888887753 2
Q ss_pred CCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCeEE
Q 016311 87 SGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLI 166 (391)
Q Consensus 87 ~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~l~ 166 (391)
.++..++++|++|+++++.++++|++.+++.|+++++.+||.+ ++.+++.||+||+++|+|+|++++++.+++++|.++
T Consensus 77 ~~~~~l~~an~~~~~~~~~~~~~f~~~~~~~~~~~~~~~dF~~-~~~a~~~IN~wv~~~T~g~I~~~~~~~~i~~~t~l~ 155 (364)
T cd00172 77 EKGVELKLANRLFVQKGLTVKEDFLDLAKKYYDAEVESVDFAN-PEAAAAQINNWVEEKTNGKIKDLLSPDALDPDTRLV 155 (364)
T ss_pred CCCceeeeehhhhhhCCCchhHHHHHHHHHHhcCeeEEEcCCC-hHHHHHHHHHHHHhhhcccchhhCCCCCCCccccee
Confidence 3456899999999999999999999999999999999999987 478999999999999999999999888899999999
Q ss_pred EEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC--CeEEEEeecCCCCCCceEEEEEEecCCC
Q 016311 167 FANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGEDKRRFSMYFFLPDAK 244 (391)
Q Consensus 167 lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLp~~~~~~~~~~sm~iilP~~~ 244 (391)
++||+||+|.|+.+|++..|..++|+..+|+.+.||||++.+.++|++.+ ++++|+|||+++ ++||+||||++.
T Consensus 156 lvnai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vv~lpy~~~----~~sm~iilP~~~ 231 (364)
T cd00172 156 LVNAIYFKGKWKTPFDPELTRKRPFYVSEGESVQVPMMYQTGKFRYAEDEELDAQVLELPYKGS----DLSMLIILPKEV 231 (364)
T ss_pred eeeheeeeeccCCCCChhhceecccEeCCCcEEEEeCccccCcEEEEEcCccCcEEEEeecCCC----ceEEEEEecCCC
Confidence 99999999999999999999999999999999999999999988888776 899999999987 799999999998
Q ss_pred CChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCeeEee
Q 016311 245 DGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSS 324 (391)
Q Consensus 245 ~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~v~~ 324 (391)
.+|.+++++|+. ..++.+.+..+...++|+||||++++++||++.|++||++++|++ .||+++++. +.+++|++
T Consensus 232 ~~l~~l~~~l~~--~~l~~~~~~~~~~~v~l~lPkF~i~~~~~l~~~L~~~Gl~~~F~~-~a~~~~~~~---~~~l~v~~ 305 (364)
T cd00172 232 TGLAELEEKLSA--EKLDDLLSNLKEREVEVTLPKFKIESSLDLKEVLQALGITDLFSP-SADLSSISS---DEPLYVSK 305 (364)
T ss_pred CcHHHHHHhcCH--HHHHHHHHhCCeEEEEEEeeEEEEeeeeCcHHHHHHcCCccccCC-ccccccCCC---CCCeEEEe
Confidence 899999999973 445555555556778999999999999999999999999999998 899999887 57899999
Q ss_pred eeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEe
Q 016311 325 IFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHV 385 (391)
Q Consensus 325 ~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v 385 (391)
++|++.|+|||+|++|+++|......+ ..+.+.+|++||||+|+|+|+.|+.|||+|+|
T Consensus 306 v~hk~~ievdE~Gt~aaa~t~~~~~~~--~~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v 364 (364)
T cd00172 306 VIHKAFIEVNEEGTEAAAATAVSIVPR--RPSPPVEFKADRPFLFLIRDDTTGTILFLGRV 364 (364)
T ss_pred eeeeeEEEECCCceehhcccceeeccc--cCCCCCEEEEECCEEEEEEECCCCeEEEEEEC
Confidence 999999999999999999998543322 12335689999999999999999999999997
|
Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. |
| >cd02049 bacterial_SERPIN SERine Proteinase INhibitors (serpins), prokaryotic subgroup | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-77 Score=573.13 Aligned_cols=361 Identities=32% Similarity=0.591 Sum_probs=323.1
Q ss_pred hhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh--hHHHHHHHHHHHHHhhCC
Q 016311 7 ISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN--DQLNAFASELVAVVFADG 84 (391)
Q Consensus 7 ~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~--~~~~~~~~~l~~~l~~~~ 84 (391)
..++++||++||+++. ...+++|+||||++|+.+|+||++||+|+|++||.++||++.. .+++..++.+...+..
T Consensus 2 ~~~~~~F~~~l~~~~~-~~~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~ql~~~L~~~~~~~~~~~~~~~~l~~~l~~-- 78 (364)
T cd02049 2 NDANTRFGFKLFSELN-KEDVEKNIFISPLSIALALSMTYNGADGTTRKEMLKALGLDNIDLEDLNSALATLMDQLNT-- 78 (364)
T ss_pred cchhhHHHHHHHHHHh-hcCCCCCEEECHHHHHHHHHHHhhhcCchHHHHHHHHhCCCCCCHHHHHHHHHHHHHHHhc--
Confidence 3578999999999998 4567899999999999999999999999999999999999863 5788888888877752
Q ss_pred CCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCe
Q 016311 85 SPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTR 164 (391)
Q Consensus 85 ~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~ 164 (391)
...+..++++|++|++++++++++|.+.++++|++++..+||.+ + .+++.||+||+++|+|+|++++. .++++|+
T Consensus 79 -~~~~~~l~~an~i~~~~~~~~~~~f~~~~~~~~~~~v~~~dF~~-~-~a~~~IN~wv~~~T~g~I~~~~~--~i~~~t~ 153 (364)
T cd02049 79 -HDKTVELIIANSIWIEPGFTLKPDFLQTIKDYYQAYVLELDFQS-P-AAAEEINRWVKEKTKGKIDKIVD--KIDPDDV 153 (364)
T ss_pred -CCCCcEEEeehhhHhhCCCCccHHHHHHHHHhhcccceeeCCCC-H-HHHHHHHHHHHHhhcChHHHhcC--CCCCCce
Confidence 23457899999999999999999999999999999999999987 4 58999999999999999999996 3999999
Q ss_pred EEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccCCeEEEEeecCCCCCCceEEEEEEecCCC
Q 016311 165 LIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPDAK 244 (391)
Q Consensus 165 l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~~~~vveLp~~~~~~~~~~sm~iilP~~~ 244 (391)
++++||+||+|.|+.||++..|..++|+..+|+.+.||||++.+.++|.+.+++++++|||.++ +++|+||||++.
T Consensus 154 lvlvna~~fk~~W~~~F~~~~T~~~~F~~~~~~~~~v~mM~~~~~~~y~~~~~~~~l~Lpy~~~----~~sm~iiLP~~~ 229 (364)
T cd02049 154 MFLINAVYFKGDWQEPFDKQSTYEAPFYLPDGSTKEVPFMSRTGNFRYLETPGFQAVRLPYGDG----RLSMYVFLPKEN 229 (364)
T ss_pred EEEEeeEEEeeeecCCCChhhcccCcCCCCCCCEEECcccCCcCcEeeEEcCCCeEEEeecCCC----cEEEEEEecCCC
Confidence 9999999999999999999999999999999999999999999999998888999999999987 799999999999
Q ss_pred CChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCeeEee
Q 016311 245 DGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSS 324 (391)
Q Consensus 245 ~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~v~~ 324 (391)
.+|.+++++|+. ..+..+....+...++|.||||++++++||.++|++||++++|++..|||+++++ .+++|++
T Consensus 230 ~~l~~l~~~l~~--~~~~~~~~~~~~~~v~v~lPkF~i~~~~~L~~~L~~mGi~~~F~~~~a~~s~~~~----~~l~vs~ 303 (364)
T cd02049 230 VSLREFVKTLTA--EKWRKWIEQFRMREGSLSLPRFQLEYEIELRDALKALGMEEAFTPDAADFSKLGE----GNLYISK 303 (364)
T ss_pred CCHHHHHHHhCH--HHHHHHHHhCceeEEEEEeeeEEccceechHHHHHHCcccccCCCCcCCCCCCCC----CCeEEEe
Confidence 999999999973 3455555555566789999999999999999999999999999987799999876 5799999
Q ss_pred eeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEe
Q 016311 325 IFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHV 385 (391)
Q Consensus 325 ~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v 385 (391)
++|++.|+|||+|++|+|+|.+....++.+.+++++|++||||+|+|+|+.|+.|||+|||
T Consensus 304 v~hka~iev~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v 364 (364)
T cd02049 304 VIHKTFIEVNEEGTEAAAATSVEITETSAPAGEPFTMVADRPFLFAIRDNRTGSILFMGAV 364 (364)
T ss_pred eeeeEEEEEccCceeecccceeeeeeccCCCCCCceEEeeCCEEEEEEECCCCcEEEEEeC
Confidence 9999999999999999999985443333321345789999999999999999999999996
|
Little information about specific functions is available for this subgroup, most likely they are inhibitory members of the serpin superfamily. In general, serpins exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors. |
| >cd02046 hsp47 Heat shock protein 47 (Hsp47), also called colligin, because of its collagen binding ability, is a chaperone specific for procollagen | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-77 Score=571.63 Aligned_cols=359 Identities=22% Similarity=0.389 Sum_probs=315.7
Q ss_pred hhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh--hHHHHHHHHHHHHHhhCC
Q 016311 7 ISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN--DQLNAFASELVAVVFADG 84 (391)
Q Consensus 7 ~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~--~~~~~~~~~l~~~l~~~~ 84 (391)
..++++||++||+++. ...+++|+|+||+||+.+|+|++.||+|+|++||.++|++... .+++..++++...+..
T Consensus 4 ~~~~~~f~~~l~~~~~-~~~~~~N~v~SP~si~~aLa~l~~Ga~g~T~~ql~~~L~~~~~~~~~~~~~~~~l~~~l~~-- 80 (366)
T cd02046 4 ADRSAGLAFNLYHAMA-KDKGVENILLSPVVVASSLGLVSMGGKASTASQAKAVLSADKLKDEHVHTGLSELLNEVSN-- 80 (366)
T ss_pred hhhhhHHHHHHHHHhh-ccCCCCeEEEChHHHHHHHHHHHhhcCccHHHHHHHHhCCCCCCcHHHHHHHHHHHHHhhc--
Confidence 4578899999999998 4567899999999999999999999999999999999998642 4677788888766532
Q ss_pred CCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCe
Q 016311 85 SPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTR 164 (391)
Q Consensus 85 ~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~ 164 (391)
....+..+.++|++|+++++.++++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|++++. +++++|+
T Consensus 81 ~~~~~~~l~~an~~~~~~~~~l~~~F~~~~~~~y~~~~~~vdF~~-~~~a~~~IN~wv~~~T~g~I~~~~~--~i~~~t~ 157 (366)
T cd02046 81 STARNVTWKIGNRLYGPSSVSFADDFVKNSKKHYNYEHSKINFRD-KRSALNSINEWAAQTTDGKLPEVTK--DVEKTDG 157 (366)
T ss_pred CCCCCcEEEEeeehhhcCCCChhHHHHHHHHHHhcCeeEEecCCC-hHHHHHHHHHHHHHhcCCchhHhhc--cCCcchH
Confidence 112456899999999999999999999999999999999999987 5788999999999999999999984 6888999
Q ss_pred EEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc--CCeEEEEeecCCCCCCceEEEEEEecC
Q 016311 165 LIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF--DGFKVLGLPYKQGEDKRRFSMYFFLPD 242 (391)
Q Consensus 165 l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLp~~~~~~~~~~sm~iilP~ 242 (391)
++|+||+||+|.|+.+|++..|..++|+..+|+.+.||||++.+.+.|+.. .++++++|||+++ +++|+||||+
T Consensus 158 l~lvnaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~y~~~~~~~~~vl~LPy~~~----~~sm~iiLP~ 233 (366)
T cd02046 158 ALIVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVSVPMMHRTGLYGYYDDEENKLQIVEMPLAHK----LSSMIFIMPY 233 (366)
T ss_pred hhhhheEEEcchhcCCCCHHhceeccEEeCCCeEEEhhHhhccCceeeEEeCCCCeEEEEEEcCCC----cEEEEEEecC
Confidence 999999999999999999999999999999999999999999887776654 5899999999987 7999999999
Q ss_pred CCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCeeE
Q 016311 243 AKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYV 322 (391)
Q Consensus 243 ~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~v 322 (391)
+..+|.++++.|+. ..+..+.+..+...++|.||||++++++||+++|++||++++|++..||||+|++ .++++|
T Consensus 234 ~~~~L~~l~~~L~~--~~l~~~~~~~~~~~v~l~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~i~~---~~~l~v 308 (366)
T cd02046 234 HVEPLERLEKLLTR--EQLKTWISKMKKRAVAISLPKVSLEVSHDLQKHLGDLGLTEAIDKSKADLSKISG---KKDLYL 308 (366)
T ss_pred CCCCHHHHHHHhCH--HHHHHHHHhcceeEEEEEcceEEeeEEEcHHHHHHHcCCccccCCCCCCcccCCC---CCceee
Confidence 99999999999973 3455555555566789999999999999999999999999999876799999987 468999
Q ss_pred eeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEe
Q 016311 323 SSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHV 385 (391)
Q Consensus 323 ~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v 385 (391)
++++|++.|||||+|++|++++.. ... .+.+.+|+|||||+|+|+|+.|+.|||+|||
T Consensus 309 s~v~hka~ieV~E~G~~aaa~~~~----~~~-~~~~~~f~~nrPF~f~I~~~~t~~iLF~G~v 366 (366)
T cd02046 309 SNVFHAAALEWDTEGNPFDPDIYG----REE-MRNPKLFYADHPFIFLVKDNKTNSILFIGRL 366 (366)
T ss_pred eeeEEEEEEEECCCcchhhhhhhh----ccc-CCCCCEEEecCCEEEEEEECCCCcEEEEEeC
Confidence 999999999999999999866421 111 1224689999999999999999999999996
|
It has been shown to be essential for collagen biosynthesis, but its exact function is still unclear. Hsp47 is a non-inhibitory member of the SERPIN superfamily and corresponds to clade H. |
| >cd02047 HCII Heparin cofactor II (HCII) inhibits thrombin, the final protease of the coagulation cascade | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-76 Score=578.29 Aligned_cols=363 Identities=28% Similarity=0.453 Sum_probs=319.2
Q ss_pred hhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC---------hhHHHHHHH
Q 016311 4 RESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS---------NDQLNAFAS 74 (391)
Q Consensus 4 ~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~---------~~~~~~~~~ 74 (391)
+....++++||++||+++....++++|+++||+||+.+|+||++||+|+|++||.++||+++ ..+++..++
T Consensus 63 ~~~~~~~~~Fa~~L~~~l~~~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~ql~~~Lg~~~~~~~~~~~~~~~~~~~~~ 142 (436)
T cd02047 63 QRLNILNANFGFNLYRVLKDQVNTSDNILLAPVGISTAMGMISLGLKGQTQEQVLSTLGFKDFVNASSKYEITTVHNLFR 142 (436)
T ss_pred hHHHHHHhHHHHHHHHHHhhccCCCCcEEEChHHHHHHHHHHHhhcccHHHHHHHHHhcccccccccccccHHHHHHHHH
Confidence 45566789999999999973235789999999999999999999999999999999999963 135777888
Q ss_pred HHHHHHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccC
Q 016311 75 ELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVL 154 (391)
Q Consensus 75 ~l~~~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l 154 (391)
.+.+.+.. ...+..++++|++|+++++.++++|++.++++|+++++.+||++ + .++..||+||+++|+|+|++++
T Consensus 143 ~l~~~l~~---~~~~~~L~~an~l~v~~~~~l~~~F~~~~~~~y~a~v~~vdF~~-~-~~~~~IN~wV~~~T~g~I~~~l 217 (436)
T cd02047 143 KLTHRLFR---RNFGYTLRSVNDLYIKKDFPILLDFKNNVKTYYFAEAQIADFSD-P-AFITKTNNRIQKLTKGLIKEAL 217 (436)
T ss_pred HHHHHhhc---CCCCcEEeeeeehhhhCCCCccHHHHHHHHHHhcCceEEeCCCC-H-HHHHHHHHHHHHhcCCcccccc
Confidence 88776642 23567899999999999999999999999999999999999987 4 4567899999999999999999
Q ss_pred CCCCCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC--CeEEEEeecCCCCCCc
Q 016311 155 PPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGEDKR 232 (391)
Q Consensus 155 ~~~~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLp~~~~~~~~ 232 (391)
. .++++|+++|+||+||+|.|+.+|++..|..++|+..+|++++||||++.+.++|...+ ++++++|||++
T Consensus 218 ~--~i~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~MM~~~~~~~y~~~~~l~~~vleLPy~~----- 290 (436)
T cd02047 218 E--NVDPATLMMILNCIYFKGTWENKFPVEMTHNRNFRLNEKEVVKVPMMQTKGNFLAAADPELDCDILQLPYVG----- 290 (436)
T ss_pred c--cCCcccceeeeeeeEEechhhCcCCcccccCcCCEeCCCCEEEEehhcccceEEEEEcCCcCcEEEEecCCC-----
Confidence 5 78899999999999999999999999999999999999999999999988877776544 68999999986
Q ss_pred eEEEEEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCC
Q 016311 233 RFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMV 312 (391)
Q Consensus 233 ~~sm~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is 312 (391)
++||+|+||++..+|.+++++|+ ...+..+....+...++|.||||++++++||+++|++||++++|+. .|||++|+
T Consensus 291 ~~SM~iiLP~~~~gL~~l~~~L~--~~~l~~~~~~~~~~~v~v~LPKFkie~~~dL~~~L~~lGi~~lF~~-~adfs~is 367 (436)
T cd02047 291 NISMLIVVPHKLSGMKTLEKQIT--PQVVERWQKSMTNRTREVVLPKFKLEKNYNLIESLKLMGITDLFTE-KGNMAGVS 367 (436)
T ss_pred CeeEEEEeCcccCCHHHHHHHhC--HHHHHHHHHhCceeEEEEEeccEEEEeeecHHHHHHhcChhhhcCC-cccccccC
Confidence 49999999999999999999997 3455555555555667999999999999999999999999999997 79999998
Q ss_pred CCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCC
Q 016311 313 DSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389 (391)
Q Consensus 313 ~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~ 389 (391)
+ .+++|++++|++.|+|||+|++|+|+|.+....++ .+.+|++||||+|+|+|+.|+.|||+|||.+|.
T Consensus 368 ~----~~l~vs~v~hka~IeVdE~GteAaa~T~~~~~~~~----~~~~f~~drPFlf~I~d~~t~~iLF~G~v~~P~ 436 (436)
T cd02047 368 D----EKIAIDLFKHQGTITVNEEGTEAAAVTTVGFMPLS----TQVRFIVDRPFLFLIYEHRTNCLLFMGRVANPS 436 (436)
T ss_pred C----CCeEEEeeeeeeEEEEcCCcccchhccccccccCC----CCcEEEeeCCEEEEEEECCCCcEEEEEEecCCC
Confidence 7 46999999999999999999999999975333222 235799999999999999999999999999994
|
HCII is allosterically activated by binding to cell surface glycosaminoglycans (GAGs). The specificity of HCII for thrombin is conferred by a highly acidic hirudin-like N-terminal tail, which becomes available after GAG binding for interaction with the anion-binding exosite I of thrombin. This subgroup corresponds to clade D of the serpin superfamily. |
| >cd02056 alpha-1-antitrypsin_like alpha-1-antitrypsin_like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-76 Score=571.36 Aligned_cols=355 Identities=27% Similarity=0.468 Sum_probs=317.2
Q ss_pred hhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh----hHHHHHHHHHHHHHhhCC
Q 016311 9 NQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN----DQLNAFASELVAVVFADG 84 (391)
Q Consensus 9 ~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~----~~~~~~~~~l~~~l~~~~ 84 (391)
++++||++||+++. ...+++|+|+||++|+.+|+|+++||+|+|++||.++||++.. ++++..++.+...+..
T Consensus 1 ~~~~F~~~l~~~~~-~~~~~~N~v~SP~si~~~L~ml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l~~-- 77 (361)
T cd02056 1 ANADFAFRLYRQLA-SESPSKNIFFSPVSISTALAMLSLGARSSTLAQILEGLGFNLTEISEEEIHQGFQHLLHLLNQ-- 77 (361)
T ss_pred CccHHHHHHHHHHh-hcCCCCcEEEChHHHHHHHHHHHCccchhHHHHHHHHhcCCccCCCHHHHHHHHHHHHHHHcC--
Confidence 46899999999997 4568899999999999999999999999999999999999743 4678888888877742
Q ss_pred CCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCe
Q 016311 85 SPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTR 164 (391)
Q Consensus 85 ~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~ 164 (391)
...+..+.++|++|+++++.++++|++.++++|++++..+||.+ +..+++.||+|++++|+|+|+++++ +++++|.
T Consensus 78 -~~~~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~~~~~~~dF~~-~~~~~~~IN~wv~~~T~g~I~~~~~--~i~~~t~ 153 (361)
T cd02056 78 -PDSGLQLNMGNALFLDKRLKPLDKFLEDVKHLYESEAFSTDFQD-SAEAKKQINDYVEKKTHGKIVDLVK--DLDSDTV 153 (361)
T ss_pred -CCCcceEEeeeehhhhCCCChhHHHHHHHHHHhcCceEeeCCCC-hHHHHHHHHHHHHHHhhhhHHhhcC--CCCCCce
Confidence 23456899999999999999999999999999999999999986 5788999999999999999999996 6899999
Q ss_pred EEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC--CeEEEEeecCCCCCCceEEEEEEecC
Q 016311 165 LIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGEDKRRFSMYFFLPD 242 (391)
Q Consensus 165 l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLp~~~~~~~~~~sm~iilP~ 242 (391)
++++||+||+|.|+.+|++..|..++|+..+|+.+.||||++.+.++|+..+ ++++|+|||++ +++|+||||+
T Consensus 154 lvlvna~~Fk~~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~~veLPy~~-----~~sm~iiLP~ 228 (361)
T cd02056 154 MVLVNYIYFKGKWEKPFDPELTQEEDFFVDEKTTVKVPMMHQTGRYDYLHDSELSCTVVQMPYKG-----NATAFFVLPD 228 (361)
T ss_pred EEEEEEEeeeehccCCCCcccCcccCCEeCCCcEEEeecccccCcEeeEEcCCCCcEEEEEecCC-----CcEEEEEecC
Confidence 9999999999999999999999999999999999999999999888877665 88999999986 4899999999
Q ss_pred CCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCeeE
Q 016311 243 AKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYV 322 (391)
Q Consensus 243 ~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~v 322 (391)
++ +|.++++.|+ ...+.++....+...++|+||||++++++||+++|++||++++|+. .|||++|++ ..+++|
T Consensus 229 ~~-~l~~l~~~l~--~~~l~~~~~~~~~~~v~v~lPkF~i~~~~~l~~~L~~~Gi~~~F~~-~adfs~i~~---~~~l~v 301 (361)
T cd02056 229 EG-KMKQVEAALS--RDTLKKWSKLLSKRSVDLYLPKFSISGTYNLKDILPKMGITDVFSD-KADLSGITE---QPNLKV 301 (361)
T ss_pred cc-hHHHHHHhhC--HHHHHHHHHhCceeEEEEEeeeEEEeeeechHHHHHhcChhhhcCC-cCCccccCC---CCCEEE
Confidence 87 8999999997 3445555555556678999999999999999999999999999986 899999997 468999
Q ss_pred eeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEe
Q 016311 323 SSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHV 385 (391)
Q Consensus 323 ~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v 385 (391)
++++|++.|+|||+|++|+|+|.+....++. .+.+|++||||+|+|+|+.|+.|||+|+|
T Consensus 302 s~v~qk~~iev~E~Gt~aaa~t~~~~~~~~~---~~~~f~~drPF~f~I~~~~t~~iLF~G~v 361 (361)
T cd02056 302 SKAVHKAVLDVDEKGTEAAAATGVEITPMSA---LPPILKFNRPFLLLIFDRTTESILFLGKV 361 (361)
T ss_pred EeeeeeeEEEEcCCCcccccccchhhhcccC---CCCEEEEeCCEEEEEEECCCCcEEEEEeC
Confidence 9999999999999999999999854443332 24589999999999999999999999997
|
This family contains a variety of different members of clade A of the serpin superfamily. They include the classical serine proteinase inhibitors, alpha-1-antitrypsin and alpha-1-antichymotrypsin, protein C inhibitor, kallistatin, and noninhibitory serpins, like corticosteroid and thyroxin binding globulins. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. Many serpins, such as antitrypsin and antichymotrypsin, function as serine protease inhibitors which regulate blood coagulation cascades. Non-inhibitory serpins perform many diverse functions such as chaperoning proteins or transporting hormones. Serpins are of medical interest because mutants have been associated with blood clotting disorders, emphysema, cirrhosis, and dementia. |
| >smart00093 SERPIN SERine Proteinase INhibitors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-76 Score=571.01 Aligned_cols=352 Identities=37% Similarity=0.613 Sum_probs=312.7
Q ss_pred HHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh----hHHHHHHHHHHHHHhhCCCCCCCC
Q 016311 15 LSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN----DQLNAFASELVAVVFADGSPSGGP 90 (391)
Q Consensus 15 ~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~----~~~~~~~~~l~~~l~~~~~~~~~~ 90 (391)
++||+++. ..++++|+|+||+||+.+|+|++.||+|+|++||.++||++.. .+++..++.+...+.. ...+.
T Consensus 1 ~~l~~~l~-~~~~~~N~v~SP~si~~~L~ml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l~~---~~~~~ 76 (359)
T smart00093 1 FDLYKELA-KESPDKNIFFSPVSISSALAMLSLGAKGSTATQILEVLGFNLTELSEADIHQGFQHLLQLLNR---PDSQL 76 (359)
T ss_pred ChHHHHHh-ccCCCCeEEEChHHHHHHHHHHHcccCchHHHHHHHHcCCCCCCCCHHHHHHHHHHHHHHHhC---CCCcc
Confidence 37899997 4567899999999999999999999999999999999999853 3678888888877642 23446
Q ss_pred eeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCeEEEEEe
Q 016311 91 RLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANA 170 (391)
Q Consensus 91 ~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~l~lvna 170 (391)
.++++|++|++++++++++|++.++++|+++++.+||.+.++.+++.||+||+++|+|+|+++++ +++++|.++++||
T Consensus 77 ~l~~an~i~~~~~~~l~~~f~~~~~~~~~~~~~~~dF~~~~~~a~~~IN~wv~~~T~g~I~~~~~--~i~~~t~lvlvna 154 (359)
T smart00093 77 ELKTANALFVDKSLKLKDSFLEDIKKLYGAEVQSVDFSDKAEEAKKQINDWVEKKTQGKIKDLLS--DLDSDTRLVLVNA 154 (359)
T ss_pred eEEeeeeehccCCCchhHHHHHHHHHHhcCeeEEecCCCCHHHHHHHHHHHHHHhhhchHHHhcc--cCCCCceEEEEee
Confidence 89999999999999999999999999999999999999855679999999999999999999996 4889999999999
Q ss_pred eeeccccccccccCCCcccCeEeCCCceEeecccccccc-cccccc--CCeEEEEeecCCCCCCceEEEEEEecCCCCCh
Q 016311 171 LYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKN-QFVSAF--DGFKVLGLPYKQGEDKRRFSMYFFLPDAKDGL 247 (391)
Q Consensus 171 ~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~-~~~~~~--~~~~vveLp~~~~~~~~~~sm~iilP~~~~~l 247 (391)
+||+|.|+.+|++..|..++|+..+|+.+.||||++.+. ++|++. .++++|+|||++ ++||+||||++ .+|
T Consensus 155 iyFkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~y~~~~~~~~~vv~Lpy~~-----~~sm~iilP~~-~~l 228 (359)
T smart00093 155 IYFKGKWKTPFDPELTREEDFHVDETTTVKVPMMSQTGRTFNYGHDEELNCQVLELPYKG-----NASMLIILPDE-GGL 228 (359)
T ss_pred EEEeeECCCCCCcccceecccEeCCCeEEEEeceeccCceeEEEEcCCCCcEEEEEecCC-----CeeEEEEccCc-cHH
Confidence 999999999999999999999999999999999999887 777654 478999999996 49999999998 589
Q ss_pred HHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCeeEeeeee
Q 016311 248 PTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQ 327 (391)
Q Consensus 248 ~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~v~~~~q 327 (391)
.+++++|+ ...+..+....+...++|+||||++++++||+++|++||++++|+. .|||++|++ +.+++|++++|
T Consensus 229 ~~l~~~l~--~~~l~~~~~~~~~~~v~l~lPkf~i~~~~~l~~~L~~lGl~~~F~~-~adfs~i~~---~~~l~vs~v~h 302 (359)
T smart00093 229 EKLEKALT--PETLKKWMKSLTKRSVELYLPKFKIEGTYDLKDVLEKLGITDLFSN-KADLSGISE---DKDLKVSKVLH 302 (359)
T ss_pred HHHHHhhC--HHHHHHHHHhccceEEEEEccEEEEEEEecHHHHHHHcCcchhccC-ccCcccccC---CCCeEEEeeee
Confidence 99999997 3345555444555678999999999999999999999999999995 899999987 46899999999
Q ss_pred eeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 328 KSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 328 ~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
++.|+|||+|++|+|+|.+....++. +.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus 303 ka~ieVdE~Gt~aaa~t~~~~~~~~~----~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P 359 (359)
T smart00093 303 KAVLEVNEEGTEAAAATGVIAVPRSL----PPEFKANRPFLFLIRDNKTGSILFMGKVVNP 359 (359)
T ss_pred EEEEEEcCCCccccccccccccccCC----CceEEecCCEEEEEEECCCCeEEEEEecCCC
Confidence 99999999999999999854433332 3689999999999999999999999999998
|
|
| >cd02052 PEDF Pigment epithelium-derived factor (PEDF)_like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-76 Score=567.96 Aligned_cols=358 Identities=25% Similarity=0.419 Sum_probs=314.9
Q ss_pred chhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC--hhHHHHHHHHHHHH
Q 016311 2 DVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS--NDQLNAFASELVAV 79 (391)
Q Consensus 2 ~~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~--~~~~~~~~~~l~~~ 79 (391)
+......+.++||++||+++. ...+++|+++||+||+.+|+||+.||+|+|++||+++||++. ..+++..++.+...
T Consensus 11 ~~~~l~~~~~~Fa~~l~~~l~-~~~~~~Nvv~SP~si~~~L~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~l~~~ 89 (374)
T cd02052 11 PRNKLAAAVSNFGYDLYRQQA-SRDPTANVFLSPLSIATALSQLSLGAGERTESQIHRALYYDLLNDPELHDTYKDLLAS 89 (374)
T ss_pred cHHHHHHHHHHHHHHHHHHHh-ccCCCCcEEEChHHHHHHHHHHHhccChHHHHHHHHHhCCCCCChHHHHHHHHHHHHH
Confidence 345667889999999999998 457889999999999999999999999999999999999864 35688888988877
Q ss_pred HhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCC
Q 016311 80 VFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSV 159 (391)
Q Consensus 80 l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~ 159 (391)
+.. .+..++++|++|++++++++++|++.++++|++++..+||.. .+++.||+||+++|+|+|+++++ ++
T Consensus 90 l~~-----~~~~l~~an~i~v~~~~~l~~~f~~~~~~~~~~~~~~~~~~~---~~~~~IN~wv~~~T~g~I~~~l~--~i 159 (374)
T cd02052 90 LTA-----PAKGLKSASRILLERKLRLRLEFVNQVEKSYGERPRILAGNA---LDLQEINDWVQQQTGGKVDRFVK--EI 159 (374)
T ss_pred hcC-----CCccchhhhHHHHhCCCchhHHHHHHHHHHhhCccccccCCH---HHHHHHHHHHHHhhcCcHHHhCC--CC
Confidence 742 223699999999999999999999999999999999999843 68899999999999999999996 48
Q ss_pred CCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccc-ccccccc--CCeEEEEeecCCCCCCceEEE
Q 016311 160 DNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKK-NQFVSAF--DGFKVLGLPYKQGEDKRRFSM 236 (391)
Q Consensus 160 ~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~-~~~~~~~--~~~~vveLp~~~~~~~~~~sm 236 (391)
+++|.++|+||+||+|.|+.+|++..|..++|+..+|++++||||++.+ .++|... .++++|+|||+++ +||
T Consensus 160 ~~~t~l~lvNa~yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~~~~~vveLPy~~~-----~sm 234 (374)
T cd02052 160 PRNVSILLLGSAYFKGQWITKFDKRNTVLTDFHLDEQRTVVVPMMSDPNAPVRYGLDSDLNCKIAQLPLTGG-----VSI 234 (374)
T ss_pred CCccceEEEeeEEEechhcCCCCcccCccccEEcCCCcEEEEEeeccCCcceeeEEcCCCCcEEEEEecCCC-----eEE
Confidence 8999999999999999999999999999999999999999999999854 5666554 4789999999864 999
Q ss_pred EEEecCCCC-ChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCC
Q 016311 237 YFFLPDAKD-GLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSP 315 (391)
Q Consensus 237 ~iilP~~~~-~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~ 315 (391)
+||||++.. +|..++++|+. ..++.+....+...++|.||||++++++||+++|++||++++|+. ||||+|++
T Consensus 235 ~iiLP~~~~~~L~~l~~~l~~--~~~~~~~~~~~~~~v~v~lPKF~i~~~~~l~~~L~~lGl~~~F~~--adfs~i~~-- 308 (374)
T cd02052 235 MFFLPDKVTQNLTLIEESLTS--EFVHDIDRELKTVKAVLTLPKLKLSYETELLPSLQELKLQSLFAS--PDFTKITS-- 308 (374)
T ss_pred EEEecCCCCCCHHHHHhhcCH--HHHHHHHHhCeEEEEEEECccEEEEEEechHHHHHhcCCcccccc--cchhhccc--
Confidence 999999865 69999999973 345555555556678999999999999999999999999999984 99999986
Q ss_pred CCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 316 VGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 316 ~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
.+++|++++|++.|+|||+|++|+|+|.+... ++ .+.+|++||||+|+|+|+.||.|||+|||.+|
T Consensus 309 --~~l~v~~v~hk~~ieVdE~Gt~aaa~t~~~~~-~~----~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 374 (374)
T cd02052 309 --KPIKLSHVHHKAVLELNEDGAETAPTPGSATA-LT----FPLEYHVDRPFLFVLRDEDTGALLFIGKVLDP 374 (374)
T ss_pred --cceEeEeeEEEEEEEECCCccccccccccccc-cC----CCeEEEeeCCEEEEEEECCCCcEEEEEEecCC
Confidence 46999999999999999999999999974322 21 24689999999999999999999999999998
|
PEDF is non-inhibitory member of the Serpin superfamily. It exhibits neurotrophic, neuroprotective and antiangiogenic properties and is widely expressed in the developing and adult nervous systems. This subgroup corresponds to clade F1 of the serpin superfamily. |
| >PF00079 Serpin: Serpin (serine protease inhibitor); InterPro: IPR023796 Peptide proteinase inhibitors can be found as single domain proteins or as single or multiple domains within proteins; these are referred to as either simple or compound inhibitors, respectively | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-76 Score=568.47 Aligned_cols=365 Identities=35% Similarity=0.627 Sum_probs=327.3
Q ss_pred hhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC--hhHHHHHHHHHHHHHhhCCC
Q 016311 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS--NDQLNAFASELVAVVFADGS 85 (391)
Q Consensus 8 ~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~--~~~~~~~~~~l~~~l~~~~~ 85 (391)
.++++||++||+++. ...+++|+|+||++|+.+|+||++||+|+|++||.++||++. ..+++..++.+...+.. .
T Consensus 1 ~a~~~f~~~L~~~~~-~~~~~~N~v~SP~si~~~L~~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~~~l~~~l~~--~ 77 (371)
T PF00079_consen 1 AANNQFALKLFKALS-KSNPDENFVFSPLSIYSALAMLYLGASGETRKELRKVLGLPGSDDEEIHEYFKKLLQSLNS--S 77 (371)
T ss_dssp HHHHHHHHHHHHHHH-HHSTTSSEEE-HHHHHHHHHHHHHTSCHHHHHHHHHHTTCTTSTHHHHHHHHHHHHHHHHS--C
T ss_pred ChHHHHHHHHHHHHH-hhCCCCcEEEChHHHHHHHHHHHhhccCCHHHHHHHHhhhcccccccchhhhhhhhhhhhc--c
Confidence 368999999999998 456899999999999999999999999999999999999973 47788889999888763 2
Q ss_pred CCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCeE
Q 016311 86 PSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRL 165 (391)
Q Consensus 86 ~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~l 165 (391)
+..+..+.++|++|++++++++++|++.++++|+++++.+||.+. ..+++.||+|++++|+|+|++++++++++++|.+
T Consensus 78 ~~~~~~~~~~~~l~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~-~~~~~~IN~wv~~~T~g~I~~~v~~~~i~~~t~~ 156 (371)
T PF00079_consen 78 PSDNPQLKLANKLFVDKNLPLKPEFKKTLKKYFNAEVESVDFSDP-PQAAKEINKWVSEKTNGKIKNLVSPNDIDPDTRL 156 (371)
T ss_dssp STSSSEEEEEEEEEEETTSEBEHHHHHHHHHHHSEEEEEEETTSH-HHHHHHHHHHHHHHTTTSSSTSSSTTSSSTTEEE
T ss_pred ccccccceeeeeeecccccccccccchhhhhcccccccccccccc-chhhhhhcchhhhhccceeeccccccchhhHHHH
Confidence 346789999999999999999999999999999999999999984 5699999999999999999999998899999999
Q ss_pred EEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC--CeEEEEeecCCCCCCceEEEEEEecCC
Q 016311 166 IFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGEDKRRFSMYFFLPDA 243 (391)
Q Consensus 166 ~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLp~~~~~~~~~~sm~iilP~~ 243 (391)
+++||+||+|.|+.+|++..|..++|+..+|+++.|+||++.+.++|++.+ ++++|+|||++ +++|+||||++
T Consensus 157 vlina~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~~l~~~~v~Lp~~~-----~~sm~iilP~~ 231 (371)
T PF00079_consen 157 VLINAIYFKGKWKYPFDPENTEKRPFYVSDGKSVSVPMMHQSGRFRYAEDEDLDAQVVELPYKG-----NFSMLIILPDE 231 (371)
T ss_dssp EEEEEEEEEEEBSSTEEGGGEEEEEEECSSSEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBST-----SEEEEEEEESS
T ss_pred hhcccccccccccccccccccccccccccccccceEEEEecccccccccccccceeEEEecccc-----ceeeEEEEecc
Confidence 999999999999999999999999999999999999999999888877655 99999999976 49999999999
Q ss_pred CCChHHHHHHhcCchHHHhhcCCCCceeeee--eeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCee
Q 016311 244 KDGLPTLLEKMGSESKFLDHHLPSQRVEVGD--FRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLY 321 (391)
Q Consensus 244 ~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~--l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~ 321 (391)
..+|.+++++|+. ..+..++...+...++ |.||||++++++||.++|++||++++|++..|||++|++ ..+++
T Consensus 232 ~~~l~~l~~~l~~--~~l~~~~~~~~~~~~~~~l~lPkf~i~~~~dl~~~L~~lGi~~~F~~~~adfs~i~~---~~~~~ 306 (371)
T PF00079_consen 232 GDGLDELEKKLTS--ERLQEIISNLKMRKVDEELSLPKFKIESSIDLKELLKKLGIKDLFDPDSADFSGISD---DEPLY 306 (371)
T ss_dssp TTTHHHHHHHHSH--HHHHHHHHHCEEEEEEEEEEEEEEEEEEEEEHHHHHHHTTTTGGGSTTTSSCTTTBS---SSTEE
T ss_pred ccchhhhhhhccc--ccccccccccccccccceeeecccccccccccceeeehhhccccccccccccccccc---ceeee
Confidence 8899999999983 3455665555555566 999999999999999999999999999955899999997 47999
Q ss_pred EeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 322 VSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 322 v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
|++++|++.|+|||+|++|+|+|.+ .. .....+++.+|++||||+|+|+|+.||.|||+|+|.||
T Consensus 307 v~~v~qk~~i~v~E~G~~a~a~t~~-~~-~~~~~~~~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P 371 (371)
T PF00079_consen 307 VSDVIQKAVIEVDEEGTEAAAATAV-MA-SISSPPPPIEFIADRPFLFFIRDRSTGSILFMGKVVDP 371 (371)
T ss_dssp EEEEEEEEEEEEESSEEEEEEEEEE-EE-EESSSSSSEEEECSSEEEEEEEETTTTEEEEEEEESST
T ss_pred eeeccceeeeccccccccccccccc-cc-cccccccCcEEEEcCCEEEEEEECCCCcEEEEEEecCC
Confidence 9999999999999999999999942 22 22223457899999999999999999999999999999
|
In many cases they are synthesised as part of a larger precursor protein, either as a prepropeptide or as an N-terminal domain associated with an inactive peptidase or zymogen. This domain prevents access of the substrate to the active site. Removal of the N-terminal inhibitor domain either by interaction with a second peptidase or by autocatalytic cleavage activates the zymogen. Other inhibitors interact direct with proteinases using a simple noncovalent lock and key mechanism; while yet others use a conformational change-based trapping mechanism that depends on their structural and thermodynamic properties. Serpins (SERine Proteinase INhibitors) [, , ] belong to MEROPS inhibitor family I4, clan ID. Serpins are proteins that are primarily known as irreversible serine protease inhibitors active against S1 (IPR001254 from INTERPRO), S8 (IPR000209 from INTERPRO) and C14 (IPR002398 from INTERPRO) peptidases. There are both extra- and intra-cellular serpins, which are found in all groups of organisms with the notable exception of fungi [, ]. In contrast to "rigid" proteinase inhibitors, such as those of the Kunitz or Kazal families, the serpins are metastable proteins (active-state proteins) which interact with their substrate and irreversibly trap the acyl intermediate as a result of a major conformational change []; they are best described as suicide substrate inhibitors. The common structure of these proteins is a multi-domain fold containing a bundle of 8 or 9 alpha helices and a beta sandwich formed by 3 beta sheets. The reactive centre loop (RCL) is found in the C-terminal part of these proteins. Serpins and their homologues are a group of high molecular weight (40 to 50 kDa) structurally related proteins involved in a number of fundamental biological processes such as blood coagulation, complement activation, fibrinolysis, angiogenesis, inflammation, tumour suppression and hormone transport. All known serpins have been classified into 16 clades and 10 orphan sequences; the vertebrate serpins can be conveniently classified into six sub-groups []. In human plasma they represent approximately 2% of the total protein, of which 70% is alpha-1-antitrypsin. On the basis of strong sequence similarities, a number of proteins with no known inhibitory activity also belong to this family, these include: angiotensinogen, corticosteroid-binding globulin and thyroxin-binding globulin []. This entry represents the structural domain of serpins. It consists of a cluster of helices and a beta-sandwich.; PDB: 3PZF_A 3B9F_I 1MTP_A 1SNG_A 1ANT_I 2ZNH_B 1BR8_I 1SR5_A 1E03_L 1AZX_L .... |
| >cd02055 PZI Protein Z-dependent protease inhibitor (ZPI) is a member of the serpin superfamily of proteinase inhibitors (clade A10) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-75 Score=557.38 Aligned_cols=355 Identities=27% Similarity=0.432 Sum_probs=307.7
Q ss_pred hhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh-----hHHHHHHHHHHHHH
Q 016311 6 SISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN-----DQLNAFASELVAVV 80 (391)
Q Consensus 6 ~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~-----~~~~~~~~~l~~~l 80 (391)
++.++++||++||+++. . .+++|+|+||+||+.+|+|+++||+|+|++||.++||++.. .+++..++.+.+.+
T Consensus 2 ~~~~~~~Fa~~l~~~~~-~-~~~~Nvv~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~~~l~~~~ 79 (365)
T cd02055 2 FAEETANFGFNLLRKIA-M-KHDGNIIFSPFGMSLAMAGLLLAAEGETERQIAKALHLHALKDRDPGLLPALFKGLKDNI 79 (365)
T ss_pred cchhhhHHHHHHHHHHh-c-CCCCcEEEChHHHHHHHHHHHhhcCchHHHHHHHHcCCCCCccccHHHHHHHHHHHHHHh
Confidence 46788999999999997 3 46789999999999999999999999999999999999642 34666777776655
Q ss_pred hhCCCCCCCCeeeeeee--eeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCC
Q 016311 81 FADGSPSGGPRLSVANG--VWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGS 158 (391)
Q Consensus 81 ~~~~~~~~~~~l~~~n~--i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~ 158 (391)
. .+..+.++++ +|+++++.++++|++.++++|++++..+||.+ ++.+++.||+||+++|+|+|++++. +
T Consensus 80 ~------~~~~~~l~~~~~~~v~~~~~l~~~F~~~~~~~y~~~~~~vdF~~-~~~a~~~IN~wv~~~T~g~I~~~~~--~ 150 (365)
T cd02055 80 S------RNEELGFTQGIFAFIHKDFDVKEAFFNLSKQYFDMECLCMDFQN-ASQAKFLINHNIKKETKGKIPELFD--E 150 (365)
T ss_pred c------CCcceehHHHHHHHHHCCCCccHHHHHHHHHHhcCeeEEECCCC-hHHHHHHHHHHHHHhhcchHHHHhh--c
Confidence 2 1223455555 59999999999999999999999999999987 5678899999999999999999995 6
Q ss_pred CCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccc--cCCeEEEEeecCCCCCCceEEE
Q 016311 159 VDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSA--FDGFKVLGLPYKQGEDKRRFSM 236 (391)
Q Consensus 159 ~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLp~~~~~~~~~~sm 236 (391)
++++|+++++||+||+|.|+.||++..|..++|+..+|+.+.||||++.+.++|.. ..++++++|||++ +++|
T Consensus 151 i~~~t~l~lvnai~Fkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vv~LPy~~-----~~sm 225 (365)
T cd02055 151 IDPESKLILLDYIFFKGKWLTPFDPEFTEIDTFHIDKYKSIKVPMMFGADKFASTFDENFRCHVIKLPYKG-----KATM 225 (365)
T ss_pred CCccchhhhhHHHHHHHHHhCCCChhhCccceEEcCCCcEEEehhhcccCceeeEEeCCCCeEEEEeeeCC-----CcEE
Confidence 88999999999999999999999999999999999999999999999988776544 4578999999996 4899
Q ss_pred EEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCC
Q 016311 237 YFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPV 316 (391)
Q Consensus 237 ~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~ 316 (391)
+||||++..+|.++++.|+. ..+..+....+...++|.||||++++++||+++|++||++++|++ .|||++|+.+
T Consensus 226 ~iiLP~~~~~l~~l~~~l~~--~~l~~~~~~~~~~~v~l~lPKF~i~~~~~l~~~L~~lGi~~~F~~-~adls~i~~~-- 300 (365)
T cd02055 226 LIVIMEKGEDHLALEDHLTM--DLVESWLANMKSRNMDIFFPKFKLDQKYEMHELLRALGIKNIFAP-FADLSELLAD-- 300 (365)
T ss_pred EEEEcCCCCCHHHHHHHhhH--HHHHHHHHhccceEEEEEEEEEEEEEEeehHHHHHHcCcchhhcC-cCCcccccCC--
Confidence 99999998899999999973 345555554455667999999999999999999999999999987 7999998642
Q ss_pred CCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEe
Q 016311 317 GKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHV 385 (391)
Q Consensus 317 ~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v 385 (391)
+++++|++++|++.|||||+|++|+|+|......++. +..|++||||+|+|+|+.+|.|||+|||
T Consensus 301 ~~~l~vs~v~hka~ievdE~Gt~aaa~t~~~~~~~~~----~~~f~~nrPF~f~I~~~~~~~~LF~G~v 365 (365)
T cd02055 301 GKHLQVSQVLQKAVIEVDEKGTEAAAAIGSEIIAFSM----PPVIKVDRPFHFMIFEETFGMLLFIGRV 365 (365)
T ss_pred CCcEEEEeeeEEEEEEEccCCchhhhhhcceecccCC----CCeEEeeCCEEEEEEECCCCcEEEEEeC
Confidence 4689999999999999999999999999743333332 2479999999999999999999999996
|
ZPI inhibits coagulation factor Xa , dependent on protein Z (PZ), a vitamin K-dependent plasma protein. ZPI also inhibits factor XIa in a process that does not require PZ. In general, SERine Proteinase INhibitors (serpins) exhibit conformational polymorphism shifting from native to cleaved, latent, delta, or polymorphic forms. |
| >cd02053 alpha2AP Alpha2-antiplasmin (alpha2AP) is the primary inhibitor of plasmin, a proteinase that digests fibrin, the main component of blood clots | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-74 Score=547.63 Aligned_cols=346 Identities=27% Similarity=0.462 Sum_probs=295.6
Q ss_pred hhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHHhhCCCC
Q 016311 7 ISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFADGSP 86 (391)
Q Consensus 7 ~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~~ 86 (391)
..++++||++||++++ ..++++|+|+||+||+.+|+|+++||+|+|++||.++||++....++. +.+.+.+ .
T Consensus 2 ~~~~~~F~~~l~~~~~-~~~~~~N~v~SP~si~~aL~~l~~Ga~g~T~~el~~~L~~~~~~~~~~----~~~~l~~---~ 73 (351)
T cd02053 2 ARAMMGFSTDLLSEVA-QESTKPNLILSPLSIALALSHLALGAQNETEQRLLKTLHAESLPCLHH----LLSRLRQ---D 73 (351)
T ss_pred CcchhhHHHHHHHHHH-hhCCCCcEEECcHHHHHHHHHHHhhcChHHHHHHHHhcCCCChHHHHH----HHHHHhc---c
Confidence 3568899999999998 457889999999999999999999999999999999999976544433 3333332 1
Q ss_pred CCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCeEE
Q 016311 87 SGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLI 166 (391)
Q Consensus 87 ~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~l~ 166 (391)
..+..++++|++|++++++++++|.+.++++|++++ +||...+..+++.||+||+++|+|+|++++. +++++|.++
T Consensus 74 ~~~~~l~~an~i~v~~~~~~~~~f~~~~~~~~~~~~--~~~~~~~~~~~~~IN~wv~~~T~g~I~~~~~--~~~~~t~~v 149 (351)
T cd02053 74 LGPGALRLATRMYLQKGFEIKESFLEESEKLYGAKP--VSLTGTKEDDLANINKWVKEATEGQIPNFLS--DLPHDTVLL 149 (351)
T ss_pred CCccEeehhhHHHHhCCCchhHHHHHHHHHHcCCEE--eecCCCCHHHHHHHHHHHHHhccCchhHhcC--CCCcchHhh
Confidence 244689999999999999999999999999999875 5665445678999999999999999999985 688999999
Q ss_pred EEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccc-ccccc--ccCCeEEEEeecCCCCCCceEEEEEEecCC
Q 016311 167 FANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKK-NQFVS--AFDGFKVLGLPYKQGEDKRRFSMYFFLPDA 243 (391)
Q Consensus 167 lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~-~~~~~--~~~~~~vveLp~~~~~~~~~~sm~iilP~~ 243 (391)
++||+||+|.|+.+|++..|.+++|+..+|++++||||+... .++|. +..++++++|||++ ++||+||||++
T Consensus 150 lvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~~vleLPy~~-----~~Sm~iiLP~~ 224 (351)
T cd02053 150 LLNAIHFKGFWRNKFDPSLTQRDAFHLDDDFTVSVEMMQASTYPLRWFHLEQPEIQVAKFPFKG-----NMSFVVLMPTP 224 (351)
T ss_pred eeeEEEEeeeecCCCChhcCeecceEECCCceEEeehhcccccceeeEecCCCCeEEEEEecCC-----CeEEEEEeccc
Confidence 999999999999999999999999999999999999998653 45544 44588999999996 49999999998
Q ss_pred CC-ChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCeeE
Q 016311 244 KD-GLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYV 322 (391)
Q Consensus 244 ~~-~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~v 322 (391)
.. +|.+++++|+. ..+..+.. +...++|+||||++++++||.++|++||++++|+. |||++|++ .+++|
T Consensus 225 ~~~~l~~~~~~l~~--~~l~~~~~--~~~~v~v~lPKFki~~~~~L~~~L~~lGi~~~F~~--adfs~i~~----~~~~v 294 (351)
T cd02053 225 FTWNVSQVLANLNW--DDLYRRLP--KERPTKVKLPKLKLDYQLELNEALSQLGLQELFQA--PDLSGISD----EPLFV 294 (351)
T ss_pred ccccHHHHHHhCCH--HHHHHhhc--cceEEEEEccCEEEEeeechHHHHHhCCchhcccc--ccccccCC----CCcee
Confidence 66 49999999972 33433332 22346899999999999999999999999999985 99999987 46999
Q ss_pred eeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEe
Q 016311 323 SSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHV 385 (391)
Q Consensus 323 ~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v 385 (391)
++++|++.|||||+|++|+|+|.+.. .++ ..+|+|||||+|+|+|+.||.|||+|+|
T Consensus 295 s~v~hka~ieVdE~Gt~aaa~t~~~~-~~~-----~~~f~~drPF~f~I~~~~t~~~LF~G~v 351 (351)
T cd02053 295 SSVQHQSTLELSEKGVEASAATSVAT-SRS-----LSSFSVNRPFLFFIFEDTMGLPLFMGSV 351 (351)
T ss_pred eeeeEEEEEEECCCcceehhcceeec-ccc-----cCeEEcCCCEEEEEEECCCCCEEEEEeC
Confidence 99999999999999999999997432 222 2379999999999999999999999996
|
Alpha2-Antiplasmin forms an inactive 1 : 1 stoichiometric complex with plasmin. It also rapidly crosslinks to fibrin during blood clotting by activated coagulation factor XIII, and as a consequence fibrin becomes more resistant to fibrinolysis. Therefore alpha2AP is important in modulating the effectiveness and persistence of fibrin with respect to its susceptibility to digestion and removal by plasmin. This subgroup corresponds to clade F2 of the serpin superfamily. |
| >PHA02948 serine protease inhibitor-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-74 Score=548.66 Aligned_cols=349 Identities=24% Similarity=0.409 Sum_probs=295.2
Q ss_pred hhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHHhhCCCCCC
Q 016311 9 NQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFADGSPSG 88 (391)
Q Consensus 9 ~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~~~~ 88 (391)
++++||++||+++. ...+++|++|||+||+.+|+|++.||+|+|++||.++||++. .+++..++.+.+.+... ...
T Consensus 20 ~~~~f~~~l~~~l~-~~~~~~Nv~~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~-~~~~~~~~~l~~~~~~~--~~~ 95 (373)
T PHA02948 20 GFTNAGILAYKNIQ-DGNEDDNIVFSPFGYSFSMFMSLLPASGNTRVELLKTMDLRK-RDLGPAFTELISGLAKL--KTS 95 (373)
T ss_pred cchHHHHHHHHHHH-hcCCCCCEEEchHHHHHHHHHHHhccCCcHHHHHHHHhCCCc-hhHHHHHHHHHHHHhcc--ccc
Confidence 67899999999997 456788999999999999999999999999999999999974 35677777777666421 112
Q ss_pred CCe-eeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCeEEE
Q 016311 89 GPR-LSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIF 167 (391)
Q Consensus 89 ~~~-l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~l~l 167 (391)
+.. +.++|++|+++++.++++|++. +|+++++.+||.+ .+++.||+||+++| +|++++++.+++++|+++|
T Consensus 96 ~~~~~~~an~~~v~~~~~~~~~f~~~---~~~~~v~~vdF~~---~a~~~IN~WV~~~T--~I~~~~~~~~i~~~t~lvL 167 (373)
T PHA02948 96 KYTYTDLTYQSFVDNTVCIKPSYYQQ---YHRFGLYRLNFRR---DAVNKINSIVERRS--GMSNVVDSTMLDNNTLWAI 167 (373)
T ss_pred CcchHHHHHHHHHhcCCCccHHHHHH---HhhCceEecCccH---HHHHHHHHHHHhcC--CCcccCCCCCCCCCceEEE
Confidence 223 3689999999999999999974 4567899999973 68899999999998 5999998888999999999
Q ss_pred EEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccc----ccccCCeEEEEeecCCCCCCceEEEEEEecCC
Q 016311 168 ANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQF----VSAFDGFKVLGLPYKQGEDKRRFSMYFFLPDA 243 (391)
Q Consensus 168 vna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~----~~~~~~~~vveLp~~~~~~~~~~sm~iilP~~ 243 (391)
+||+||+|.|+.+|++..|.+++|+..+| .+.||||++.+.+. +.++.++++++|||+++ ++||+|+||++
T Consensus 168 vNaiyFkg~W~~~F~~~~T~~~~F~~~~~-~~~V~mM~~~~~~~~~~~~~~~~~~~vl~LPY~~~----~~sM~iiLP~~ 242 (373)
T PHA02948 168 INTIYFKGTWQYPFDITKTHNASFTNKYG-TKTVPMMNVVTKLQGNTITIDDEEYDMVRLPYKDA----NISMYLAIGDN 242 (373)
T ss_pred EEEEEEeeeecCCCCcccCeeceeEeCCC-CEEchhheeccccccceeeccCcCceEEEEecCCC----cEEEEEEcCCc
Confidence 99999999999999999999999998777 57899999876542 33556899999999987 79999999963
Q ss_pred CCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCeeEe
Q 016311 244 KDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVS 323 (391)
Q Consensus 244 ~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~v~ 323 (391)
+.++++.|+. ..+..+.+..+...++|+||||++++++||+++|+ +|++++|++..||||+|++ ++++|+
T Consensus 243 ---l~~l~~~l~~--~~l~~~~~~~~~~~v~v~lPKFki~~~~~L~~~L~-~~i~~~F~~~~Adfs~is~----~~l~vs 312 (373)
T PHA02948 243 ---MTHFTDSITA--AKLDYWSSQLGNKVYNLKLPRFSIENKRDIKSIAE-MMAPSMFNPDNASFKHMTR----DPLYIY 312 (373)
T ss_pred ---HHHHHHHhCH--HHHHHHHHhCcceEEEEEeeCEeeeeeccHHHHHH-hhhHhhCCCCcCchhhhcc----CceEEE
Confidence 8888888873 34555544444556789999999999999999995 6699999875799999986 469999
Q ss_pred eeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 324 SIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 324 ~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
+++|++.|+|||+|++|+|+|.+....++. +.+|++||||+|+|+|+.||.|||+|+|.+|
T Consensus 313 ~v~hka~IeVdE~GteAaAaT~~~~~~~~~----~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 373 (373)
T PHA02948 313 KMFQNAKIDVDEQGTVAEASTIMVATARSS----PEELEFNTPFVFIIRHDITGFILFMGKVESP 373 (373)
T ss_pred eeEEEEEEEECCCceEEeecceeeeeccCC----CCeEEeeCCEEEEEEECCCCcEEEEEEecCC
Confidence 999999999999999999999753332221 3469999999999999999999999999998
|
|
| >cd02050 C1_inh C1 inhibitor (C1-Inh) is a protease inhibitor of the serpin family | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-72 Score=539.52 Aligned_cols=343 Identities=26% Similarity=0.412 Sum_probs=293.0
Q ss_pred hhhHHHHHHHHHhhhcCC-CCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh-hHHHHHHHHHHHHHhhCCCC
Q 016311 9 NQTDVALSLTKHVALTEA-KDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN-DQLNAFASELVAVVFADGSP 86 (391)
Q Consensus 9 ~~~~fa~~L~~~l~~~~~-~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~-~~~~~~~~~l~~~l~~~~~~ 86 (391)
++++||++||++++. .. +++|+|+||+||+.+|+||+.||+|+|++||.++|+++.. .+++..++.+.+
T Consensus 1 ~~~~F~~~l~~~~~~-~~~~~~N~v~SP~si~~aL~ml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~l~~-------- 71 (352)
T cd02050 1 ALGEFSLKLYQHLSE-SAKPDTNLLFSPVSIALLLSHLLLGARGKTQRRLESILSYPHDFACVHSALKKLKN-------- 71 (352)
T ss_pred CcchHHHHHHHHHhh-ccCCCCCEEEChHHHHHHHHHHhcccCccHHHHHHHhcCCCCchhHHHHHHHHhhh--------
Confidence 468999999999983 34 7899999999999999999999999999999999999754 345555554432
Q ss_pred CCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCeEE
Q 016311 87 SGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLI 166 (391)
Q Consensus 87 ~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~l~ 166 (391)
...++++|+||++++++++++|.+.++++|++++..+||.. +.+++.||+||+++|+|+|+++++ +++++|+++
T Consensus 72 --~~~l~~an~i~~~~~~~l~~~f~~~~~~~y~~~~~~~~~~~--~~a~~~IN~wv~~~T~g~I~~~~~--~i~~~t~l~ 145 (352)
T cd02050 72 --KLGLLSASQIFHHPDLHLRESFTNESWQFYKARPRELSNNS--ELNLEMINSWVAKATNNKIPRLLD--SLPSETRLV 145 (352)
T ss_pred --cchhHHHHHHHHhCCCCccHHHHHHHHHHhCCcceeecCCh--HHHHHHHHHHHHHHhcchHHHHhc--ccCCCceEE
Confidence 12588999999999999999999999999999999999853 578999999999999999999984 689999999
Q ss_pred EEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccc-ccccc--ccCCeEEEEeecCCCCCCceEEEEEEecCC
Q 016311 167 FANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKK-NQFVS--AFDGFKVLGLPYKQGEDKRRFSMYFFLPDA 243 (391)
Q Consensus 167 lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~-~~~~~--~~~~~~vveLp~~~~~~~~~~sm~iilP~~ 243 (391)
++||+||+|.|+++|++..|..++|+..++ ++.||||++.. .++|. ...++++++|||.+ ++||+|+||++
T Consensus 146 lvnaiyFkg~W~~~F~~~~T~~~~F~~~~~-~~~V~mM~~~~~~~~~~~~~~l~~~v~~lp~~~-----~~sm~iiLP~~ 219 (352)
T cd02050 146 LLNAVYFQAQWKKKFDTKHTVLLPFKRNGD-PVKVPVMYSKKYPVASFTDPRLKAQVGRLELSG-----GLSLVVLVPRG 219 (352)
T ss_pred EEeeEEEeeecCCCCCcccCccCceeECCc-eEEeeEeecCccceeeEEcCCcCeEEEEecCCC-----ceEEEEEeeCC
Confidence 999999999999999999999999998654 88999998764 23333 34478999999985 59999999987
Q ss_pred C-CChHHHHHHhcCchHHHhhc---CCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCC
Q 016311 244 K-DGLPTLLEKMGSESKFLDHH---LPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKN 319 (391)
Q Consensus 244 ~-~~l~~l~~~L~~~~~~l~~~---~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~ 319 (391)
. .+|.+++++|+. ..+..+ +.......++|.||||++++++||+++|++||++++|+. |||++|+. +.+
T Consensus 220 ~~~~l~~l~~~l~~--~~~~~~~~~l~~~~~~~v~l~lPKF~i~~~~dl~~~L~~lGi~~~F~~--adfs~i~~---~~~ 292 (352)
T cd02050 220 PKEDLEAVERALTP--PAFLAMLEKMAANTPQRTEVTLPRIKLDLAVDMVALMHKLGLFGLFLD--ANLCGLYQ---DPE 292 (352)
T ss_pred CCCCHHHHHHhcCH--HHHHHHHHhhhhcCceEEEEEcceEEEeeccchHHHHHHcCChhhccc--cchhhccC---CCC
Confidence 5 689999999973 233333 222233457999999999999999999999999999974 99999997 467
Q ss_pred eeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEe
Q 016311 320 LYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHV 385 (391)
Q Consensus 320 l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v 385 (391)
++|++++|++.|+|||+|++|+|+|.+.. .++ ..+|++||||+|+|+|+.||.|||+|||
T Consensus 293 l~v~~v~hk~~ieVdE~Gt~Aaa~t~~~~-~~~-----~~~f~~drPF~f~I~~~~t~~~LF~G~v 352 (352)
T cd02050 293 LAVDAAQHRAVLTLTEKGVEAAAATATSF-ART-----ALSFEALQPFLFVLWDDQAKVPLFMGRV 352 (352)
T ss_pred eEEEeeEEeeEEEECCCchhhhhhccccc-ccc-----cceEEcCCCEEEEEEECCCCceEEEEeC
Confidence 99999999999999999999999997432 222 2479999999999999999999999997
|
It plays a pivotal role in regulating the activation of the classical complement pathway and of the contact system, via regulating bradykinin formation, inhibiting factor XII and kallikrein of the contact system, and via acting on factor XI in the coagulation cascade. This subgroup corresponds to clade G of the serpin superfamily. |
| >PHA02660 serpin-like protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-72 Score=535.18 Aligned_cols=341 Identities=23% Similarity=0.401 Sum_probs=288.6
Q ss_pred hhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHHhhCCC
Q 016311 6 SISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFADGS 85 (391)
Q Consensus 6 ~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~ 85 (391)
.++...+||++||+++. ++|+++||+||+.+|+|+++||+|+|++||.++||+.... +
T Consensus 11 ~~~~~~~f~~~l~~~~~-----~~Nvv~SP~Si~~aL~ml~~GA~G~T~~el~~~L~~~~~~-~---------------- 68 (364)
T PHA02660 11 IIKMSLDLGFCILKSLH-----RFNIVFSPESLKAFLHVLYLGSERETKNELSKYIGHAYSP-I---------------- 68 (364)
T ss_pred HHHHHHHHHHHHHHhcC-----CCCEEEChHHHHHHHHHHHhhcCchHHHHHHHHhCccccc-c----------------
Confidence 46778899999999995 3799999999999999999999999999999999985321 0
Q ss_pred CCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCeE
Q 016311 86 PSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRL 165 (391)
Q Consensus 86 ~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~l 165 (391)
....+..+|++|+++++.++++|++.++. |++++..+||.++++.+++.||+||+++|+ |.+++ +++++|++
T Consensus 69 --~~~~l~~an~l~v~~~~~l~~~F~~~~~~-~~~~v~~vdF~~~~~~a~~~IN~WV~~~T~--I~~~~---~~~~~t~l 140 (364)
T PHA02660 69 --RKNHIHNITKVYVDSHLPIHSAFVASMND-MGIDVILADLANHAEPIRRSINEWVYEKTN--IINFL---HYMPDTSI 140 (364)
T ss_pred --chhhHHHHHHHHHhcCCchhHHHHHHHHH-cCCceEEeccccCHHHHHHHHHHHHHhccC--Ccccc---ccCCCchh
Confidence 01124568999999999999999999987 899999999987667799999999999999 88887 47889999
Q ss_pred EEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccCCeEEEEeecCCCCCCceEEEEEEecCCC-
Q 016311 166 IFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPDAK- 244 (391)
Q Consensus 166 ~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~~~~vveLp~~~~~~~~~~sm~iilP~~~- 244 (391)
+|+||+||+|.|+.+|++..|..++|+..+|+.+.||||++.+.++|...+++++++|||++++ .++|+||||++.
T Consensus 141 ~LvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~vleLPY~~~~---~~sM~iiLP~~~~ 217 (364)
T PHA02660 141 LIINAVQFNGLWKYPFLRKKTTMDIFNIDKVSFKYVNMMTTKGIFNAGRYHQSNIIEIPYDNCS---RSHMWIVFPDAIS 217 (364)
T ss_pred hhhhhhhcccHhhcCCCcccCcccccccCCCceEeceeccccCeeeeeecCCCeEEECccCCCC---ceEEEEEeeCCcc
Confidence 9999999999999999999999999999999999999999998888877778999999999741 479999999874
Q ss_pred -CChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCC-CCCee-
Q 016311 245 -DGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPV-GKNLY- 321 (391)
Q Consensus 245 -~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~-~~~l~- 321 (391)
.+|.++++.|+. ..+..+....+...++|.||||++++++||+++|++||++++|+. |||++|++... ..+++
T Consensus 218 ~~~L~~l~~~l~~--~~l~~~~~~~~~~~v~l~LPKFki~~~~~L~~~L~~lGi~~~F~~--Adfs~i~~~~~~~~~l~~ 293 (364)
T PHA02660 218 NDQLNQLENMMHG--DTLKAFKHASRKKYLEISIPKFRIEHSFNAEHLLPSAGIKTLFTN--PNLSRMITQGDKEDDLYP 293 (364)
T ss_pred cchHHHHHHhhhH--HHHHHHHhhCceeEEEEEccceEeeeeechHHHHHHcCchhhccc--cCccccccCCCccccccc
Confidence 579999999973 234444444444567899999999999999999999999999974 99999986210 12577
Q ss_pred -EeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCC--------CCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 322 -VSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLS--------DKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 322 -v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~--------~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
|++++|++.|||||+|++|+|+|.. . ...+.+ .+.+|++||||+|+|++ ++.|||+|||.+|
T Consensus 294 ~vs~v~hka~ieVdE~GteAaaat~~-~--~~~~~~~~~~~~~~~~~~f~~drPFlf~I~~--~~~iLF~G~v~~P 364 (364)
T PHA02660 294 LPPSLYQKIILEIDEEGTNTKNIAKK-M--RRNPQDEDTQQHLFRIESIYVNRPFIFIIEY--ENEILFIGRISIP 364 (364)
T ss_pred ccccceEeeEEEECCCCcHHHHhhhh-h--hhcccccccccccCCCceEEcCCCEEEEEec--CCeEEEEEEecCC
Confidence 7999999999999999999998852 1 111110 12479999999999986 5899999999998
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 391 | ||||
| 3le2_A | 393 | Structure Of Arabidopsis Atserpin1. Native Stressed | 1e-137 | ||
| 1att_A | 429 | Crystal Structure Of Cleaved Bovine Antithrombin Ii | 1e-38 | ||
| 2dut_A | 423 | Crystal Structure Of A M-Loop Deletion Variant Of M | 7e-38 | ||
| 1ath_A | 432 | The Intact And Cleaved Human Antithrombin Iii Compl | 1e-37 | ||
| 2b4x_L | 427 | Crystal Structure Of Antithrombin-Iii Length = 427 | 1e-37 | ||
| 1dzg_I | 432 | N135q-S380c-Antithrombin-Iii Length = 432 | 1e-37 | ||
| 2hij_I | 432 | Crystal Structure Of P14 Alanine Variant Of Antithr | 1e-37 | ||
| 1dzh_I | 432 | P14-Fluorescein-N135q-S380c-Antithrombin-Iii Length | 2e-37 | ||
| 1tb6_I | 432 | 2.5a Crystal Structure Of The Antithrombin-Thrombin | 2e-37 | ||
| 3kcg_I | 432 | Crystal Structure Of The Antithrombin-Factor Ixa- P | 2e-37 | ||
| 2gd4_I | 443 | Crystal Structure Of The Antithrombin-S195a Factor | 6e-37 | ||
| 2b4x_I | 427 | Crystal Structure Of Antithrombin-Iii Length = 427 | 1e-36 | ||
| 4eb1_I | 440 | Hyperstable In-Frame Insertion Variant Of Antithrom | 7e-36 | ||
| 1oyh_I | 432 | Crystal Structure Of P13 Alanine Variant Of Antithr | 2e-35 | ||
| 3fgq_A | 397 | Crystal Structure Of Native Human Neuroserpin Lengt | 8e-35 | ||
| 2h4r_A | 415 | Crystal Structure Of Wildtype Ment In The Native Co | 9e-35 | ||
| 3f5n_A | 407 | Structure Of Native Human Neuroserpin Length = 407 | 9e-35 | ||
| 1by7_A | 382 | Human Plasminogen Activator Inhibitor-2. Loop (66-9 | 2e-34 | ||
| 2arq_A | 382 | Human Plasminogen Activator Inhibitor-2.[loop (66-9 | 3e-34 | ||
| 3ozq_A | 376 | Crystal Structure Of Serpin48, Which Is A Highly Sp | 3e-32 | ||
| 3vvj_A | 392 | Structure Of Ovalbumin From Emu (Dromaius Novaeholl | 3e-31 | ||
| 2h4q_A | 382 | Crystal Structure Of A M-Loop Deletion Variant Of M | 2e-30 | ||
| 3lw2_A | 379 | Mouse Plasminogen Activator Inhibitor-1 (Pai-1) Len | 1e-28 | ||
| 1k9o_I | 378 | Crystal Structure Of Michaelis Serpin-Trypsin Compl | 2e-28 | ||
| 1dvn_A | 379 | Latent Form Of Plasminogen Activator Inhibitor-1 (P | 5e-28 | ||
| 1c5g_A | 402 | Plasminogen Activator Inhibitor-1 Length = 402 | 5e-28 | ||
| 1a7c_A | 379 | Human Plasminogen Activator Inhibitor Type-1 In Com | 5e-28 | ||
| 4aqh_A | 383 | Plasminogen Activator Inhibitor Type-1 In Complex W | 5e-28 | ||
| 3cvm_A | 392 | High Resolution Structure Of A Stable Plasminogen A | 6e-28 | ||
| 4ga7_A | 389 | Crystal Structure Of Human Serpinb1 Mutant Length = | 7e-28 | ||
| 3ut3_A | 375 | A Novel Pai-i Inhibitor And Its Structural Mechanis | 8e-28 | ||
| 1b3k_A | 379 | Plasminogen Activator Inhibitor-1 Length = 379 | 9e-28 | ||
| 3eox_A | 379 | High Quality Structure Of Cleaved Pai-1-Stab Length | 9e-28 | ||
| 1db2_A | 377 | Crystal Structure Of Native Plasminogen Activator I | 1e-27 | ||
| 3r4l_A | 379 | Human Very Long Half Life Plasminogen Activator Inh | 2e-27 | ||
| 2h4p_A | 394 | Crystal Structure Of Wildtype Ment In The Cleaved C | 2e-27 | ||
| 2zv6_A | 401 | Crystal Structure Of Human Squamous Cell Carcinoma | 3e-27 | ||
| 1dvm_A | 379 | Active Form Of Human Pai-1 Length = 379 | 4e-27 | ||
| 1jti_A | 385 | Loop-Inserted Structure Of P1-P1' Cleaved Ovalbumin | 5e-27 | ||
| 3q02_A | 379 | Crystal Structure Of Plasminogen Activator Inhibito | 1e-26 | ||
| 1sek_A | 378 | The Structure Of Active Serpin K From Manduca Sexta | 4e-26 | ||
| 3pzf_A | 397 | 1.75a Resolution Structure Of Serpin-2 From Anophel | 6e-26 | ||
| 1ova_C | 386 | Crystal Structure Of Uncleaved Ovalbumin At 1.95 An | 1e-25 | ||
| 1ova_A | 386 | Crystal Structure Of Uncleaved Ovalbumin At 1.95 An | 1e-25 | ||
| 1ova_B | 386 | Crystal Structure Of Uncleaved Ovalbumin At 1.95 An | 1e-25 | ||
| 4dy0_A | 379 | Crystal Structure Of Native Protease Nexin-1 With H | 2e-25 | ||
| 1uhg_A | 385 | Crystal Structure Of S-ovalbumin At 1.9 Angstrom Re | 2e-25 | ||
| 3f02_A | 359 | Cleaved Human Neuroserpin Length = 359 | 3e-25 | ||
| 1hle_A | 345 | Crystal Structure Of Cleaved Equine Leucocyte Elast | 7e-25 | ||
| 3h5c_A | 423 | X-Ray Structure Of Protein Z-Protein Z Inhibitor Co | 1e-24 | ||
| 3f1s_A | 385 | Crystal Structure Of Protein Z Complexed With Prote | 1e-24 | ||
| 3nda_A | 377 | Crystal Structure Of Serpin From Tick Ixodes Ricinu | 2e-23 | ||
| 1qmn_A | 401 | Alpha1-Antichymotrypsin Serpin In The Delta Conform | 2e-23 | ||
| 3dlw_A | 411 | Antichymotrypsin Length = 411 | 6e-23 | ||
| 1oo8_A | 394 | Crystal Structure Of A1pi-Pittsburgh In The Native | 8e-23 | ||
| 1xu8_A | 380 | The 2.8 A Structure Of A Tumour Suppressing Serpin | 1e-22 | ||
| 1atu_A | 374 | Uncleaved Alpha-1-Antitrypsin Length = 374 | 2e-22 | ||
| 1wz9_A | 375 | The 2.1 A Structure Of A Tumour Suppressing Serpin | 4e-22 | ||
| 1iz2_A | 394 | Interactions Causing The Kinetic Trap In Serpin Pro | 1e-21 | ||
| 4ajt_A | 427 | The Cystal Structure Of Mouse Protein-Z Dependent P | 1e-21 | ||
| 1jmj_A | 480 | Crystal Structure Of Native Heparin Cofactor Ii Len | 2e-21 | ||
| 1jmo_A | 480 | Crystal Structure Of The Heparin Cofactor Ii-S195a | 2e-21 | ||
| 1kct_A | 394 | Alpha1-Antitrypsin Length = 394 | 2e-21 | ||
| 2pee_A | 387 | Crystal Structure Of A Thermophilic Serpin, Tengpin | 3e-21 | ||
| 1xqg_A | 389 | 3.10 A Crystal Structure Of Maspin, Space Group P 4 | 3e-21 | ||
| 2vh4_A | 381 | Structure Of A Loop C-sheet Serpin Polymer Length = | 3e-21 | ||
| 2pef_A | 373 | Crystal Structure Of A Thermophilic Serpin, Tengpin | 4e-21 | ||
| 3t1p_A | 371 | Crystal Structure Of An Alpha-1-Antitrypsin Trimer | 4e-21 | ||
| 9pai_A | 346 | Cleaved Substrate Variant Of Plasminogen Activator | 4e-21 | ||
| 1psi_A | 394 | Intact Recombined Alpha1-Antitrypsin Mutant Phe 51 | 5e-21 | ||
| 1hp7_A | 394 | A 2.1 Angstrom Structure Of An Uncleaved Alpha-1-An | 6e-21 | ||
| 2ol2_A | 395 | High Resolution Structure Of Native Pci In Space Gr | 6e-21 | ||
| 2qug_A | 394 | Crystal Structure Of Alpha-1-Antitrypsin, Crystal F | 7e-21 | ||
| 2vdx_A | 373 | Crystal Structure Of The Reactive Loop Cleaved Cort | 8e-21 | ||
| 3ne4_A | 424 | 1.8 Angstrom Structure Of Intact Native Wild-Type A | 9e-21 | ||
| 3drm_A | 404 | 2.2 Angstrom Crystal Structure Of Thr114phe Alpha1- | 1e-20 | ||
| 1qlp_A | 394 | 2.0 Angstrom Structure Of Intact Alpha-1-Antitrypsi | 1e-20 | ||
| 2hi9_A | 363 | Crystal Structure Of Human Native Protein C Inhibit | 1e-20 | ||
| 4if8_A | 414 | Structure Of Vaspin Length = 414 | 3e-20 | ||
| 3caa_A | 341 | Cleaved Antichymotrypsin A347r Length = 341 | 7e-20 | ||
| 1as4_A | 341 | Cleaved Antichymotrypsin A349r Length = 341 | 7e-20 | ||
| 2ach_A | 360 | Crystal Structure Of Cleaved Human Alpha1-antichymo | 8e-20 | ||
| 3dru_A | 404 | Crystal Structure Of Gly117phe Alpha1-Antitrypsin L | 9e-20 | ||
| 4caa_A | 341 | Cleaved Antichymotrypsin T345r Length = 341 | 3e-19 | ||
| 1jjo_C | 261 | Crystal Structure Of Mouse Neuroserpin (Cleaved For | 4e-19 | ||
| 1lq8_A | 346 | Crystal Structure Of Cleaved Protein C Inhibitor Le | 9e-19 | ||
| 3dy0_A | 336 | Crystal Structure Of Cleaved Pci Bound To Heparin L | 2e-18 | ||
| 1yxa_A | 398 | Serpina3n, A Murine Orthologue Of Human Antichymotr | 3e-18 | ||
| 4afx_A | 387 | Crystal Structure Of The Reactive Loop Cleaved Zpi | 8e-18 | ||
| 2d26_A | 358 | Active Site Distortion Is Sufficient For Proteinase | 3e-17 | ||
| 3sto_A | 406 | Serpin From The Trematode Schistosoma Haematobium L | 9e-17 | ||
| 1d5s_A | 334 | Crystal Structure Of Cleaved Antitrypsin Polymer Le | 1e-16 | ||
| 3ndd_A | 343 | Cleaved Antitrypsin With P10 Pro, And P9-P6 Asp Len | 2e-16 | ||
| 7api_A | 347 | The S Variant Of Human Alpha1-Antitrypsin, Structur | 2e-16 | ||
| 1ezx_A | 335 | Crystal Structure Of A Serpin:protease Complex Leng | 2e-16 | ||
| 3ndf_A | 343 | Cleaved Antitrypsin With P8-P6 Asp Length = 343 | 2e-16 | ||
| 2r9y_A | 430 | Structure Of Antiplasmin Length = 430 | 4e-16 | ||
| 1qmb_A | 326 | Cleaved Alpha-1-Antitrypsin Polymer Length = 326 | 9e-16 | ||
| 4au2_A | 392 | Crystal Structure Of A Hsp47-Collagen Complex Lengt | 9e-16 | ||
| 4bb2_A | 340 | Crystal Structure Of Cleaved Corticosteroid-binding | 1e-15 | ||
| 1sng_A | 370 | Structure Of A Thermophilic Serpin In The Native St | 2e-15 | ||
| 2oay_A | 390 | Crystal Structure Of Latent Human C1-Inhibitor Leng | 8e-15 | ||
| 1imv_A | 398 | 2.85 A Crystal Structure Of Pedf Length = 398 | 2e-14 | ||
| 1mtp_A | 323 | The X-Ray Crystal Structure Of A Serpin From A Ther | 3e-14 | ||
| 1f0c_A | 305 | Structure Of The Viral Serpin Crma Length = 305 | 5e-14 | ||
| 1c8o_A | 300 | 2.9 A Structure Of Cleaved Viral Serpin Crma Length | 2e-13 | ||
| 4au3_A | 392 | Crystal Structure Of A Hsp47-Collagen Complex Lengt | 3e-13 | ||
| 2ceo_A | 379 | Thyroxine-Binding Globulin Complex With Thyroxine L | 3e-13 | ||
| 4au3_B | 392 | Crystal Structure Of A Hsp47-Collagen Complex Lengt | 3e-13 | ||
| 2xn6_A | 350 | Crystal Structure Of Thyroxine-Binding Globulin Com | 9e-11 | ||
| 2v95_A | 371 | Struture Of Corticosteroid-Binding Globulin In Comp | 1e-10 | ||
| 1m93_B | 245 | 1.65 A Structure Of Cleaved Viral Serpin Crma Lengt | 1e-10 | ||
| 2xn5_A | 350 | Crystal Structure Of Thyroxine-Binding Globulin Com | 1e-10 | ||
| 2riv_A | 343 | Crystal Structure Of The Reactive Loop Cleaved Huma | 7e-10 | ||
| 2riw_A | 338 | The Reactive Loop Cleaved Human Thyroxine Binding G | 7e-10 |
| >pdb|3LE2|A Chain A, Structure Of Arabidopsis Atserpin1. Native Stressed Conforma Length = 393 | Back alignment and structure |
|
| >pdb|1ATT|A Chain A, Crystal Structure Of Cleaved Bovine Antithrombin Iii At 3.2 Angstroms Resolution Length = 429 | Back alignment and structure |
|
| >pdb|2DUT|A Chain A, Crystal Structure Of A M-Loop Deletion Variant Of Ment In The Native Conformation Length = 423 | Back alignment and structure |
|
| >pdb|1ATH|A Chain A, The Intact And Cleaved Human Antithrombin Iii Complex As A Model For Serpin-Proteinase Interactions Length = 432 | Back alignment and structure |
|
| >pdb|2B4X|L Chain L, Crystal Structure Of Antithrombin-Iii Length = 427 | Back alignment and structure |
|
| >pdb|1DZG|I Chain I, N135q-S380c-Antithrombin-Iii Length = 432 | Back alignment and structure |
|
| >pdb|2HIJ|I Chain I, Crystal Structure Of P14 Alanine Variant Of Antithrombin Length = 432 | Back alignment and structure |
|
| >pdb|1DZH|I Chain I, P14-Fluorescein-N135q-S380c-Antithrombin-Iii Length = 432 | Back alignment and structure |
|
| >pdb|1TB6|I Chain I, 2.5a Crystal Structure Of The Antithrombin-Thrombin-Heparin Ternary Complex Length = 432 | Back alignment and structure |
|
| >pdb|3KCG|I Chain I, Crystal Structure Of The Antithrombin-Factor Ixa- Pentasaccharide Complex Length = 432 | Back alignment and structure |
|
| >pdb|2GD4|I Chain I, Crystal Structure Of The Antithrombin-S195a Factor Xa-Pentasaccharide Complex Length = 443 | Back alignment and structure |
|
| >pdb|2B4X|I Chain I, Crystal Structure Of Antithrombin-Iii Length = 427 | Back alignment and structure |
|
| >pdb|4EB1|I Chain I, Hyperstable In-Frame Insertion Variant Of Antithrombin Length = 440 | Back alignment and structure |
|
| >pdb|1OYH|I Chain I, Crystal Structure Of P13 Alanine Variant Of Antithrombin Length = 432 | Back alignment and structure |
|
| >pdb|3FGQ|A Chain A, Crystal Structure Of Native Human Neuroserpin Length = 397 | Back alignment and structure |
|
| >pdb|2H4R|A Chain A, Crystal Structure Of Wildtype Ment In The Native Conformation Length = 415 | Back alignment and structure |
|
| >pdb|3F5N|A Chain A, Structure Of Native Human Neuroserpin Length = 407 | Back alignment and structure |
|
| >pdb|1BY7|A Chain A, Human Plasminogen Activator Inhibitor-2. Loop (66-98) Deletion Mutant Length = 382 | Back alignment and structure |
|
| >pdb|2ARQ|A Chain A, Human Plasminogen Activator Inhibitor-2.[loop (66-98) Deletion Mutant] Complexed With Peptide N-Acetyl-Teaaagdggvmtgr-Oh Length = 382 | Back alignment and structure |
|
| >pdb|3OZQ|A Chain A, Crystal Structure Of Serpin48, Which Is A Highly Specific Serpin In The Insect Tenebrio Molitor Length = 376 | Back alignment and structure |
|
| >pdb|3VVJ|A Chain A, Structure Of Ovalbumin From Emu (Dromaius Novaehollandiae) Length = 392 | Back alignment and structure |
|
| >pdb|2H4Q|A Chain A, Crystal Structure Of A M-Loop Deletion Variant Of Ment In The Cleaved Conformation Length = 382 | Back alignment and structure |
|
| >pdb|3LW2|A Chain A, Mouse Plasminogen Activator Inhibitor-1 (Pai-1) Length = 379 | Back alignment and structure |
|
| >pdb|1K9O|I Chain I, Crystal Structure Of Michaelis Serpin-Trypsin Complex Length = 378 | Back alignment and structure |
|
| >pdb|1DVN|A Chain A, Latent Form Of Plasminogen Activator Inhibitor-1 (Pai-1) Length = 379 | Back alignment and structure |
|
| >pdb|1C5G|A Chain A, Plasminogen Activator Inhibitor-1 Length = 402 | Back alignment and structure |
|
| >pdb|1A7C|A Chain A, Human Plasminogen Activator Inhibitor Type-1 In Complex With A Pentapeptide Length = 379 | Back alignment and structure |
|
| >pdb|4AQH|A Chain A, Plasminogen Activator Inhibitor Type-1 In Complex With The Inhibitor Az3976 Length = 383 | Back alignment and structure |
|
| >pdb|3CVM|A Chain A, High Resolution Structure Of A Stable Plasminogen Activator Inhibitor Type-1 In Its Protease Cleaved Form Length = 392 | Back alignment and structure |
|
| >pdb|4GA7|A Chain A, Crystal Structure Of Human Serpinb1 Mutant Length = 389 | Back alignment and structure |
|
| >pdb|3UT3|A Chain A, A Novel Pai-i Inhibitor And Its Structural Mechanism Length = 375 | Back alignment and structure |
|
| >pdb|1B3K|A Chain A, Plasminogen Activator Inhibitor-1 Length = 379 | Back alignment and structure |
|
| >pdb|3EOX|A Chain A, High Quality Structure Of Cleaved Pai-1-Stab Length = 379 | Back alignment and structure |
|
| >pdb|1DB2|A Chain A, Crystal Structure Of Native Plasminogen Activator Inhibitor- 1 Length = 377 | Back alignment and structure |
|
| >pdb|3R4L|A Chain A, Human Very Long Half Life Plasminogen Activator Inhibitor Type-1 Length = 379 | Back alignment and structure |
|
| >pdb|2H4P|A Chain A, Crystal Structure Of Wildtype Ment In The Cleaved Conformation Length = 394 | Back alignment and structure |
|
| >pdb|2ZV6|A Chain A, Crystal Structure Of Human Squamous Cell Carcinoma Antigen 1 Length = 401 | Back alignment and structure |
|
| >pdb|1DVM|A Chain A, Active Form Of Human Pai-1 Length = 379 | Back alignment and structure |
|
| >pdb|1JTI|A Chain A, Loop-Inserted Structure Of P1-P1' Cleaved Ovalbumin Mutant R339t Length = 385 | Back alignment and structure |
|
| >pdb|3Q02|A Chain A, Crystal Structure Of Plasminogen Activator Inhibitor-1 In A Metastable Active Conformation. Length = 379 | Back alignment and structure |
|
| >pdb|1SEK|A Chain A, The Structure Of Active Serpin K From Manduca Sexta And A Model For Serpin-Protease Complex Formation Length = 378 | Back alignment and structure |
|
| >pdb|3PZF|A Chain A, 1.75a Resolution Structure Of Serpin-2 From Anopheles Gambiae Length = 397 | Back alignment and structure |
|
| >pdb|1OVA|C Chain C, Crystal Structure Of Uncleaved Ovalbumin At 1.95 Angstroms Resolution Length = 386 | Back alignment and structure |
|
| >pdb|1OVA|A Chain A, Crystal Structure Of Uncleaved Ovalbumin At 1.95 Angstroms Resolution Length = 386 | Back alignment and structure |
|
| >pdb|1OVA|B Chain B, Crystal Structure Of Uncleaved Ovalbumin At 1.95 Angstroms Resolution Length = 386 | Back alignment and structure |
|
| >pdb|4DY0|A Chain A, Crystal Structure Of Native Protease Nexin-1 With Heparin Length = 379 | Back alignment and structure |
|
| >pdb|1UHG|A Chain A, Crystal Structure Of S-ovalbumin At 1.9 Angstrom Resolution Length = 385 | Back alignment and structure |
|
| >pdb|3F02|A Chain A, Cleaved Human Neuroserpin Length = 359 | Back alignment and structure |
|
| >pdb|1HLE|A Chain A, Crystal Structure Of Cleaved Equine Leucocyte Elastase Inhibitor Determined At 1.95 Angstroms Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3H5C|A Chain A, X-Ray Structure Of Protein Z-Protein Z Inhibitor Complex Length = 423 | Back alignment and structure |
|
| >pdb|3F1S|A Chain A, Crystal Structure Of Protein Z Complexed With Protein Z-Dependent Inhibitor Length = 385 | Back alignment and structure |
|
| >pdb|3NDA|A Chain A, Crystal Structure Of Serpin From Tick Ixodes Ricinus Length = 377 | Back alignment and structure |
|
| >pdb|1QMN|A Chain A, Alpha1-Antichymotrypsin Serpin In The Delta Conformation (Partial Loop Insertion) Length = 401 | Back alignment and structure |
|
| >pdb|3DLW|A Chain A, Antichymotrypsin Length = 411 | Back alignment and structure |
|
| >pdb|1OO8|A Chain A, Crystal Structure Of A1pi-Pittsburgh In The Native Conformation Length = 394 | Back alignment and structure |
|
| >pdb|1XU8|A Chain A, The 2.8 A Structure Of A Tumour Suppressing Serpin Length = 380 | Back alignment and structure |
|
| >pdb|1ATU|A Chain A, Uncleaved Alpha-1-Antitrypsin Length = 374 | Back alignment and structure |
|
| >pdb|1WZ9|A Chain A, The 2.1 A Structure Of A Tumour Suppressing Serpin Length = 375 | Back alignment and structure |
|
| >pdb|1IZ2|A Chain A, Interactions Causing The Kinetic Trap In Serpin Protein Folding Length = 394 | Back alignment and structure |
|
| >pdb|4AJT|A Chain A, The Cystal Structure Of Mouse Protein-Z Dependent Protease Inhibitor(Mzpi) Length = 427 | Back alignment and structure |
|
| >pdb|1JMJ|A Chain A, Crystal Structure Of Native Heparin Cofactor Ii Length = 480 | Back alignment and structure |
|
| >pdb|1JMO|A Chain A, Crystal Structure Of The Heparin Cofactor Ii-S195a Thrombin Complex Length = 480 | Back alignment and structure |
|
| >pdb|1KCT|A Chain A, Alpha1-Antitrypsin Length = 394 | Back alignment and structure |
|
| >pdb|2PEE|A Chain A, Crystal Structure Of A Thermophilic Serpin, Tengpin, In The Native State Length = 387 | Back alignment and structure |
|
| >pdb|1XQG|A Chain A, 3.10 A Crystal Structure Of Maspin, Space Group P 4 21 2 Length = 389 | Back alignment and structure |
|
| >pdb|2VH4|A Chain A, Structure Of A Loop C-sheet Serpin Polymer Length = 381 | Back alignment and structure |
|
| >pdb|2PEF|A Chain A, Crystal Structure Of A Thermophilic Serpin, Tengpin, In The Latent State Length = 373 | Back alignment and structure |
|
| >pdb|3T1P|A Chain A, Crystal Structure Of An Alpha-1-Antitrypsin Trimer Length = 371 | Back alignment and structure |
|
| >pdb|9PAI|A Chain A, Cleaved Substrate Variant Of Plasminogen Activator Inhibitor-1 Length = 346 | Back alignment and structure |
|
| >pdb|1PSI|A Chain A, Intact Recombined Alpha1-Antitrypsin Mutant Phe 51 To Leu Length = 394 | Back alignment and structure |
|
| >pdb|1HP7|A Chain A, A 2.1 Angstrom Structure Of An Uncleaved Alpha-1-Antitrypsin Shows Variability Of The Reactive Center And Other Loops Length = 394 | Back alignment and structure |
|
| >pdb|2OL2|A Chain A, High Resolution Structure Of Native Pci In Space Group P21 Length = 395 | Back alignment and structure |
|
| >pdb|2QUG|A Chain A, Crystal Structure Of Alpha-1-Antitrypsin, Crystal Form A Length = 394 | Back alignment and structure |
|
| >pdb|2VDX|A Chain A, Crystal Structure Of The Reactive Loop Cleaved Corticosteroid Binding Globulin Length = 373 | Back alignment and structure |
|
| >pdb|3NE4|A Chain A, 1.8 Angstrom Structure Of Intact Native Wild-Type Alpha-1-Antitrypsin Length = 424 | Back alignment and structure |
|
| >pdb|3DRM|A Chain A, 2.2 Angstrom Crystal Structure Of Thr114phe Alpha1- Antitrypsin Length = 404 | Back alignment and structure |
|
| >pdb|1QLP|A Chain A, 2.0 Angstrom Structure Of Intact Alpha-1-Antitrypsin: A Canonical Template For Active Serpins Length = 394 | Back alignment and structure |
|
| >pdb|2HI9|A Chain A, Crystal Structure Of Human Native Protein C Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|4IF8|A Chain A, Structure Of Vaspin Length = 414 | Back alignment and structure |
|
| >pdb|3CAA|A Chain A, Cleaved Antichymotrypsin A347r Length = 341 | Back alignment and structure |
|
| >pdb|1AS4|A Chain A, Cleaved Antichymotrypsin A349r Length = 341 | Back alignment and structure |
|
| >pdb|2ACH|A Chain A, Crystal Structure Of Cleaved Human Alpha1-antichymotrypsin At 2.7 Angstroms Resolution And Its Comparison With Other Serpins Length = 360 | Back alignment and structure |
|
| >pdb|3DRU|A Chain A, Crystal Structure Of Gly117phe Alpha1-Antitrypsin Length = 404 | Back alignment and structure |
|
| >pdb|4CAA|A Chain A, Cleaved Antichymotrypsin T345r Length = 341 | Back alignment and structure |
|
| >pdb|1JJO|C Chain C, Crystal Structure Of Mouse Neuroserpin (Cleaved Form) Length = 261 | Back alignment and structure |
|
| >pdb|1LQ8|A Chain A, Crystal Structure Of Cleaved Protein C Inhibitor Length = 346 | Back alignment and structure |
|
| >pdb|3DY0|A Chain A, Crystal Structure Of Cleaved Pci Bound To Heparin Length = 336 | Back alignment and structure |
|
| >pdb|1YXA|A Chain A, Serpina3n, A Murine Orthologue Of Human Antichymotrypsin Length = 398 | Back alignment and structure |
|
| >pdb|4AFX|A Chain A, Crystal Structure Of The Reactive Loop Cleaved Zpi In I2 Space Group Length = 387 | Back alignment and structure |
|
| >pdb|2D26|A Chain A, Active Site Distortion Is Sufficient For Proteinase Inhibit Second Crystal Structure Of Covalent Serpin-Proteinase Complex Length = 358 | Back alignment and structure |
|
| >pdb|3STO|A Chain A, Serpin From The Trematode Schistosoma Haematobium Length = 406 | Back alignment and structure |
|
| >pdb|1D5S|A Chain A, Crystal Structure Of Cleaved Antitrypsin Polymer Length = 334 | Back alignment and structure |
|
| >pdb|3NDD|A Chain A, Cleaved Antitrypsin With P10 Pro, And P9-P6 Asp Length = 343 | Back alignment and structure |
|
| >pdb|7API|A Chain A, The S Variant Of Human Alpha1-Antitrypsin, Structure And Implications For Function And Metabolism Length = 347 | Back alignment and structure |
|
| >pdb|1EZX|A Chain A, Crystal Structure Of A Serpin:protease Complex Length = 335 | Back alignment and structure |
|
| >pdb|3NDF|A Chain A, Cleaved Antitrypsin With P8-P6 Asp Length = 343 | Back alignment and structure |
|
| >pdb|2R9Y|A Chain A, Structure Of Antiplasmin Length = 430 | Back alignment and structure |
|
| >pdb|1QMB|A Chain A, Cleaved Alpha-1-Antitrypsin Polymer Length = 326 | Back alignment and structure |
|
| >pdb|4AU2|A Chain A, Crystal Structure Of A Hsp47-Collagen Complex Length = 392 | Back alignment and structure |
|
| >pdb|4BB2|A Chain A, Crystal Structure Of Cleaved Corticosteroid-binding Globulin In Complex With Progesterone Length = 340 | Back alignment and structure |
|
| >pdb|1SNG|A Chain A, Structure Of A Thermophilic Serpin In The Native State Length = 370 | Back alignment and structure |
|
| >pdb|2OAY|A Chain A, Crystal Structure Of Latent Human C1-Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1IMV|A Chain A, 2.85 A Crystal Structure Of Pedf Length = 398 | Back alignment and structure |
|
| >pdb|1MTP|A Chain A, The X-Ray Crystal Structure Of A Serpin From A Thermophilic Prokaryote Length = 323 | Back alignment and structure |
|
| >pdb|1F0C|A Chain A, Structure Of The Viral Serpin Crma Length = 305 | Back alignment and structure |
|
| >pdb|1C8O|A Chain A, 2.9 A Structure Of Cleaved Viral Serpin Crma Length = 300 | Back alignment and structure |
|
| >pdb|4AU3|A Chain A, Crystal Structure Of A Hsp47-Collagen Complex Length = 392 | Back alignment and structure |
|
| >pdb|2CEO|A Chain A, Thyroxine-Binding Globulin Complex With Thyroxine Length = 379 | Back alignment and structure |
|
| >pdb|4AU3|B Chain B, Crystal Structure Of A Hsp47-Collagen Complex Length = 392 | Back alignment and structure |
|
| >pdb|2XN6|A Chain A, Crystal Structure Of Thyroxine-Binding Globulin Complexed With Thyroxine-Fluoresein Length = 350 | Back alignment and structure |
|
| >pdb|2V95|A Chain A, Struture Of Corticosteroid-Binding Globulin In Complex With Cortisol Length = 371 | Back alignment and structure |
|
| >pdb|1M93|B Chain B, 1.65 A Structure Of Cleaved Viral Serpin Crma Length = 245 | Back alignment and structure |
|
| >pdb|2XN5|A Chain A, Crystal Structure Of Thyroxine-Binding Globulin Complexed With Furosemide Length = 350 | Back alignment and structure |
|
| >pdb|2RIV|A Chain A, Crystal Structure Of The Reactive Loop Cleaved Human Thyroxine Binding Globulin Length = 343 | Back alignment and structure |
|
| >pdb|2RIW|A Chain A, The Reactive Loop Cleaved Human Thyroxine Binding Globulin Complexed With Thyroxine Length = 338 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3le2_A Serpin-ZX; apoplast, glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase; 2.20A {Arabidopsis thaliana} Length = 393 | Back alignment and structure |
|---|
Score = 471 bits (1213), Expect = e-166
Identities = 247/391 (63%), Positives = 317/391 (81%), Gaps = 3/391 (0%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
MDVRESIS Q V+++L KHV T +++SN++FSP+SI+V+LS+I+AGS G T DQ+LSF
Sbjct: 3 MDVRESISLQNQVSMNLAKHVITTVSQNSNVIFSPASINVVLSIIAAGSAGATKDQILSF 62
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
LK S DQLN+F+SE+V+ V ADGS +GGP+LSVANG WID+SLS K +FKQ++++ YKA
Sbjct: 63 LKFSSTDQLNSFSSEIVSAVLADGSANGGPKLSVANGAWIDKSLSFKPSFKQLLEDSYKA 122
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
ASNQ DFQ+KA EV EVN WAEKETNGL+ EVLP GS D+ T+LIFANALYFKG WNE
Sbjct: 123 ASNQADFQSKAVEVIAEVNSWAEKETNGLITEVLPEGSADSMTKLIFANALYFKGTWNEK 182
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
FD S T++ +FHLL+G + PFMTSKK Q+VSA+DGFKVLGLPY QG+DKR+FSMYF+L
Sbjct: 183 FDESLTQEGEFHLLDGNKVTAPFMTSKKKQYVSAYDGFKVLGLPYLQGQDKRQFSMYFYL 242
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
PDA +GL LL+K+ S FLD+H+P ++V+V +F+IP+FK SFG + S VLKGLGL P
Sbjct: 243 PDANNGLSDLLDKIVSTPGFLDNHIPRRQVKVREFKIPKFKFSFGFDASNVLKGLGLTSP 302
Query: 301 FSGEGGGLAEMVDSP-VGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLS-DK 358
FS GL EMV+SP +GKNL VS+IF K+ IEVNEEGTEAAAASA + LR +++ D+
Sbjct: 303 FS-GEEGLTEMVESPEMGKNLCVSNIFHKACIEVNEEGTEAAAASAGVIKLRGLLMEEDE 361
Query: 359 IDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389
IDFVADHPF+ ++ E++TG+V+F G V++PL
Sbjct: 362 IDFVADHPFLLVVTENITGVVLFIGQVVDPL 392
|
| >3kcg_I Antithrombin-III, ATIII; michaelis complex, blood coagulation, calcium, disulfide bond, EGF-like domain, glycoprotein, hemophilia, hydrolase; HET: NAG FUC MAN NTP; 1.70A {Homo sapiens} PDB: 1e04_I* 1ath_A 1ant_L* 1br8_L 1azx_I* 1dzh_L* 1e03_L* 1dzg_L* 1e05_L* 1jvq_L* 1lk6_L* 1nq9_I* 1oyh_L* 1r1l_L* 1sr5_A* 2ant_L* 2beh_L* 2hij_L* 2znh_A* 3evj_I* ... Length = 432 | Back alignment and structure |
|---|
Score = 378 bits (973), Expect = e-129
Identities = 113/396 (28%), Positives = 195/396 (49%), Gaps = 16/396 (4%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
V E + A + +H+A ++ + N+ SP SI ++ G+ TL QL+
Sbjct: 46 RRVWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEV 105
Query: 61 LK-----SKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVD 115
K K++DQ++ F ++L ++ + +L AN ++ D+SL+ T++ + +
Sbjct: 106 FKFDTISEKTSDQIHFFFAKLNCRLYRK--ANKASKLVSANRLFGDKSLTFNETYQDISE 163
Query: 116 NVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKG 175
VY A +DF+ A + +N W +T G + +V+P +++ T L+ N +YFKG
Sbjct: 164 LVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKG 223
Query: 176 AWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKN-QFVSAFDGFKVLGLPYKQGEDKRRF 234
W F T+ F+ +G S M + ++ +G +VL LP+K +
Sbjct: 224 LWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDD----I 279
Query: 235 SMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKG 294
+M LP + L + +++ E L L + +PRF+I G + + L+
Sbjct: 280 TMVLILPKPEKSLAKVEKELTPE--VLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQD 337
Query: 295 LGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIV 354
+GLV FS E L +V +LYVS F K+F+EVNEEG+EAAA++A + RS+
Sbjct: 338 MGLVDLFSPEKSKLPGIVAEG-RDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLN 396
Query: 355 LSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390
+++ F A+ PF+ IRE ++F G V NP
Sbjct: 397 -PNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCV 431
|
| >1sng_A COG4826: serine protease inhibitor; serine protease inhibitor (serpin), native state., hydrolase inhibitor; 1.76A {Thermobifida fusca} SCOP: e.1.1.1 Length = 370 | Back alignment and structure |
|---|
Score = 370 bits (951), Expect = e-127
Identities = 90/389 (23%), Positives = 169/389 (43%), Gaps = 31/389 (7%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
M + + AL L + +A D +++SP S+ L +++AG++ T +L +
Sbjct: 5 MSGGFLRDDHLEFALHLHRRLA-EAVPDGEVIWSPYSVAXALGVLAAGARATTRTELTTL 63
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
L + L A + + P L+ +W+ + ++++F+ + + +
Sbjct: 64 LGTDPAPLLAALDRAV----------TDSPDLASRTVLWVSADVPVRSSFRATMHDRPDS 113
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
DF+T V VN T G+++E+LP G+V R I NAL+ K W
Sbjct: 114 DVRTADFRTNPEGVRATVNADIADATRGMIRELLPQGAVTPDLRAILTNALWAKARWTTP 173
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
F++ T+ F G +VPFM K + G++++ L ++ L
Sbjct: 174 FEAHLTRAGTFR-TPRGPKRVPFMHRTKTMPYATARGWRMVTLHA-----HDELAVDVLL 227
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
P + + + L S VE+ +PRF+++ ++ +VL G+
Sbjct: 228 PPGTNAAAVPTAPLLTA---LHRRSASTSVEL---ALPRFELTQPHQLVEVLAEAGVRTL 281
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVL-SDKI 359
F+ L+ + P LYV ++ ++ + V+E G E AAA+AA ++L + I
Sbjct: 282 FT-ASADLSGISTVP----LYVDTVIHQARLRVDERGAEGAAATAAMMLLAGAMPPRRTI 336
Query: 360 DFVADHPFVFMIREDMTGLVMFTGHVLNP 388
F D PF ++R G ++F G + +P
Sbjct: 337 RFSVDRPFHIVVRR--RGAILFLGSIADP 363
|
| >1sek_A Serpin K; serine protease inhibitor, protease; 2.10A {Manduca sexta} SCOP: e.1.1.1 PDB: 1k9o_I Length = 378 | Back alignment and structure |
|---|
Score = 369 bits (951), Expect = e-127
Identities = 103/384 (26%), Positives = 179/384 (46%), Gaps = 21/384 (5%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSND 67
+ + V N+V S S+ L ++ S G + D+LL L +++
Sbjct: 13 ESNDQFTAQMFSEVV-KANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPNDN 71
Query: 68 QLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDF 127
++L V G L +A+ +++ + L L + F V +V+ + VDF
Sbjct: 72 VTKDVFADLNRGV----RAVKGVDLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDF 127
Query: 128 QTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTK 187
K+ E + +N W E +TN +K ++ P ++D +TR + NA+YFKG+W + F+ +T
Sbjct: 128 V-KSVEAAGAINKWVEDQTNNRIKNLVDPDALDETTRSVLVNAIYFKGSWKDKFNKERTM 186
Query: 188 DYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFLPDAK 244
D DFH+ +IKVP M K A K++ + Y+ + SM LP+
Sbjct: 187 DRDFHVSKDKTIKVPTM-IGKKDVRYADVPELDAKMIEMSYEGDQ----ASMIIILPNQV 241
Query: 245 DGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGE 304
DG+ L +K+ + K L + +P+FKI ++ +VL + + F+
Sbjct: 242 DGITALEQKL-KDPKALSRAEERLYNTEVEIYLPKFKIETTTDLKEVLSNMNIKKLFTPG 300
Query: 305 GGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVAD 364
L ++ + ++LYV + QK+FIEVNEEG EAAAA+A + S +
Sbjct: 301 AARLENLLKTK--ESLYVDAAIQKAFIEVNEEGAEAAAANAFKITTYS--FHFVPKVEIN 356
Query: 365 HPFVFMIREDMTGLVMFTGHVLNP 388
PF F ++ + + F+G + P
Sbjct: 357 KPFFFSLKYNRNSM--FSGVCVQP 378
|
| >3ozq_A Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molitor} Length = 376 | Back alignment and structure |
|---|
Score = 360 bits (926), Expect = e-123
Identities = 113/393 (28%), Positives = 192/393 (48%), Gaps = 28/393 (7%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
++E + S+ K V + + +N + SP S LL+L +G +G T +++
Sbjct: 6 ATLQEFPNAVNSFTPSVYKEVL--KTEKANFLVSPFSAATLLALAQSGCRGDTAEEIRQV 63
Query: 61 LK-SKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYK 119
L ++ E+++ + + L AN +++ + S++ F+++ VY
Sbjct: 64 LHFVGDREKAEGAVKEVLSKL-----TNEEYTLHTANKIYVKTNFSVREEFQKIAVEVYG 118
Query: 120 AASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNE 179
A S VDF + + ++ +N W E++T ++ ++ P ++N TR++ NALYF W
Sbjct: 119 AQSENVDFS-EKNDAAKLMNAWVEEQTQHKIQNLVDPEILNNLTRVVLINALYFNAKWLV 177
Query: 180 TFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSM 236
F T+ DFH ++V M + F K+L LP+K G S+
Sbjct: 178 PFPPFHTRKSDFHKSAKEVVQVDTMYLDEQYFNYYECHHLDAKLLELPFKGG-----ASL 232
Query: 237 YFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLG 296
L + +GL +L K+ FL H+L Q V V +P+FKI ++ KVLK LG
Sbjct: 233 TIVLSNQIEGLVSLESKIKRS--FLPHNLTKQLVNV---ALPKFKIESTVDFKKVLKKLG 287
Query: 297 LVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLS 356
+ F + L+ + +L +S+I QKSFI+V+EEG EAAAA+ V+L + L
Sbjct: 288 VKKAFG-DEADLSGIAGEK--GDLVISNIVQKSFIDVSEEGVEAAAATYIPVILPEMALP 344
Query: 357 DK-IDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
D F+ DHPF+F I+ G+++F G V
Sbjct: 345 DSPKQFIVDHPFIFYIKV--KGMILFAGRVTTL 375
|
| >3pzf_A Serpin 2; protease inhibitor, melanization, hydrolase inhibito; 1.75A {Anopheles gambiae} Length = 397 | Back alignment and structure |
|---|
Score = 360 bits (926), Expect = e-123
Identities = 98/393 (24%), Positives = 184/393 (46%), Gaps = 27/393 (6%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSK-------GPTLDQLLSF 60
Q + L K + + +SN+V SP S+ +LL+LI S T +L S
Sbjct: 20 QRQNEFDLMFVKEIF--KNHNSNVVLSPFSVKILLTLIYEASDTSFGNAVSNTKRELSSV 77
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
+++ + D ++ +L+ + L++A ++D+ + + N ++Q+ + Y A
Sbjct: 78 IQNDNIDHTRSYYKQLLESAQ---QDNKDYDLNIATNFFVDDFIEVINKYQQIANTHYHA 134
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
+V + + + +N W + TNG ++E++ P S++ + N +YFKG W
Sbjct: 135 MLEKVSYS-NPTQTAATINNWVSEHTNGRLREIVTPDSLE-GAVITLVNVIYFKGLWTYP 192
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMY 237
F F+ G +M + QF G ++L LPY+ + +MY
Sbjct: 193 FPEVANNVKPFYGTRGKPTNAQYM-EQNGQFYYDNSADLGAQILRLPYRGNK----LAMY 247
Query: 238 FFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGL 297
F LP+ + + +L+++ S S L L + +P+FK F ++++ L+ +G+
Sbjct: 248 FILPNPDNTVNQVLDRINSAS--LHQALWYMEENEVNVTLPKFKFDFSEQLNEPLQQVGI 305
Query: 298 VLPFSGEGGGLAEMVDSPVG-KNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLS 356
FS + L + + VS IFQK+ I +NE G+EA AA+ +V +
Sbjct: 306 REIFS-QNASLPLLARGRGARDEVRVSRIFQKAGITINELGSEAYAATEIQLVNKFGGDG 364
Query: 357 DKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389
+I F A+ PF+F I ++ G ++F G + NP+
Sbjct: 365 VQI-FNANRPFIFFIEDETLGTMLFAGKIENPV 396
|
| >2pef_A Serine protease inhibitor; serpin; 1.60A {Thermoanaerobacter tengcongensis} PDB: 2vh4_A 2pee_A Length = 373 | Back alignment and structure |
|---|
Score = 353 bits (907), Expect = e-120
Identities = 88/387 (22%), Positives = 174/387 (44%), Gaps = 23/387 (5%)
Query: 4 RESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK- 62
+ I N D ++ L K+ N + SP S + L++ + G+ TL Q+ L
Sbjct: 7 EKFIYNTADFSIELFKNSI---DDKENSLISPLSAMLALAMTANGADNETLAQMEKALGK 63
Query: 63 SKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDE-SLSLKNTFKQVVDNVYKAA 121
S + LN + + + +L++AN +W E F Q++ + YKA
Sbjct: 64 DISIEDLNKYLYTYMKKL----PNEEKSKLTIANSIWFKENDFMPSKDFLQIIADYYKAD 119
Query: 122 SNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETF 181
+ F + ++N W + +TNG++ ++L +D + NA+ F W +
Sbjct: 120 IFKAAFDSSTVS---DINNWVKSKTNGMIDKIL--NKIDPEDVMYLINAVAFDAEWETVY 174
Query: 182 DSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLP 241
+ + + F + G KV FM S++N ++ + PY + +S LP
Sbjct: 175 EKASVHEDIFTDVYGNRQKVEFMNSEENLYIEE-ENAVGFVKPYAKNH----YSFVAILP 229
Query: 242 DAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPF 301
D + ++ + + + + ++ + +P+FK + I++++ L+ LG+ F
Sbjct: 230 DENISVNEYIKTLTGQK--FIDLIKNAKITLVRASLPKFKYEYTIKMNETLESLGMTDAF 287
Query: 302 SGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDF 361
+ +++ S NLY+S + K+FI V+E GT+A A ++ + I ++ K
Sbjct: 288 LPDKADFSKLGKSD-IGNLYISEVLHKTFISVDELGTKAGAVTSVDITAAGIPVNFKT-V 345
Query: 362 VADHPFVFMIREDMTGLVMFTGHVLNP 388
+ PF+F I ++ T L +F G VL+
Sbjct: 346 KLNRPFIFAIIDNSTNLPIFIGTVLSL 372
|
| >2h4r_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 2.70A {Gallus gallus} PDB: 2dut_A Length = 415 | Back alignment and structure |
|---|
Score = 348 bits (894), Expect = e-118
Identities = 113/421 (26%), Positives = 188/421 (44%), Gaps = 49/421 (11%)
Query: 5 ESISN-QTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK- 62
E +S + + L + +D N+ FSP SI L+L +KG T ++ L
Sbjct: 7 EQVSASIGNFTVDLFNKLN-ETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHF 65
Query: 63 ------------------------SKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGV 98
++Q S ++ A P L AN +
Sbjct: 66 TEAVRAESSSVARPSRGRPKRRRMDPEHEQAENIHSGFKELLTAFNKPRNNYSLRSANRI 125
Query: 99 WIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGS 158
+++++ +L T+ Q+ YKA +V+F+T + +E+N W EK+T +K +L
Sbjct: 126 YVEKTYALLPTYLQLSKKYYKAEPQKVNFKTAPEQSRKEINTWVEKQTESKIKNLLSSDD 185
Query: 159 VDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD-- 216
V +TRLI NA+YFK W F + KT F L S V M ++ F
Sbjct: 186 VKATTRLILVNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVKMM-YMRDTFPVLIMEK 244
Query: 217 -GFKVLGLPYKQGEDKRRFSMYFFLPD----AKDGLPTLLEKMGSE--SKFLD-HHLPSQ 268
FK++ LPY + E SM+ LPD GL L ++ E S++ D +
Sbjct: 245 MNFKMIELPYVKRE----LSMFILLPDDIKDGTTGLEQLERELTYERLSEWADSKMMTET 300
Query: 269 RVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQK 328
V++ +P+F + I++ L+ +G+ F+ M D K+L +S + +
Sbjct: 301 LVDL---HLPKFSLEDRIDLRDTLRNMGMTTAFT-TNADFRGMTDK---KDLAISKVIHQ 353
Query: 329 SFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
SF+ V+E+GTEAAAA+A + + V++ + F DHPF F IR + + ++F G P
Sbjct: 354 SFVAVDEKGTEAAAATAVIISFTTSVINHVLKFKVDHPFHFFIRHNKSKTILFFGRFCCP 413
Query: 389 L 389
+
Sbjct: 414 V 414
|
| >2arr_A Plasminogen activator inhibitor-2; serpin, peptide binding, hydrolase inhibitor-PEPT complex; 1.55A {Homo sapiens} PDB: 2arq_A 1jrr_A 1by7_A Length = 382 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-117
Identities = 111/396 (28%), Positives = 191/396 (48%), Gaps = 27/396 (6%)
Query: 5 ESISN-QTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK- 62
E + T AL+L KH+A + NL SP SI ++++ GS+G T DQ+ S L+
Sbjct: 2 EDLCVANTLFALNLFKHLA-KASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMASVLQF 60
Query: 63 SKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAAS 122
++ + S ++ A + +G L N ++ ++S S + + ++ Y +
Sbjct: 61 NEVGAAADKIHSSFRSLSSAINASTGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEP 120
Query: 123 NQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFD 182
VDF A E +++N W + +T G + +LP GSVD TR++ NA+YFKG W F+
Sbjct: 121 QAVDFLECAEEARKKINSWVKTQTKGKIPNLLPEGSVDGDTRMVLVNAVYFKGKWKTPFE 180
Query: 183 SSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGEDKRRFSMYFFL 240
+ F + + V M ++ + + ++L LPY G+ SM+ L
Sbjct: 181 KKLNGLFPFRVNSAQRTPVQMMYLREKLNIGYIEDLKAQILELPYA-GD----VSMFLLL 235
Query: 241 PD----AKDGLPTLLEKMGSESKFLD----HHLPSQRVEVGDFRIPRFKISFGIEVSKVL 292
PD GL L ++ + K + VEV IP+FK+ E+ +L
Sbjct: 236 PDEIADVSTGLELLESEITYD-KLNKWTSKDKMAEDEVEV---YIPQFKLEEHYELRSIL 291
Query: 293 KGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRS 352
+ +G+ F+ + M + +L++S +F ++ ++VNEEGTEAAA + + R+
Sbjct: 292 RSMGMEDAFNKGRANFSGMSER---NDLFLSEVFHQAMVDVNEEGTEAAAGTGGVMTGRT 348
Query: 353 IVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
FVADHPF+F+I +T ++F G +P
Sbjct: 349 --GHGGPQFVADHPFLFLIMHKITNCILFFGRFSSP 382
|
| >3sto_A Serine protease inhibitor; serpin fold, hydrolase inhibitor; 2.41A {Schistosoma haematobium} Length = 406 | Back alignment and structure |
|---|
Score = 340 bits (874), Expect = e-115
Identities = 83/407 (20%), Positives = 176/407 (43%), Gaps = 31/407 (7%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLI--SAGSKGPTLDQLL 58
D +IS+ + V + N + P I L ++ S G++G T Q+
Sbjct: 10 DDPYANISSHKAFTHAYLSTVT-ADFGGDNFLTCPLGILFTLGILLGSGGAQGRTGYQIG 68
Query: 59 SFLK----------SKSNDQLNAFASELVAVVFADGS---PSGGPRLSVANGVWIDESLS 105
++ S++ ++ + EL + ++ + + ++ G++++++
Sbjct: 69 KTMRLKSTSSSWNSSEAQQEMKSLYQELNNSLTSEKTFLNEKEENVVRISTGIFVEKTYE 128
Query: 106 LKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRL 165
++ F + + N + QVDF + ++N W ++++NGL+++ + + T +
Sbjct: 129 VERRFNESIANDSEGELKQVDFS-NRTSATVDINDWVDQQSNGLLEKFFTD-DIPDDTAM 186
Query: 166 IFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLG 222
I N YF+ W F+ T+ DF++ I V M +++ GF+++
Sbjct: 187 ILVNVFYFRDFWQSPFEPHYTRKEDFYISPDRQITVDMM-TQEGVMKYGKFEDEGFEIVS 245
Query: 223 LPYKQGEDKRRFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKI 282
P F+ LP K L E + K L ++ + + R+P+F +
Sbjct: 246 KPLNNTR----FTFVIVLPLEKWSLNGATELLNGN-KVLSEYVKNLKETTVSLRLPKFTL 300
Query: 283 SFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAA 342
+++ LK +G+V F L+ + +P NLYV+ Q + +++NE G EA
Sbjct: 301 KNTLDLVPTLKSIGVVDLFDPVKSDLSGITPNP---NLYVNEFIQTNVLKLNESGIEATT 357
Query: 343 ASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389
++ V S ++ ++DF HPF+ I + + + V+NP+
Sbjct: 358 VTSPIFVPFSAIIP-EVDFHVTHPFICFIYDQQLTMPIMAAKVMNPV 403
|
| >1lj5_A Plasminogen activator inhibitor-1; beta-barrell, blood clotting; 1.80A {Homo sapiens} SCOP: e.1.1.1 PDB: 1dvn_A 1c5g_A 1a7c_A* 3q02_A 3q03_A 3r4l_A* 1oc0_A 1b3k_A 3pb1_I 1dvm_A 3eox_A 3cvm_A 1db2_A 9pai_A 3lw2_A 9pai_B Length = 379 | Back alignment and structure |
|---|
Score = 338 bits (869), Expect = e-114
Identities = 98/390 (25%), Positives = 172/390 (44%), Gaps = 29/390 (7%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK-SKSN 66
+D + + + VA +KD N+VFSP + +L+++ + G T Q+ + + +
Sbjct: 10 HLASDFGVRVFQQVA-QASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDD 68
Query: 67 DQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVD 126
+ L + P +S + +++ L L F ++++ QVD
Sbjct: 69 KGMAPALRHLYKELM---GPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVD 125
Query: 127 FQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKT 186
F + +N W + T G++ +L G+VD TRL+ NALYF G W F S T
Sbjct: 126 FS-EVERARFIINDWVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSST 184
Query: 187 KDYDFHLLNGGSIKVPFMTSKKNQFVSAFD------GFKVLGLPYKQGEDKRRFSMYFFL 240
FH +G ++ VP M ++ N+F + +L LPY SM+
Sbjct: 185 HRRLFHKSDGSTVSVPMM-AQTNKFNYTEFTTPDGHYYDILELPYHGDT----LSMFIAA 239
Query: 241 PDAKDGLPTLLEKMGSESKFLD--HHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLV 298
P K+ + L + S ++ + +P+F + +++ K L+ LG+
Sbjct: 240 PYEKEVPLSALTNILSAQLISHWKGNMTRLPRLL---VLPKFSLETEVDLRKPLENLGMT 296
Query: 299 LPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDK 358
F + D + L+V+ QK IEVNE GT A++++A V R
Sbjct: 297 DMFRQFQADFTSLSDQ---EPLHVAQALQKVKIEVNESGTVASSSTAVIVSARMAP---- 349
Query: 359 IDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
+ + D PF+F++R + TG V+F G V+ P
Sbjct: 350 EEIIMDRPFLFVVRHNPTGTVLFMGQVMEP 379
|
| >3f5n_A Neuroserpin; cleaved form, fenib, human, tissue PLAS activator, hydrolase inhibitor; 3.15A {Homo sapiens} Length = 407 | Back alignment and structure |
|---|
Score = 338 bits (869), Expect = e-114
Identities = 112/393 (28%), Positives = 193/393 (49%), Gaps = 31/393 (7%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK--SKS 65
D+++++ + +D N++FSP SI + + ++ G++G T ++ + S
Sbjct: 21 EAIADLSVNMYNRLR-ATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSLK 79
Query: 66 NDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQV 125
N + +F E +V + + +AN +++ + F Q++ + AA N V
Sbjct: 80 NGEEFSFLKEFSNMVT---AKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHV 136
Query: 126 DFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSK 185
DF + V+ +N W E TN LVK+++ P D +T L NA+YFKG W F
Sbjct: 137 DFS-QNVAVANYINKWVENNTNNLVKDLVSPRDFDAATYLALINAVYFKGNWKSQFRPEN 195
Query: 186 TKDYDFHLLNGGSIKVPFMTSKKNQF---------VSAFDGFKVLGLPYKQGEDKRRFSM 236
T+ + F + +++P M ++ +F A ++VL +PY+ E SM
Sbjct: 196 TRTFSFTKDDESEVQIPMM-YQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDE----ISM 250
Query: 237 YFFLPDAKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGL 295
L + L TL + ++ + + + Q+VEV +PRF + I++ VLK L
Sbjct: 251 MLVLSRQEVPLATLEPLVKAQLVEEWANSVKKQKVEV---YLPRFTVEQEIDLKDVLKAL 307
Query: 296 GLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVL 355
G+ F + L + D+ K +++S KSF+EVNEEG+EAAA S + R VL
Sbjct: 308 GITEIFI-KDANLTGLSDN---KEIFLSKAIHKSFLEVNEEGSEAAAVSGMIAISRMAVL 363
Query: 356 SDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
+ + DHPF F+IR TG ++F G V++P
Sbjct: 364 YPQ--VIVDHPFFFLIRNRRTGTILFMGRVMHP 394
|
| >1wz9_A Maspin precursor; serpin, tumor suppressor, serpinb5, signaling protein; HET: CME; 2.10A {Homo sapiens} PDB: 1xu8_A 1xqg_A 1xqj_A Length = 375 | Back alignment and structure |
|---|
Score = 336 bits (864), Expect = e-114
Identities = 94/396 (23%), Positives = 178/396 (44%), Gaps = 34/396 (8%)
Query: 5 ESISN-QTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKS 63
+++ + A+ L K + + N++FSP + LSL G+KG T +++ L
Sbjct: 2 DALQLANSAFAVDLFKQLC-EKEPLGNVLFSPICLSTSLSLAQVGAKGDTANEIGQVLHF 60
Query: 64 KSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASN 123
++ + + + V S L + +++D+SL+L F Y
Sbjct: 61 ENVKDVPFGFQTVTSDVN---KLSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELE 117
Query: 124 QVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDS 183
VDF+ K E ++N + T+G + +L SV++ T+++ NA YF G W + F
Sbjct: 118 TVDFKDKLEETKGQINNSIKDLTDGHFENILADNSVNDQTKILVVNAAYFVGKWMKKFPE 177
Query: 184 SKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFL 240
S+TK+ F L + V M + + F K++ LP++ SM+ L
Sbjct: 178 SETKECPFRLNKTDTKPVQMM-NMEATFCMGNIDSINCKIIELPFQNKH----LSMFILL 232
Query: 241 P----DAKDGLPTLLEKMGSESKFLD----HHLPSQRVEVGDFRIPRFKISFGIEVSKVL 292
P D GL + +++ SE + + +V++ IP+FK+ I+ L
Sbjct: 233 PKDVEDESTGLEKIEKQLNSE-SLSQWTNPSTMANAKVKL---SIPKFKVEKMIDPKACL 288
Query: 293 KGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRS 352
+ LGL FS + + M ++ K + +S++ K +E+ E+G ++ A ++
Sbjct: 289 ENLGLKHIFSEDTSDFSGMSET---KGVALSNVIHKVCLEITEDGGDSIEVPGARILQHK 345
Query: 353 IVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
+ ADHPF+++IR + T ++F G +P
Sbjct: 346 ------DELNADHPFIYIIRHNKTRNIIFFGKFCSP 375
|
| >1uhg_A Ovalbumin, S-ovalbumin; allergen, egg white protein, serpin; HET: SEP NAG; 1.90A {Gallus gallus} SCOP: e.1.1.1 PDB: 1ova_A* 1jti_A Length = 385 | Back alignment and structure |
|---|
Score = 335 bits (862), Expect = e-113
Identities = 98/399 (24%), Positives = 174/399 (43%), Gaps = 36/399 (9%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK----- 62
+ + + K + + N+ + P +I L+++ G+K T Q+ ++
Sbjct: 5 AASMEFCFDVFKELK-VHHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLP 63
Query: 63 -SKSNDQLNAFASELVAVVFAD-----GSPSGGPRLSVANGVWIDESLSLKNTFKQVVDN 116
+ + S V D P+ S+A+ ++ +E + + Q V
Sbjct: 64 GFGDSIEAQCGTSVNVHSSLRDILNQITKPNDVYSFSLASRLYAEERYPILPEYLQCVKE 123
Query: 117 VYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGA 176
+Y+ ++FQT A + +N W E +TNG+++ VL P SVD+ T ++ NA+ FKG
Sbjct: 124 LYRGGLEPINFQTAADQARELINSWVESQTNGIIRNVLQPSSVDSQTAMVLVNAIVFKGL 183
Query: 177 WNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRR 233
W + F T+ F + S V M + F A K+L LP+ G
Sbjct: 184 WEKAFKDEDTQAMPFRVTEQESKPVQMM-YQIGLFRVASMASEKMKILELPFASGT---- 238
Query: 234 FSMYFFLPDAKDGLPTLLEKMGSESKFLD----HHLPSQRVEVGDFRIPRFKISFGIEVS 289
SM LPD GL L + E K + + + ++++V +PR K+ ++
Sbjct: 239 MSMLVLLPDEVSGLEQLESIINFE-KLTEWTSSNVMEERKIKV---YLPRMKMEEKYNLT 294
Query: 290 KVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVV 349
VL +G+ FS L+ + + ++L +S + E+NE G E ++ A V
Sbjct: 295 SVLMAMGITDVFS-SSANLSGISSA---ESLKISQAVHAAHAEINEAGREVVGSAEAGVD 350
Query: 350 LRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
S+ +F ADHPF+F I+ T V+F G ++P
Sbjct: 351 AASV----SEEFRADHPFLFCIKHIATNAVLFFGRCVSP 385
|
| >4dy0_A GLIA-derived nexin; serpin, protease inhibitor, thrombin, cell surface, hydrolas inhibitor; HET: IDS SGN; 2.35A {Homo sapiens} PDB: 4dy7_C Length = 379 | Back alignment and structure |
|---|
Score = 334 bits (860), Expect = e-113
Identities = 99/387 (25%), Positives = 171/387 (44%), Gaps = 27/387 (6%)
Query: 10 QTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQL 69
++ + + + N+V SP I +L ++ G+ G T QL ++ N
Sbjct: 12 GSNTGIQVFNQIV-KSRPHDNIVISPHGIASVLGMLQLGADGRTKKQLAMVMRYGVNGVG 70
Query: 70 NAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQT 129
A+ S ++VAN V++ + ++ F +V++ V+F+
Sbjct: 71 KILKKINKAI----VSKKNKDIVTVANAVFVKNASEIEVPFVTRNKDVFQCEVRNVNFE- 125
Query: 130 KAAEVSREVNMWAEKETNGLVKEVLPPGSVD-NSTRLIFANALYFKGAWNETFDSSKTKD 188
A +N W + ET ++ +L P +D TRL+ NA+YFKG W F TK
Sbjct: 126 DPASACDSINAWVKNETRDMIDNLLSPDLIDGVLTRLVLVNAVYFKGLWKSRFQPENTKK 185
Query: 189 YDFHLLNGGSIKVPFMTSKKNQFVSAFD-----GFKVLGLPYKQGEDKRRFSMYFFLPDA 243
F +G S +VP + + + + LPY SM LP
Sbjct: 186 RTFVAADGKSYQVPMLAQLSVFRCGSTSAPNDLWYNFIELPYHGES----ISMLIALPTE 241
Query: 244 KDG-LPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPF 301
L ++ + +++ + +RV+V +P+F ++ + LK LG+ F
Sbjct: 242 SSTPLSAIIPHISTKTIDSWMSIMVPKRVQV---ILPKFTAVAQTDLKEPLKVLGITDMF 298
Query: 302 SGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDF 361
A++ + +NL+VS I QK+ IEV+E+GT+A+AA+ A ++ RS F
Sbjct: 299 DSSKANFAKI--TTGSENLHVSHILQKAKIEVSEDGTKASAATTAILIARSSP----PWF 352
Query: 362 VADHPFVFMIREDMTGLVMFTGHVLNP 388
+ D PF+F IR + TG V+F G + P
Sbjct: 353 IVDRPFLFFIRHNPTGAVLFMGQINKP 379
|
| >2zv6_A Serpin B3; serine proteinase inhibitor, reactive site loop, acetylation, alternative splicing, cytoplasm, polymorphism, protease inhibitor; 2.70A {Homo sapiens} Length = 401 | Back alignment and structure |
|---|
Score = 332 bits (853), Expect = e-112
Identities = 107/397 (26%), Positives = 182/397 (45%), Gaps = 28/397 (7%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK----- 62
T L + ++K++N+ +SP SI L ++ G+K T Q+ L
Sbjct: 17 EANTKFMFDLFQQ--FRKSKENNIFYSPISITSALGMVLLGAKDNTAQQIKKVLHFDQVT 74
Query: 63 --------SKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVV 114
+ D+ + ++ + L +AN ++ +++ + +
Sbjct: 75 ENTTGKAATYHVDRSGNVHHQFQKLLTEFNKSTDAYELKIANKLFGEKTYLFLQEYLDAI 134
Query: 115 DNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFK 174
Y+ + VDF E +++N W E +TN +K ++P G++ ++T L+ NA+YFK
Sbjct: 135 KKFYQTSVESVDFANAPEESRKKINSWVESQTNEKIKNLIPEGNIGSNTTLVLVNAIYFK 194
Query: 175 GAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDK 231
G W + F+ TK+ F + M + F A KVL +PYK +
Sbjct: 195 GQWEKKFNKEDTKEEKFWPNKNTYKSIQMM-RQYTSFHFASLEDVQAKVLEIPYKGKD-- 251
Query: 232 RRFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKV 291
SM LP+ DGL L EK+ +E L + R D +PRFK+ ++
Sbjct: 252 --LSMIVLLPNEIDGLQKLEEKLTAEKLMEWTSLQNMRETRVDLHLPRFKVEESYDLKDT 309
Query: 292 LKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLR 351
L+ +G+V F+G+ L+ M S + L +S + K+F+EV EEG EAAAA+A
Sbjct: 310 LRTMGMVDIFNGD-ADLSGMTGS---RGLVLSGVLHKAFVEVTEEGAEAAAATAVVGFGS 365
Query: 352 SIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
S S +F +HPF+F IR++ T ++F G +P
Sbjct: 366 SP-TSTNEEFHCNHPFLFFIRQNKTNSILFYGRFSSP 401
|
| >1mtp_A Serine proteinase inhibitor (serpin), chain A; structural genomics, protease inhibitor; 1.50A {Thermobifida fusca} SCOP: e.1.1.1 Length = 323 | Back alignment and structure |
|---|
Score = 325 bits (835), Expect = e-110
Identities = 79/350 (22%), Positives = 152/350 (43%), Gaps = 28/350 (8%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
M + + AL L + +A D +++SP S+ L +++AG++ T +L +
Sbjct: 1 MSGGFLRDDHLEFALHLHRRLA-EAVPDGEVIWSPYSVACALGVLAAGARATTRTELTTL 59
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
L + L A + + P L+ +W+ + ++++F+ + + +
Sbjct: 60 LGTDPAPLLAALDRAV----------TDSPDLASRTVLWVSADVPVRSSFRATMHDRPDS 109
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
DF+T V VN T G+++E+LP G+V R I NAL+ K W
Sbjct: 110 DVRTADFRTNPEGVRATVNADIADATRGMIRELLPQGAVTPDLRAILTNALWAKARWTTP 169
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
F++ T++ F G +VPFM K + G++++ L ++ L
Sbjct: 170 FEAHLTREGTFR-TPRGPKRVPFMHRTKTMPYATARGWRMVTLHA-----HDELAVDVLL 223
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
P + + + L S VE+ +PRF+++ ++ +VL G+
Sbjct: 224 PPGTNAAAVPTAPLLTA---LHRRSASTSVEL---ALPRFELTQPHQLVEVLAEAGVRTL 277
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVL 350
F+ L+ + LYV ++ ++ + V+E G E AAA+AA ++L
Sbjct: 278 FT-ASADLSGIST----VPLYVDTVIHQARLRVDERGAEGAAATAAMMLL 322
|
| >3f1s_A Protein Z-dependent protease inhibitor; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens} PDB: 3h5c_A* Length = 385 | Back alignment and structure |
|---|
Score = 322 bits (828), Expect = e-108
Identities = 104/390 (26%), Positives = 182/390 (46%), Gaps = 34/390 (8%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQL-----LSFLK 62
++ SL + ++ D N+VFSP + + ++ + G+ GPT Q+ L LK
Sbjct: 18 KETSNFGFSLLRKIS--MRHDGNMVFSPFGMSLAMTGLMLGATGPTETQIKRGLHLQALK 75
Query: 63 SKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAAS 122
L + L + S + L+ + +I + +K TF + +
Sbjct: 76 PTKPGLLPSLFKGLRETL----SRNLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTEC 131
Query: 123 NQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFD 182
++F+ A++ R +N + KET G + ++ ++ T+LI + + FKG W FD
Sbjct: 132 VPMNFR-NASQAKRLMNHYINKETRGKIPKLFD--EINPETKLILVDYILFKGKWLTPFD 188
Query: 183 SSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFF 239
T+ FHL +IKVP M +F S FD VL LPY+ +M
Sbjct: 189 PVFTEVDTFHLDKYKTIKVPMM-YGAGKFASTFDKNFRCHVLKLPYQGNA-----TMLVV 242
Query: 240 LPDAKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLV 298
L + L + + ++ + ++ ++ +EV P+FK+ E+ ++L+ +G+
Sbjct: 243 LMEKMGDHLALEDYLTTDLVETWLRNMKTRNMEV---FFPKFKLDQKYEMHELLRQMGIR 299
Query: 299 LPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDK 358
FS L+E+ S G+NL VS + Q++ IEV+E GTEA A + + S+
Sbjct: 300 RIFS-PFADLSEL--SATGRNLQVSRVLQRTVIEVDERGTEAVAGILSEITAYSMPP--- 353
Query: 359 IDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
D PF FMI E+ +G+++F G V+NP
Sbjct: 354 -VIKVDRPFHFMIYEETSGMLLFLGRVVNP 382
|
| >3nda_A Serpin-2; vaccination target, TICK, hydrolase inhibitor; HET: 1PE; 1.80A {Ixodes ricinus} Length = 377 | Back alignment and structure |
|---|
Score = 322 bits (827), Expect = e-108
Identities = 97/394 (24%), Positives = 175/394 (44%), Gaps = 29/394 (7%)
Query: 1 MDVRESISN-QTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLS 59
M ++ L L + + + N+ FSP S+ + + AG++G T +L
Sbjct: 1 MQEEAKLTKANNRFGLRLLRALP--SGPEKNVFFSPYSVSTAMGMAFAGARGQTQQELSQ 58
Query: 60 FLK----SKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVD 115
L ++ + + + S L VAN I +L+L N+++ +
Sbjct: 59 GLGFSDVDLTDAGVLDAYTHHTERLK---STPSNSTLDVANAAAIQRTLALLNSYESALQ 115
Query: 116 NVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKG 175
+ + A ++VDF + VN W +++T+ ++++ +D T L+ NA+YFKG
Sbjct: 116 SSFGAELHKVDFAGEPQAAVDFVNNWVKRKTHDKIEKLFNE-PLDPDTLLVLLNAIYFKG 174
Query: 176 AWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKR 232
WN F T+ F ++V M + + F +V+ LPY+ +
Sbjct: 175 EWNTAFVKEHTEKRQFFNGGVTPVEVDTM-RLEARIKYRFFDDLQVEVVELPYRGLD--- 230
Query: 233 RFSMYFFLPDAKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKV 291
++M LP G+ L + + + + L +++ V +P+FK+ +
Sbjct: 231 -YTMAILLPKENTGVEGLKQNLTIDRFQNYLSDLRERKITV---LLPKFKLETKYSLKAP 286
Query: 292 LKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLR 351
L+ LG+ F G L+ + D +L VS++ K+ +EVNEEGT AAA + +V
Sbjct: 287 LQSLGIKQIFE-SGADLSGIND----GSLRVSAVEHKAVVEVNEEGTVAAATTGVVIVPY 341
Query: 352 SIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHV 385
S+ + + F DHPF+F IR T + F G V
Sbjct: 342 SLGP-EPVVFRVDHPFLFFIRNTRTDDIFFVGQV 374
|
| >2r9y_A Alpha-2-antiplasmin; inhibitory serpin, plasmin inhibitor, AC phase, glycoprotein, protease inhibitor, secreted, serine P inhibitor, sulfation; 2.65A {Mus musculus} Length = 430 | Back alignment and structure |
|---|
Score = 320 bits (823), Expect = e-107
Identities = 91/391 (23%), Positives = 163/391 (41%), Gaps = 36/391 (9%)
Query: 2 DVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFL 61
+ R L VA + SNLV SP S+ + LS ++ G++ TL L L
Sbjct: 17 ETRRLAQAMMAFTTDLFSLVA-QTSTSSNLVLSPLSVALALSHLALGAQNQTLHSLHRVL 75
Query: 62 KSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAA 121
+ L S G + +A +++ + +K+ F + + ++ A
Sbjct: 76 HMNTGSCLPHLLSHFY-------QNLGPGTIRLAARIYLQKGFPIKDDFLEQSERLFGAK 128
Query: 122 SNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETF 181
++ + + +N W ++ T G +++ L + +ST L+ NA++F G W F
Sbjct: 129 PVKLTGKQEED--LANINQWVKEATEGKIEDFLS--ELPDSTVLLLLNAIHFHGFWRTKF 184
Query: 182 DSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYF 238
D S T+ FHL ++ V M + +V P+K S
Sbjct: 185 DPSLTQKDFFHLDERFTVSVDMMHAVSYPLRWFLLEQPEIQVAHFPFKNN-----MSFVV 239
Query: 239 FLPDAKD-GLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGL 297
+P + + +L + + L + +V +P+ + +++ L LGL
Sbjct: 240 VMPTYFEWNVSEVLANLTWD-TLYHPSLQERPTKV---WLPKLHLQQQLDLVATLSQLGL 295
Query: 298 VLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSD 357
F G L + + +NL VSS+ +S +E++E G EAAAA++ + S+
Sbjct: 296 QELFQ--GPDLRGISE----QNLVVSSVQHQSTMELSEAGVEAAAATSVAMNRMSLS--- 346
Query: 358 KIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
F + PF+F I ED G+ +F G V NP
Sbjct: 347 --SFTVNRPFLFFIMEDTIGVPLFVGSVRNP 375
|
| >1jmo_A HC-II, heparin cofactor II, HLS2, serin; serpin, thrombin, protease, inhibition, inhibitor, blood CLO; HET: TYS NDG NAG; 2.20A {Homo sapiens} SCOP: e.1.1.1 PDB: 1jmj_A* Length = 480 | Back alignment and structure |
|---|
Score = 320 bits (821), Expect = e-106
Identities = 97/391 (24%), Positives = 166/391 (42%), Gaps = 32/391 (8%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK-SKSN 66
A +L + + N+ +P I + +IS G KG T +Q+ S L
Sbjct: 109 ILNAKFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFV 168
Query: 67 DQLNAFASELVAVVFAD-----GSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAA 121
+ + + + +F + G L N ++I + + FK V Y A
Sbjct: 169 NASSKYEITTIHNLFRKLTHRLFRRNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAE 228
Query: 122 SNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETF 181
+ DF A + N K T GL+K+ L ++D +T+++ N +YFKG+W F
Sbjct: 229 AQIADFSDPAFI--SKTNNHIMKLTKGLIKDALE--NIDPATQMMILNCIYFKGSWVNKF 284
Query: 182 DSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYF 238
T +++F L +KV M K F++A D +L L Y G SM
Sbjct: 285 PVEMTHNHNFRLNEREVVKVSMM-QTKGNFLAANDQELDCDILQLEYVGG-----ISMLI 338
Query: 239 FLPDAKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGL 297
+P G+ TL ++ + + ++ EV +P+FK+ + + LK +G+
Sbjct: 339 VVPHKMSGMKTLEAQLTPRVVERWQKSMTNRTREV---LLPKFKLEKNYNLVESLKLMGI 395
Query: 298 VLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSD 357
+ F + G +A + D + + + I VNEEGT+A + + S
Sbjct: 396 RMLFD-KNGNMAGISDQR----IAIDLFKHQGTITVNEEGTQATTVTTVGFMPLST---- 446
Query: 358 KIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
++ F D PF+F+I E T ++F G V NP
Sbjct: 447 QVRFTVDRPFLFLIYEHRTSCLLFMGRVANP 477
|
| >4au2_A HSP47, serpin peptidase inhibitor, clade H (heat shock P 47), member 1, (collagen binding...; chaperone-peptide complex; 2.30A {Canis lupus familiaris} PDB: 4au3_A 4au4_A 4awr_A 4au3_B Length = 392 | Back alignment and structure |
|---|
Score = 314 bits (807), Expect = e-105
Identities = 83/387 (21%), Positives = 161/387 (41%), Gaps = 28/387 (7%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK--SKS 65
+A SL + +A + N++ SP + L L+S G K T Q + L
Sbjct: 11 ERSAGLAFSLYQAMA-KDQAVENILLSPVVVASSLGLVSLGGKATTASQAKAVLSAEQLR 69
Query: 66 NDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQV 125
+++++A EL+ + S + + + ++ S+S F + Y +++
Sbjct: 70 DEEVHAGLGELLRSLS--NSTARNVTWKLGSRLYGPSSVSFAEDFVRSSKQHYNCEHSKI 127
Query: 126 DFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSK 185
+F+ + +N WA + T+G + EV V+ + + NA++FK W+E F
Sbjct: 128 NFR-DKRSALQSINEWAAQTTDGKLPEVTK--DVERTDGALLVNAMFFKPHWDEKFHHKM 184
Query: 186 TKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFLPD 242
+ F + ++ V M + + D +++ +P S+ +P
Sbjct: 185 VDNRGFMVTRSYTVGVTMM-HRTGLYNYYDDEKEKLQIVEMPLAHKL----SSLIILMPH 239
Query: 243 AKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPF 301
+ L L + + E K + + V + +P+ + ++ K L GLGL
Sbjct: 240 HVEPLERLEKLLTKEQLKIWMGKMQKKAVAI---SLPKGVVEVTHDLQKHLAGLGLTEAI 296
Query: 302 SGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDF 361
L+ M K+LY++S+F + E + EG LRS F
Sbjct: 297 DKNKADLSRMSGK---KDLYLASVFHATAFEWDTEGNPFDQDIYGREELRS-----PKLF 348
Query: 362 VADHPFVFMIREDMTGLVMFTGHVLNP 388
ADHPF+F++R+ +G ++F G ++ P
Sbjct: 349 YADHPFIFLVRDTQSGSLLFIGRLVRP 375
|
| >1qmn_A AACT, alpha-1-antichymotrypsin; serpin, serine proteinase inhibitor, partial loop insertion, loop-sheet polymerization, emphysema, disease mutation; 2.27A {Homo sapiens} SCOP: e.1.1.1 PDB: 3dlw_A Length = 401 | Back alignment and structure |
|---|
Score = 313 bits (805), Expect = e-104
Identities = 102/388 (26%), Positives = 177/388 (45%), Gaps = 25/388 (6%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQL---LSF-LKS 63
S D A SL K + +A D N++FSP SI L+ +S G+ TL ++ L F L
Sbjct: 29 SANVDFAFSLYKQLV-LKAPDKNVIFSPPSISTALAFLSLGAHNTTLTEILKGLKFNLTE 87
Query: 64 KSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASN 123
S +++ L+ + S +LS+ N +++ E LSL + F + +Y + +
Sbjct: 88 TSEAEIHQSFQHLLRTLN---QSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAF 144
Query: 124 QVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDS 183
DFQ +A + +N + + T G + +++ +D+ T ++ N ++FK W FD
Sbjct: 145 ATDFQ-DSAAAKKLINDYVKNGTRGKITDLIK--DLDSQTMMVLVNYIFFKAKWEMPFDP 201
Query: 184 SKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFL 240
T F+L + VP M+ D V+ L Y S F L
Sbjct: 202 QDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNA-----SALFIL 256
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
PD +D + + + E + E+G+ +P+F IS ++ +L LG+
Sbjct: 257 PD-QDKMEEVEAMLLPE-TLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEA 314
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKID 360
F+ L+ + + +NL VS + K+ ++V EEGTEA+AA+A + L S ++ +
Sbjct: 315 FT-SKADLSGITGA---RNLAVSQVVHKAVLDVFEEGTEASAATAVKITLLSALVETRTI 370
Query: 361 FVADHPFVFMIREDMTGLVMFTGHVLNP 388
+ PF+ +I T + F V NP
Sbjct: 371 VRFNRPFLMIIVPTDTQNIFFMSKVTNP 398
|
| >2oay_A C1-inhibitor, plasma protease C1 inhibitor, C1 INH, C1INH; latent serpin, RCL insertion, immune system,hydrolase inhibi; HET: NAG; 2.35A {Homo sapiens} Length = 390 | Back alignment and structure |
|---|
Score = 313 bits (803), Expect = e-104
Identities = 94/389 (24%), Positives = 160/389 (41%), Gaps = 38/389 (9%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK-SKSN 66
D +L L + + ++N+ FSP SI LL+ + G+ T L S L K
Sbjct: 34 DALVDFSLKLYHAFSAMKKVETNMAFSPFSIASLLTQVLLGAGENTKTNLESILSYPKDF 93
Query: 67 DQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVD 126
++ ++ + ++ L++++TF +Y ++ +
Sbjct: 94 TCVHQALKGFTTKG-----------VTSVSQIFHSPDLAIRDTFVNASRTLYSSSPRVLS 142
Query: 127 FQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKT 186
+ A +N W K TN + +L S+ + TRL+ NA+Y W TFD KT
Sbjct: 143 NNSDAN--LELINTWVAKNTNNKISRLL--DSLPSDTRLVLLNAIYLSAKWKTTFDPKKT 198
Query: 187 KDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFLPD- 242
+ FH IKVP M SKK D KV L S+ +P
Sbjct: 199 RMEPFHF-KNSVIKVPMMNSKKYPVAHFIDQTLKAKVGQLQLS-----HNLSLVILVPQN 252
Query: 243 AKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPF 301
K L + + + K + L + + +PR K++ ++ +++ L F
Sbjct: 253 LKHRLEDMEQALSPSVFKAIMEKLEMSKFQPTLLTLPRIKVTTSQDMLSIMEKLEFF-DF 311
Query: 302 SGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDF 361
S + L + + P +L VS++ ++ +E+ E G EAAAASA +V +V F
Sbjct: 312 SYDLN-LCGLTEDP---DLQVSAMQHQTVLELTETGVEAAAASAISVARTLLV------F 361
Query: 362 VADHPFVFMIREDMTGLVMFTGHVLNPLA 390
PF+FM+ + +F G V +P A
Sbjct: 362 EVQQPFLFMLWDQQHKFPVFMGRVYDPRA 390
|
| >2vdx_A Corticosteroid-binding globulin; transport protein, cortisol binding globulin, glycoprotein, lipid-binding, disease mutation, CBG, SERP cleaved; 1.84A {Homo sapiens} PDB: 2vdy_A* Length = 373 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-104
Identities = 95/394 (24%), Positives = 184/394 (46%), Gaps = 34/394 (8%)
Query: 5 ESISN-QTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK- 62
+++ D A SL KH+ + N+ SP SI + L+++S G+ G T QLL L
Sbjct: 5 RGLASANVDFAFSLYKHLV-ALSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGF 63
Query: 63 ---SKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYK 119
+S +++ L + +++ N +++D SL L +F + + Y+
Sbjct: 64 NLTERSETEIHQGFQHLHQLFA---KSDTSLEMTMGNALFLDGSLELLESFSADIKHYYE 120
Query: 120 AASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNE 179
+ ++FQ A SR++N + + +T G + ++ +D+ L+ N ++FKG W +
Sbjct: 121 SEVLAMNFQ-DWATASRQINSYVKNKTQGKIVDLFS--GLDSPAILVLVNYIFFKGTWTQ 177
Query: 180 TFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSM 236
FD + T++ +F++ +KVP M + + D +++ + Y ++
Sbjct: 178 PFDLASTREENFYVDETTVVKVPMM-LQSSTISYLHDSELPCQLVQMNYVGNG-----TV 231
Query: 237 YFFLPDAKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGL 295
+F LPD K + T++ + ++ L S +V++ IP+ IS ++ VL+ +
Sbjct: 232 FFILPD-KGKMNTVIAALSRDTINRWSAGLTSSQVDL---YIPKVTISGVYDLGDVLEEM 287
Query: 296 GLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVL 355
G+ F+ + + L S + K+ +++NEEGTEAA A + RS
Sbjct: 288 GIADLFT-TQANFSRITQD---AQLKSSKVVHKAVLQLNEEGTEAAGAMFLEAIPRSKP- 342
Query: 356 SDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389
I + PF+ MI + T +F V+NP+
Sbjct: 343 ---IILRFNQPFIIMIFDHFTWSSLFLARVMNPV 373
|
| >1yxa_A Serine (OR cysteine) proteinase inhibitor, clade 3N; serpin, antichymotrypsin, protease inhibitor, reactive centr plasma, hydrolase inhibitor; 2.10A {Mus musculus} Length = 398 | Back alignment and structure |
|---|
Score = 311 bits (799), Expect = e-104
Identities = 105/395 (26%), Positives = 179/395 (45%), Gaps = 26/395 (6%)
Query: 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQL--- 57
+D S TD A SL K + + D+N+VFSP SI L+L+S G+KG TL+++
Sbjct: 22 LDSLTLASINTDFAFSLYKELV-LKNPDTNIVFSPLSISAALALVSLGAKGNTLEEILEG 80
Query: 58 LSF-LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDN 116
L F L S ++ L+ + P ++S + ++I++ + F++
Sbjct: 81 LKFNLTETSEADIHQGFGHLLQRLN---QPKDQVQISTGSALFIEKRQQILTEFQEKAKT 137
Query: 117 VYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGA 176
+Y+A + DFQ + + + +N + K+T G++KE++ +D T ++ N +YFK
Sbjct: 138 LYQAEAFTADFQ-QPRQAKKLINDYVRKQTQGMIKELVS--DLDKRTLMVLVNYIYFKAK 194
Query: 177 WNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRR 233
W FD T +F+ + VP M+ + D V+ L Y G
Sbjct: 195 WKVPFDPLDTFKSEFYCGKRRPVIVPMMSMEDLTTPYFRDEELSCTVVELKYT-GN---- 249
Query: 234 FSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLK 293
S F LPD + + + + E + + + +P+F IS + VL
Sbjct: 250 ASALFILPD-QGRMQQVEASLQPE-TLRKWKNSLKPRMIDELHLPKFSISTDYSLEDVLS 307
Query: 294 GLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSI 353
LG+ FS L+ + + K+L VS + K+ ++V E GTEAAAA+ V S
Sbjct: 308 KLGIREVFS-TQADLSAITGT---KDLRVSQVVHKAVLDVAETGTEAAAATGVKFVPMSA 363
Query: 354 VLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
L + + PF+ MI + T + F + NP
Sbjct: 364 KL-YPLTVYFNRPFLIMIFDTETEIAPFIAKIANP 397
|
| >1imv_A PEDF, pigment epithelium-derived factor; serpin, angiogenesis, signaling protein; HET: NAG; 2.85A {Homo sapiens} SCOP: e.1.1.1 Length = 398 | Back alignment and structure |
|---|
Score = 304 bits (782), Expect = e-101
Identities = 84/388 (21%), Positives = 166/388 (42%), Gaps = 35/388 (9%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK--SKS 65
+ ++ L + + + + +N++ SP S+ LS +S G+ T + L S
Sbjct: 36 AAVSNFGYDLYRVRS-SMSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDLIS 94
Query: 66 NDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQV 125
+ ++ EL+ V A L A+ + ++ L +K++F ++ Y +
Sbjct: 95 SPDIHGTYKELLDTVTAPQK-----NLKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVL 149
Query: 126 DFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSK 185
+ +E+N W + + G + + + ++ +FKG W FDS K
Sbjct: 150 TGNPRLDL--QEINNWVQAQMKGKLARSTK--EIPDEISILLLGVAHFKGQWVTKFDSRK 205
Query: 186 TKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFLPD 242
T DF+L +++VP M+ K D K+ LP G S+ FFLP
Sbjct: 206 TSLEDFYLDEERTVRVPMMSDPKAVLRYGLDSDLSCKIAQLPLT-GS----MSIIFFLPL 260
Query: 243 -AKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
L + E + SE +D L + + + +P+ K+S+ EV+K L+ + L
Sbjct: 261 KVTQNLTLIEESLTSEFIHDIDRELKTVQAVL---TVPKLKLSYEGEVTKSLQEMKLQSL 317
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKID 360
F +++ GK + ++ + ++ E NE+G + + +D
Sbjct: 318 FD--SPDFSKI----TGKPIKLTQVEHRAGFEWNEDGAGTTPSPGLQPAHLTFP----LD 367
Query: 361 FVADHPFVFMIREDMTGLVMFTGHVLNP 388
+ + PF+F++R+ TG ++F G +L+P
Sbjct: 368 YHLNQPFIFVLRDTDTGALLFIGKILDP 395
|
| >3ne4_A Alpha-1-antitrypsin; serpin, LUNG disease, liver disease, polymerisation, hydrolase inhibitor; 1.81A {Homo sapiens} PDB: 1qlp_A 2qug_A 3cwl_A 3cwm_A* 1psi_A 3drm_A 1kct_A 3dru_A 1hp7_A 1iz2_A* 1oph_A 1oo8_A 1atu_A 1d5s_B 1qmb_B Length = 424 | Back alignment and structure |
|---|
Score = 303 bits (779), Expect = e-100
Identities = 100/389 (25%), Positives = 178/389 (45%), Gaps = 33/389 (8%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQL---LSF-LKS 63
N + A SL + +A ++ +N+ FSP SI +++S G+K T D++ L+F L
Sbjct: 58 PNLAEFAFSLYRQLA-HQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTE 116
Query: 64 KSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASN 123
Q++ EL+ + P +L+ NG+++ E L L + F + V +Y + +
Sbjct: 117 IPEAQIHEGFQELLRTLN---QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAF 173
Query: 124 QVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDS 183
V+F E +++N + EK T G + +++ +D T N ++FKG W F+
Sbjct: 174 TVNFG-DTEEAKKQINDYVEKGTQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEV 230
Query: 184 SKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFL 240
T++ DFH+ ++KVP M + F VL + Y + FFL
Sbjct: 231 KDTEEEDFHVDQVTTVKVPMM-KRLGMFNIQHCKKLSSWVLLMKYLGNA-----TAIFFL 284
Query: 241 PDAKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVL 299
PD + L L ++ + + + + +P+ I+ ++ VL LG+
Sbjct: 285 PD-EGKLQHLENELTHDIITKFLENEDRRSASL---HLPKLSITGTYDLKSVLGQLGITK 340
Query: 300 PFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKI 359
FS G L+ + + L +S K+ + ++E+GTEAA A + SI
Sbjct: 341 VFS-NGADLSGVTEE---APLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSIPP---- 392
Query: 360 DFVADHPFVFMIREDMTGLVMFTGHVLNP 388
+ + PFVF++ E T +F G V+NP
Sbjct: 393 EVKFNKPFVFLMIEQNTKSPLFMGKVVNP 421
|
| >3b9f_I Protein C inhibitor; michaelis complex, acute phase, blood coagulation, cleavage of basic residues, disease mutation; HET: NAG FUC SGN IDS; 1.60A {Homo sapiens} PDB: 2ol2_A* Length = 395 | Back alignment and structure |
|---|
Score = 301 bits (772), Expect = e-100
Identities = 97/389 (24%), Positives = 193/389 (49%), Gaps = 33/389 (8%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK----S 63
S++ D L + +A + A N+ FSP SI + L+++S G+ T Q+L L
Sbjct: 32 SSRRDFTFDLYRALA-SAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQK 90
Query: 64 KSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASN 123
S +L+ +L+ + P G +LS+ N ++ D + L++TF + +Y A +
Sbjct: 91 SSEKELHRGFQQLLQELN---QPRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTF 147
Query: 124 QVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDS 183
+F+ +A +++N + K+T G + ++L ++D++ +I N ++FK W +F+
Sbjct: 148 PTNFR-DSAGAMKQINDYVAKQTKGKIVDLLK--NLDSNAVVIMVNYIFFKAKWETSFNH 204
Query: 184 SKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFL 240
T++ DF++ + ++VP M S+++Q+ D +V+G+PY+ + F L
Sbjct: 205 KGTQEQDFYVTSETVVRVPMM-SREDQYHYLLDRNLSCRVVGVPYQGNA-----TALFIL 258
Query: 241 PDAKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVL 299
P + + + + ++ + +++E+ +P+F I ++ KVL LG+
Sbjct: 259 PS-EGKMQQVENGLSEKTLRKWLKMFKKRQLEL---YLPKFSIEGSYQLEKVLPSLGISN 314
Query: 300 PFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKI 359
F+ L+ + + N+ VS + K+ +EV+E GT AAAA+ RS L +
Sbjct: 315 VFT-SHADLSGISNH---SNIQVSEMVHKAVVEVDESGTRAAAATGTIFTFRSARL-NSQ 369
Query: 360 DFVADHPFVFMIREDMTGLVMFTGHVLNP 388
V + PF+ I ++ ++F G V P
Sbjct: 370 RLVFNRPFLMFIVDNN---ILFLGKVNRP 395
|
| >2ceo_A Thyroxine-binding globulin; transport, serpin, hormone trans thyroxine, disease mutation, glycoprotein; HET: T44; 2.80A {Homo sapiens} Length = 379 | Back alignment and structure |
|---|
Score = 298 bits (764), Expect = 7e-99
Identities = 92/390 (23%), Positives = 165/390 (42%), Gaps = 30/390 (7%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQL---LSF-LKS 63
S D A +L + E D N+ FSP SI L ++S G+ T ++ L F L
Sbjct: 8 SINADFAFNLYRRFT-VETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTD 66
Query: 64 KSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASN 123
++ L+ + P L + N ++I + L F V +Y+
Sbjct: 67 TPMVEIQHGFQHLICSLN---FPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVF 123
Query: 124 QVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDS 183
DF + +E+N E +T G V ++ + +T ++ N ++FK W FD
Sbjct: 124 STDFS-NISAAKQEINSHVEMQTKGKVVGLIQ--DLKPNTIMVLVNYIHFKAQWANPFDP 180
Query: 184 SKTKD-YDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFF 239
SKT+D F + +++VP M + Q+ D VL + Y + ++ F
Sbjct: 181 SKTEDSSSFLIDKTTTVQVPMM-HQMEQYYHLVDMELNCTVLQMDYSKNA----LAL-FV 234
Query: 240 LPDAKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLV 298
LP + + ++ M S++ K + L V++ +P+F IS ++ L +G+
Sbjct: 235 LPK-EGQMESVEAAMSSKTLKKWNRLLQKGWVDL---FVPKFSISATYDLGATLLKMGIQ 290
Query: 299 LPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDK 358
+S E + + + L +S+ K+ + + E+GTEAAA + +
Sbjct: 291 HAYS-ENADFSGLTED---NGLKLSNAAHKAVLHIGEKGTEAAAVPEVELSDQPENTFLH 346
Query: 359 IDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
D F+ +I E T ++F G V+NP
Sbjct: 347 PIIQIDRSFMLLILERSTRSILFLGKVVNP 376
|
| >2v95_A Corticosteroid-binding globulin; transport protein, CBG, RCL, serpin, secreted, transport, glycoprotein, lipid-binding, glucocorticoids; HET: HCY; 1.93A {Rattus norvegicus} Length = 371 | Back alignment and structure |
|---|
Score = 297 bits (763), Expect = 9e-99
Identities = 76/386 (19%), Positives = 168/386 (43%), Gaps = 31/386 (8%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF-LKSKSN 66
D A +L + + D N + SP SI + L+++S GS Q L F L S
Sbjct: 11 PTNVDFAFNLYQRLV-ALNPDKNTLISPVSISMALAMVSLGSAQTQSLQSLGFNLTETSE 69
Query: 67 DQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVD 126
+++ L ++ G +++ N +++ + L LK++F V Y++ + +D
Sbjct: 70 AEIHQSFQYLNYLLK---QSDTGLEMNMGNAMFLLQKLKLKDSFLADVKQYYESEALAID 126
Query: 127 FQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKT 186
F+ + S+++N + +T G ++ V +D+ I N ++ +G W F T
Sbjct: 127 FE-DWTKASQQINQHVKDKTQGKIEHVFS--DLDSPASFILVNYIFLRGIWELPFSPENT 183
Query: 187 KDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFLPDA 243
++ DF++ ++KVP M + D +++ + Y + +F LPD
Sbjct: 184 REEDFYVNETSTVKVPMM-VQSGSIGYFRDSVFPCQLIQMDYVGNG-----TAFFILPD- 236
Query: 244 KDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFS 302
+ + T++ + ++ + ++V + IP+F +S ++ VL+ L + +
Sbjct: 237 QGQMDTVIAALSRDTIDRWGKLMTPRQVNL---YIPKFSMSDTYDLKDVLEDLNIKDLLT 293
Query: 303 GEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFV 362
+ L + ++ K+ ++++E + + A + LR S+ +D
Sbjct: 294 -NQSDFSGNTKD---VPLTL-TMVHKAMLQLDEGNVLPNSTNGAPLHLR----SEPLDIK 344
Query: 363 ADHPFVFMIREDMTGLVMFTGHVLNP 388
+ PF+ ++ + T + V+NP
Sbjct: 345 FNKPFILLLFDKFTWSSLMMSQVVNP 370
|
| >2wxw_A Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 3.30A {Homo sapiens} PDB: 2x0b_B Length = 453 | Back alignment and structure |
|---|
Score = 298 bits (766), Expect = 3e-98
Identities = 69/401 (17%), Positives = 133/401 (33%), Gaps = 47/401 (11%)
Query: 10 QTDVALSLTKHVA-LTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQ 68
+ + + L V SP+++ L+ + G+ T D+L + L D+
Sbjct: 78 ANFLGFRIYGMHSELWGVVHGATVLSPTAVFGTLASLYLGALDHTADRLQAILGVPWKDK 137
Query: 69 --------------LNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVV 114
L A LVA LS GV+ L LK F Q +
Sbjct: 138 NCTSRLDAHKVLSALQAVQGLLVAQ--GRADSQAQLLLSTVVGVFTAPGLHLKQPFVQGL 195
Query: 115 DNVYKAASNQ-VDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYF 173
+ +DF + + +++ + + T L SVD + L F ++F
Sbjct: 196 ALYTPVVLPRSLDFT-ELDVAAEKIDRFMQAVTGWKTGCSLMGASVD--STLAFNTYVHF 252
Query: 174 KGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGED 230
+G S + +F + N S+ VP + S F D F V +P+ +
Sbjct: 253 QGKM--KGFSLLAEPQEFWVDNSTSVSVPML-SGMGTFQHWSDIQDNFSVTQVPFTES-- 307
Query: 231 KRRFSMYFFLPDAKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVS 289
+ P L + ++ L + + + +P+ + ++
Sbjct: 308 ---ACLLLIQPHYASDLDKVEGLTFQQNSLNWMKKLSPRTIHL---TMPQLVLQGSYDLQ 361
Query: 290 KVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVV 349
+L L E L ++ + + V + F E+ + E ++
Sbjct: 362 DLLAQAELPAILHTE-LNLQKLSNDR----IRVGEVLNSIFFELEADEREPTESTQQLNK 416
Query: 350 LRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390
+ + PF+F + + + F G V NPL+
Sbjct: 417 PEVLE------VTLNRPFLFAVYDQSATALHFLGRVANPLS 451
|
| >2wxy_C Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 2.10A {Mus musculus} PDB: 2wxx_A 2wy0_C 2wxz_A 2wxz_C 2wy1_A Length = 453 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 1e-97
Identities = 76/402 (18%), Positives = 132/402 (32%), Gaps = 44/402 (10%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK----- 62
V + K + + S + SP ++ L GS PT QL + L
Sbjct: 75 MITNFVGFRMYKMLNEAGSGASGAILSPPALFGTLVSFYLGSLDPTASQLQTLLDVPVKE 134
Query: 63 ---------SKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQV 113
K L A LV S S+ G++ LK++F Q
Sbjct: 135 GDCTSRLDGHKVLAALRAVQGLLVTQ--GGSSSQTPLLQSIVVGLFTAPGFRLKHSFVQS 192
Query: 114 VDNVYKAASNQ-VDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALY 172
+ A + +D T + ++N + + T + L V + L+F ++
Sbjct: 193 LALFTPALFPRSLDLSTDPVLATEKINRFIKAVTGWKMNLPL--EGVSTDSTLLFNTYVH 250
Query: 173 FKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGE 229
F+G ++F + N S+ VP + S F D F V +P
Sbjct: 251 FQGTMRGFSQ--LPGVHEFWVDNSISVSVPMI-SGTGNFQHWSDAQNNFSVTCVPLG--- 304
Query: 230 DKRRFSMYFFLPDAKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEV 288
R ++ P L + + + P + + + +P+ +I +
Sbjct: 305 --ERATLLLIQPHCISDLDRVEALIFQNDLLTWIENPPPRAIRL---TLPQLEIRGSYNL 359
Query: 289 SKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATV 348
+L L E L + D N V + +E+ + G E ++
Sbjct: 360 QDLLAEDKLPTLLGAEAN-LNNIGD----TNPRVGEVLNSILLEL-KAGEEEQPTTSVQQ 413
Query: 349 VLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390
L D PF+F I E +G + F G V NP +
Sbjct: 414 PGSPEAL----DVTLSSPFLFAIYEQDSGTLHFLGRVNNPQS 451
|
| >1hle_A Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 Length = 345 | Back alignment and structure |
|---|
Score = 289 bits (741), Expect = 8e-96
Identities = 103/353 (29%), Positives = 171/353 (48%), Gaps = 25/353 (7%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSND 67
+ T A+ L + + N+ SP SI L++I G++G T Q+ L + +
Sbjct: 7 TANTHFAVDLFRALN-ESDPTGNIFISPLSISSALAMIFLGTRGNTAAQVSKALYFDTVE 65
Query: 68 QLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDF 127
+++ L A + P L +AN ++ +++ + F +Y A VDF
Sbjct: 66 DIHSRFQSLNADIN---KPGAPYILKLANRLYGEKTYNFLADFLASTQKMYGAELASVDF 122
Query: 128 QTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTK 187
Q + +E+N W + +T G + E+L G VDN T+L+ NA+YFKG W + F T+
Sbjct: 123 QQAPEDARKEINEWVKGQTEGKIPELLVKGMVDNMTKLVLVNAIYFKGNWQQKFMKEATR 182
Query: 188 DYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFLPD-- 242
D F L + V M +K +F + +VL LPY+ E SM LPD
Sbjct: 183 DAPFRLNKKDTKTVKMM-YQKKKFPYNYIEDLKCRVLELPYQGKE----LSMIILLPDDI 237
Query: 243 --AKDGLPTLLEKMGSE--SKFL-DHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGL 297
GL + +++ + ++ +L V V +PRFK+ +++ L LG+
Sbjct: 238 EDESTGLEKIEKQLTLDKLREWTKPENLYLAEVNV---HLPRFKLEESYDLTSHLARLGV 294
Query: 298 VLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVL 350
F+ L+ M + ++L+VS I KSF+++NEEGTEAAAA+A T++L
Sbjct: 295 QDLFNRGKADLSGMSGA---RDLFVSKIIHKSFVDLNEEGTEAAAATAGTILL 344
|
| >3f02_A Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 3fgq_A 1jjo_C 1jjo_A Length = 359 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 2e-93
Identities = 96/356 (26%), Positives = 170/356 (47%), Gaps = 29/356 (8%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK--SKS 65
D+++++ + +D N++FSP SI + + ++ G++G T ++ + S
Sbjct: 21 EAIADLSVNMYNRLR-ATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSLK 79
Query: 66 NDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQV 125
N + +F E +V + + +AN +++ + F Q++ + AA N V
Sbjct: 80 NGEEFSFLKEFSNMVT---AKESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHV 136
Query: 126 DFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSK 185
DF + V+ +N W E TN LVK+++ P D +T L NA+YFKG W F
Sbjct: 137 DFS-QNVAVANYINKWVENNTNNLVKDLVSPRDFDAATYLALINAVYFKGNWKSQFRPEN 195
Query: 186 TKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---------GFKVLGLPYKQGEDKRRFSM 236
T+ + F + +++P M ++ +F ++VL +PY+ E SM
Sbjct: 196 TRTFSFTKDDESEVQIPMM-YQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGDE----ISM 250
Query: 237 YFFLPDAKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGL 295
L + L TL + ++ + + + Q+VEV +PRF + I++ VLK L
Sbjct: 251 MLVLSRQEVPLATLEPLVKAQLVEEWANSVKKQKVEV---YLPRFTVEQEIDLKDVLKAL 307
Query: 296 GLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLR 351
G+ F + L + D+ K +++S KSF+EVNEEG+EAAA S + R
Sbjct: 308 GITEIFI-KDANLTGLSDN---KEIFLSKAIHKSFLEVNEEGSEAAAVSGMIAISR 359
|
| >2h4p_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_A Length = 394 | Back alignment and structure |
|---|
Score = 274 bits (703), Expect = 2e-89
Identities = 100/380 (26%), Positives = 166/380 (43%), Gaps = 49/380 (12%)
Query: 5 ESISN-QTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK- 62
E +S + + L + +D N+ FSP SI L+L +KG T ++ L
Sbjct: 27 EQVSASIGNFTVDLFNKLN-ETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHF 85
Query: 63 -------------------SKSNDQLNAFASELVAVVFAD-----GSPSGGPRLSVANGV 98
+ +E + F + P L AN +
Sbjct: 86 TEAVRAESSSVARPSRGRPKRRRMDPEHEQAENIHSGFKELLTAFNKPRNNYSLRSANRI 145
Query: 99 WIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGS 158
+++++ +L T+ Q+ YKA +V+F+T + +E+N W EK+T +K +L
Sbjct: 146 YVEKTYALLPTYLQLSKKYYKAEPQKVNFKTAPEQSRKEINTWVEKQTESKIKNLLSSDD 205
Query: 159 VDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD-- 216
V +TRLI NA+YFK W F + KT F L S V M ++ F
Sbjct: 206 VKATTRLILVNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVKMM-YMRDTFPVLIMEK 264
Query: 217 -GFKVLGLPYKQGEDKRRFSMYFFLPD----AKDGLPTLLEKMGSE--SKFLD-HHLPSQ 268
FK++ LPY + E SM+ LPD GL L ++ E S++ D +
Sbjct: 265 MNFKMIELPYVKRE----LSMFILLPDDIKDGTTGLEQLERELTYERLSEWADSKMMTET 320
Query: 269 RVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQK 328
V++ +P+F + I++ L+ +G+ F+ M D K+L +S + +
Sbjct: 321 LVDL---HLPKFSLEDRIDLRDTLRNMGMTTAFT-TNADFRGMTDK---KDLAISKVIHQ 373
Query: 329 SFIEVNEEGTEAAAASAATV 348
SF+ V+E+GTEAAAA+A +
Sbjct: 374 SFVAVDEKGTEAAAATAVII 393
|
| >1as4_A Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_A* 4caa_A 3caa_A Length = 341 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 2e-87
Identities = 92/350 (26%), Positives = 160/350 (45%), Gaps = 25/350 (7%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK----S 63
S D A SL K + +A D N++FSP SI L+ +S G+ TL ++L LK
Sbjct: 9 SANVDFAFSLYKQLV-LKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTE 67
Query: 64 KSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASN 123
S +++ L+ + S +LS+ N +++ E LSL + F + +Y + +
Sbjct: 68 TSEAEIHQSFQHLLRTLN---QSSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAF 124
Query: 124 QVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDS 183
DFQ +A + +N + + T G + +++ +D+ T ++ N ++FK W FD
Sbjct: 125 ATDFQ-DSAAAKKLINDYVKNGTRGKITDLIK--DLDSQTMMVLVNYIFFKAKWEMPFDP 181
Query: 184 SKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFL 240
T F+L + VP M+ D V+ L Y S F L
Sbjct: 182 QDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGNA-----SALFIL 236
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
PD +D + + + E + E+G+ +P+F IS ++ +L LG+
Sbjct: 237 PD-QDKMEEVEAMLLPE-TLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEA 294
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVL 350
F+ L+ + + +NL VS + K+ ++V EEGTEA+ A+A + L
Sbjct: 295 FT-SKADLSGITGA---RNLAVSQVVHKAVLDVFEEGTEASRATAVKITL 340
|
| >1f0c_A ICE inhibitor; apoptosis, caspase inhibitor, protease inhibitor, serpin, viral protein; 2.26A {Cowpox virus} SCOP: e.1.1.1 PDB: 1c8o_A Length = 305 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 5e-86
Identities = 82/341 (24%), Positives = 147/341 (43%), Gaps = 45/341 (13%)
Query: 15 LSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFAS 74
+ + + +A + K N+ SP SI +L+++ G+ G T +QL +++ +++
Sbjct: 1 MDIFREIA-SSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEADK------- 52
Query: 75 ELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEV 134
N V+ S K++F + + + ++ VDF
Sbjct: 53 -----------NKDDISFKSMNKVYGRYSAVFKDSFLRKIGDNFQT----VDFTD--CRT 95
Query: 135 SREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLL 194
+N + T G + +L + T L+ +A+YFK W F+ T DY F++
Sbjct: 96 VDAINKCVDIFTEGKINPLLDE-PLSPDTCLLAISAVYFKAKWLMPFEKEFTSDYPFYVS 154
Query: 195 NGGSIKVPFMTSKKNQFVSAFD-----GFKVLGLPYKQGEDKRRFSMYFFLPDAKDGLPT 249
+ V M+ F A F ++ LPY G+ SM LPD DGL +
Sbjct: 155 PTEMVDVSMMSMYGEAFNHASVKESFGNFSIIELPYV-GD----TSMVVILPDNIDGLES 209
Query: 250 LLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGL 308
+ + + + K + + ++V IP+FK++ + L LGL F G
Sbjct: 210 IEQNLTDTNFKKWCDSMDAMFIDV---HIPKFKVTGSYNLVDALVKLGLTEVFG-STGDY 265
Query: 309 AEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVV 349
+ M + ++ V ++ K++I+VNEE TEAAAA+ A V
Sbjct: 266 SNMCN----SDVSVDAMIHKTYIDVNEEYTEAAAATCALVA 302
|
| >3ndd_A Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 3ndf_A 7api_A* 8api_A* 9api_A* 1d5s_A 1ezx_A 3t1p_A 2d26_A 1qmb_A Length = 343 | Back alignment and structure |
|---|
Score = 263 bits (675), Expect = 6e-86
Identities = 87/352 (24%), Positives = 159/352 (45%), Gaps = 29/352 (8%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQL---LSF-LKS 63
N + A SL + +A ++ +N+ FSP SI +++S G+K T D++ L+F L
Sbjct: 13 PNLAEFAFSLYRQLA-HQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTE 71
Query: 64 KSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASN 123
Q++ EL+ + P +L+ NG+++ E L L + F + V +Y + +
Sbjct: 72 IPEAQIHEGFQELLRTLN---QPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAF 128
Query: 124 QVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDS 183
V+F E +++N + EK T G + +++ +D T N ++FKG W F+
Sbjct: 129 TVNFG-DTEEAKKQINDYVEKGTQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEV 185
Query: 184 SKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFL 240
T++ DFH+ ++KVP M + F VL + Y + FFL
Sbjct: 186 KDTEEEDFHVDQVTTVKVPMM-KRLGMFNIQHAKKLSSWVLLMKYLGNA-----TAIFFL 239
Query: 241 PDAKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVL 299
PD + L L ++ + + + + +P+ I+ ++ VL LG+
Sbjct: 240 PD-EGKLQHLENELTHDIITKFLENEDRRSASL---HLPKLSITGTYDLKSVLGQLGITK 295
Query: 300 PFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLR 351
FS G L+ + + L +S K+ + ++E+GTEAA + R
Sbjct: 296 VFS-NGADLSGVTEE---APLKLSKAVHKAVLTIDEKGTEAAPDDDDEAIPR 343
|
| >3dy0_A N-terminus plasma serine protease inhibitor; serpin, blood clotting, hydrolase inhibitor; HET: IDS SGN; 1.55A {Homo sapiens} PDB: 1lq8_A* 2hi9_A* Length = 336 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 6e-84
Identities = 86/351 (24%), Positives = 175/351 (49%), Gaps = 29/351 (8%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK----S 63
S++ D L + +A + A N+ FSP SI + L+++S G+ T Q+L L
Sbjct: 7 SSRRDFTFDLYRALA-SAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQK 65
Query: 64 KSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASN 123
S +L+ +L+ + P G +LS+ N ++ D + L++TF + +Y A +
Sbjct: 66 SSEKELHRGFQQLLQELN---QPRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTF 122
Query: 124 QVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDS 183
+F+ +A +++N + K+T G + ++L ++D++ +I N ++FK W +F+
Sbjct: 123 PTNFR-DSAGAMKQINDYVAKQTKGKIVDLLK--NLDSNAVVIMVNYIFFKAKWETSFNH 179
Query: 184 SKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFL 240
T++ DF++ + ++VP M S+++Q+ D +V+G+PY+ + F L
Sbjct: 180 KGTQEQDFYVTSETVVRVPMM-SREDQYHYLLDRNLSCRVVGVPYQGNA-----TALFIL 233
Query: 241 PDAKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVL 299
P + + + + ++ + +++E+ +P+F I ++ KVL LG+
Sbjct: 234 PS-EGKMQQVENGLSEKTLRKWLKMFKKRQLEL---YLPKFSIEGSYQLEKVLPSLGISN 289
Query: 300 PFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVL 350
F+ L+ + + N+ VS + K+ +EV+E GT AAAA+
Sbjct: 290 VFT-SHADLSGISNH---SNIQVSEMVHKAVVEVDESGTRAAAATGTIFTF 336
|
| >2xn6_A Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn7_A* 2xn5_A* 2riv_A 2xn3_A* 2riw_A* Length = 350 | Back alignment and structure |
|---|
Score = 252 bits (646), Expect = 1e-81
Identities = 83/355 (23%), Positives = 152/355 (42%), Gaps = 30/355 (8%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK----S 63
S D A +L + E D N+ FSP SI L ++S G+ T +++ L
Sbjct: 13 SINADFAFNLYRRFT-VETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTD 71
Query: 64 KSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASN 123
++ L+ + P L + N ++I + L F V +Y+
Sbjct: 72 TPMVEIQHGFQHLICSLN---FPKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVF 128
Query: 124 QVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDS 183
DF + +E+N E +T G V ++ + +T ++ N ++FK W FD
Sbjct: 129 STDFS-NISAAKQEINSHVEMQTKGKVVGLIQ--DLKPNTIMVLVNYIHFKAQWANPFDP 185
Query: 184 SKTKD-YDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFF 239
SKT+D F + +++VP M + +Q+ D VL + Y + ++ F
Sbjct: 186 SKTEDSSSFLIDKTTTVQVPMM-HQMDQYYHLVDMELNCTVLQMDYSKNA----LAL-FV 239
Query: 240 LPDAKDGLPTLLEKMGSES-KFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLV 298
LP + + ++ M S++ K + L V++ +P+F IS ++ L +G+
Sbjct: 240 LPK-EGQMESVEAAMSSKTLKKWNRLLQKGWVDL---FVPKFSISATYDLGATLLKMGIQ 295
Query: 299 LPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSI 353
+S E + + + L +S+ K+ + + E+GTEAA A + RSI
Sbjct: 296 HAYS-ENADFSGLTED---NGLKLSNAAHKAVLHIGEKGTEAAGAMFLEAIPRSI 346
|
| >1m93_B Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 Length = 245 | Back alignment and structure |
|---|
Score = 236 bits (604), Expect = 2e-76
Identities = 68/261 (26%), Positives = 117/261 (44%), Gaps = 26/261 (9%)
Query: 92 LSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVK 151
N V+ S K++F + + + ++ VDF + +N + T G +
Sbjct: 4 FKSMNKVYGRYSAVFKDSFLRKIGDNFQT----VDFTD--SRTVDAINKSVDIFTEGKIN 57
Query: 152 EVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQF 211
+L + T L+ +A+YFK W F+ T DY F++ + V M+ F
Sbjct: 58 PLLDE-PLSPDTSLLAISAVYFKAKWLMPFEKEFTSDYPFYVSPTEMVDVSMMSMYGEAF 116
Query: 212 VSAFD-----GFKVLGLPYKQGEDKRRFSMYFFLPDAKDGLPTLLEKMGSES-KFLDHHL 265
A F ++ LPY G+ SM LPD DGL ++ + + + K +
Sbjct: 117 NHASVKESFGNFSIIELPYV-GD----TSMVVILPDNIDGLESIEQNLTDTNFKKWSDSM 171
Query: 266 PSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSI 325
+ ++V IP+FK++ + L LGL F G + M + ++ V ++
Sbjct: 172 DAMFIDV---HIPKFKVTGSYNLVDALVKLGLTEVFG-STGDYSNMSN----SDVSVDAM 223
Query: 326 FQKSFIEVNEEGTEAAAASAA 346
K++I+VNEE TEAAAA++A
Sbjct: 224 IHKTYIDVNEEYTEAAAATSA 244
|
| >3f02_C Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 1jjo_E Length = 48 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 1e-08
Identities = 13/29 (44%), Positives = 19/29 (65%)
Query: 360 DFVADHPFVFMIREDMTGLVMFTGHVLNP 388
+ DHPF F+IR TG ++F G V++P
Sbjct: 7 QVIVDHPFFFLIRNRRTGTILFMGRVMHP 35
|
| >2h4p_B MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_B Length = 34 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 1e-06
Identities = 11/32 (34%), Positives = 17/32 (53%)
Query: 358 KIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389
+ F DHPF F IR + + ++F G P+
Sbjct: 2 VLKFKVDHPFHFFIRHNKSKTILFFGRFCCPV 33
|
| >1hle_B Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 Length = 31 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 1e-06
Identities = 12/29 (41%), Positives = 19/29 (65%)
Query: 360 DFVADHPFVFMIREDMTGLVMFTGHVLNP 388
+F ADHPF+F IR + + ++F G +P
Sbjct: 3 NFNADHPFIFFIRHNPSANILFLGRFSSP 31
|
| >1m93_A Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 Length = 55 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 3e-06
Identities = 13/48 (27%), Positives = 27/48 (56%), Gaps = 1/48 (2%)
Query: 15 LSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK 62
+ + + +A K N+ SP SI +L+++ G+ G T +QL +++
Sbjct: 1 MDIFREIAS-SMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVE 47
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 391 | |||
| 3le2_A | 393 | Serpin-ZX; apoplast, glycoprotein, protease inhibi | 100.0 | |
| 4ga7_A | 389 | Leukocyte elastase inhibitor; serpin, conformation | 100.0 | |
| 2h4r_A | 415 | MENT, heterochromatin-associated protein MENT; ser | 100.0 | |
| 3f5n_A | 407 | Neuroserpin; cleaved form, fenib, human, tissue PL | 100.0 | |
| 3kcg_I | 432 | Antithrombin-III, ATIII; michaelis complex, blood | 100.0 | |
| 3ne4_A | 424 | Alpha-1-antitrypsin; serpin, LUNG disease, liver d | 100.0 | |
| 1uhg_A | 385 | Ovalbumin, S-ovalbumin; allergen, egg white protei | 100.0 | |
| 3sto_A | 406 | Serine protease inhibitor; serpin fold, hydrolase | 100.0 | |
| 1wz9_A | 375 | Maspin precursor; serpin, tumor suppressor, serpin | 100.0 | |
| 3nda_A | 377 | Serpin-2; vaccination target, TICK, hydrolase inhi | 100.0 | |
| 2arr_A | 382 | Plasminogen activator inhibitor-2; serpin, peptide | 100.0 | |
| 2ceo_A | 379 | Thyroxine-binding globulin; transport, serpin, hor | 100.0 | |
| 2zv6_A | 401 | Serpin B3; serine proteinase inhibitor, reactive s | 100.0 | |
| 1lj5_A | 379 | Plasminogen activator inhibitor-1; beta-barrell, b | 100.0 | |
| 4au2_A | 392 | HSP47, serpin peptidase inhibitor, clade H (heat s | 100.0 | |
| 4dy0_A | 379 | GLIA-derived nexin; serpin, protease inhibitor, th | 100.0 | |
| 2vdx_A | 373 | Corticosteroid-binding globulin; transport protein | 100.0 | |
| 1sek_A | 378 | Serpin K; serine protease inhibitor, protease; 2.1 | 100.0 | |
| 3pzf_A | 397 | Serpin 2; protease inhibitor, melanization, hydrol | 100.0 | |
| 3f1s_A | 385 | Protein Z-dependent protease inhibitor; PZ, ZPI, c | 100.0 | |
| 3ozq_A | 376 | Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molito | 100.0 | |
| 4ajt_A | 427 | Protein Z-dependent protease inhibitor; blood clot | 100.0 | |
| 1yxa_A | 398 | Serine (OR cysteine) proteinase inhibitor, clade 3 | 100.0 | |
| 1qmn_A | 401 | AACT, alpha-1-antichymotrypsin; serpin, serine pro | 100.0 | |
| 3b9f_I | 395 | Protein C inhibitor; michaelis complex, acute phas | 100.0 | |
| 1jmo_A | 480 | HC-II, heparin cofactor II, HLS2, serin; serpin, t | 100.0 | |
| 2v95_A | 371 | Corticosteroid-binding globulin; transport protein | 100.0 | |
| 2pef_A | 373 | Serine protease inhibitor; serpin; 1.60A {Thermoan | 100.0 | |
| 2wxy_C | 453 | Angiotensinogen, serpin A8; glycoprotein, hyperten | 100.0 | |
| 1imv_A | 398 | PEDF, pigment epithelium-derived factor; serpin, a | 100.0 | |
| 1sng_A | 370 | COG4826: serine protease inhibitor; serine proteas | 100.0 | |
| 2wxw_A | 453 | Angiotensinogen, serpin A8; glycoprotein, hyperten | 100.0 | |
| 2r9y_A | 430 | Alpha-2-antiplasmin; inhibitory serpin, plasmin in | 100.0 | |
| 2oay_A | 390 | C1-inhibitor, plasma protease C1 inhibitor, C1 INH | 100.0 | |
| 1hle_A | 345 | Horse leukocyte elastase inhibitor; hydrolase inhi | 100.0 | |
| 3f02_A | 359 | Neuroserpin; cleaved form, fenib, human, disease M | 100.0 | |
| 3ndd_A | 343 | Alpha-1-antitrypsin; serpin, hydrolase inhibitor; | 100.0 | |
| 2h4p_A | 394 | MENT, heterochromatin-associated protein MENT; ser | 100.0 | |
| 3dy0_A | 336 | N-terminus plasma serine protease inhibitor; serpi | 100.0 | |
| 2xn6_A | 350 | Thyroxine-binding globulin; transport, cleaved pro | 100.0 | |
| 4afx_A | 387 | Protein Z dependent protease inhibitor; hydrolase | 100.0 | |
| 1as4_A | 341 | Antichymotrypsin, ACT; serpin, serine protease inh | 100.0 | |
| 1mtp_A | 323 | Serine proteinase inhibitor (serpin), chain A; str | 100.0 | |
| 1f0c_A | 305 | ICE inhibitor; apoptosis, caspase inhibitor, prote | 100.0 | |
| 1m93_B | 245 | Serine proteinase inhibitor 2; serpin, CRMA, apopt | 100.0 | |
| 1m93_A | 55 | Serine proteinase inhibitor 2; serpin, CRMA, apopt | 99.45 | |
| 3ndd_B | 36 | Alpha-1-antitrypsin; serpin, hydrolase inhibitor; | 99.39 | |
| 2riv_B | 40 | Thyroxine-binding globulin; TBG, serpin, cleaved, | 99.38 | |
| 2xn6_B | 35 | Thyroxine-binding globulin; transport, cleaved pro | 99.38 | |
| 1hle_B | 31 | Horse leukocyte elastase inhibitor; hydrolase inhi | 99.37 | |
| 4afx_B | 36 | Protein Z dependent protease inhibitor; hydrolase | 99.37 | |
| 2h4p_B | 34 | MENT, heterochromatin-associated protein MENT; ser | 99.36 | |
| 1as4_B | 37 | Antichymotrypsin, ACT; serpin, serine protease inh | 99.36 | |
| 1m93_C | 41 | Serine proteinase inhibitor 2; serpin, CRMA, apopt | 99.24 | |
| 3f02_C | 48 | Neuroserpin; cleaved form, fenib, human, disease M | 99.24 | |
| 1mtp_B | 43 | Serine proteinase inhibitor (serpin), chain B; str | 99.18 | |
| 3dy0_B | 29 | C-terminus plasma serine protease inhibitor; serpi | 99.1 |
| >3le2_A Serpin-ZX; apoplast, glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase; 2.20A {Arabidopsis thaliana} SCOP: e.1.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-89 Score=659.30 Aligned_cols=386 Identities=63% Similarity=1.041 Sum_probs=347.6
Q ss_pred CchhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHH
Q 016311 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVV 80 (391)
Q Consensus 1 ~~~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l 80 (391)
||+++.+.++++||++||+++.....+++|++|||+||+.+|+|+++||+|+|++||.++||++..++++..++.+...+
T Consensus 3 ~~~~~~~~~~~~Fa~~L~~~l~~~~~~~~Ni~~SP~Si~~aLaml~~GA~G~T~~ql~~~L~~~~~~~~~~~~~~l~~~l 82 (393)
T 3le2_A 3 MDVRESISLQNQVSMNLAKHVITTVSQNSNVIFSPASINVVLSIIAAGSAGATKDQILSFLKFSSTDQLNSFSSEIVSAV 82 (393)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHHHTSCTTCCEEECHHHHHHHHHHHHHTCCTHHHHHHHHHHTCSSHHHHHHHHHHTHHHH
T ss_pred ccHHHHHHhhhHHHHHHHHHHhcccCCCCCEEECHHHHHHHHHHHHhcCCCcHHHHHHHHhCCCCHHHHHHHHHHHHHHh
Confidence 89999999999999999999932557889999999999999999999999999999999999997788899999988887
Q ss_pred hhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCC
Q 016311 81 FADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVD 160 (391)
Q Consensus 81 ~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~ 160 (391)
..+..+..+..+.++|+||+++++++.++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|++++++++++
T Consensus 83 ~~~~~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~ 162 (393)
T 3le2_A 83 LADGSANGGPKLSVANGAWIDKSLSFKPSFKQLLEDSYKAASNQADFQSKAVEVIAEVNSWAEKETNGLITEVLPEGSAD 162 (393)
T ss_dssp HSCCGGGTSCEEEEEEEEEEETTSCBCHHHHHHHHHHSCCEEEEECHHHHHHHHHHHHHHHHHHHTTTSCCCSSCTTCSC
T ss_pred hccccCCCCcEEEeeeehhhcCCCCcChHHHHHHHHhhcceEEEecccccHHHHHHHHHHHHHHhhcCchhhhCCccCCC
Confidence 64332346778999999999999999999999999999999999999876788999999999999999999999988999
Q ss_pred CcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccCCeEEEEeecCCCCCCceEEEEEEe
Q 016311 161 NSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240 (391)
Q Consensus 161 ~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~~~~vveLp~~~~~~~~~~sm~iil 240 (391)
++|+++|+||+||+|.|+.+|++..|..++|+..+|++++||||++++.++|...+++++|+|||++++++.++||+|||
T Consensus 163 ~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~~~~~~~~~vleLPy~~~~~~~~~sm~iiL 242 (393)
T 3le2_A 163 SMTKLIFANALYFKGTWNEKFDESLTQEGEFHLLDGNKVTAPFMTSKKKQYVSAYDGFKVLGLPYLQGQDKRQFSMYFYL 242 (393)
T ss_dssp TTCCEEEEEEEEEECCBSSCCCGGGCEEEEEECTTSCEEEEEEEECCSCEEEEEETTEEEEEEEBCCTTCSCCEEEEEEE
T ss_pred CCcEEEEEEeeeEecccccCCChhhccccccEeCCCcEEEEccccccCeeeeeeccCcEEEEeecCCCCCCCcEEEEEEe
Confidence 99999999999999999999999999999999999999999999998877777777999999999984222279999999
Q ss_pred cCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCC---
Q 016311 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVG--- 317 (391)
Q Consensus 241 P~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~--- 317 (391)
|+++.+|.+++++|+....++.+++...++..++|.||||++++++||+++|++||++++|++ .||||+|++ .
T Consensus 243 P~~~~~l~~l~~~L~~~~~~l~~~~~~~~v~~~~l~lPKF~i~~~~~L~~~L~~lGi~~~F~~-~Adfsgis~---~~~~ 318 (393)
T 3le2_A 243 PDANNGLSDLLDKIVSTPGFLDNHIPRRQVKVREFKIPKFKFSFGFDASNVLKGLGLTSPFSG-EEGLTEMVE---SPEM 318 (393)
T ss_dssp ESSTTCHHHHHHHHHHSTTTGGGCCCCSEEEEEEEEEECEEEEEEEETHHHHHHTTCCGGGST-TTCCTTTBS---CHHH
T ss_pred CCCCCCHHHHHHHHhcCHHHHHHhhhhceeeecceECcEEeccCCcchHHHHHhCCchhhcCC-cCCcccccc---cccc
Confidence 999999999999997433456667766666666899999999999999999999999999998 899999997 4
Q ss_pred -CCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccC-CCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 318 -KNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVL-SDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 318 -~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~-~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
.+++|++++|++.|+|||+|++|+|+|++.+..++.+. +++++|+|||||+|+|+|+.|+.|||+|||.+|..
T Consensus 319 ~~~l~vs~v~hka~ieV~E~GteAaAaT~~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 393 (393)
T 3le2_A 319 GKNLCVSNIFHKACIEVNEEGTEAAAASAGVIKLRGLLMEEDEIDFVADHPFLLVVTENITGVVLFIGQVVDPLH 393 (393)
T ss_dssp HTTCCCCEEEEEEEEEECSCBCSCCCCCCCHHHHHTTTSCCCEEEEECCSCEEEEEEETTTCCEEEEEEESCTTC
T ss_pred CCCeeEeEEEEEEEEEEcCCCchhhcccceeeeeccCCCCCCCceEEecCCEEEEEEECCCCcEEEEEEecCCCC
Confidence 58999999999999999999999999987666666543 22368999999999999999999999999999974
|
| >4ga7_A Leukocyte elastase inhibitor; serpin, conformational change, serine protease inhibitor, Ca inhibitor, chymase inhibitor, chymotrypsin inhibitor; 2.90A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-86 Score=641.01 Aligned_cols=371 Identities=29% Similarity=0.462 Sum_probs=327.8
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHHhh
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFA 82 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l~~ 82 (391)
|..+..++++||++||+++. ...+++|++|||+||+.+|+|+++||+|+|++||.++||++..++++..++.+...+.+
T Consensus 11 ~~~l~~~~~~Fa~~L~~~l~-~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~ 89 (389)
T 4ga7_A 11 MEQLSSANTRFALDLFLALS-ENNPAGNIFISPFSISSAMAMVFLGTRGNTAAQLSKTFHFNTVEEVHSRFQSLNADINK 89 (389)
T ss_dssp CCHHHHHHHHHHHHHHHHHH-HHCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTGGGCTTHHHHHHHHHHHHTC
T ss_pred HHHHHHHHhHHHHHHHHHHh-hcCCCCCEEEchHHHHHHHHHHHhhccCcHHHHHHHHhCCCCHHHHHHHHHHHHHHHhC
Confidence 55678899999999999998 45678999999999999999999999999999999999998667888899999888753
Q ss_pred CCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCc
Q 016311 83 DGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNS 162 (391)
Q Consensus 83 ~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~ 162 (391)
...+..+.++|+||+++++++.++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|++++++++++++
T Consensus 90 ---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~g~I~~ll~~~~l~~~ 166 (389)
T 4ga7_A 90 ---RGASYILKLANRLYGEKTYNFLPEFLVSTQKTYGADLASVDFQHASEDARKTINQWVKGQTEGKIPELLASGMVDNM 166 (389)
T ss_dssp ---TTCSSEEEEEEEEEEETTSCBCHHHHHHHHHHTSCCEEEECHHHHHHHHHHHHHHHHHHHTTTSSTTSSCTTSSCTT
T ss_pred ---CCCCcEEEEeeeeeecCCCccCHHHHHHHHHHhCCeeEecccccCHHHHHHHHHHHHHHhhCCchhhccCCCCCCCC
Confidence 34567899999999999999999999999999999999999997678899999999999999999999998899999
Q ss_pred CeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccc--cCCeEEEEeecCCCCCCceEEEEEEe
Q 016311 163 TRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSA--FDGFKVLGLPYKQGEDKRRFSMYFFL 240 (391)
Q Consensus 163 t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLp~~~~~~~~~~sm~iil 240 (391)
|+++|+||+||+|.|+.+|++..|.+++|+..+|++++||||++.+.++|.. ..++++|+|||+++ ++||+|||
T Consensus 167 t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~----~~sm~iiL 242 (389)
T 4ga7_A 167 TKLVLVNAIYFKGNWKDKFMKEATTNAPFRLNKKDRKTVKMMYQKKKFAYGYIEDLKCRVLELPYQGE----ELSMVILL 242 (389)
T ss_dssp CCEEEEEEEEEECCBSSCCCTTTCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTS----SEEEEEEE
T ss_pred ceEEEEEEEEEEeeecCCCCccCccccceEeCCCcEEEEEEEEEeeeEEEEEECCCCEEEEEEECCCC----CEEEEEEe
Confidence 9999999999999999999999999999999999999999999998766544 55899999999987 79999999
Q ss_pred cCCC----CChHHHHHHhcCchHHHhhcC--CCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCC
Q 016311 241 PDAK----DGLPTLLEKMGSESKFLDHHL--PSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDS 314 (391)
Q Consensus 241 P~~~----~~l~~l~~~L~~~~~~l~~~~--~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~ 314 (391)
|++. .+|.+++++|+ ...+..|. ...+...++|.||||++++++||+++|++||++++|++..||||+|++
T Consensus 243 P~~~~~~~~~L~~le~~L~--~~~l~~~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~~~Adfsgis~- 319 (389)
T 4ga7_A 243 PDDIEDESTGLKKIEEQLT--LEKLHEWTKPENLDFIEVNVSLPRFKLEESYTLNSDLARLGVQDLFNSSKADLSGMSG- 319 (389)
T ss_dssp ESSCCSSSSSCHHHHHHCC--HHHHHHHHSGGGCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTBC-
T ss_pred cCCCccccccHHHHHHHhC--HHHHHHHhhhhcCcceEEEEEeccEEEEEeechHHHHHHcCcHhhcCCCcCCcccccC-
Confidence 9998 88999999997 34555565 345566789999999999999999999999999999976899999998
Q ss_pred CCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 315 PVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 315 ~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
..+++|++++||+.|+|||+|++|+|+|++.+..++. +.+..|+|||||+|+|+|+.||.|||+|+|.+|
T Consensus 320 --~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~s~--~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 389 (389)
T 4ga7_A 320 --ARDIFISKIVHKSFVEVNEEGTEAAAATAGIATFCMD--DPEENFTADHPFLFFIRHNSSGSILFLGRFSSP 389 (389)
T ss_dssp --CSSCCEEEEEEEEEEEECSCBC----------CCCSS--SCEEEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred --CCCcceeeEEEEEEEEecCCCcccccccccccccccC--CCCCcEEccCCEEEEEEECCCCcEEEEEEecCC
Confidence 4689999999999999999999999999866555544 235689999999999999999999999999999
|
| >2h4r_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 2.70A {Gallus gallus} PDB: 2dut_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-85 Score=636.20 Aligned_cols=375 Identities=29% Similarity=0.503 Sum_probs=328.7
Q ss_pred chhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh---------------
Q 016311 2 DVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN--------------- 66 (391)
Q Consensus 2 ~~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~--------------- 66 (391)
++..+..++++||++||+++. ...+++|+||||+||+.+|+|+++||+|+|++||.++||++..
T Consensus 5 ~~~~l~~~~~~Fa~~l~~~l~-~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~ 83 (415)
T 2h4r_A 5 SMEQVSASIGNFTVDLFNKLN-ETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAVRAESSSVARPSRGR 83 (415)
T ss_dssp HHHHHHHHHHHHHHHHHHHHH-TTCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTSCCC---------------
T ss_pred hHHHHHHHHHHHHHHHHHHHh-ccCCCCCEEEchHHHHHHHHHHHhhccchHHHHHHHHhCCCccccccccccccccccc
Confidence 567788999999999999998 4567899999999999999999999999999999999999752
Q ss_pred -------------hHHHHHHHHHHHHHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHH
Q 016311 67 -------------DQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAE 133 (391)
Q Consensus 67 -------------~~~~~~~~~l~~~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~ 133 (391)
++++..++.+...+.+ ...+..++++|+||+++++.+.++|++.++++|+++++.+||.++++.
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~ 160 (415)
T 2h4r_A 84 PKRRRMDPEHEQAENIHSGFKELLTAFNK---PRNNYSLRSANRIYVEKTYALLPTYLQLSKKYYKAEPQKVNFKTAPEQ 160 (415)
T ss_dssp ------------CHHHHHHHHHHHHHHTC---SSCSSEEEEEEEEEEETTSCBCHHHHHHHHHHHSCCCEEECTTTCHHH
T ss_pred ccccccccccccHHHHHHHHHHHHHHHhC---CCCCcEEEEEEeehhhCCCCcCHHHHHHHHHHhCCeEEEecCCCCHHH
Confidence 5778888888887753 335678999999999999999999999999999999999999766889
Q ss_pred HHHHHHHHHHHHhCCcccccCCCCCCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccc
Q 016311 134 VSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVS 213 (391)
Q Consensus 134 a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~ 213 (391)
+++.||+||+++|+|+|++++++++++++|+++|+||+||+|.|+.+|++..|..++|+..+|+.++||||++.+.++|+
T Consensus 161 a~~~IN~WV~~~T~gkI~~ll~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~ 240 (415)
T 2h4r_A 161 SRKEINTWVEKQTESKIKNLLSSDDVKATTRLILVNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVL 240 (415)
T ss_dssp HHHHHHHHHHHHTTTSCCCCSCGGGCCSSCCEEEEEEEEEECBBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEE
T ss_pred HHHHHHHHHHHHhcCchhhhcCccccCCcceEEEEEhheEeceecCCCCcccCeeeEEEecCCcEEEeeEEeecCcEeEE
Confidence 99999999999999999999998889999999999999999999999999999999999999999999999998866654
Q ss_pred c--cCCeEEEEeecCCCCCCceEEEEEEecCCC----CChHHHHHHhcCchHHHhhcCC--CCceeeeeeeceeeeeecc
Q 016311 214 A--FDGFKVLGLPYKQGEDKRRFSMYFFLPDAK----DGLPTLLEKMGSESKFLDHHLP--SQRVEVGDFRIPRFKISFG 285 (391)
Q Consensus 214 ~--~~~~~vveLp~~~~~~~~~~sm~iilP~~~----~~l~~l~~~L~~~~~~l~~~~~--~~~~~~v~l~lPkf~i~~~ 285 (391)
. ..++++|+|||+++ ++||+||||++. .+|.+++++|+ ...+..|.. ..+...++|.||||+++++
T Consensus 241 ~~~~l~~~vleLPY~~~----~~sm~iiLP~~~~~~~~~L~~le~~L~--~~~l~~~~~~~~~~~~~v~v~lPKF~i~~~ 314 (415)
T 2h4r_A 241 IMEKMNFKMIELPYVKR----ELSMFILLPDDIKDGTTGLEQLERELT--YERLSEWADSKMMTETLVDLHLPKFSLEDR 314 (415)
T ss_dssp EETTTTEEEEEEEBGGG----SEEEEEEEESSCCSSSSSCHHHHTTCC--HHHHHHHHTCTTCEEEEEEEEEECEEECCE
T ss_pred EeCCCCEEEEEeeCCCC----cEEEEEEecCCCcccccCHHHHHHHhC--HhHHHHHhhhhcccceeEEEECCeEEEeee
Confidence 4 56899999999987 799999999998 89999999997 345666655 4555678999999999999
Q ss_pred CCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeec
Q 016311 286 IEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADH 365 (391)
Q Consensus 286 ~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~dr 365 (391)
+||+++|++||++++|+. .||||+|++ ..+++|++++|++.|+|||+|++|+|+|++.+..++.+.+++.+|+|||
T Consensus 315 ~dL~~~L~~lGi~~~F~~-~Adfsgis~---~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~~~~~~~~f~~dr 390 (415)
T 2h4r_A 315 IDLRDTLRNMGMTTAFTT-NADFRGMTD---KKDLAISKVIHQSFVAVDEKGTEAAAATAVIISFTTSVINHVLKFKVDH 390 (415)
T ss_dssp EECHHHHHHTTCCGGGST-TCCCTTTBS---SSCCCCCEEEEEEEEEECSSBSSCCC---------------CEEEECCS
T ss_pred ecHHHHHHHcChhhhhcC-ccccccccC---CCCeEEEEEEEEEEEEecCCCcccccccchhhccccCCCCCCcEEEecC
Confidence 999999999999999995 899999998 4689999999999999999999999999876655555333237899999
Q ss_pred CeeEEEEECCCCcEEEEEEecCCCC
Q 016311 366 PFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 366 PF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
||+|+|+|+.||.|||+|||.+|..
T Consensus 391 PFlf~I~~~~t~~iLF~G~v~~P~~ 415 (415)
T 2h4r_A 391 PFHFFIRHNKSKTILFFGRFCCPVE 415 (415)
T ss_dssp CEEEEEEETTTTEEEEEEEECSCCC
T ss_pred CEEEEEEECCCCcEEEEEEeCCCCC
Confidence 9999999999999999999999973
|
| >3f5n_A Neuroserpin; cleaved form, fenib, human, tissue PLAS activator, hydrolase inhibitor; 3.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-85 Score=638.32 Aligned_cols=370 Identities=29% Similarity=0.536 Sum_probs=326.9
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh--hHHHHHHHHHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN--DQLNAFASELVAVV 80 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~--~~~~~~~~~l~~~l 80 (391)
|..+.+++++||++||+++. ...+++|++|||+||+.+|+|+++||+|+|++||.++||++.. .+++..++.+...+
T Consensus 16 ~~~l~~~~~~Fa~~L~~~l~-~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~~~~~~~~~~~l~~~l 94 (407)
T 3f5n_A 16 ATFPEEAIADLSVNMYNRLR-ATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSLKNGEEFSFLKEFSNMV 94 (407)
T ss_dssp ---CTHHHHHHHHHHHHHHH-HTTTTSCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHCCC----CCCHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHHHHHHHH-hhCCCCCEEEchHHHHHHHHHHHhhcCchHHHHHHHHhCCCCCCHHHHHHHHHHHHHHH
Confidence 45677899999999999998 4567899999999999999999999999999999999999854 36778888888776
Q ss_pred hhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCC
Q 016311 81 FADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVD 160 (391)
Q Consensus 81 ~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~ 160 (391)
.+ +..+..+.++|+||+++++.+.++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|++++++++++
T Consensus 95 ~~---~~~~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~ 170 (407)
T 3f5n_A 95 TA---KESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFSQ-NVAVANYINKWVENNTNNLVKDLVSPRDFD 170 (407)
T ss_dssp TC----CCSCEEEEEEEEEEETTCCBCTTHHHHHHHTSCCEEEEECTTS-HHHHHHHHHHHHHHTTTTCSCCCCCGGGCC
T ss_pred hc---cCCCcEEEEEEEEEEeCCCccCHHHHHHHHHhhcCceEEcCCCC-hHHHHHHHHHHHHHhhCCchhhcCCcccCC
Confidence 42 34667899999999999999999999999999999999999994 789999999999999999999999988999
Q ss_pred CcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC--C------eEEEEeecCCCCCCc
Q 016311 161 NSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--G------FKVLGLPYKQGEDKR 232 (391)
Q Consensus 161 ~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~------~~vveLp~~~~~~~~ 232 (391)
++|+++|+||+||+|.|+.+|++..|..++|+..+|++++||||++.+.++|++.+ + +++|+|||+++
T Consensus 171 ~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~f~y~~~~~l~~~~~~~~~vleLPY~~~---- 246 (407)
T 3f5n_A 171 AATYLALINAVYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGD---- 246 (407)
T ss_dssp TTCCEEEEEEEEEECCBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEEEEEEEEECC-----CEEEEEEEEBTTS----
T ss_pred CCceEEEEEeeeeecccccCCCccCceeeeEEcCCCeEEEEeEEEEeeeeeeEEccccccccCcceEEEEEECCCC----
Confidence 99999999999999999999999999999999999999999999999888877644 4 99999999987
Q ss_pred eEEEEEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCC
Q 016311 233 RFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMV 312 (391)
Q Consensus 233 ~~sm~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is 312 (391)
++||+||||+++.+|.+++++|+ ...+.+|....+...++|.||||++++++||+++|++||++++|+. .||||+|+
T Consensus 247 ~~sm~iiLP~~~~~L~~l~~~L~--~~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis 323 (407)
T 3f5n_A 247 EISMMLVLSRQEVPLATLEPLVK--AQLVEEWANSVKKQKVEVYLPRFTVEQEIDLKDVLKALGITEIFIK-DANLTGLS 323 (407)
T ss_dssp SEEEEEEECCTTCCGGGTGGGCC--HHHHHHHHHHCEEEEEEEEEECEEEEEEEEHHHHHHHTTCCGGGST-TCCCTTTB
T ss_pred cEEEEEEECCCCCCHHHHHHHhC--HHHHHHHHHhCcceEEEEECCCEEEeeecChHHHHHhCCchhhcCC-CCCccccc
Confidence 79999999999999999999997 3345556555566778999999999999999999999999999996 89999998
Q ss_pred CCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCC
Q 016311 313 DSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389 (391)
Q Consensus 313 ~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~ 389 (391)
+ ..+++|++++||+.|+|||+|++|+|+|++.+..++.+.+ ..|+|||||+|+|+|+.||.|||+|+|.+|.
T Consensus 324 ~---~~~l~vs~v~hka~ieVnE~GteAAAaT~~~~~~~~~~~~--~~f~~drPFlF~I~~~~t~~iLF~G~v~~P~ 395 (407)
T 3f5n_A 324 D---NKEIFLSKAIHKSFLEVNEEGSEAAAVSGMIAISRMAVLY--PQVIVDHPFFFLIRNRRTGTILFMGRVMHPE 395 (407)
T ss_dssp S---CTTCCCCEEEEEEEEEECSCBCCCCC-----CCSSSEEEE--CEEECCSCEEEEEEETTTCCEEEEEEESCCC
T ss_pred C---CCCceeeeEEEEEEEEecCCccccccccceeeccccCCCC--CcEEecCCEEEEEEECCCCcEEEEEEeCCcC
Confidence 7 4789999999999999999999999999865555554322 3899999999999999999999999999996
|
| >3kcg_I Antithrombin-III, ATIII; michaelis complex, blood coagulation, calcium, disulfide bond, EGF-like domain, glycoprotein, hemophilia, hydrolase; HET: NAG FUC MAN NTP; 1.70A {Homo sapiens} SCOP: e.1.1.1 PDB: 1e04_I* 1ath_A 1ant_L* 1br8_L 1azx_I* 1dzh_L* 1e03_L* 1dzg_L* 1e05_L* 1jvq_L* 1lk6_L* 1nq9_I* 1oyh_L* 1r1l_L* 1sr5_A* 2ant_L* 2beh_L* 2hij_L* 2znh_A* 3evj_I* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-86 Score=642.14 Aligned_cols=378 Identities=29% Similarity=0.514 Sum_probs=336.6
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC-----hhHHHHHHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS-----NDQLNAFASELV 77 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~-----~~~~~~~~~~l~ 77 (391)
+.++..++++||++||++++....+++|++|||+||+.+|+|+++||+|+|++||.++||++. .++++..++.+.
T Consensus 48 ~~~l~~~~~~Fa~~L~k~l~~~~~~~~Ni~~SP~SI~~aLaml~~GA~G~T~~ql~~~L~~~~~~~~~~~~i~~~f~~l~ 127 (432)
T 3kcg_I 48 VWELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLN 127 (432)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHSCTTSCCCBCHHHHHHHHHHHHTTCCHHHHHHHHHHTTCTTSCHHHHHTHHHHHHHHH
T ss_pred HHHHHHHHhHHHHHHHHHHhhccCCCCCEEEcHHHHHHHHHHHHhhcccHHHHHHHHHhCCCccccccHHHHHHHHHHHH
Confidence 456778999999999999984345689999999999999999999999999999999999973 156888888888
Q ss_pred HHHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCC
Q 016311 78 AVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPG 157 (391)
Q Consensus 78 ~~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~ 157 (391)
..+.+.. ..+..+.++|+||+++++.+.++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|+++++++
T Consensus 128 ~~l~~~~--~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~gkI~~ll~~~ 205 (432)
T 3kcg_I 128 CRLYRKA--NKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSE 205 (432)
T ss_dssp HHHHHHH--TTTEEEEEEEEEEEETTSCCCHHHHHHHHHHHSSCCEEECHHHHHHHHHHHHHHHHHHHTTTSSCCSSCTT
T ss_pred HHHhccc--CCCcEEEEEEEEEEcCCCccCHHHHHHHHHHhCCeEEeccCCCCHHHHHHHHHHHHHhhccCchhccCCcc
Confidence 7775311 14568999999999999999999999999999999999999976677778899999999999999999988
Q ss_pred CCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC-CeEEEEeecCCCCCCceEEE
Q 016311 158 SVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD-GFKVLGLPYKQGEDKRRFSM 236 (391)
Q Consensus 158 ~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~-~~~vveLp~~~~~~~~~~sm 236 (391)
+++++|.++|+||+||+|.|+.+|++..|..++|+..+|+.++||||++.+.++|+..+ ++++++|||+++ ++||
T Consensus 206 ~l~~~T~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~~~~vleLPy~~~----~~sm 281 (432)
T 3kcg_I 206 AINELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGD----DITM 281 (432)
T ss_dssp SSCTTCCEEEEEEEEEEECBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEEEEEEECGGGCEEEEEEBTTS----SEEE
T ss_pred cCCCCceEEEEeHHhhhhhhhcCCCcccceeeeEEECCCeEEEEEEEEecceeeEEEecCCcEEEEEEcCCC----ceEE
Confidence 89999999999999999999999999999999999999999999999999888777655 899999999988 7999
Q ss_pred EEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCC
Q 016311 237 YFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPV 316 (391)
Q Consensus 237 ~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~ 316 (391)
+||||+++.+|.+++++|+ ...+.+|+...+...++|.||||++++++||+++|++||++++|++..||||||++..
T Consensus 282 ~iiLP~~~~~L~~le~~L~--~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfsgis~~~- 358 (432)
T 3kcg_I 282 VLILPKPEKSLAKVEKELT--PEVLQEWLDELEEMMLVVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEG- 358 (432)
T ss_dssp EEEECCTTSCHHHHHHSCC--HHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTSCSS-
T ss_pred EEEecCCCCCHHHHHHHcC--HHHHHHHHHhCceeeEEEEecCEEEecccchhhhHhhCCchhhccCccCCcccccccC-
Confidence 9999999999999999997 3456666665666778999999999999999999999999999996589999998731
Q ss_pred CCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 317 GKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 317 ~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
..+++|++++|++.|+|||+|++|+|+|++.+..++.+ +.++.|+|||||+|+|+|+.||.|||+|||.+|.+
T Consensus 359 ~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~s~~-~~~~~F~adrPFlf~I~d~~t~~iLF~G~V~~P~~ 431 (432)
T 3kcg_I 359 RDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLN-PNRVTFKANRPFLVFIREVPLNTIIFMGRVANPCV 431 (432)
T ss_dssp SSCCCCCEEEEEEEEEECSCBCCCCCCCCCCCEESSCC-TTCEEEECCSCCEEEEEETTTTEEEEEC-CCCCCC
T ss_pred CCCceeeeEEEEEEEEecCCCccccccchhhcccccCC-CCCcEEecCCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 25799999999999999999999999998665555542 33578999999999999999999999999999985
|
| >3ne4_A Alpha-1-antitrypsin; serpin, LUNG disease, liver disease, polymerisation, hydrolase inhibitor; 1.81A {Homo sapiens} PDB: 1qlp_A 2qug_A 3cwl_A 3cwm_A* 1psi_A 3drm_A 1kct_A 3dru_A 1hp7_A 1iz2_A* 1oph_A 1oo8_A 1atu_A 1d5s_B 1qmb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-84 Score=631.73 Aligned_cols=365 Identities=27% Similarity=0.459 Sum_probs=329.5
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC----hhHHHHHHHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS----NDQLNAFASELVA 78 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~----~~~~~~~~~~l~~ 78 (391)
+..+..++++||++||+++. ...+++|++|||+||+.+|+|+++||+|+|++||.++||++. .++++..++.++.
T Consensus 53 ~~~l~~~~~~Fa~~L~~~l~-~~~~~~Ni~~SP~SI~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~i~~~f~~ll~ 131 (424)
T 3ne4_A 53 FNKITPNLAEFAFSLYRQLA-HQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLR 131 (424)
T ss_dssp -CTTHHHHHHHHHHHHHHHH-HHCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHH-hhCCCCCEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 45677899999999999998 457789999999999999999999999999999999999974 2578899999998
Q ss_pred HHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCC
Q 016311 79 VVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGS 158 (391)
Q Consensus 79 ~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~ 158 (391)
.+.+ +..+..++++|+||+++++.+.++|++.++++|++++..+||.+ ++.+++.||+||+++|+|+|+++++ +
T Consensus 132 ~l~~---~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~wV~~~T~gkI~~ll~--~ 205 (424)
T 3ne4_A 132 TLNQ---PDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGD-TEEAKKQINDYVEKGTQGKIVDLVK--E 205 (424)
T ss_dssp HHTC---SSCSSCCEEEEEEEEETTSCBCHHHHHHHHTTTCCEEEEECTTS-HHHHHHHHHHHHHHHTTTSSCSCCC--C
T ss_pred HhcC---CCCCcEEEEEEEEEEcCCCCcCHHHHHHHHHhhcceEEEecCCC-hHHHHHHHHHHHHHhhCCCcccccc--C
Confidence 8753 34567899999999999999999999999999999999999995 7899999999999999999999997 7
Q ss_pred CCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc--CCeEEEEeecCCCCCCceEEE
Q 016311 159 VDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF--DGFKVLGLPYKQGEDKRRFSM 236 (391)
Q Consensus 159 ~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLp~~~~~~~~~~sm 236 (391)
++++|.++|+||+||+|.|+.||++..|.+++|+..+|++++||||++.+.++|... .++++|+|||+++ ++|
T Consensus 206 l~~~t~lvLvNaiyFKg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~~~-----~sm 280 (424)
T 3ne4_A 206 LDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGN-----ATA 280 (424)
T ss_dssp CCTTCCEEEEEEEEEECCBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTT-----EEE
T ss_pred CCCcchhhhhhHHhhehhhhcCCCcccceeEeeeccCCcEEEEEEEEeecceeEEEecCCCeEEEEEecCCC-----eEE
Confidence 999999999999999999999999999999999999999999999999987776654 4899999999975 899
Q ss_pred EEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCC
Q 016311 237 YFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPV 316 (391)
Q Consensus 237 ~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~ 316 (391)
+||||++ .+|.+++++|+ ...+.+|.+..+...++|.||||++++++||+++|++|||+++|++ .||||||++
T Consensus 281 ~iiLP~~-~~l~~le~~L~--~~~l~~~~~~l~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~--- 353 (424)
T 3ne4_A 281 IFFLPDE-GKLQHLENELT--HDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSN-GADLSGVTE--- 353 (424)
T ss_dssp EEEEECT-TCHHHHHHHCC--HHHHHHHHHCCCCEEEEEEEECEEEEEEEEHHHHHHHTTCCGGGST-TCCCTTTBS---
T ss_pred EEEEcCc-CCHHHHHHHhC--HHHHHHHHHhCccceEEEEcCCEEEEeecchhhhhhhCChhhhcCC-CCCcccccC---
Confidence 9999998 57999999997 3456666555556678999999999999999999999999999998 899999998
Q ss_pred CCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 317 GKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 317 ~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
..+++|++++||+.|+|||+|++|+|+|++.+..++. +..|++||||+|+|+|+.||.|||+|+|.||.+
T Consensus 354 ~~~l~Vs~v~hka~ieVnE~GteAAAaT~~~~~~~s~----~~~f~~drPFlf~I~d~~t~~iLF~G~v~~P~~ 423 (424)
T 3ne4_A 354 EAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSI----PPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQ 423 (424)
T ss_dssp SSCCCCCEEEEEEEEEECSSSSSSCCCCCCCCCCSSC----CCEEECCSCEEEEEEETTTCCEEEEEEESCTTC
T ss_pred CCCcceeeEEEEEEEEEcCCCcccccccceeeeecCC----CCceeccCCEEEEEEECCCCeEEEEEEecCCCC
Confidence 4789999999999999999999999999865443332 347999999999999999999999999999986
|
| >1uhg_A Ovalbumin, S-ovalbumin; allergen, egg white protein, serpin; HET: SEP NAG; 1.90A {Gallus gallus} SCOP: e.1.1.1 PDB: 1ova_A* 1jti_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-85 Score=629.78 Aligned_cols=365 Identities=25% Similarity=0.444 Sum_probs=330.3
Q ss_pred hhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh-----------h---HHHH
Q 016311 6 SISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN-----------D---QLNA 71 (391)
Q Consensus 6 ~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~-----------~---~~~~ 71 (391)
+..++++||++||+++. ...+++|+||||+||+.+|+|+++||+|+|++||.++||++.. + +++.
T Consensus 3 l~~~~~~Fa~~l~~~l~-~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~ 81 (385)
T 1uhg_A 3 IGAASMEFCFDVFKELK-VHHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDSIEAQCGTSVNVHS 81 (385)
T ss_dssp HHHHHHHHHHHHHHHHH-HHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHHTCTTCTTCSHHHHTTTTSCTTTTH
T ss_pred hhhHHHHHHHHHHHHHH-hcCCCCCEEECHHHHHHHHHHHHhhccCcHHHHHHHHhCCCcccccccccccccchHHHHHH
Confidence 45789999999999998 4567899999999999999999999999999999999999753 3 7888
Q ss_pred HHHHHHHHHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCccc
Q 016311 72 FASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVK 151 (391)
Q Consensus 72 ~~~~l~~~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~ 151 (391)
.++.+...+.+ ...+..++++|+||+++++.+.++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|+
T Consensus 82 ~~~~l~~~l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV~~~T~gkI~ 158 (385)
T 1uhg_A 82 SLRDILNQITK---PNDVYSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAADQARELINSWVESQTNGIIR 158 (385)
T ss_dssp HHHHHHHHHTS---CCSSEEEEEEEEEEEETTSCBCHHHHHHHHHHCSSCEEEECCTTTHHHHHHHHHHHHHHHTTTCSC
T ss_pred HHHHHHHHHhC---CCCCcEEEEEEEeeccCCCCccHHHHHHHHHHhCCEEEEecCCCCHHHHHHHHHHHHHHHhcCchh
Confidence 89998888753 234678999999999999999999999999999999999999766889999999999999999999
Q ss_pred ccCCCCCCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccc--cCCeEEEEeecCCCC
Q 016311 152 EVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSA--FDGFKVLGLPYKQGE 229 (391)
Q Consensus 152 ~~l~~~~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLp~~~~~ 229 (391)
+++++++++++|+++|+||+||+|.|+.+|++..|..++|+..+|++++||||++.+.++|+. ..++++|+|||+++
T Consensus 159 ~l~~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~- 237 (385)
T 1uhg_A 159 NVLQPSSVDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMPFRVTEQESKPVQMMYQIGLFRVASMASEKMKILELPFASG- 237 (385)
T ss_dssp CCSCTTSSCTTCCEEEEEEEEEEECEEECCCGGGCEEEEECCCC--CEEEEEEEEEEEEEEEEEGGGTEEEEEEEBTTS-
T ss_pred hhCCcccCCCccceEeeeeeEEeeeecCCCCcCCCcCcEEEECCCeEEEEEEEEeeceEEEEEeCCCCeEEEEeccCCC-
Confidence 999988999999999999999999999999999999999999999999999999988766654 55899999999987
Q ss_pred CCceEEEEEEecCCCCChHHHHHHhcCchHHHhhcCC--CCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCC
Q 016311 230 DKRRFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLP--SQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGG 307 (391)
Q Consensus 230 ~~~~~sm~iilP~~~~~l~~l~~~L~~~~~~l~~~~~--~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~ad 307 (391)
++||+||||++..+|.+++++|+ ...+.+|.. ..+...++|.||||++++++||+++|++||++++|+. .||
T Consensus 238 ---~~sm~iiLP~~~~~l~~l~~~L~--~~~l~~~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Ad 311 (385)
T 1uhg_A 238 ---TMSMLVLLPDEVSGLEQLESIIN--FEKLTEWTSSNVMEERKIKVYLPRMKMEEKYNLTSVLMAMGITDVFSS-SAN 311 (385)
T ss_dssp ---SEEEEEEEESSTTCHHHHHHHCC--HHHHHHHTSTTTCEEEEEEEEEECEEEEEEEEHHHHHHHHTCCGGGST-TCC
T ss_pred ---cEEEEEEeCCCCCCHHHHHHHhC--hhHHHHHhhhhcccceEEEEEccceeecceecHHHHHHHcChhhhhcC-ccc
Confidence 79999999999999999999997 456777766 4566778999999999999999999999999999995 899
Q ss_pred CcCCCCCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecC
Q 016311 308 LAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLN 387 (391)
Q Consensus 308 fs~is~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~ 387 (391)
||+|++ ..+++|++++|++.|+|||+|++|+|+|++.+..++. +.+|+|||||+|+|+|+.||.|||+|||.+
T Consensus 312 fs~is~---~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~----~~~f~~drPFlf~I~~~~t~~iLF~G~v~~ 384 (385)
T 1uhg_A 312 LSGISS---AESLKISQAVHAAHAEINEAGREVVGSAEAGVDAASV----SEEFRADHPFLFCIKHIATNAVLFFGRCVS 384 (385)
T ss_dssp CTTTBC---STTCCEEEEEEEEEEEECSCEEECCCHHHHHHHHTTC----CCEEECCSCEEEEEEETTTCCEEEEEEESC
T ss_pred cccccC---CCCeEEEEEEEEEEEEecCCCcccccccchheeccCC----CCEEEeeCCEEEEEEECCCCcEEEEEEcCC
Confidence 999998 4689999999999999999999999999866555543 358999999999999999999999999999
Q ss_pred C
Q 016311 388 P 388 (391)
Q Consensus 388 P 388 (391)
|
T Consensus 385 P 385 (385)
T 1uhg_A 385 P 385 (385)
T ss_dssp C
T ss_pred C
Confidence 8
|
| >3sto_A Serine protease inhibitor; serpin fold, hydrolase inhibitor; 2.41A {Schistosoma haematobium} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-85 Score=633.70 Aligned_cols=374 Identities=22% Similarity=0.437 Sum_probs=319.7
Q ss_pred hhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHh--cCChhhHHHHHhhcCCCC----------hhHHHH
Q 016311 4 RESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISA--GSKGPTLDQLLSFLKSKS----------NDQLNA 71 (391)
Q Consensus 4 ~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~--ga~g~t~~el~~~L~~~~----------~~~~~~ 71 (391)
.....++++||++||+++. ...+++|++|||+||+.+|+|+++ ||+|+|++||.++||++. .++++.
T Consensus 13 ~~~~~~~~~Fa~~l~~~l~-~~~~~~Ni~~SP~Si~~aLaml~~~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~~~~ 91 (406)
T 3sto_A 13 YANISSHKAFTHAYLSTVT-ADFGGDNFLTCPLGILFTLGILLGSGGAQGRTGYQIGKTMRLKSTSSSWNSSEAQQEMKS 91 (406)
T ss_dssp ---CCHHHHHHHHHHHHHT-GGGTTSCEEECHHHHHHHHHHHHHTSCSCHHHHHHHHHHTTCSTTSSSCCHHHHHHHHHH
T ss_pred hhccchhhHHHHHHHHHHh-hcCCCCCEEEccHHHHHHHHHHHhccccCchHHHHHHHHhCCCcccccccccCCHHHHHH
Confidence 4456789999999999997 456789999999999999999999 999999999999999974 257888
Q ss_pred HHHHHHHHHhhCCC---CCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCC
Q 016311 72 FASELVAVVFADGS---PSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNG 148 (391)
Q Consensus 72 ~~~~l~~~l~~~~~---~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g 148 (391)
.++.+...+.+... ...+..+.++|+||+++++.+.++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|
T Consensus 92 ~~~~l~~~l~~~~~~~~~~~~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~g 170 (406)
T 3sto_A 92 LYQELNNSLTSEKTFLNEKEENVVRISTGIFVEKTYEVERRFNESIANDSEGELKQVDFSN-RTSATVDINDWVDQQSNG 170 (406)
T ss_dssp HHHHHHHHHHTCEECC---CEESEEEEEEEEEETTSCCCHHHHHHHHTCSSEEEEEECTTS-HHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHhccCcccccCCCcEEEEEeeeeecCCCccCHHHHHHHHHHhCCeEEEeCCCC-hHHHHHHHHHHHHHHhcC
Confidence 99998887763210 01146799999999999999999999999999999999999954 788999999999999999
Q ss_pred cccccCCCCCCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc--CCeEEEEeecC
Q 016311 149 LVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF--DGFKVLGLPYK 226 (391)
Q Consensus 149 ~i~~~l~~~~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLp~~ 226 (391)
+|+++++++ ++++|+++|+||+||+|.|+.+|++..|..++|+..+|++++||||++.+.++|+.. .++++|+|||+
T Consensus 171 kI~~ll~~~-l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~~~V~mM~~~~~~~y~~~~~~~~~vleLPy~ 249 (406)
T 3sto_A 171 LLEKFFTDD-IPDDTAMILVNVFYFRDFWQSPFEPHYTRKEDFYISPDRQITVDMMTQEGVMKYGKFEDEGFEIVSKPLN 249 (406)
T ss_dssp CC---------CCSCCEEEEEEEEECEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBS
T ss_pred cchhhccCC-CCCCceEEEEEeeEEEeecccCCCccCCcCceEECCCCeEEEEeEEEeeCceEEEEEcCCCeEEEEEecC
Confidence 999999876 999999999999999999999999999999999999999999999999987777654 68999999999
Q ss_pred CCCCCceEEEEEEecCCCCChHHHHHHhc-CchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCC
Q 016311 227 QGEDKRRFSMYFFLPDAKDGLPTLLEKMG-SESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEG 305 (391)
Q Consensus 227 ~~~~~~~~sm~iilP~~~~~l~~l~~~L~-~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~ 305 (391)
++ ++||+||||++..+|.+++++|+ .. .+.+|.+..+...++|.||||++++++||+++|++||++++|++..
T Consensus 250 ~~----~~sm~iiLP~~~~~l~~l~~~L~~~~--~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~ 323 (406)
T 3sto_A 250 NT----RFTFVIVLPLEKWSLNGATELLNGNK--VLSEYVKNLKETTVSLRLPKFTLKNTLDLVPTLKSIGVVDLFDPVK 323 (406)
T ss_dssp ST----TEEEEEEEESSSSCCTTHHHHHSSSS--CHHHHHTTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTT
T ss_pred CC----cEEEEEEecCCCCCHHHHHHHcCchH--HHHHHHHhCcEeEEEEEecCEEEeeecChhhhhhhCCchhhcCCCC
Confidence 97 79999999999889999999998 43 4555666666777899999999999999999999999999999767
Q ss_pred CCCcCCCCCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEe
Q 016311 306 GGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHV 385 (391)
Q Consensus 306 adfs~is~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v 385 (391)
||||+|++ ..+++|++++|++.|+|||+|++|+|+|++.+..++.. +.+..|++||||+|+|+|+.||.|||+|||
T Consensus 324 Adfsgis~---~~~l~vs~v~hka~ieV~E~GteAaAaT~~~~~~~s~~-~~~~~f~~drPFlf~I~~~~t~~iLF~G~v 399 (406)
T 3sto_A 324 SDLSGITP---NPNLYVNEFIQTNVLKLNESGIEATTVTSPIFVPFSAI-IPEVDFHVTHPFICFIYDQQLTMPIMAAKV 399 (406)
T ss_dssp CCCTTTCS---STTCCCSEEEEEEEEEECSSEESCCC-------CCCSC-CCSEEEECCSCEEEEEEETTTTEEEEEEEE
T ss_pred CCcccccC---CCCceEEEEEEEEEEEecCCcccccccceeeeecccCC-CCCceEEeeCCEEEEEEECCCCcEEEEEEe
Confidence 99999998 46899999999999999999999999998666555542 345789999999999999999999999999
Q ss_pred cCCCC
Q 016311 386 LNPLA 390 (391)
Q Consensus 386 ~~P~~ 390 (391)
.+|.+
T Consensus 400 ~~P~~ 404 (406)
T 3sto_A 400 MNPVL 404 (406)
T ss_dssp SSCC-
T ss_pred CCccC
Confidence 99985
|
| >1wz9_A Maspin precursor; serpin, tumor suppressor, serpinb5, signaling protein; HET: CME; 2.10A {Homo sapiens} PDB: 1xu8_A 1xqg_A 1xqj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-85 Score=627.73 Aligned_cols=366 Identities=25% Similarity=0.419 Sum_probs=322.4
Q ss_pred hhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHHhhC
Q 016311 4 RESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFAD 83 (391)
Q Consensus 4 ~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l~~~ 83 (391)
..+..++++||++||+++. ...+++|++|||+||+.+|+|+++||+|+|++||.++||++..++++..++.+...+.+
T Consensus 2 ~~l~~~~~~Fa~~l~~~l~-~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~- 79 (375)
T 1wz9_A 2 DALQLANSAFAVDLFKQLC-EKEPLGNVLFSPICLSTSLSLAQVGAKGDTANEIGQVLHFENVKDVPFGFQTVTSDVNK- 79 (375)
T ss_dssp HHHHHHHHHHHHHHHHHHH-HHCTTSCCEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCHHHHHHHHHHHHHH-
T ss_pred hhHhHHHHHHHHHHHHHHh-ccCCCCCEEECHHHHHHHHHHHHhhccCcHHHHHHHHhCCCCHHHHHHHHHHHHHHhhc-
Confidence 3677899999999999998 44678999999999999999999999999999999999998667788889988887754
Q ss_pred CCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcC
Q 016311 84 GSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNST 163 (391)
Q Consensus 84 ~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t 163 (391)
...+..++++|+||+++++.+.++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|++++++++++++|
T Consensus 80 --~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV~~~T~g~I~~l~~~~~l~~~t 157 (375)
T 1wz9_A 80 --LSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKDKLEETKGQINNSIKDLTDGHFENILADNSVNDQT 157 (375)
T ss_dssp --HTTTSEEEEEEEEEEEGGGCCCHHHHHHHTTTTTTTEEEECTTTCHHHHHHHHHHHHHHHTTTSCSCTTTTSCCCTTC
T ss_pred --CCCCcEEEEeeeeeeeCCcchhHHHHHHHHHHhCCEEEEecCCCCHHHHHHHHHHHHHHHhcCchhhccCcccCCccc
Confidence 234678999999999999999999999999999999999999766889999999999999999999999988999999
Q ss_pred eEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccc--cCCeEEEEeecCCCCCCceEEEEEEec
Q 016311 164 RLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSA--FDGFKVLGLPYKQGEDKRRFSMYFFLP 241 (391)
Q Consensus 164 ~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLp~~~~~~~~~~sm~iilP 241 (391)
+++|+||+||+|.|+.+|++..|..++|+..+|+.++||||++.+.++|.. ..++++++|||+++ ++||+||||
T Consensus 158 ~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~----~~sm~iiLP 233 (375)
T 1wz9_A 158 KILVVNAAYFVGKWMKKFPESETKECPFRLNKTDTKPVQMMNMEATFCMGNIDSINCKIIELPFQNK----HLSMFILLP 233 (375)
T ss_dssp CEEEEEEEEEECCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBGGG----SEEEEEEEE
T ss_pred hhhheeheeeecccCCCCCccCceeeeEEeCCCeEEEEEEEEeeeeEeeEEeCCcceEEEEeecCCC----eEEEEEEec
Confidence 999999999999999999999999999999999999999999998766554 55899999999987 799999999
Q ss_pred ----CCCCChHHHHHHhcCchHHHhhcCC--CCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCC
Q 016311 242 ----DAKDGLPTLLEKMGSESKFLDHHLP--SQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSP 315 (391)
Q Consensus 242 ----~~~~~l~~l~~~L~~~~~~l~~~~~--~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~ 315 (391)
++..+|.+++++|+ ...+..|.. ..+...++|.||||++++++||+++|++||++++|++..|||++|++
T Consensus 234 ~~~~~~~~~l~~l~~~L~--~~~l~~~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfsgis~-- 309 (375)
T 1wz9_A 234 KDVEDESTGLEKIEKQLN--SESLSQWTNPSTMANAKVKLSIPKFKVEKMIDPKACLENLGLKHIFSEDTSDFSGMSE-- 309 (375)
T ss_dssp SSCCCHHHHHHHHHHHCC--HHHHHHHTCGGGCEEEEEEEEEECEEEEEEECHHHHHHHHTCCSTTCTTTCCCTTTCC--
T ss_pred CcccccCccHHHHHHHhC--HHHHHHHhhhhcceeeeEEEEcceEEecceechHHHHhhCChhhhcCCCCCcccccCC--
Confidence 77678999999997 345677766 45667789999999999999999999999999999965799999997
Q ss_pred CCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 316 VGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 316 ~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
+.+++|++++|++.|+|||+|++|+|+|++.+..++ .+|++||||+|+|+|+.||.|||+|||.+|
T Consensus 310 -~~~l~vs~v~hka~ieV~E~GteAaAaT~~~~~~~~------~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 375 (375)
T 1wz9_A 310 -TKGVALSNVIHKVCLEITEDGGDSIEVPGARILQHK------DELNADHPFIYIIRHNKTRNIIFFGKFCSP 375 (375)
T ss_dssp -CTTCCEEEEEEEEEEEECSCC------------CEE------EEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred -CCCeEEEEEEEeeeEEecCCCcccccccchhhcccC------CEEEecCCEEEEEEECCCCcEEEEEEeCCC
Confidence 468999999999999999999999999986444333 479999999999999999999999999998
|
| >3nda_A Serpin-2; vaccination target, TICK, hydrolase inhibitor; HET: 1PE; 1.80A {Ixodes ricinus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-84 Score=625.50 Aligned_cols=367 Identities=26% Similarity=0.412 Sum_probs=331.2
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC----hhHHHHHHHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS----NDQLNAFASELVA 78 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~----~~~~~~~~~~l~~ 78 (391)
|..+..++++||++||+++.. .. ++|++|||+||+.+|+|+++||+|+|++||.++||++. .++++..++.+..
T Consensus 4 ~~~l~~~~~~Fa~~l~~~l~~-~~-~~Ni~~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~i~~~~~~l~~ 81 (377)
T 3nda_A 4 EAKLTKANNRFGLRLLRALPS-GP-EKNVFFSPYSVSTAMGMAFAGARGQTQQELSQGLGFSDVDLTDAGVLDAYTHHTE 81 (377)
T ss_dssp HHHHHHHHHHHHHHHHHHSCC-BT-TBCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTTGGGTCCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhh-cC-CCCEEEecHHHHHHHHHHHhhccchhHHHHHHHhCCCCcCCCHHHHHHHHHHHHH
Confidence 567788999999999999973 34 89999999999999999999999999999999999974 2678889999888
Q ss_pred HHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCC
Q 016311 79 VVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGS 158 (391)
Q Consensus 79 ~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~ 158 (391)
.+.+ +..+..++++|+||+++++++.++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|++++ +++
T Consensus 82 ~l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV~~~T~g~I~~ll-~~~ 157 (377)
T 3nda_A 82 RLKS---TPSNSTLDVANAAAIQRTLALLNSYESALQSSFGAELHKVDFAGEPQAAVDFVNNWVKRKTHDKIEKLF-NEP 157 (377)
T ss_dssp HHHH---CCCSSEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTTCHHHHHHHHHHHHHHHTTTSCCCSC-SSC
T ss_pred HhcC---CCCCcEEEEEeEEEEeCCCCchHHHHHHHHHhccCceEEecCCCCHHHHHHHHHHHHHHHhcCchhhhc-CCC
Confidence 8764 245678999999999999999999999999999999999999766889999999999999999999999 789
Q ss_pred CCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc--CCeEEEEeecCCCCCCceEEE
Q 016311 159 VDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF--DGFKVLGLPYKQGEDKRRFSM 236 (391)
Q Consensus 159 ~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLp~~~~~~~~~~sm 236 (391)
++++|+++|+||+||+|.|+.||++..|..++|+..+|++++||||++.+.++|+.. .++++++|||+++ ++||
T Consensus 158 l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~~~~~vleLPy~~~----~~sm 233 (377)
T 3nda_A 158 LDPDTLLVLLNAIYFKGEWNTAFVKEHTEKRQFFNGGVTPVEVDTMRLEARIKYRFFDDLQVEVVELPYRGL----DYTM 233 (377)
T ss_dssp CCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEETTTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTS----SEEE
T ss_pred CCCCceEEEEehheeccccccCCCCccccccceecCCCeEEEEeeEeeECeEEEEEEcCCCeEEEEEecCCC----cEEE
Confidence 999999999999999999999999999999999999999999999999987777654 5899999999987 7999
Q ss_pred EEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCC
Q 016311 237 YFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPV 316 (391)
Q Consensus 237 ~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~ 316 (391)
+||||++..+|.+++++|+ ...+.+|++..+...++|.||||++++++||+++|++||++++|++ .||||+|++
T Consensus 234 ~iiLP~~~~~l~~l~~~L~--~~~l~~~~~~~~~~~v~v~lPkF~i~~~~~L~~~L~~lGi~~~F~~-~Adfsgis~--- 307 (377)
T 3nda_A 234 AILLPKENTGVEGLKQNLT--IDRFQNYLSDLRERKITVLLPKFKLETKYSLKAPLQSLGIKQIFES-GADLSGIND--- 307 (377)
T ss_dssp EEEEESSTTCHHHHHHHCC--HHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCHHHHS---
T ss_pred EEEEcCCCCCHHHHHHHhC--HHHHHHHHHhCCeEEEEEEecceEeEeecCHHHHHHhCCchhhcCC-CCCCcccCC---
Confidence 9999999889999999997 3456666555566778999999999999999999999999999998 899999987
Q ss_pred CCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecC
Q 016311 317 GKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLN 387 (391)
Q Consensus 317 ~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~ 387 (391)
.+++|++++|++.|+|||+|++|+|+|++.+..++.+ +++..|++||||+|+|+|+.||.|||+|||.+
T Consensus 308 -~~l~vs~v~hka~ieV~E~GteAaAaT~~~~~~~s~~-~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~ 376 (377)
T 3nda_A 308 -GSLRVSAVEHKAVVEVNEEGTVAAATTGVVIVPYSLG-PEPVVFRVDHPFLFFIRNTRTDDIFFVGQVNK 376 (377)
T ss_dssp -SCEEEEEEEEEEEEEECSSEEEEEEEEEEEEEEC----CCCCEEECCSCEEEEEEETTTCCEEEEEEECC
T ss_pred -CCceEeEEEEEEEEEECCCCccccccceeeeecccCC-CCCCeEEeeCCEEEEEEECCCCcEEEEEEEec
Confidence 5799999999999999999999999998665555543 23568999999999999999999999999986
|
| >2arr_A Plasminogen activator inhibitor-2; serpin, peptide binding, hydrolase inhibitor-PEPT complex; 1.55A {Homo sapiens} PDB: 2arq_A 1jrr_A 1by7_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-84 Score=626.94 Aligned_cols=368 Identities=29% Similarity=0.507 Sum_probs=317.9
Q ss_pred hhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC----hhHHHHHHHHHHHHH
Q 016311 5 ESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS----NDQLNAFASELVAVV 80 (391)
Q Consensus 5 ~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~----~~~~~~~~~~l~~~l 80 (391)
.+..++++||++||+++. ..++++|+||||+||+.+|+|+++||+|+|++||.++||++. .++++..++.+...+
T Consensus 3 ~l~~~~~~Fa~~l~~~l~-~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l 81 (382)
T 2arr_A 3 DLCVANTLFALNLFKHLA-KASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMASVLQFNEVGAAADKIHSSFRSLSSAI 81 (382)
T ss_dssp CTTHHHHHHHHHHHHHHH-HHCSSSCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTTTTC-----CHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHh-hcCCCCCEEEchHHHHHHHHHHHhhccCcHHHHHHHHhCCCCccccHHHHHHHHHHHHHHH
Confidence 567899999999999998 456789999999999999999999999999999999999986 357888899998887
Q ss_pred hhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCC
Q 016311 81 FADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVD 160 (391)
Q Consensus 81 ~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~ 160 (391)
.+ ...+..++++|+||+++++.+.++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|++++++++++
T Consensus 82 ~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wV~~~T~g~I~~l~~~~~l~ 158 (382)
T 2arr_A 82 NA---STGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARKKINSWVKTQTKGKIPNLLPEGSVD 158 (382)
T ss_dssp HC---CCSSEEEEEEEEEEEETTCCCCHHHHHHHHHHHCCCCEEECHHHHHHHHHHHHHHHHHHHTTTSSCCCSCTTSSC
T ss_pred hC---CCCCcEEEeeeehHHhCCCCccHHHHHHHHHHhCCEEEEecCcCcHHHHHHHHHHHHHHHhcCchhhhCCCcCCC
Confidence 53 234678999999999999999999999999999999999999655789999999999999999999999988999
Q ss_pred CcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccc--cCCeEEEEeecCCCCCCceEEEEE
Q 016311 161 NSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSA--FDGFKVLGLPYKQGEDKRRFSMYF 238 (391)
Q Consensus 161 ~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLp~~~~~~~~~~sm~i 238 (391)
++|+++|+||+||+|.|+.+|++..|..++|+..+|+.++||||++.+.++|+. ..++++++|||++. +||+|
T Consensus 159 ~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~-----~sm~i 233 (382)
T 2arr_A 159 GDTRMVLVNAVYFKGKWKTPFEKKLNGLFPFRVNSAQRTPVQMMYLREKLNIGYIEDLKAQILELPYAGD-----VSMFL 233 (382)
T ss_dssp TTEEEEEEEEEEEEECBSSCCEECC---EEEEEETTEEEEECEEEEEEEEEEEEEGGGTEEEEEEEBSSS-----EEEEE
T ss_pred CcceEEEEEeeEecccccCCCChhhcccceEecCCCceeeeeEEeccCcEeEEEECCCCeEEEEecCCCc-----EEEEE
Confidence 999999999999999999999999999999999999999999999988766654 56999999999983 99999
Q ss_pred EecCCC----CChHHHHHHhcCchHHHhhcCCC--CceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCC
Q 016311 239 FLPDAK----DGLPTLLEKMGSESKFLDHHLPS--QRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMV 312 (391)
Q Consensus 239 ilP~~~----~~l~~l~~~L~~~~~~l~~~~~~--~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is 312 (391)
|||++. .+|.+++++|+ ...+..|... .+...++|.||||++++++||+++|++||++++|++..||||+|+
T Consensus 234 iLP~~~~~~~~~l~~l~~~L~--~~~l~~~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfsgis 311 (382)
T 2arr_A 234 LLPDEIADVSTGLELLESEIT--YDKLNKWTSKDKMAEDEVEVYIPQFKLEEHYELRSILRSMGMEDAFNKGRANFSGMS 311 (382)
T ss_dssp EEEC--CCSSSSCHHHHHHCC--HHHHHHHHCC--CEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGCTTTCCCTTTC
T ss_pred EecCCCccccccHHHHHHHhC--HHHHHHHhhhccccceEEEEECcCEEeeccccHHHHHHhcCccccCCCCCCChhhcC
Confidence 999988 89999999997 3456666542 455678999999999999999999999999999996579999999
Q ss_pred CCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 313 DSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 313 ~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
+ ..+++|++++|++.|+|||+|++|+|+|++.+..++.+ .+.+|+|||||+|+|+|+.||.|||+|||.+|
T Consensus 312 ~---~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~~--~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 382 (382)
T 2arr_A 312 E---RNDLFLSEVFHQAMVDVNEEGTEAAAGTGGVMTGRTGH--GGPQFVADHPFLFLIMHKITNCILFFGRFSSP 382 (382)
T ss_dssp T---TCCEEEEEEEEEEEEEECCCBC----------CCCCCC--CSCEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred C---CCCeEEEEEEEeeeeeecCCCcccccccchhhccccCC--CCCeEEecCCEEEEEEECCCCcEEEEEEeCCC
Confidence 8 46899999999999999999999999998655555542 24689999999999999999999999999998
|
| >2ceo_A Thyroxine-binding globulin; transport, serpin, hormone trans thyroxine, disease mutation, glycoprotein; HET: T44; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-84 Score=622.28 Aligned_cols=369 Identities=24% Similarity=0.354 Sum_probs=325.6
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh----hHHHHHHHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN----DQLNAFASELVA 78 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~----~~~~~~~~~l~~ 78 (391)
...+..++++||++||+++. ...+++|++|||+||+.+|+|+++||+|+|++||.++||++.. ++++..++.+..
T Consensus 3 ~~~l~~~~~~Fa~~l~~~l~-~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~ 81 (379)
T 2ceo_A 3 LYKMSSINADFAFNLYRRFT-VETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVEIQHGFQHLIC 81 (379)
T ss_dssp -CHHHHHHHHHHHHHHHHHH-HHSTTSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHH-hcCCCCCEEEchHHHHHHHHHHHhhccchHHHHHHHHhCCCCcCCCHHHHHHHHHHHHH
Confidence 35677899999999999997 4567899999999999999999999999999999999999742 578889999988
Q ss_pred HHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCC
Q 016311 79 VVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGS 158 (391)
Q Consensus 79 ~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~ 158 (391)
.+.. ...+..++++|+||+++++.+.++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ +
T Consensus 82 ~l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~l~~--~ 155 (379)
T 2ceo_A 82 SLNF---PKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSN-ISAAKQEINSHVEMQTKGKVVGLIQ--D 155 (379)
T ss_dssp HHSS---CCTTEEEEEEEEEEEETTSCBCHHHHHHHHHHHCEEEEEECTTC-HHHHHHHHHHHHHHHTTTSSCCCCC--C
T ss_pred HhhC---CCCCcEEEEeEhhhhhCCCChhHHHHHHHHHHhCCeeeecCCCC-HHHHHHHHHHHHHHHhCCcchhhcc--C
Confidence 8753 23557899999999999999999999999999999999999985 7889999999999999999999996 4
Q ss_pred CCCcCeEEEEEeeeeccccccccccCCCcccC-eEeCCCceEeeccccccccccccccC--CeEEEEeecCCCCCCceEE
Q 016311 159 VDNSTRLIFANALYFKGAWNETFDSSKTKDYD-FHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGEDKRRFS 235 (391)
Q Consensus 159 ~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~-F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLp~~~~~~~~~~s 235 (391)
++++|+++|+||+||+|.|+.+|++..|.+++ |+..+|++++||||++.+.++|++.+ ++++|+|||+++ .+
T Consensus 156 l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~-----~s 230 (379)
T 2ceo_A 156 LKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMEQYYHLVDMELNCTVLQMDYSKN-----AL 230 (379)
T ss_dssp CCSSCCEEEEEEEEEEEBBSSCCCGGGCEEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-----EE
T ss_pred CCCCCEEEEEEHhhhhchhcCCCChhhCccCCceEeCCCcEEEEEEEEeeeeEeEEEeCCCCeEEEEeecCCC-----ee
Confidence 99999999999999999999999999999999 99999999999999999877776644 799999999986 59
Q ss_pred EEEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCC
Q 016311 236 MYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSP 315 (391)
Q Consensus 236 m~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~ 315 (391)
|+||||++ .+|.+++++|+ ...+..|.+..+...++|.||||++++++||+++|++||++++|+. .||||+|++
T Consensus 231 m~iiLP~~-~~l~~l~~~L~--~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~-- 304 (379)
T 2ceo_A 231 ALFVLPKE-GQMESVEAAMS--SKTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSE-NADFSGLTE-- 304 (379)
T ss_dssp EEEEEECT-TCHHHHHHHCS--HHHHHHHHHHCEEEEEEEEEECEEEEEEEETHHHHHHHTCCTTTST-TCCCTTTBS--
T ss_pred EEEEeeCC-CcHHHHHHHhC--HHHHHHHHHhcccCcceEECCcEEEeeeecHHHHHHhcCccccccC-CCCcccCCC--
Confidence 99999998 68999999997 3445555555556678999999999999999999999999999985 899999998
Q ss_pred CCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 316 VGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 316 ~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
..+++|++++|++.|+|||+|++|+|+|++.+..++.+.+++.+|+|||||+|+|+|+.||.|||+|||.+|..
T Consensus 305 -~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 378 (379)
T 2ceo_A 305 -DNGLKLSNAAHKAVLHIGEKGTEAAAVPEVELSDQPENTFLHPIIQIDRSFMLLILERSTRSILFLGKVVNPTE 378 (379)
T ss_dssp -SSCCCCCEEEEEEEEEECSSBSSCCCCCC--------CCSCSCEEECCSCEEEEEEETTTTEEEEEEEESCSBC
T ss_pred -CCCeEEeccceeEEEEecCCCcccccccchhhccccCCCCCCCeEEecCCEEEEEEECCCCcEEEEEecCCCCC
Confidence 46899999999999999999999999998666555544333478999999999999999999999999999975
|
| >2zv6_A Serpin B3; serine proteinase inhibitor, reactive site loop, acetylation, alternative splicing, cytoplasm, polymorphism, protease inhibitor; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-84 Score=630.10 Aligned_cols=368 Identities=27% Similarity=0.479 Sum_probs=316.8
Q ss_pred hhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh----------------hH
Q 016311 5 ESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN----------------DQ 68 (391)
Q Consensus 5 ~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~----------------~~ 68 (391)
.+..++++||++||+++. ...+ +|+||||+||+.+|+|+++||+|+|++||.++||++.. ++
T Consensus 14 ~~~~~~~~Fa~~l~~~l~-~~~~-~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~ 91 (401)
T 2zv6_A 14 SLSEANTKFMFDLFQQFR-KSKE-NNIFYSPISITSALGMVLLGAKDNTAQQIKKVLHFDQVTENTTGKAATYHVDRSGN 91 (401)
T ss_dssp HHHHHHHHHHHHHHHHHH-HHCC-SCEEECHHHHHHHHHHHHHTCCTHHHHHHHHHTTC--------------------C
T ss_pred HHHHHHHHHHHHHHHHHh-hCCC-CCEEEchHHHHHHHHHHHHhccChHHHHHHHHhCCCcccccccccccccccccHHH
Confidence 356789999999999998 3456 99999999999999999999999999999999999752 46
Q ss_pred HHHHHHHHHHHHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCC
Q 016311 69 LNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNG 148 (391)
Q Consensus 69 ~~~~~~~l~~~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g 148 (391)
++..++.+...+.+ ...+..++++|+||+++++.+.++|++.++++|+++++.+||.++++.+++.||+||+++|+|
T Consensus 92 ~~~~~~~l~~~l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~g 168 (401)
T 2zv6_A 92 VHHQFQKLLTEFNK---STDAYELKIANKLFGEKTYLFLQEYLDAIKKFYQTSVESVDFANAPEESRKKINSWVESQTNE 168 (401)
T ss_dssp THHHHHHHHHHHHS---CCSSCCEEEECCEEEETTSCCCHHHHHHHHHHHSCCEEEECTTTCHHHHHHHHHHHHHHHTTT
T ss_pred HHHHHHHHHHHhhC---CCCCcEEEEEEEEEecCCCChhHHHHHHHHHHhCCEEEEccCCCCHHHHHHHHHHHHHHhhCC
Confidence 78888888888753 235678999999999999999999999999999999999999766889999999999999999
Q ss_pred cccccCCCCCCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccc--cCCeEEEEeecC
Q 016311 149 LVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSA--FDGFKVLGLPYK 226 (391)
Q Consensus 149 ~i~~~l~~~~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLp~~ 226 (391)
+|++++++++++++|+++|+||+||+|.|+.+|++..|..++|+..+|+.++||||++.+.++|.. ..++++|+|||+
T Consensus 169 kI~~ll~~~~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~f~~~~~~~l~~~vleLPY~ 248 (401)
T 2zv6_A 169 KIKNLIPEGNIGSNTTLVLVNAIYFKGQWEKKFNKEDTKEEKFWPNKNTYKSIQMMRQYTSFHFASLEDVQAKVLEIPYK 248 (401)
T ss_dssp CSCCSSCTTTSCTTCCEEEEEEEEECCCBSSCCCTTSEEEEEECSSSSCCEEEEEEEEEEEEEECEETTTTEEEEEEEBT
T ss_pred ccccccCcccCCCcceEEEEEhheeccccCCCCCCCCceeeEEEecCCceEEeEEEeccCceeEEEeCCCCEEEEEeecC
Confidence 999999988999999999999999999999999999999999999999999999999988666544 568999999999
Q ss_pred CCCCCceEEEEEEecCCCCChHHHHHHhcCchHHHhhcCC--CCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCC
Q 016311 227 QGEDKRRFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLP--SQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGE 304 (391)
Q Consensus 227 ~~~~~~~~sm~iilP~~~~~l~~l~~~L~~~~~~l~~~~~--~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~ 304 (391)
++ ++||+||||++..+|.+++++|+ ...+.+|.. ..+...++|.||||++++++||+++|++||++++|+.
T Consensus 249 ~~----~~sm~iiLP~~~~~L~~le~~L~--~~~l~~~~~~~~~~~~~v~v~lPKFkie~~~dL~~~L~~lGi~~~F~~- 321 (401)
T 2zv6_A 249 GK----DLSMIVLLPNEIDGLQKLEEKLT--AEKLMEWTSLQNMRETRVDLHLPRFKVEESYDLKDTLRTMGMVDIFNG- 321 (401)
T ss_dssp TS----SSEEEEEEESSTTCHHHHHHHCC--HHHHHHHTCGGGCEEEEEEEEEECCEEEEEEECHHHHHHTTCCGGGST-
T ss_pred CC----cEEEEEEecCCCCCHHHHHHHhC--HhHHHHHhhhcccceeEEEEEeeeEEEEEEecHHHHHHhcCccccCCC-
Confidence 87 79999999999889999999997 345677765 4556678999999999999999999999999999995
Q ss_pred CCCCcCCCCCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEE
Q 016311 305 GGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGH 384 (391)
Q Consensus 305 ~adfs~is~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~ 384 (391)
.||||+|++ ..+++|++++|++.|+|||+|++|+|+|++.+..++.+. ++.+|+|||||+|+|+|+.||.|||+|+
T Consensus 322 ~Adfsgis~---~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~~~-~~~~f~~drPFlF~I~~~~t~~iLF~G~ 397 (401)
T 2zv6_A 322 DADLSGMTG---SRGLVLSGVLHKAFVEVTEEGAEAAAATAVVGFGSSPTS-TNEEFHCNHPFLFFIRQNKTNSILFYGR 397 (401)
T ss_dssp TCCCHHHHS---SSCCCEEEEEEEEEEECCSCC--------------------CEEEECSSCEEEEECCTTTTCCCCEEE
T ss_pred cccccccCC---CCCeEEEEEEEEEEEEecCCCcccccccchhhccccCCC-CCCEEEecCCEEEEEEECCCCeEEEEEE
Confidence 899999998 468999999999999999999999999987665555432 2378999999999999999999999999
Q ss_pred ecCC
Q 016311 385 VLNP 388 (391)
Q Consensus 385 v~~P 388 (391)
|.+|
T Consensus 398 v~~P 401 (401)
T 2zv6_A 398 FSSP 401 (401)
T ss_dssp ECCC
T ss_pred eCCC
Confidence 9998
|
| >1lj5_A Plasminogen activator inhibitor-1; beta-barrell, blood clotting; 1.80A {Homo sapiens} SCOP: e.1.1.1 PDB: 1dvn_A 1c5g_A 1a7c_A* 3q02_A 3q03_A 3r4l_A* 1oc0_A 1b3k_A 3pb1_I 1dvm_A 3eox_A 3cvm_A 1db2_A 9pai_A 3lw2_A 9pai_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-84 Score=626.35 Aligned_cols=370 Identities=26% Similarity=0.461 Sum_probs=332.1
Q ss_pred CchhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh-hHHHHHHHHHHHH
Q 016311 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN-DQLNAFASELVAV 79 (391)
Q Consensus 1 ~~~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~-~~~~~~~~~l~~~ 79 (391)
+++..+..++++||++||+++.. ..+++|+||||+||+.+|+|+++||+|+|++||.++||++.. .+++..++.+...
T Consensus 3 ~~~~~l~~~~~~Fa~~l~~~l~~-~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~l~~~ 81 (379)
T 1lj5_A 3 HPPSYVAHLASDFGVRVFQQVAQ-ASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKE 81 (379)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHH-HSTTBCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTSCTTSTTHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHHHHHHHHhh-cCCCCCEEEchHHHHHHHHHHHhhccChHHHHHHHHhCCCCCHHHHHHHHHHHHHH
Confidence 45778889999999999999972 357899999999999999999999999999999999999865 5788888888887
Q ss_pred HhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCC
Q 016311 80 VFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSV 159 (391)
Q Consensus 80 l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~ 159 (391)
+.. ...+..++++|+||+++++.+.++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++++++
T Consensus 82 l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~Wv~~~T~g~I~~l~~~~~l 157 (379)
T 1lj5_A 82 LMG---PWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSE-VERARFIINDWVKTHTKGMISNLLGKGAV 157 (379)
T ss_dssp HHC---GGGSSEEEEEEEEEEETTSCCCTTHHHHHHHHHSCCCEEECTTS-HHHHHHHHHHHHHHTTTTSCCCSSCTTSS
T ss_pred HhC---CCCCcEEEEEEeeeeeCCcchhHHHHHHHHHHhCCEEEEECCCC-hHHHHHHHHHHHHhhcCCccccccCcccC
Confidence 753 23457899999999999999999999999999999999999986 57889999999999999999999998889
Q ss_pred CCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccc--c--c-CCeEEEEeecCCCCCCceE
Q 016311 160 DNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVS--A--F-DGFKVLGLPYKQGEDKRRF 234 (391)
Q Consensus 160 ~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~--~--~-~~~~vveLp~~~~~~~~~~ 234 (391)
+++|+++|+||+||+|.|+.+|++..|.+++|+..+|++++||||++.+.++|+ . + .++++++|||+++ ++
T Consensus 158 ~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~gl~~~vleLPy~~~----~~ 233 (379)
T 1lj5_A 158 DQLTRLVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGD----TL 233 (379)
T ss_dssp CTTCCEEEEEEEEEEEEBSSCCCCCTTCEEEEECTTSCEEEEEEEEEEEEEEEEEEECTTSCEEEEEEEEBTTS----SE
T ss_pred CCccceeeeeeeeecccccCCCCcccccceeEEeCCCeEEEEeEEeeEeeeceeeeEcCCCCceEEEEEecCCC----cE
Confidence 999999999999999999999999999999999999999999999999877763 3 3 4799999999987 79
Q ss_pred EEEEEec-CCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCC
Q 016311 235 SMYFFLP-DAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVD 313 (391)
Q Consensus 235 sm~iilP-~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~ 313 (391)
||+|||| ++..+|.+++++|+ ...+..|....+...++|.||||++++++||+++|++||++++|++..|||++|++
T Consensus 234 sm~iiLP~~~~~~l~~l~~~L~--~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~is~ 311 (379)
T 1lj5_A 234 SMFIAAPYEKEVPLSALTNILS--AQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSD 311 (379)
T ss_dssp EEEEEEESSTTSCTHHHHTTCC--HHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTCS
T ss_pred EEEEEEecCCCCCHHHHHHHhC--HHHHHHHHHhCcceEEEEEeeEEEEeeeechHHHHHhcCCccCCCCCCCCccccCC
Confidence 9999999 88889999999997 34455555555566789999999999999999999999999999985699999998
Q ss_pred CCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 314 SPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 314 ~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
..+++|++++|++.|+|||+|++|+|+|++.+..++ .+.+|+|||||+|+|+|+.||.|||+|+|.+|
T Consensus 312 ---~~~l~vs~v~hka~ieV~E~GteAaAaT~~~~~~~~----~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 379 (379)
T 1lj5_A 312 ---QEPLHVAQALQKVKIEVNESGTVASSSTAVIVSARM----APEEIIMDRPFLFVVRHNPTGTVLFMGQVMEP 379 (379)
T ss_dssp ---SSCCCEEEEEEEEEEEECSSEEEEEEEEEEEESSCC----CCCCCCBCCEEEEEEEETTTTEEEEEEEEECC
T ss_pred ---CCCeEEeeeeEEeEEEecCCCcCcccccceeecccC----CCCEEEecCCEEEEEEECCCCeEEEEEEecCC
Confidence 468999999999999999999999999985443332 24579999999999999999999999999998
|
| >4au2_A HSP47, serpin peptidase inhibitor, clade H (heat shock P 47), member 1, (collagen binding...; chaperone-peptide complex; 2.30A {Canis lupus familiaris} PDB: 4au3_A 4au4_A 4awr_A 4au3_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-84 Score=624.84 Aligned_cols=366 Identities=21% Similarity=0.374 Sum_probs=324.0
Q ss_pred hhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh--hHHHHHHHHHHHHHh
Q 016311 4 RESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN--DQLNAFASELVAVVF 81 (391)
Q Consensus 4 ~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~--~~~~~~~~~l~~~l~ 81 (391)
.++++++++||++||++++ ..++++|+||||+||+.+|+|+++||+|+|++||.++||++.. .+++..++.+...+.
T Consensus 7 ~~l~~~~~~Fa~~L~~~l~-~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~l~~~l~ 85 (392)
T 4au2_A 7 ATLAERSAGLAFSLYQAMA-KDQAVENILLSPVVVASSLGLVSLGGKATTASQAKAVLSAEQLRDEEVHAGLGELLRSLS 85 (392)
T ss_dssp HHHHHHHHHHHHHHHHHHH-HCTTCCSEEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTCTTSCHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHHHHh-hcCCCCeEEECHHHHHHHHHHHHhhcCcHHHHHHHHhcCCCCCCHHHHHHHHHHHHHHHh
Confidence 4677899999999999998 5678899999999999999999999999999999999999853 678888888887764
Q ss_pred hCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCC
Q 016311 82 ADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDN 161 (391)
Q Consensus 82 ~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~ 161 (391)
. ....+..+.++|++|+++++.+.++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ ++++
T Consensus 86 ~--~~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~l~~--~~~~ 160 (392)
T 4au2_A 86 N--STARNVTWKLGSRLYGPSSVSFAEDFVRSSKQHYNCEHSKINFRD-KRSALQSINEWAAQTTDGKLPEVTK--DVER 160 (392)
T ss_dssp C-------CCCEEEEEEEEETTCCCCHHHHHHHHHHHCEEEEEECTTS-HHHHHHHHHHHHHHHTTTSSCCSCS--CCCC
T ss_pred c--CCCCCceEEEEEEEEeecCCchhHHHHHHHHHhhCCeeEEecCCC-hHHHHHHHHHHHHHhcCCCccchhc--ccCC
Confidence 2 123456899999999999999999999999999999999999986 7889999999999999999999996 6999
Q ss_pred cCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccc--cCCeEEEEeecCCCCCCceEEEEEE
Q 016311 162 STRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSA--FDGFKVLGLPYKQGEDKRRFSMYFF 239 (391)
Q Consensus 162 ~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLp~~~~~~~~~~sm~ii 239 (391)
+|.++|+||+||+|.|+.+|++..|..++|+..+|+++.||||++.+.++|.. ..++++|+|||+++ .++|+|+
T Consensus 161 ~t~lvLvNAiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~----~~sm~il 236 (392)
T 4au2_A 161 TDGALLVNAMFFKPHWDEKFHHKMVDNRGFMVTRSYTVGVTMMHRTGLYNYYDDEKEKLQIVEMPLAHK----LSSLIIL 236 (392)
T ss_dssp SSSEEEEEEEEECCCBSSCCCTTSEEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBGGG----SEEEEEE
T ss_pred cchhhheehhheeccccCCCCccccccCceecCCCceeEEeeeeecceeeEEeeccCceeEEEeecCCC----cEEEEEE
Confidence 99999999999999999999999999999999999999999999998766554 56899999999998 8999999
Q ss_pred ecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCC
Q 016311 240 LPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKN 319 (391)
Q Consensus 240 lP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~ 319 (391)
+|++..++.++++.|+ ...+..+....+...++|.||||++++++||+++|++||++++|++..||||+|++ ..+
T Consensus 237 lP~~~~~l~~le~~l~--~~~l~~~~~~~~~~~v~v~lPKFkie~~~dL~~~L~~lGi~~~F~~~~Adfs~is~---~~~ 311 (392)
T 4au2_A 237 MPHHVEPLERLEKLLT--KEQLKIWMGKMQKKAVAISLPKGVVEVTHDLQKHLAGLGLTEAIDKNKADLSRMSG---KKD 311 (392)
T ss_dssp EESSSCCTHHHHHHCC--HHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHHTCCTTTCTTTCCCHHHHS---SSC
T ss_pred eCCCCCcHHHHHHHhh--HHHHHHHHhcccceEEEEEecceEEEEEechHHHHHhcCCcccCCCCCCccccCCC---CCC
Confidence 9999999999999997 44566666666677789999999999999999999999999999986899999998 478
Q ss_pred eeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCC
Q 016311 320 LYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389 (391)
Q Consensus 320 l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~ 389 (391)
++|++++|++.|+|||+|++|+|+|.+... ...+..|+|||||+|+|+|+.||.|||+|+|.||.
T Consensus 312 l~vs~v~hka~ieVnE~GteAaaat~~~~~-----~~~~~~f~~drPFlf~I~d~~t~~iLF~G~v~~P~ 376 (392)
T 4au2_A 312 LYLASVFHATAFEWDTEGNPFDQDIYGREE-----LRSPKLFYADHPFIFLVRDTQSGSLLFIGRLVRPK 376 (392)
T ss_dssp CCEEEEEEEEEEEECSCBCSCC-------------CCSCEEEECCSCEEEEEEETTTCCEEEEEEESCCS
T ss_pred eEEEeeEEEEEEEECCCcccchhhheeccc-----CCCCCEEEeeCCEEEEEEECCCCcEEEEEEEeCCC
Confidence 999999999999999999999998874322 12256899999999999999999999999999996
|
| >4dy0_A GLIA-derived nexin; serpin, protease inhibitor, thrombin, cell surface, hydrolas inhibitor; HET: IDS SGN; 2.35A {Homo sapiens} PDB: 4dy7_C | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-84 Score=621.91 Aligned_cols=369 Identities=26% Similarity=0.463 Sum_probs=319.0
Q ss_pred chhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHHh
Q 016311 2 DVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVF 81 (391)
Q Consensus 2 ~~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l~ 81 (391)
|..++.+++++||++||++++ +.++++|+||||+||+.+|+|+++||+|+|++||.++||++.. +++..++.+...+.
T Consensus 4 ~~~~l~~~~~~f~~~L~~~l~-~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~-~~~~~~~~l~~~l~ 81 (379)
T 4dy0_A 4 NPLSLEELGSNTGIQVFNQIV-KSRPHDNIVISPHGIASVLGMLQLGADGRTKKQLAMVMRYGVN-GVGKILKKINKAIV 81 (379)
T ss_dssp CHHHHHHHHHHHHHHHHHHHH-HHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHHTSCST-TTHHHHHHHHHHHH
T ss_pred CccCHHHHhhHHHHHHHHHHH-hhCcCCcEEECHHHHHHHHHHHHHHcChHHHHHHHHHhCCChh-HHHHHHHHHHHHHh
Confidence 456777899999999999998 5678999999999999999999999999999999999999753 45666777776665
Q ss_pred hCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCC
Q 016311 82 ADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDN 161 (391)
Q Consensus 82 ~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~ 161 (391)
. ..++..+.++|+||+++++.+.+.|++.++++|+++++.+||.+ +..+++.||+||+++|+|+|+++++++.+++
T Consensus 82 ~---~~~~~~l~~an~l~~~~~~~~~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~wV~~~T~g~I~~ll~~~~~~~ 157 (379)
T 4dy0_A 82 S---KKNKDIVTVANAVFVKNASEIEVPFVTRNKDVFQCEVRNVNFED-PASACDSINAWVKNETRDMIDNLLSPDLIDG 157 (379)
T ss_dssp C---GGGSSCCEEEEEEEESCTTSSCHHHHHHHHHHHCEEEEECCTTS-HHHHHHHHHHHHHHHTTTCCCCCCCGGGCCT
T ss_pred c---cCCCceeeeeeeeeeEccccccchhhhhhhhcCCcEEEEeccCC-hHHHHHHHHHHHHHhcCCcccccCCcccCCc
Confidence 3 23556799999999999999999999999999999999999986 7899999999999999999999999888876
Q ss_pred -cCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccc-----cCCeEEEEeecCCCCCCceEE
Q 016311 162 -STRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSA-----FDGFKVLGLPYKQGEDKRRFS 235 (391)
Q Consensus 162 -~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~-----~~~~~vveLp~~~~~~~~~~s 235 (391)
.|+++|+||+||+|.|+.+|++..|..++|+..+|+++.||||++.+.++|.. +.++++|+|||+++ ++|
T Consensus 158 ~~T~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~v~mM~~~~~~~~~~~~~~~~l~~~vl~LPy~~~----~~s 233 (379)
T 4dy0_A 158 VLTRLVLVNAVYFKGLWKSRFQPENTKKRTFVAADGKSYQVPMLAQLSVFRCGSTSAPNDLWYNFIELPYHGE----SIS 233 (379)
T ss_dssp TTCCEEEEEEEEECCCBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEEEEEEEEECTTSCEEEEEEEEBTTS----SEE
T ss_pred ccceEEEEEEEEEEeeecCCCchhhCeeeeEEeCCCceEEeeeeEeeeeecccccccccccceEEEEeccCCC----ceE
Confidence 49999999999999999999999999999999999999999999988665543 34799999999998 899
Q ss_pred EEEEecCCCC-ChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCC
Q 016311 236 MYFFLPDAKD-GLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDS 314 (391)
Q Consensus 236 m~iilP~~~~-~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~ 314 (391)
|+||||++.. +|.++++.|+ ...+.+++...+...++|.||||++++++||+++|++||++++|++..||||+|++.
T Consensus 234 m~iiLP~~~~~~l~~~~~~l~--~~~l~~~~~~~~~~~v~v~lPKFki~~~~~L~~~L~~lGi~~~F~~~~Adfs~is~~ 311 (379)
T 4dy0_A 234 MLIALPTESSTPLSAIIPHIS--TKTIDSWMSIMVPKRVQVILPKFTAVAQTDLKEPLKVLGITDMFDSSKANFAKITTG 311 (379)
T ss_dssp EEEEEESSTTSCGGGTSTTCC--HHHHHHHHTTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGSTTTCCCTTTCC-
T ss_pred EEEEecCccccchhHhhhhcC--HHHHHHHHHhccceEEEEeccceEEEEEeechHhHHhCCchhhcCCCCCCcccccCC
Confidence 9999997654 6899888886 456777777777788999999999999999999999999999998768999999873
Q ss_pred CCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 315 PVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 315 ~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
.++++|++++||+.|+|||+|++|+|+|++.+..++. +.+|+|||||+|+|+|+.||.|||+|||.||
T Consensus 312 --~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~s~----~~~f~~drPFlf~I~d~~t~~iLF~G~v~~P 379 (379)
T 4dy0_A 312 --SENLHVSHILQKAKIEVSEDGTKASAATTAILIARSS----PPWFIVDRPFLFFIRHNPTGAVLFMGQINKP 379 (379)
T ss_dssp ----CCCCCEEEEEEEEEECSCBC------------CCC----CCEEECCSCEEEEEEETTTTEEEEEEEESCC
T ss_pred --CCCeEeeeeEEEEEEEECCCceeecccceeeeccCCC----CCEEEecCCEEEEEEECCCCCEEEEEEecCC
Confidence 3689999999999999999999999999866554443 4589999999999999999999999999999
|
| >2vdx_A Corticosteroid-binding globulin; transport protein, cortisol binding globulin, glycoprotein, lipid-binding, disease mutation, CBG, SERP cleaved; 1.84A {Homo sapiens} PDB: 2vdy_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-83 Score=617.59 Aligned_cols=364 Identities=25% Similarity=0.415 Sum_probs=325.4
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC----hhHHHHHHHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS----NDQLNAFASELVA 78 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~----~~~~~~~~~~l~~ 78 (391)
.+.+..++++||++||+++. ...+++|+||||+||+.+|+|+++||+|+|++||.++||++. .++++..++.+..
T Consensus 4 ~~~l~~~~~~Fa~~l~~~l~-~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~ 82 (373)
T 2vdx_A 4 HRGLASANVDFAFSLYKHLV-ALSPKKNIFISPVSISMALAMLSLGTCGHTRAQLLQGLGFNLTERSETEIHQGFQHLHQ 82 (373)
T ss_dssp --CHHHHHHHHHHHHHHHHH-HHCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHH-hcCCCCCEEEccHHHHHHHHHHHhhccchHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 45677899999999999997 456789999999999999999999999999999999999974 2678889999988
Q ss_pred HHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCC
Q 016311 79 VVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGS 158 (391)
Q Consensus 79 ~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~ 158 (391)
.+.+ +..+..++++|+||+++++.+.++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ +
T Consensus 83 ~l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~l~~--~ 156 (373)
T 2vdx_A 83 LFAK---SDTSLEMTMGNALFLDGSLELLESFSADIKHYYESEVLAMNFQD-WATASRQINSYVKNKTQGKIVDLFS--G 156 (373)
T ss_dssp HHHS---CCSSCEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTS-HHHHHHHHHHHHHHHTTTCSCCSSC--C
T ss_pred Hhhc---cCCcccceeEEEEEEECCCChHHHHHHHHHHHhCCeeEeecCcc-hHHHHHHHHHHHHHHhcCchhhhcc--C
Confidence 8763 23567899999999999999999999999999999999999985 7889999999999999999999995 5
Q ss_pred CCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC--CeEEEEeecCCCCCCceEEE
Q 016311 159 VDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGEDKRRFSM 236 (391)
Q Consensus 159 ~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLp~~~~~~~~~~sm 236 (391)
++++|+++|+||+||+|.|+.+|++..|.+++|+..+|++++||||++.+.++|++.+ ++++++|||+++ .+|
T Consensus 157 l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~-----~sm 231 (373)
T 2vdx_A 157 LDSPAILVLVNYIFFKGTWTQPFDLASTREENFYVDETTVVKVPMMLQSSTISYLHDSELPCQLVQMNYVGN-----GTV 231 (373)
T ss_dssp -CCCCSEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEECSSSSEEEEEEEBSSS-----EEE
T ss_pred CCCCCeEEEEEHHhhhhhhhCcCCccccccceEEeCCCcEEEEEEEEeeeeEeeEEeCCCCeEEEEEecCCC-----eEE
Confidence 9999999999999999999999999999999999999999999999999877776644 799999999985 799
Q ss_pred EEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCC
Q 016311 237 YFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPV 316 (391)
Q Consensus 237 ~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~ 316 (391)
+||||+++ +|.+++++|+ ...+..|.+..+...++|.||||++++++||+++|++||++++|+. .||||+|++
T Consensus 232 ~iiLP~~~-~l~~l~~~L~--~~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~--- 304 (373)
T 2vdx_A 232 FFILPDKG-KMNTVIAALS--RDTINRWSAGLTSSQVDLYIPKVTISGVYDLGDVLEEMGIADLFTT-QANFSRITQ--- 304 (373)
T ss_dssp EEEEECTT-CHHHHHHTCS--HHHHHHHHHHCEEEEEEEEEECCEEEEEEECHHHHHHTTCCGGGST-TCCCTTTCS---
T ss_pred EEEecCCC-CHHHHHHHhC--HHHHHHHHHhhhceeeEEeeeEEEeecccchHHHHHhcCchhhccC-CCCcccccC---
Confidence 99999987 7999999997 3445555555556678999999999999999999999999999985 899999998
Q ss_pred CCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCC
Q 016311 317 GKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389 (391)
Q Consensus 317 ~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~ 389 (391)
..+++|++++|++.|+|||+|++|+|+|++.+..++. +..|+|||||+|+|+|+.||.|||+|||.+|.
T Consensus 305 ~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~----~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~ 373 (373)
T 2vdx_A 305 DAQLKSSKVVHKAVLQLNEEGTEAAGAMFLEAIPRSK----PIILRFNQPFIIMIFDHFTWSSLFLARVMNPV 373 (373)
T ss_dssp SCCEEEEEEEEEEEEEECSSEEEEEEEEEEEEEEC-C----CEEEECCSCEEEEEEETTTCCEEEEEEESCCC
T ss_pred CCCeEEeeeeeeeeEEecCCcccccccccccccccCC----CceEEecCCEEEEEEECCCCcEEEEEEeCCCC
Confidence 4689999999999999999999999999865443332 46899999999999999999999999999995
|
| >1sek_A Serpin K; serine protease inhibitor, protease; 2.10A {Manduca sexta} SCOP: e.1.1.1 PDB: 1k9o_I | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-83 Score=619.10 Aligned_cols=369 Identities=28% Similarity=0.467 Sum_probs=325.3
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHHhh
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFA 82 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l~~ 82 (391)
|..+..++++||++||+++. ...+++|+||||+||+.+|+|+++||+|+|++||.++||++..+.....++.+...+.
T Consensus 8 ~~~l~~~~~~Fa~~l~~~l~-~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~- 85 (378)
T 1sek_A 8 QKILRESNDQFTAQMFSEVV-KANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPNDNVTKDVFADLNRGVR- 85 (378)
T ss_dssp HHHHHHHHHHHHHHHHHHHH-HTSTTSCEEECSTTTHHHHHHHHHHCCHHHHHHHHHHHTCCCHHHHHHHHHHHHHTCS-
T ss_pred HHHHHHHHHHHHHHHHHHHH-hcCCCCCEEEcHHHHHHHHHHHHhhcCCcHHHHHHHHhCCCCCchHHHHHHHHHHHHh-
Confidence 34677899999999999998 4567899999999999999999999999999999999999875322245666665443
Q ss_pred CCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCc
Q 016311 83 DGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNS 162 (391)
Q Consensus 83 ~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~ 162 (391)
..++..++++|++|+++++.+.++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|++++++++++++
T Consensus 86 ---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~ 161 (378)
T 1sek_A 86 ---AVKGVDLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDFVK-SVEAAGAINKWVEDQTNNRIKNLVDPDALDET 161 (378)
T ss_dssp ---CCTTEEEEEEEEEEEETTSCBCHHHHHHHHHTTCCEEEEECGGG-HHHHHHHHHHHHHHHTTTSSCCCSCGGGCCTT
T ss_pred ---ccCCCeEEeeeehhhhCCCCHhHHHHHHHHHHhCCeeEeeCCcC-HHHHHHHHHHHHHHHhCCcccccCCcccCCCC
Confidence 12456799999999999999999999999999999999999975 78899999999999999999999998899999
Q ss_pred CeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC--CeEEEEeecCCCCCCceEEEEEEe
Q 016311 163 TRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGEDKRRFSMYFFL 240 (391)
Q Consensus 163 t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLp~~~~~~~~~~sm~iil 240 (391)
|+++|+||+||+|.|+.+|++..|.+++|+..+|++++||||++.+.++|++.+ ++++|+|||+++ ++||+|||
T Consensus 162 t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~----~~sm~iiL 237 (378)
T 1sek_A 162 TRSVLVNAIYFKGSWKDKFNKERTMDRDFHVSKDKTIKVPTMIGKKDVRYADVPELDAKMIEMSYEGD----QASMIIIL 237 (378)
T ss_dssp CCEEEEEEEEEEECBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEEGGGTEEEEEEEBGGG----SEEEEEEE
T ss_pred CeEEEEEeeEEeccccCCCCCCCcccceEEeCCCEEEEeeEEEeeceEeEEEeCCCCeEEEEEECCCC----cEEEEEEE
Confidence 999999999999999999999999999999999999999999999877777644 789999999987 79999999
Q ss_pred cCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCe
Q 016311 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNL 320 (391)
Q Consensus 241 P~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l 320 (391)
|++..+|.+++++|+. ...+..|.+..+...++|.||||++++++||+++|++||++++|+...|||++|++. ..++
T Consensus 238 P~~~~~l~~l~~~L~~-~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~i~~~--~~~l 314 (378)
T 1sek_A 238 PNQVDGITALEQKLKD-PKALSRAEERLYNTEVEIYLPKFKIETTTDLKEVLSNMNIKKLFTPGAARLENLLKT--KESL 314 (378)
T ss_dssp ESSTTTHHHHHHHTTS-TTHHHHHHTTCEEEEEEEEEECEEEEEEEEHHHHHHHTTCCGGGSTTTCCCTTTBTT--CCCC
T ss_pred eCCCCCHHHHHHHhcc-hhHHHHHHHhccceEEEEEeeeEEeecccccHHHHHhcCCcccccCCcCCchhhcCC--CCCe
Confidence 9998899999999982 124556666666677899999999999999999999999999995448999999873 2579
Q ss_pred eEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 321 YVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 321 ~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
+|++++|++.|+|||+|++|+|+|++.+..++.+. +.+|++||||+|+|+| +++|||+|||.+|
T Consensus 315 ~vs~v~hka~ieV~E~GteAaAaT~~~~~~~~~~~--~~~f~~drPFlf~I~~--~~~iLF~G~v~~P 378 (378)
T 1sek_A 315 YVDAAIQKAFIEVNEEGAEAAAANAFKITTYSFHF--VPKVEINKPFFFSLKY--NRNSMFSGVCVQP 378 (378)
T ss_dssp CCCEEEEEEEEEECSCBSSCTTSSTTCCCCSCCCC--CCEEECCSCEEEEEEE--TTEEEEEEEESCC
T ss_pred EEeeeeeEEEEEeCCCCcccccccchhhccccCCC--CCeEEecCCEEEEEEe--CCEEEEEEEecCC
Confidence 99999999999999999999999986555455432 3479999999999999 6899999999998
|
| >3pzf_A Serpin 2; protease inhibitor, melanization, hydrolase inhibito; 1.75A {Anopheles gambiae} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-83 Score=618.78 Aligned_cols=369 Identities=25% Similarity=0.449 Sum_probs=321.5
Q ss_pred hhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhh------HHHHHhhcCCCC-hhHHHHHHHHHHHH
Q 016311 7 ISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPT------LDQLLSFLKSKS-NDQLNAFASELVAV 79 (391)
Q Consensus 7 ~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t------~~el~~~L~~~~-~~~~~~~~~~l~~~ 79 (391)
...+++||++||++++. .+++|++|||+||+.+|+|+++||+|+| .+|+.+.|++.. .++++..++.++..
T Consensus 19 ~~~~~~Fa~~L~k~l~~--~~~~Ni~~SP~SI~~aLaml~~GA~G~T~~~~~~~~~~l~~l~~~~~~~~~~~~~~~ll~~ 96 (397)
T 3pzf_A 19 GQRQNEFDLMFVKEIFK--NHNSNVVLSPFSVKILLTLIYEASDTSFGNAVSNTKRELSSVIQNDNIDHTRSYYKQLLES 96 (397)
T ss_dssp SCCCCHHHHHHHHHHHH--TCSSCEEECHHHHHHHHHHHHHHSGGGCC-CCCHHHHHGGGGSSTTCHHHHHHHHHHHHHH
T ss_pred cchhhHHHHHHHHHHHh--CCCCCEEEchHHHHHHHHHHHhhcCCCCccChHHHHHHHHHcCCCCchHHHHHHHHHHHHH
Confidence 35789999999999983 6789999999999999999999999998 777777776643 35677778888887
Q ss_pred HhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCC
Q 016311 80 VFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSV 159 (391)
Q Consensus 80 l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~ 159 (391)
+.+ ..++..+.++|+||+++++.+.++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++++.+
T Consensus 97 l~~---~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~~~~~ 172 (397)
T 3pzf_A 97 AQQ---DNKDYDLNIATNFFVDDFIEVINKYQQIANTHYHAMLEKVSYSN-PTQTAATINNWVSEHTNGRLREIVTPDSL 172 (397)
T ss_dssp HHC---CCSSCEEEEEEEEEEETTCCBCHHHHHHHHHHHCEEEEEECTTS-HHHHHHHHHHHHHHHTTTSCCCCCCGGGG
T ss_pred Hhc---CCCCcEEEEeeeeeEeCCCccchHHHHHHHHHhCCeEEEeCCCC-hHHHHHHHHHHHHHHhCCcccccCCCCCc
Confidence 753 34567899999999999999999999999999999999999987 68899999999999999999999987778
Q ss_pred CCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc--CCeEEEEeecCCCCCCceEEEE
Q 016311 160 DNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF--DGFKVLGLPYKQGEDKRRFSMY 237 (391)
Q Consensus 160 ~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLp~~~~~~~~~~sm~ 237 (391)
+ +|.++|+||+||+|.|+.+|++..|..++|+..+|++++||||++.+.++|... .++++++|||+++ .+||+
T Consensus 173 ~-~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~----~~sm~ 247 (397)
T 3pzf_A 173 E-GAVITLVNVIYFKGLWTYPFPEVANNVKPFYGTRGKPTNAQYMEQNGQFYYDNSADLGAQILRLPYRGN----KLAMY 247 (397)
T ss_dssp T-TCSEEEEEEEEEEEEBSSCCCCCSCCEEEECCSSSSCEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTS----SEEEE
T ss_pred c-cceeEEeeheecccccCccCCcccccccccccCCCcEEEEEEEEecCCcCeEEccCCCEEEEEEEcCCC----ceEEE
Confidence 7 899999999999999999999999999999999999999999999988777654 4899999999987 79999
Q ss_pred EEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCC-
Q 016311 238 FFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPV- 316 (391)
Q Consensus 238 iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~- 316 (391)
||||++..+|.+++++|+ ...+.+|....+...++|.||||++++++||+++|++||++++|++ .||||+|++...
T Consensus 248 iiLP~~~~~l~~le~~L~--~~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~~~~ 324 (397)
T 3pzf_A 248 FILPNPDNTVNQVLDRIN--SASLHQALWYMEENEVNVTLPKFKFDFSEQLNEPLQQVGIREIFSQ-NASLPLLARGRGA 324 (397)
T ss_dssp EEEECTTSCHHHHHHHCC--HHHHHHHHHTCEEEEEEEEEECEEEEEEEESHHHHHHTTCCGGGST-TCCCTTTBCC---
T ss_pred EEECCCCCCHHHHHHhhC--HHHHHHHHhhCceEEEEEEcCcEEEEeccChHHHHHhCCchhhcCC-CCCcccccCCCCC
Confidence 999999889999999997 4566667666667778999999999999999999999999999998 699999997320
Q ss_pred CCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 317 GKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 317 ~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
..+++|++++|++.|+|||+|++|+|+|++.+..++.+.+.+ .|+|||||+|+|+|+.||.|||+|+|.+|.+
T Consensus 325 ~~~l~vs~v~hka~ieVnE~GteAAAaT~~~~~~~~~~~~~~-~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 397 (397)
T 3pzf_A 325 RDEVRVSRIFQKAGITINELGSEAYAATEIQLVNKFGGDGVQ-IFNANRPFIFFIEDETLGTMLFAGKIENPVF 397 (397)
T ss_dssp --CCCCCEEEEEEEEEECSSEESCCCCSCC--------CCCE-EEECCSCEEEEEEETTTCCEEEEEEESSCCC
T ss_pred CCceEEEeEEEEEEEEECCCccccccccceeeeccccCCCCC-eEEecCCEEEEEEECCCCcEEEEEEecCCcC
Confidence 135999999999999999999999999986555444322223 4999999999999999999999999999974
|
| >3f1s_A Protein Z-dependent protease inhibitor; PZ, ZPI, complex, serpin, protease inhibitor, protease, GLYC secreted, serine protease inhibitor, blood coagulation; HET: FLC NAG; 2.30A {Homo sapiens} PDB: 3h5c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-83 Score=619.37 Aligned_cols=366 Identities=26% Similarity=0.413 Sum_probs=329.6
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC----hhHHHHHHHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS----NDQLNAFASELVA 78 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~----~~~~~~~~~~l~~ 78 (391)
+.++..++++||++||+++. ...++ |++|||+||+.+|+|+++||+|+|++||.++||++. .++++..++.+..
T Consensus 13 ~~~l~~~~~~Fa~~l~~~l~-~~~~~-Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~ 90 (385)
T 3f1s_A 13 RQQLAKETSNFGFSLLRKIS-MRHDG-NMVFSPFGMSLAMTGLMLGATGPTETQIKRGLHLQALKPTKPGLLPSLFKGLR 90 (385)
T ss_dssp HHHHHHHHHHHHHHHHHHHH-HHCCS-CEEECHHHHHHHHHHHTTTCCTHHHHHHHHHTTCTTCCCSSTTHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHh-hCCCC-cEEEchHHHHHHHHHHHHhcchHHHHHHHHhcCCCCCcCCHHHHHHHHHHHHH
Confidence 55677899999999999998 34556 999999999999999999999999999999999985 2678889999888
Q ss_pred HHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCC
Q 016311 79 VVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGS 158 (391)
Q Consensus 79 ~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~ 158 (391)
.+.+ ...+..++++|+||+++++.+.++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|++++ ++
T Consensus 91 ~l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~l~--~~ 164 (385)
T 3f1s_A 91 ETLS---RNLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNFRN-ASQAKRLMNHYINKETRGKIPKLF--DE 164 (385)
T ss_dssp HHHH---HCSSSCEEEEEEEEEETTSCBCHHHHHHHHHHHCEEEEEECCSS-HHHHHHHHHHHHHHHTTTSSSCCC--SC
T ss_pred Hhhc---CCCCcEEEEEEEEEEECCCchhHHHHHHHHHHhCCeeEEeCCCC-hHHHHHHHHHHHHHHhcCchhhHh--hc
Confidence 8764 23557899999999999999999999999999999999999985 789999999999999999999999 57
Q ss_pred CCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC--CeEEEEeecCCCCCCceEEE
Q 016311 159 VDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGEDKRRFSM 236 (391)
Q Consensus 159 ~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLp~~~~~~~~~~sm 236 (391)
++++|+++|+||+||+|.|+.+|++..|.+++|+..+|++++||||++.+.++|++.+ ++++|+||| ++ ++||
T Consensus 165 l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy-~~----~~sm 239 (385)
T 3f1s_A 165 INPETKLILVDYILFKGKWLTPFDPVFTEVDTFHLDKYKTIKVPMMYGAGKFASTFDKNFRCHVLKLPY-QG----NATM 239 (385)
T ss_dssp CCTTCCEEEEEEEEEECCBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEE-TT----TEEE
T ss_pred cCCCCeEEEEEhhhccchhcCCCCccCccceEEEECCCEEEEEEEEeccCcccEEEeCCCCeEEEEecC-CC----cEEE
Confidence 9999999999999999999999999999999999999999999999999877776644 789999999 65 7999
Q ss_pred EEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCC
Q 016311 237 YFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPV 316 (391)
Q Consensus 237 ~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~ 316 (391)
+||||++..+|.+++++|+ ...+.+|.+..+...++|.||||++++++||+++|++||++++|+. .|||++|++.
T Consensus 240 ~iiLP~~~~~L~~l~~~L~--~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~~-- 314 (385)
T 3f1s_A 240 LVVLMEKMGDHLALEDYLT--TDLVETWLRNMKTRNMEVFFPKFKLDQKYEMHELLRQMGIRRIFSP-FADLSELSAT-- 314 (385)
T ss_dssp EEEEECTTSCHHHHGGGCC--HHHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCTTTBCC--
T ss_pred EEEeCCCCCCHHHHHHHhh--HHHHHHHHHhccceeeEEeeeEEEEEeeecHHHHHHhcCccccccC-CCCcccccCC--
Confidence 9999999889999999997 3456666666667778999999999999999999999999999995 8999999872
Q ss_pred CCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 317 GKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 317 ~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
+.+++|++++|++.|+|||+|++|+|+|++.+..+ +.+.+|+|||||+|+|+|+.||.|||+|||.+|..
T Consensus 315 ~~~l~vs~v~hka~ieV~E~GteAaAaT~~~~~~~----~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 384 (385)
T 3f1s_A 315 GRNLQVSRVLQRTVIEVDERGTEAVAGILSEITAY----SMPPVIKVDRPFHFMIYEETSGMLLFLGRVVNPTL 384 (385)
T ss_dssp CSCCCCCEEEEEEEEEECSCBCCCCCCCCCCCCSS----CCCCEEECCSCEEEEEEETTTCCEEEEEEESCTTC
T ss_pred CCCeEEEEEEEeeEEEecCCcceeccccccccccC----CCCCEEEecCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 25799999999999999999999999998544332 23568999999999999999999999999999975
|
| >3ozq_A Serpin48; SPE, hydrolase I; 1.90A {Tenebrio molitor} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-83 Score=615.83 Aligned_cols=364 Identities=29% Similarity=0.495 Sum_probs=320.1
Q ss_pred chhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh-hHHHHHHHHHHHHH
Q 016311 2 DVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN-DQLNAFASELVAVV 80 (391)
Q Consensus 2 ~~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~-~~~~~~~~~l~~~l 80 (391)
++..+..++++||++||+++. ..+++|++|||+||+.+|+|+++||+|+|++||.++||++.. .+++..++.++..+
T Consensus 7 ~~~~l~~~~~~Fa~~l~~~l~--~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~l~~l 84 (376)
T 3ozq_A 7 TLQEFPNAVNSFTPSVYKEVL--KTEKANFLVSPFSAATLLALAQSGCRGDTAEEIRQVLHFVGDREKAEGAVKEVLSKL 84 (376)
T ss_dssp --CHHHHHHHHHHHHHHHHHH--HHCCSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCSCHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHhHHHHHHHHHHh--hCCCCCEEEcHHHHHHHHHHHHhHCchHHHHHHHHHHCCCCcHHHHHHHHHHHHHHh
Confidence 567788999999999999996 257889999999999999999999999999999999999654 45666777776654
Q ss_pred hhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCC
Q 016311 81 FADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVD 160 (391)
Q Consensus 81 ~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~ 160 (391)
. ..+..+.++|+||+++++++.++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|++++++++++
T Consensus 85 ~-----~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~wV~~~T~gkI~~ll~~~~l~ 158 (376)
T 3ozq_A 85 T-----NEEYTLHTANKIYVKTNFSVREEFQKIAVEVYGAQSENVDFSE-KNDAAKLMNAWVEEQTQHKIQNLVDPEILN 158 (376)
T ss_dssp B-----CSSCEEEEEEEEEEETTSCCCHHHHHHHHHTTSCEEEEECCSS-HHHHHHHHHHHHHHHTTTCSCCCSCGGGCC
T ss_pred c-----CCCcEEeeehhHHHhCCCcchHHHHHHHHHhhCCeeEEecCCC-hHHHHHHHHHHHHhhhcCchhhccCcccCC
Confidence 2 2345899999999999999999999999999999999999998 478999999999999999999999888999
Q ss_pred CcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccc-cccccccccc--CCeEEEEeecCCCCCCceEEEE
Q 016311 161 NSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMT-SKKNQFVSAF--DGFKVLGLPYKQGEDKRRFSMY 237 (391)
Q Consensus 161 ~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~-~~~~~~~~~~--~~~~vveLp~~~~~~~~~~sm~ 237 (391)
++|+++|+||+||+|.|+.||++..|..++|+..+|++++||||+ +.+.++|++. .++++++|||+++ +||+
T Consensus 159 ~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~~~~~vleLPy~~~-----~sm~ 233 (376)
T 3ozq_A 159 NLTRVVLINALYFNAKWLVPFPPFHTRKSDFHKSAKEVVQVDTMYLDEQYFNYYECHHLDAKLLELPFKGG-----ASLT 233 (376)
T ss_dssp TTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTS-----CEEE
T ss_pred CcceEEEEehhhhhhhhccCCCcccceeeeeEecCCcEEEEeehhhccCceeEEEecCCCeEEEEEeCCCC-----EEEE
Confidence 999999999999999999999999999999999999999999999 8887777654 4799999999985 9999
Q ss_pred EEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCC
Q 016311 238 FFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVG 317 (391)
Q Consensus 238 iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~ 317 (391)
||||+++.+|.+++++|+. ..+.+ ..+...++|.||||++++++||+++|++||++++|+. .||||+|++ .
T Consensus 234 iiLP~~~~~l~~l~~~L~~--~~l~~---~~~~~~v~v~lPKF~i~~~~~L~~~L~~lGi~~~F~~-~Adfs~is~---~ 304 (376)
T 3ozq_A 234 IVLSNQIEGLVSLESKIKR--SFLPH---NLTKQLVNVALPKFKIESTVDFKKVLKKLGVKKAFGD-EADLSGIAG---E 304 (376)
T ss_dssp EEEESSTTCHHHHHHTHHH--HHSCC---CCEEEEEEEEEECEEEEEEEEHHHHHHHHTCCGGGST-TCCCTTTSS---S
T ss_pred EEeCCCCCCHHHHHHHhCH--HHHHh---hCCeeEEEEEcccEEeecccchHHHHHhcCchhhcCC-CCCCccccC---C
Confidence 9999998899999999973 33433 3455678999999999999999999999999999995 899999998 3
Q ss_pred C-CeeEeeeeeeeEEEEcCCCchhhhhhhhhhh-hhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCC
Q 016311 318 K-NLYVSSIFQKSFIEVNEEGTEAAAASAATVV-LRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389 (391)
Q Consensus 318 ~-~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~-~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~ 389 (391)
. +++|++++|++.|+|||+|++|+|+|++.+. .++++..++.+|++||||+|+|+|+ |.|||+|||.+|.
T Consensus 305 ~~~l~vs~v~hka~ieV~E~GteAaAaT~~~~~~~~s~~~~~p~~f~~drPFlf~I~~~--~~iLF~G~v~~p~ 376 (376)
T 3ozq_A 305 KGDLVISNIVQKSFIDVSEEGVEAAAATYIPVILPEMALPDSPKQFIVDHPFIFYIKVK--GMILFAGRVTTLN 376 (376)
T ss_dssp TTSCCEEEEEEEEEEEECSSEESCCCCCCCCC---------CCEEEECCSCEEEEEEET--TEEEEEEEECCCC
T ss_pred CCCeEEeeeEeeEEEEECCCCccccccceeeecccccccCCCCceEEeECCEEEEEEEC--CEEEEEEEecCCC
Confidence 4 8999999999999999999999999986555 5554333356899999999999999 8999999999994
|
| >4ajt_A Protein Z-dependent protease inhibitor; blood clotting, ZPI; 2.50A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-83 Score=621.76 Aligned_cols=364 Identities=25% Similarity=0.409 Sum_probs=320.2
Q ss_pred hhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCC-----ChhHHHHHHHHHHH
Q 016311 4 RESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSK-----SNDQLNAFASELVA 78 (391)
Q Consensus 4 ~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~-----~~~~~~~~~~~l~~ 78 (391)
..+..++++||++||++++. ..++ |+||||+||+.+|+|+++||+|+|++||.++||++ ..++++..++.+..
T Consensus 56 ~~l~~~~~~Fa~~L~~~l~~-~~~~-Niv~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~~~~~~~i~~~f~~l~~ 133 (427)
T 4ajt_A 56 QQLSNETSSFGFNLLRKISM-RHDG-NVIFSPFGLSVAMVNLMLGTKGETKVQIENGLNLQALSQAGPLILPALFKKVKE 133 (427)
T ss_dssp HHHHHHHHHHHHHHHHHHHH-HCCS-CEEECHHHHHHHHHHHHHHCCTHHHHHHHHHHTCHHHHTSCTTHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHh-cCCC-CEEEchHHHHHHHHHHHhhcCchHHHHHHHHhCCCccccCCHHHHHHHHHHHHH
Confidence 45678899999999999973 3445 99999999999999999999999999999999998 34788999999988
Q ss_pred HHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCC
Q 016311 79 VVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGS 158 (391)
Q Consensus 79 ~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~ 158 (391)
.+. +..+..+.++|+||+++++.+.++|++.++++|++++..+||.+ ++.+++.||+||+++|+|+|++++ ++
T Consensus 134 ~l~----~~~~~~L~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll--~~ 206 (427)
T 4ajt_A 134 TFS----SNRDLGLSQGSFAFIHKDFDIKETYFNLSKKYFDIEYVSINFQN-SSQARGLINHCIVKETEGKIPKLF--DE 206 (427)
T ss_dssp HHH----TCTTSCEEEEEEEEEETTSCCCHHHHHHHHHHSCCCEEEECTTS-HHHHHHHHHHHHHHHTTTSSCSCC--SC
T ss_pred HhC----CCCCceehhhhHHHHccCCchhHHHHHHHHHhhcceeEEcCCCC-hHHHHHHHHHHHHHhhCCcccccc--cC
Confidence 875 23567899999999999999999999999999999999999964 788999999999999999999999 58
Q ss_pred CCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccc--cCCeEEEEeecCCCCCCceEEE
Q 016311 159 VDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSA--FDGFKVLGLPYKQGEDKRRFSM 236 (391)
Q Consensus 159 ~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLp~~~~~~~~~~sm 236 (391)
++++|+++|+||+||+|.|+.+|++..|..++|+..+|+.++||||++.+.+.|.. ..++++|+|||++ ++||
T Consensus 207 l~~~T~lvLvNAiyFKg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~f~~~~~~~l~~~vleLPY~~-----~~sm 281 (427)
T 4ajt_A 207 INPETKLILVDYVLFKGKWLTPFDPSFTEADTFHLDKYRAIKVPMMYREGNFTSTFDKKFRCHILKLPYQG-----NATM 281 (427)
T ss_dssp CCTTCCEEEEEEEEECCCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEEGG-----GEEE
T ss_pred CCCcceeEEeeeeeeeeeecCCCChhhccccceeccCCCEEEEEEEEecCceeEEEecCCceEEEEEEcCC-----CeEE
Confidence 99999999999999999999999999999999999999999999999988766544 4589999999997 4999
Q ss_pred EEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCC
Q 016311 237 YFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPV 316 (391)
Q Consensus 237 ~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~ 316 (391)
+||||++..+|.+++++|+ ...+..|....+...++|.||||++++++||+++|++||++++|++ .||||+|++.
T Consensus 282 ~iiLP~~~~~L~~le~~L~--~~~l~~~~~~l~~~~v~v~LPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~~-- 356 (427)
T 4ajt_A 282 LVVLMEKTGDYLALEDYLT--VDLVETWLQNMKTRKMEVFFPKFKLNQRYEMHELLKQMGIRRLFST-SADLSELSAM-- 356 (427)
T ss_dssp EEEEECTTSCHHHHTTTCC--HHHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCTTTCSS--
T ss_pred EEEecCCCCCHHHHHHhcC--HHHHHHHHHhCcceEEEEeccCEEEEeccChHHHHHHcCCchhhcC-CCCcccccCC--
Confidence 9999999779999999997 3456666666666778999999999999999999999999999998 8999999872
Q ss_pred CCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 317 GKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 317 ~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
..+++|++++|++.|+|||+|++|+|+|++.+..++. +..|+|||||+|+|+|+.||.|||+|||.+|..
T Consensus 357 ~~~l~Vs~v~hka~ieVnEeGteAAAaT~~~~~~~s~----p~~f~adrPFlF~I~d~~t~~iLF~G~v~~P~~ 426 (427)
T 4ajt_A 357 ARNLQVSRVLQQSVLEVDERGTEAVSGTLSEIIAYSM----PPAIKVNRPFHFIIYEEMSRMLLFLGRVVNPTV 426 (427)
T ss_dssp CSSCCCCEEEEEEEEEECSCBCC-------CCBCCSS----CCEEECCSCEEEEEEETTTTEEEEEEEESSCC-
T ss_pred CCCceEEEEEEEEEEEECCCcccccccceeeecccCC----CCEEEEeCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 2689999999999999999999999999865544442 358999999999999999999999999999975
|
| >1yxa_A Serine (OR cysteine) proteinase inhibitor, clade 3N; serpin, antichymotrypsin, protease inhibitor, reactive centr plasma, hydrolase inhibitor; 2.10A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-83 Score=617.77 Aligned_cols=367 Identities=28% Similarity=0.419 Sum_probs=326.6
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC----hhHHHHHHHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS----NDQLNAFASELVA 78 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~----~~~~~~~~~~l~~ 78 (391)
+..+..++++||++||+++. ...+++|+||||+||+.+|+|+++||+|+|++||.++||++. .++++..++.+..
T Consensus 24 ~~~l~~~~~~Fa~~l~~~l~-~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~ 102 (398)
T 1yxa_A 24 SLTLASINTDFAFSLYKELV-LKNPDTNIVFSPLSISAALALVSLGAKGNTLEEILEGLKFNLTETSEADIHQGFGHLLQ 102 (398)
T ss_dssp ---CHHHHHHHHHHHHHHHH-HHSTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHH-hcCCCCCEEEchHHHHHHHHHHHhhcccHHHHHHHHHhCCCcccCCHHHHHHHHHHHHH
Confidence 45667889999999999997 456789999999999999999999999999999999999974 2578888999988
Q ss_pred HHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCC
Q 016311 79 VVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGS 158 (391)
Q Consensus 79 ~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~ 158 (391)
.+.. ...+..++++|+||+++++.+.++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ +
T Consensus 103 ~l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~--~ 176 (398)
T 1yxa_A 103 RLNQ---PKDQVQISTGSALFIEKRQQILTEFQEKAKTLYQAEAFTADFQQ-PRQAKKLINDYVRKQTQGMIKELVS--D 176 (398)
T ss_dssp HHSS---CBTTBEEEEEEEEEEETTSCCCHHHHHHHHHHHSCEEEEECTTS-HHHHHHHHHHHHHHHTTTSSSCCCC--C
T ss_pred HHhC---CCCCceeeeeeEEEEeCCCchhHHHHHHHHHHhCCceeecCCCC-HHHHHHHHHHHHHHHhcCchhhhhh--c
Confidence 8753 23557899999999999999999999999999999999999985 7889999999999999999999996 4
Q ss_pred CCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccc-ccccccc--CCeEEEEeecCCCCCCceEE
Q 016311 159 VDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKK-NQFVSAF--DGFKVLGLPYKQGEDKRRFS 235 (391)
Q Consensus 159 ~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~-~~~~~~~--~~~~vveLp~~~~~~~~~~s 235 (391)
++++|+++|+||+||+|.|+.+|++..|..++|+..+|++++||||++.+ .++|+.. .++++++|||+++ .+
T Consensus 177 l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~l~~~vleLPY~~~-----~s 251 (398)
T 1yxa_A 177 LDKRTLMVLVNYIYFKAKWKVPFDPLDTFKSEFYCGKRRPVIVPMMSMEDLTTPYFRDEELSCTVVELKYTGN-----AS 251 (398)
T ss_dssp CCTTCCEEEEEEEEEECBBSSCCCGGGCEEEEECCCCSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-----EE
T ss_pred cCCCcEEEEEEHHhhhhhhhCCCCcccCeeeEEEeCCCeEEEEEEEEEcCceEEEEEeCCCCeEEEEEecCCC-----ee
Confidence 99999999999999999999999999999999999999999999999998 7777654 4799999999986 59
Q ss_pred EEEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeee-eeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCC
Q 016311 236 MYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVG-DFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDS 314 (391)
Q Consensus 236 m~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v-~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~ 314 (391)
|+||||+++ +|.+++++|+ ...+..|.+..+...+ +|.||||++++++||+++|++||++++|+. .||||+|++
T Consensus 252 m~iiLP~~~-~L~~le~~L~--~~~l~~~~~~~~~~~v~~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~- 326 (398)
T 1yxa_A 252 ALFILPDQG-RMQQVEASLQ--PETLRKWKNSLKPRMIDELHLPKFSISTDYSLEDVLSKLGIREVFST-QADLSAITG- 326 (398)
T ss_dssp EEEEEECTT-CHHHHHHTCS--HHHHHHHHHHCEEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCHHHHS-
T ss_pred EEEEecCcC-cHHHHHHHhC--HHHHHHHHHhccceeeeEEecceEEeecccchHHHHHHcCcccccCC-cCCcccCCC-
Confidence 999999986 5999999997 3455556555556678 999999999999999999999999999995 899999998
Q ss_pred CCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCC
Q 016311 315 PVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389 (391)
Q Consensus 315 ~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~ 389 (391)
..+++|++++|++.|+|||+|++|+|+|++.+..++.+ +++.+|+|||||+|+|+|+.||.|||+|||.+|.
T Consensus 327 --~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~s~~-~~~~~f~~drPFlF~I~~~~t~~iLF~G~v~~P~ 398 (398)
T 1yxa_A 327 --TKDLRVSQVVHKAVLDVAETGTEAAAATGVKFVPMSAK-LYPLTVYFNRPFLIMIFDTETEIAPFIAKIANPK 398 (398)
T ss_dssp --SSCCCCCEEEEEEEEEECSSBSSCCCCCSCCCCCCCCC-SSCCEEECCSCEEEEEEETTTCCCSEEEEESCCC
T ss_pred --CCCeEEEEEEEEEEEEEcCCccccccccchhhcccccC-CCCCeEEecCCEEEEEEECCCCcEEEEEEecCCC
Confidence 46899999999999999999999999998655555443 2356899999999999999999999999999995
|
| >1qmn_A AACT, alpha-1-antichymotrypsin; serpin, serine proteinase inhibitor, partial loop insertion, loop-sheet polymerization, emphysema, disease mutation; 2.27A {Homo sapiens} SCOP: e.1.1.1 PDB: 3dlw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-83 Score=621.61 Aligned_cols=367 Identities=27% Similarity=0.421 Sum_probs=323.9
Q ss_pred hhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh----hHHHHHHHHHHHHH
Q 016311 5 ESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN----DQLNAFASELVAVV 80 (391)
Q Consensus 5 ~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~----~~~~~~~~~l~~~l 80 (391)
.+..++++||++||+++. ...+++|+||||+||+.+|+|+++||+|+|++||.++||++.. ++++..++.+...+
T Consensus 26 ~l~~~~~~Fa~~l~~~l~-~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l 104 (401)
T 1qmn_A 26 GLASANVDFAFSLYKQLV-LKAPDKNVIFSPPSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLRTL 104 (401)
T ss_dssp -CHHHHHHHHHHHHHHHH-HHCSSSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTCCTTTCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHH-hcCCCCCEEEecHHHHHHHHHHHhhccCHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHH
Confidence 567789999999999997 4567899999999999999999999999999999999999742 57888999998887
Q ss_pred hhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCC
Q 016311 81 FADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVD 160 (391)
Q Consensus 81 ~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~ 160 (391)
.. ...+..+.++|+||+++++.+.++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ +++
T Consensus 105 ~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~--~l~ 178 (401)
T 1qmn_A 105 NQ---SSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQD-SAAAKKLINDYVKNGTRGKITDLIK--DLD 178 (401)
T ss_dssp CC---CSSSCEEEEEEEEEEESSCCCCHHHHHHHHHHHCCEEEEECGGG-HHHHHHHHHHHCSSEEEEEEEECC------
T ss_pred hc---CCCCceEEEEEEEEeeCCCchHHHHHHHHHHhcCCeEEecCccC-HHHHHHHHHHHHHHHhcCchhhhcc--CCC
Confidence 53 34567899999999999999999999999999999999999985 7889999999999999999999996 499
Q ss_pred CcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccc-ccccccC--CeEEEEeecCCCCCCceEEEE
Q 016311 161 NSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKN-QFVSAFD--GFKVLGLPYKQGEDKRRFSMY 237 (391)
Q Consensus 161 ~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~-~~~~~~~--~~~vveLp~~~~~~~~~~sm~ 237 (391)
++|+++|+||+||+|.|+.+|++..|..++|+..+|+.++||||++.+. ++|+..+ ++++|+|||+++ .+|+
T Consensus 179 ~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~l~~~vleLPY~~~-----~sm~ 253 (401)
T 1qmn_A 179 SQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGN-----ASAL 253 (401)
T ss_dssp CCCCEEEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-----EEEE
T ss_pred CCceEEEEEeeeeeehhcCCCChhcCccceEEcCCCcEEEeeEEEEcCceEEEEEeCCCceEEEEEecCCC-----eEEE
Confidence 9999999999999999999999999999999999999999999999987 7776644 799999999986 5999
Q ss_pred EEecCCCCChHHHHHHhcCchHHHhhcCCCCceeee-eeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCC
Q 016311 238 FFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVG-DFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPV 316 (391)
Q Consensus 238 iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v-~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~ 316 (391)
||||++ .+|.+++++|+ ...+.+|.+..+...+ +|.||||++++++||+++|++|||+++|+. .|||++|++
T Consensus 254 iiLP~~-~~L~~le~~L~--~~~l~~~~~~~~~~~v~~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~--- 326 (401)
T 1qmn_A 254 FILPDQ-DKMEEVEAMLL--PETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTS-KADLSGITG--- 326 (401)
T ss_dssp EEEECT-TCHHHHHTTCS--HHHHHHHHHSCEEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCHHHHS---
T ss_pred EEEECC-CCHHHHHHHhC--HHHHHHHHHhCcceEcceEeeeeEEEeccccHHHHHHhcCccccccC-cCCcccccC---
Confidence 999988 68999999997 3456666666666778 999999999999999999999999999985 899999998
Q ss_pred CCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 317 GKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 317 ~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
..+++|++++|++.|+|||+|++|+|+|++.+..++.+.+++.+|+|||||+|+|+|+.||.|||+|||.+|..
T Consensus 327 ~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~s~~~~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 400 (401)
T 1qmn_A 327 ARNLAVSQVVHKAVLDVFEEGTEASAATAVKITLLSALVETRTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQ 400 (401)
T ss_dssp SSCEEEEEEEEEEEEEECSSEEESSCCCC-----CCCCCCCSCEEECCSCEEEEEEETTSSCCSEEEEESCTTC
T ss_pred CCCeEEEeeeeEEEEEeCCCccccccccchhhccccCCCCCCceEEecCCEEEEEEECCCCcEEEEEEcCCCCC
Confidence 46899999999999999999999999998665555543333478999999999999999999999999999975
|
| >3b9f_I Protein C inhibitor; michaelis complex, acute phase, blood coagulation, cleavage of basic residues, disease mutation; HET: NAG FUC SGN IDS; 1.60A {Homo sapiens} PDB: 2ol2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-82 Score=611.88 Aligned_cols=363 Identities=26% Similarity=0.447 Sum_probs=316.9
Q ss_pred hhhhhhhh-hHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh----hHHHHHHHHHH
Q 016311 3 VRESISNQ-TDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN----DQLNAFASELV 77 (391)
Q Consensus 3 ~~~~~~~~-~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~----~~~~~~~~~l~ 77 (391)
+..+..++ ++||++||+++. ...+++|+||||+||+.+|+|+++||+|+|++||.++||++.. ++++..++.+.
T Consensus 26 ~~~l~~~~~~~Fa~~L~~~l~-~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~i~~~~~~l~ 104 (395)
T 3b9f_I 26 GATVAPSSRRDFTFDLYRALA-SAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKELHRGFQQLL 104 (395)
T ss_dssp ----------CHHHHHHHHHH-HHSTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTC----CCHHHHHHHHHHHH
T ss_pred HHHHHHhhHHHHHHHHHHHHh-ccCCCCCEEEcHHHHHHHHHHHHHHcccHHHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 45567788 999999999997 4567899999999999999999999999999999999999742 57888899988
Q ss_pred HHHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCC
Q 016311 78 AVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPG 157 (391)
Q Consensus 78 ~~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~ 157 (391)
..+.+ +..+..++++|+||+++++.+.++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++
T Consensus 105 ~~l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~-- 178 (395)
T 3b9f_I 105 QELNQ---PRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRD-SAGAMKQINDYVAKQTKGKIVDLLK-- 178 (395)
T ss_dssp HHTTS---CCTTCCEEEEEEEEEETTCCBCHHHHHHHHHHHCCEEEEECTTS-HHHHHHHHHHHHHHHTTTSSCCCCS--
T ss_pred HHHhC---CCCCceeEEEEEEEEECCCccchHHHHHHHHHhCCEeEEcCCCC-HHHHHHHHHHHHHHHhCCchhhhcc--
Confidence 87753 33567899999999999999999999999999999999999975 7889999999999999999999996
Q ss_pred CCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc--CCeEEEEeecCCCCCCceEE
Q 016311 158 SVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF--DGFKVLGLPYKQGEDKRRFS 235 (391)
Q Consensus 158 ~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLp~~~~~~~~~~s 235 (391)
+++++|+++|+||+||+|.|+.+|++..|.+++|+..+|++++||||++.+.++|+.. .++++|+|||+++ .+
T Consensus 179 ~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~~~-----~s 253 (395)
T 3b9f_I 179 NLDSNAVVIMVNYIFFKAKWETSFNHKGTQEQDFYVTSETVVRVPMMSREDQYHYLLDRNLSCRVVGVPYQGN-----AT 253 (395)
T ss_dssp CCCTTCSEEEEEEEEECCCEEECCCTTTCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-----CE
T ss_pred CCCCCceEEEEEhheeeccccCCCChhhCeeeEEEeCCCeEEEEEEEEeeeeEeEEEECCCCeEEEEEecCCC-----ee
Confidence 4999999999999999999999999999999999999999999999999987776554 4899999999986 49
Q ss_pred EEEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCC
Q 016311 236 MYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSP 315 (391)
Q Consensus 236 m~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~ 315 (391)
|+||||++ .+|.+++++|+ ...+.+|.+..+...++|.||||++++++||+++|++||++++|+. .|||++|++
T Consensus 254 m~iiLP~~-~~L~~le~~L~--~~~l~~~~~~l~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~-- 327 (395)
T 3b9f_I 254 ALFILPSE-GKMQQVENGLS--EKTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLPSLGISNVFTS-HADLSGISN-- 327 (395)
T ss_dssp EEEEEECT-TCHHHHHHHCS--HHHHHHHHHHCEEEEEEEEEECEEEEEEEEGGGTGGGGTCCGGGST-TCCCTTTBS--
T ss_pred EEEEEeCC-CCHHHHHHHhC--HHHHHHHHHhcceeEEEEEeeEEEEEEeecHHHHHHHcCCccccCC-CCCcccCcC--
Confidence 99999998 68999999997 3456666555566778999999999999999999999999999986 899999998
Q ss_pred CCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 316 VGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 316 ~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
..+++|++++|++.|+|||+|++|+|+|++.+..++.+ +.+.+|+|||||+|+|+| +.|||+|+|.+|
T Consensus 328 -~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~~~~-~~~~~f~~drPFlf~I~~---~~iLF~G~v~~P 395 (395)
T 3b9f_I 328 -HSNIQVSEMVHKAVVEVDESGTRAAAATGTIFTFRSAR-LNSQRLVFNRPFLMFIVD---NNILFLGKVNRP 395 (395)
T ss_dssp -CSSCCCSEEEEEEEEEECSCEEECCCSCSCSSBCCSCC-CCCEEEECCSCEEEEEES---SSEEEEEEESCC
T ss_pred -CCCeeeeccceEEEEEEcCCCcccccccchhhhhccCC-CCCCEEEEeCCEEEEEEc---CCEEEEEEeCCC
Confidence 47899999999999999999999999998655444432 235789999999999998 799999999998
|
| >1jmo_A HC-II, heparin cofactor II, HLS2, serin; serpin, thrombin, protease, inhibition, inhibitor, blood CLO; HET: TYS NDG NAG; 2.20A {Homo sapiens} SCOP: e.1.1.1 PDB: 1jmj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-82 Score=618.35 Aligned_cols=364 Identities=26% Similarity=0.435 Sum_probs=327.6
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcC-CCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC---------hhHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTE-AKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS---------NDQLNAF 72 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~-~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~---------~~~~~~~ 72 (391)
+..+..++++||++||+++. .. .+++|+||||+||+.+|+|+++||+|+|++||.++||++. ..+++..
T Consensus 104 ~~~l~~~~~~Fa~~L~k~l~-~~~~~~~NivfSP~SI~~aLaml~~GA~G~T~~eL~~~L~~~~~~~~~~~~~~~~i~~~ 182 (480)
T 1jmo_A 104 IQRLNILNAKFAFNLYRVLK-DQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNASSKYEITTIHNL 182 (480)
T ss_dssp HHHHHHHHHHHHHHHHHHHH-TTSCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTHHHHHHHCTTCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHH-hccCCCCCEEEcHHHHHHHHHHHHHhcCcHHHHHHHHHhCCCccccccccCCHHHHHHH
Confidence 45677889999999999997 33 6789999999999999999999999999999999999864 2678889
Q ss_pred HHHHHHHHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccc
Q 016311 73 ASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKE 152 (391)
Q Consensus 73 ~~~l~~~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~ 152 (391)
++.+...+.+ ...+..++++|+||+++++.+.++|++.++++|+++++.+||.+. .. ++.||+||+++|+|+|++
T Consensus 183 f~~ll~~l~~---~~~~~~L~~AN~lfv~~~~~l~~~F~~~~~~~y~a~~~~vDF~~~-~~-~~~IN~WV~~~T~gkI~~ 257 (480)
T 1jmo_A 183 FRKLTHRLFR---RNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIADFSDP-AF-ISKTNNHIMKLTKGLIKD 257 (480)
T ss_dssp HHHHHHHHHS---SCSSSEEEEEEEEEEETTSCCCHHHHHHHHHHHSCCEEEECTTCH-HH-HHHHHHHHHHHTTTSSCC
T ss_pred HHHHHHHhhc---CCCCceEEEEEEEeecCCCcccHHHHHHHHHhhccceeeecccCH-HH-HHHHHHHHHHhhCCChhh
Confidence 9999888763 235678999999999999999999999999999999999999874 45 889999999999999999
Q ss_pred cCCCCCCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC--CeEEEEeecCCCCC
Q 016311 153 VLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGED 230 (391)
Q Consensus 153 ~l~~~~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLp~~~~~~ 230 (391)
++ ++++++|+++|+||+||+|.|+.+|++..|..++|+..+|++++||||++.+.++|+..+ ++++|+|||+ +
T Consensus 258 ll--~~l~~~T~lvLvNAiyFKg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~-~-- 332 (480)
T 1jmo_A 258 AL--ENIDPATQMMILNCIYFKGSWVNKFPVEMTHNHNFRLNEREVVKVSMMQTKGNFLAANDQELDCDILQLEYV-G-- 332 (480)
T ss_dssp TT--CSCCTTCCEEEEEEEEEECCBSSCCCGGGCEEEEEECSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEET-T--
T ss_pred hh--cccCCCCeEEEEehHeeeccccCCCCCCCceeEEEEeCCCcEEEEEEEEEecceeeEEeCCCceEEEEEecC-C--
Confidence 99 589999999999999999999999999999999999999999999999999877776654 6999999999 5
Q ss_pred CceEEEEEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcC
Q 016311 231 KRRFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAE 310 (391)
Q Consensus 231 ~~~~sm~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~ 310 (391)
++||+||||++..+|.+++++|+ ...+.+|....+...++|.||||++++++||+++|++|||+++|+. .||||+
T Consensus 333 --~~SM~IiLP~~~~~L~~le~~L~--~~~l~~~~~~l~~~~V~v~LPKFkie~~~dL~~~L~~LGi~~~F~~-~ADfsg 407 (480)
T 1jmo_A 333 --GISMLIVVPHKMSGMKTLEAQLT--PRVVERWQKSMTNRTREVLLPKFKLEKNYNLVESLKLMGIRMLFDK-NGNMAG 407 (480)
T ss_dssp --TEEEEEEEESSGGGHHHHHHHCC--HHHHHHHHHHCEEEEEEEEEECEEEECCEECHHHHHHHTCCGGGST-TSCCTT
T ss_pred --cEEEEEEecCCCCCHHHHHHhhC--HHHHHHHHhcccceEEEEEeccEEEEEeecHHHHHHhCCccccccC-CCCcCc
Confidence 69999999998889999999997 3456666555566778999999999999999999999999999975 899999
Q ss_pred CCCCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 311 MVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 311 is~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
|++ .+++|++++|++.|+|||+|++|+|+|++.+..++. + .+|+|||||+|+|+|+.||.|||+|||.+|.+
T Consensus 408 is~----~~L~VS~v~HKa~IeVnEeGtEAAAaT~v~~~~~s~--~--~~F~aDrPFlF~I~d~~t~~iLF~G~v~~P~~ 479 (480)
T 1jmo_A 408 ISD----QRIAIDLFKHQGTITVNEEGTQATTVTTVGFMPLST--Q--VRFTVDRPFLFLIYEHRTSCLLFMGRVANPSR 479 (480)
T ss_dssp TCS----SCCCEEEEEEEEEEEECSCBSCCCCCCCCSEEECSC--C--CEEECCSCEEEEEEETTTTEEEEEEEESCTTC
T ss_pred ccC----CCceecchheeEEEEccCCccccccccccccccccC--C--CcEEecCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 987 579999999999999999999999999865544443 2 28999999999999999999999999999975
|
| >2v95_A Corticosteroid-binding globulin; transport protein, CBG, RCL, serpin, secreted, transport, glycoprotein, lipid-binding, glucocorticoids; HET: HCY; 1.93A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-82 Score=607.54 Aligned_cols=361 Identities=20% Similarity=0.366 Sum_probs=301.7
Q ss_pred chhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC----hhHHHHHHHHHH
Q 016311 2 DVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS----NDQLNAFASELV 77 (391)
Q Consensus 2 ~~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~----~~~~~~~~~~l~ 77 (391)
+...+..++++||++||+++. ...+++|++|||+||+.+|+|+++|| |++||.++||++. .++++..++.+.
T Consensus 5 ~~~~l~~~~~~Fa~~l~~~l~-~~~~~~N~v~SP~Si~~aLaml~~GA---T~~el~~~L~~~~~~~~~~~~~~~~~~l~ 80 (371)
T 2v95_A 5 SHRGLAPTNVDFAFNLYQRLV-ALNPDKNTLISPVSISMALAMVSLGS---AQTQSLQSLGFNLTETSEAEIHQSFQYLN 80 (371)
T ss_dssp GGGTTHHHHHHHHHHHHHHHH-HHCTTSCEEECHHHHHHHHHHHTTTC-----CHHHHHHTCCTTTSCHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHHHHh-ccCCCCcEEEchHHHHHHHHHHHHHH---HHHHHHHHhCCCCCCCCHHHHHHHHHHHH
Confidence 345677899999999999997 45678999999999999999999999 9999999999974 257888999998
Q ss_pred HHHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCC
Q 016311 78 AVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPG 157 (391)
Q Consensus 78 ~~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~ 157 (391)
..+.+ +..+..++++|+||+++++.+.++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++
T Consensus 81 ~~l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~l~~-- 154 (371)
T 2v95_A 81 YLLKQ---SDTGLEMNMGNAMFLLQKLKLKDSFLADVKQYYESEALAIDFED-WTKASQQINQHVKDKTQGKIEHVFS-- 154 (371)
T ss_dssp HHHTT---GGGSEEEEEEEEEEECTTCCBCHHHHHHHHHHSCCEEEECCCSS-HHHHHHHHHHHHHHHTTTCCCCSCC--
T ss_pred HHHhC---CCCCcEEEEEEEEeEeCCCchhHHHHHHHHHHhCCceEEecCcc-HHHHHHHHHHHHHHHhcCchhhhcc--
Confidence 88753 23456899999999999999999999999999999999999985 7889999999999999999999995
Q ss_pred CCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC--CeEEEEeecCCCCCCceEE
Q 016311 158 SVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGEDKRRFS 235 (391)
Q Consensus 158 ~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLp~~~~~~~~~~s 235 (391)
+++++|+++|+||+||+|.|+.+|++..|.+++|+..+|+.++||||++.+.++|++.+ ++++++|||+++ .+
T Consensus 155 ~l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~y~~~~~l~~~vleLPy~~~-----~s 229 (371)
T 2v95_A 155 DLDSPASFILVNYIFLRGIWELPFSPENTREEDFYVNETSTVKVPMMVQSGSIGYFRDSVFPCQLIQMDYVGN-----GT 229 (371)
T ss_dssp C--CCCSEEEEEEEEEEECBSSCCCGGGCEEEEEECSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-----EE
T ss_pred CCCCCceEEEEEHHhhhhhhhCcCCCcccceeEEEECCCeEEEEEEEEeeeeEeeEEeCCCCEEEEEEecCCC-----eE
Confidence 59999999999999999999999999999999999999999999999999877776544 799999999985 79
Q ss_pred EEEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCC
Q 016311 236 MYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSP 315 (391)
Q Consensus 236 m~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~ 315 (391)
|+||||+++ +|.+++++|+ ...+..|.+..+...++|.||||++++++||+++|++||++++|+. .||||+|++
T Consensus 230 m~iiLP~~~-~l~~le~~L~--~~~l~~~~~~l~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~-- 303 (371)
T 2v95_A 230 AFFILPDQG-QMDTVIAALS--RDTIDRWGKLMTPRQVNLYIPKFSMSDTYDLKDVLEDLNIKDLLTN-QSDFSGNTK-- 303 (371)
T ss_dssp EEEEEECTT-CHHHHHHHCS--HHHHHHHHHHCEEEEEEEEEECEEEEEEEEGGGTSCSCCHHHHBCC------------
T ss_pred EEEEecCCC-CHHHHHHHhC--HHHHHHHHHhhhcccceEeeeEEEeecccchHHHHHhcCCccccCC-CCCcCCCCC--
Confidence 999999987 7999999997 3455555555556678999999999999999999999999999985 899999998
Q ss_pred CCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCC
Q 016311 316 VGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389 (391)
Q Consensus 316 ~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~ 389 (391)
+.+++|+ ++|++.|+|||+|++|+|+|++.+..++. +.+|+|||||+|+|+|+.||.|||+|||.+|.
T Consensus 304 -~~~l~vs-v~hka~ieVnE~GteAaAaT~~~~~~~~~----~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~ 371 (371)
T 2v95_A 304 -DVPLTLT-MVHKAMLQLDEGNVLPNSTNGAPLHLRSE----PLDIKFNKPFILLLFDKFTWSSLMMSQVVNPA 371 (371)
T ss_dssp ----CCEE-EEEEEEEEESCCCCC----------CCCC----CEEEECCSCEEEEEEETTTCCEEEEEEESCCC
T ss_pred -CCCeeEE-EEEEEEEEecCCcccccccccccccccCC----CcEEEeeCCEEEEEEECCCCcEEEEEEecCCC
Confidence 4689999 99999999999999999999865544332 46899999999999999999999999999995
|
| >2pef_A Serine protease inhibitor; serpin; 1.60A {Thermoanaerobacter tengcongensis} PDB: 2vh4_A 2pee_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-82 Score=611.33 Aligned_cols=364 Identities=23% Similarity=0.431 Sum_probs=323.9
Q ss_pred hhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh-hHHHHHHHHHHHHHhhC
Q 016311 5 ESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN-DQLNAFASELVAVVFAD 83 (391)
Q Consensus 5 ~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~-~~~~~~~~~l~~~l~~~ 83 (391)
.+..++++||++||+++. .+++|++|||+||+.+|+|+++||+|+|++||.++||++.. ++++..++.+...+..
T Consensus 8 ~~~~~~~~Fa~~L~~~l~---~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~l~~~l~~- 83 (373)
T 2pef_A 8 KFIYNTADFSIELFKNSI---DDKENSLISPLSAMLALAMTANGADNETLAQMEKALGKDISIEDLNKYLYTYMKKLPN- 83 (373)
T ss_dssp HHHHHHHHHHHHHHHTSC---CSSSCCEECHHHHHHHHHHHHTTCCHHHHHHHHHHHHTTCCHHHHHHHHHHHHHHSCC-
T ss_pred HHHHHHHHHHHHHHHHhh---CCCCCEEEccHHHHHHHHHHHhhccChHHHHHHHHhCCCCCHHHHHHHHHHHHHHhhc-
Confidence 456789999999999995 46889999999999999999999999999999999998643 7888889998877642
Q ss_pred CCCCCCCeeeeeeeeeec-CCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCc
Q 016311 84 GSPSGGPRLSVANGVWID-ESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNS 162 (391)
Q Consensus 84 ~~~~~~~~l~~~n~i~~~-~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~ 162 (391)
..+..++++|+||++ +++.+.++|++.++++|+++++.+||. +.+++.||+||+++|+|+|+++++ +++++
T Consensus 84 ---~~~~~l~~an~l~~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~---~~a~~~IN~WV~~~T~gkI~~ll~--~l~~~ 155 (373)
T 2pef_A 84 ---EEKSKLTIANSIWFKENDFMPSKDFLQIIADYYKADIFKAAFD---SSTVSDINNWVKSKTNGMIDKILN--KIDPE 155 (373)
T ss_dssp ---BTTEEEEEEEEEEEETTTEEECHHHHHHHHHHHCCEEEEECCS---HHHHHHHHHHHHHHTTTSCCCSCS--CCCTT
T ss_pred ---CCCcEEEEEEEEEEecCCCchhHHHHHHHHHHhCCeeEecCch---HHHHHHHHHHHHHhccCchhhhhc--cCCCC
Confidence 345789999999999 799999999999999999999999997 378899999999999999999995 79999
Q ss_pred CeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccCCeEEEEeecCCCCCCceEEEEEEecC
Q 016311 163 TRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPD 242 (391)
Q Consensus 163 t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~~~~vveLp~~~~~~~~~~sm~iilP~ 242 (391)
|+++|+||+||+|.|+.+|++..|..++|+..+|++++||||++.+.+ |.++.++++++|||+++ ++||+||||+
T Consensus 156 t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~-y~~~~~~~vleLPy~~~----~~sm~iiLP~ 230 (373)
T 2pef_A 156 DVMYLINAVAFDAEWETVYEKASVHEDIFTDVYGNRQKVEFMNSEENL-YIEEENAVGFVKPYAKN----HYSFVAILPD 230 (373)
T ss_dssp CCEEEEEEEEEEEEBSSCCCGGGEEEEEEECTTSCEEEEEEEEEEEEE-EEEETTEEEEEEEBGGG----SEEEEEEEEC
T ss_pred ceEEEEEeeeeeccccccCChhhccccceecCCCeEEEechhhccCeE-EeecCCeEEEEEecCCC----cEEEEEEECC
Confidence 999999999999999999999999999999999999999999999877 77788999999999987 7999999999
Q ss_pred CCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCeeE
Q 016311 243 AKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYV 322 (391)
Q Consensus 243 ~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~v 322 (391)
++.+|.+++++|+ ...+.++++..+...++|.||||++++++||+++|++||++++|++..|||++|++.+ +.+++|
T Consensus 231 ~~~~L~~l~~~L~--~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~is~~~-~~~l~v 307 (373)
T 2pef_A 231 ENISVNEYIKTLT--GQKFIDLIKNAKITLVRASLPKFKYEYTIKMNETLESLGMTDAFLPDKADFSKLGKSD-IGNLYI 307 (373)
T ss_dssp TTSCHHHHHHHCC--HHHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTEEET-TSCCCC
T ss_pred CCCCHHHHHhhhh--hhHHHHHHhhceeeEEEEECceEEeecccchHHHHHhcCCccccCCCcCchhhcccCC-CCCeEE
Confidence 9999999999997 3456666666666778999999999999999999999999999996589999998731 137999
Q ss_pred eeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCC
Q 016311 323 SSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389 (391)
Q Consensus 323 ~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~ 389 (391)
++++|++.|+|||+|++|+|+|++.+..++.+ +.+.+|+|||||+|+|+|+.||.|||+|+|.+|.
T Consensus 308 s~v~hka~ieVnE~GteAaAaT~~~~~~~~~~-~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~p~ 373 (373)
T 2pef_A 308 SEVLHKTFISVDELGTKAGAVTSVDITAAGIP-VNFKTVKLNRPFIFAIIDNSTNLPIFIGTVLSLK 373 (373)
T ss_dssp CCEEEEEEEEECSSEEEEEEEEEESCC--------CCSEEEEEEEEEEEEETTTTEEEEEEEEEEEC
T ss_pred cchhheeEEEECCCccccccccchhhccccCC-CCCCeEEecCCEEEEEEECCCCcEEEEEEecCCC
Confidence 99999999999999999999998655555442 2356899999999999999999999999999983
|
| >2wxy_C Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 2.10A {Mus musculus} PDB: 2wxx_A 2wy0_C 2wxz_A 2wxz_C 2wy1_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-80 Score=609.87 Aligned_cols=365 Identities=19% Similarity=0.250 Sum_probs=314.8
Q ss_pred hhhhhhhhHHHHHHHHHhhhcCCCCCcE-EEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh----------hHHHHH
Q 016311 4 RESISNQTDVALSLTKHVALTEAKDSNL-VFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN----------DQLNAF 72 (391)
Q Consensus 4 ~~~~~~~~~fa~~L~~~l~~~~~~~~N~-v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~----------~~~~~~ 72 (391)
..+..++++||++||+++. ...+++|+ +|||+||+.+|+|+++||+|+|++||.++||++.. .+++..
T Consensus 71 ~~l~~~~~~Fa~~L~~~l~-~~~~~~Ni~v~SP~SI~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~ 149 (453)
T 2wxy_C 71 AQVAMITNFVGFRMYKMLN-EAGSGASGAILSPPALFGTLVSFYLGSLDPTASQLQTLLDVPVKEGDCTSRLDGHKVLAA 149 (453)
T ss_dssp HHHHHHHHHHHHHHHHHHH-HHCCCSSEEEECHHHHHHHHHHHHHTCCTTHHHHHHHHTTCCCCTTCGGGSBCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHh-hcCCCCcEEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCcccccccccccHHHHHHH
Confidence 3467789999999999998 45678999 99999999999999999999999999999999753 356777
Q ss_pred HHHHHHHHhhCC--CCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCe-eEEecCCCChHHHHHHHHHHHHHHhCCc
Q 016311 73 ASELVAVVFADG--SPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAA-SNQVDFQTKAAEVSREVNMWAEKETNGL 149 (391)
Q Consensus 73 ~~~l~~~l~~~~--~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~-~~~~df~~~~~~a~~~iN~wv~~~T~g~ 149 (391)
++.+...+.... .+..+..++++|+||+++++.+.++|++.++++|++. ++.+||..+++.+++.||+||+++|+|+
T Consensus 150 ~~~l~~~l~~~~~~~~~~~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~~vdF~~~~~~a~~~IN~WV~~~T~gk 229 (453)
T 2wxy_C 150 LRAVQGLLVTQGGSSSQTPLLQSIVVGLFTAPGFRLKHSFVQSLALFTPALFPRSLDLSTDPVLATEKINRFIKAVTGWK 229 (453)
T ss_dssp HHHHHHHHHC--------CEEEEEEEEEEECTTCCEEHHHHHHHHTTCSCEEEEECCCSSCHHHHHHHHHHHHHHHHCCC
T ss_pred HHHHHHHHhhccccCCCCccEEEEEEeEeEeCCCCccHHHHHHHHHHcCCCceeeecccCCHHHHHHHHHHHHHHhcCCc
Confidence 888877775311 1123457999999999999999999999999999996 9999995457899999999999999999
Q ss_pred ccccCCCCCCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc--CCeEEEEeecCC
Q 016311 150 VKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF--DGFKVLGLPYKQ 227 (391)
Q Consensus 150 i~~~l~~~~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLp~~~ 227 (391)
|+++++ +++++|+++|+||+||+|.|+.+|++.. .++|+..+|++++||||++++.++|+.. .++++++|||++
T Consensus 230 I~~ll~--~l~~~t~lvLvNaiyFKg~W~~~F~~~~--~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~~ 305 (453)
T 2wxy_C 230 MNLPLE--GVSTDSTLLFNTYVHFQGTMRGFSQLPG--VHEFWVDNSISVSVPMISGTGNFQHWSDAQNNFSVTCVPLGE 305 (453)
T ss_dssp CCCCCC--CCCTTCCEEEEEEEEEEEEEEEEEECSS--CEEEEEETTEEEEECEEEEEEEEEEEEETTTTEEEEEEESSS
T ss_pred hhhhhc--ccCCCCeEEEEehheeeccCCCCCCCcc--CCCcEeCCCeEEEEEEEEEeCCCCEEEecCCCcEEEEEECCC
Confidence 999995 5999999999999999999999999988 8999999999999999999987777664 489999999975
Q ss_pred CCCCceEEEEEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCC
Q 016311 228 GEDKRRFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGG 307 (391)
Q Consensus 228 ~~~~~~~sm~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~ad 307 (391)
++||+||||+++.+|.+++++|+. ..+..|++..+...++|.||||++++++||+++|++|||+++|+. .||
T Consensus 306 -----~~sm~iiLP~~~~~L~~le~~L~~--~~l~~~~~~l~~~~V~v~LPKFkie~~~dL~~~L~~lGi~~~F~~-~Ad 377 (453)
T 2wxy_C 306 -----RATLLLIQPHCISDLDRVEALIFQ--NDLLTWIENPPPRAIRLTLPQLEIRGSYNLQDLLAEDKLPTLLGA-EAN 377 (453)
T ss_dssp -----SEEEEEEEESSGGGHHHHHHHHTC---CCCTTCCCCCCEEEEEEEECEEEEEEEEHHHHHHHTTCTTTTST-TCC
T ss_pred -----CEEEEEEecCCCCCHHHHHHHhCH--HHHHHHHHhccccccEEecceEEEeccccHHHHHHhcChhhhhcc-cCC
Confidence 599999999998899999999984 346666666666778999999999999999999999999999986 899
Q ss_pred CcCCCCCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecC
Q 016311 308 LAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLN 387 (391)
Q Consensus 308 fs~is~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~ 387 (391)
||||++ .+++|++++|++.|+|||+|++|+|+|++.. + .+.+..|+|||||+|+|+|+.||.|||+|||.+
T Consensus 378 fsgis~----~~l~Vs~v~hka~ieVnEeGteAaAaT~~~~---~--~~~~~~f~~drPFlF~I~d~~t~~iLF~G~v~~ 448 (453)
T 2wxy_C 378 LNNIGD----TNPRVGEVLNSILLELKAGEEEQPTTSVQQP---G--SPEALDVTLSSPFLFAIYEQDSGTLHFLGRVNN 448 (453)
T ss_dssp CTTTBS----SCCCBCCCEEEEEEEEEEEECCCC---------------CCEEEECCSCEEEEEEETTTCCEEEEEEESC
T ss_pred cccccC----CCceeeEEEEEEEEEecCCCccccccccccc---c--CCCCceEEeeCCEEEEEEECCCCcEEEEEEeCC
Confidence 999998 3499999999999999999999999997421 1 223578999999999999999999999999999
Q ss_pred CCC
Q 016311 388 PLA 390 (391)
Q Consensus 388 P~~ 390 (391)
|..
T Consensus 449 P~~ 451 (453)
T 2wxy_C 449 PQS 451 (453)
T ss_dssp CC-
T ss_pred CCC
Confidence 975
|
| >1imv_A PEDF, pigment epithelium-derived factor; serpin, angiogenesis, signaling protein; HET: NAG; 2.85A {Homo sapiens} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-81 Score=606.14 Aligned_cols=360 Identities=22% Similarity=0.360 Sum_probs=316.3
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh--hHHHHHHHHHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN--DQLNAFASELVAVV 80 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~--~~~~~~~~~l~~~l 80 (391)
+..+..++++||++||+++. ...+++|+||||+||+.+|+|+++||+|+|++||.++||++.. .+++..++.+...+
T Consensus 31 ~~~l~~~~~~Fa~~l~~~l~-~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~l~~~l 109 (398)
T 1imv_A 31 VNKLAAAVSNFGYDLYRVRS-SMSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDLISSPDIHGTYKELLDTV 109 (398)
T ss_dssp HHHHHHHHHHHHHHHHHHHH-HHCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTGGGCCCSCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHH-ccCCCCCEEEChHHHHHHHHHHHHhcccHHHHHHHHHhCCCCCCcHHHHHHHHHHHHHh
Confidence 45677899999999999998 4567889999999999999999999999999999999999743 47888899988877
Q ss_pred hhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCC
Q 016311 81 FADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVD 160 (391)
Q Consensus 81 ~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~ 160 (391)
.. .+..+.++|+||+++++.+.++|++.++++|+++++.+| .+ ++.+++.||+||+++|+|+|+++++ +++
T Consensus 110 ~~-----~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vd-~~-~~~a~~~IN~WV~~~T~gkI~~ll~--~l~ 180 (398)
T 1imv_A 110 TA-----PQKNLKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVLT-GN-PRLDLQEINNWVQAQMKGKLARSTK--EIP 180 (398)
T ss_dssp TS-----TTSCEEEEEEEEECTTCCCCHHHHHHHHHHHCCCCEECC-SC-HHHHHHHHHHHHHHHTTTCSCCCCS--CCC
T ss_pred hC-----CCCCeEEEEEEeecCCCcHHHHHHHHHHHHhCCcceecC-CC-HHHHHHHHHHHHHHhhcCchhhhhh--ccC
Confidence 42 234578999999999999999999999999999999999 64 7889999999999999999999995 699
Q ss_pred CcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccc-ccccccc--cCCeEEEEeecCCCCCCceEEEE
Q 016311 161 NSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSK-KNQFVSA--FDGFKVLGLPYKQGEDKRRFSMY 237 (391)
Q Consensus 161 ~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~-~~~~~~~--~~~~~vveLp~~~~~~~~~~sm~ 237 (391)
++|+++|+||+||+|.|+.+|++..|..++|+..+|++++||||++. +.++|+. ..++++|+|||+++ ++|+
T Consensus 181 ~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~f~~~~~~~l~~~vleLPY~~~-----~sm~ 255 (398)
T 1imv_A 181 DEISILLLGVAHFKGQWVTKFDSRKTSLEDFYLDEERTVRVPMMSDPKAVLRYGLDSDLSCKIAQLPLTGS-----MSII 255 (398)
T ss_dssp SSCSEEEEEEEEEECCEEECCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTT-----EEEE
T ss_pred CCceEEEEEhhhhhhhhcCcCChhhCeeeEEEeCCCEEEEEEEEEEecceeEEEEecCCCeEEEEEccCCC-----eEEE
Confidence 99999999999999999999999999999999999999999999999 8777665 44899999999874 9999
Q ss_pred EEec--CCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCC
Q 016311 238 FFLP--DAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSP 315 (391)
Q Consensus 238 iilP--~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~ 315 (391)
|||| ++ .+|.+++++|+ ...+.+|.+..+...++|.||||++++++||+++|++|||+++| . .||||+|++
T Consensus 256 iiLP~~~~-~~L~~le~~L~--~~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F-~-~Adfsgis~-- 328 (398)
T 1imv_A 256 FFLPLKVT-QNLTLIEESLT--SEFIHDIDRELKTVQAVLTVPKLKLSYEGEVTKSLQEMKLQSLF-D-SPDFSKITG-- 328 (398)
T ss_dssp EEEESSCC-SCCHHHHTTCC--HHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHTTTTTHHH-H-SCCCTTTCS--
T ss_pred EEEeCCCC-CCHHHHHHHhC--HHHHHHHHHhcceeEEEEEeeeEEEEeEEchhHhhhhcChhhcc-c-ccCCCCCcC--
Confidence 9999 66 68999999997 34566666555667789999999999999999999999999999 5 799999987
Q ss_pred CCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 316 VGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 316 ~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
.+++|++++|++.|+|||+|++|+|+|++.+... ..+.+|+|||||+|+|+|+.||.|||+|+|.+|..
T Consensus 329 --~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~----~~~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 397 (398)
T 1imv_A 329 --KPIKLTQVEHRAGFEWNEDGAGTTPSPGLQPAHL----TFPLDYHLNQPFIFVLRDTDTGALLFIGKILDPRG 397 (398)
T ss_dssp --SCCCEEEEEEEEEEEECSCEEECC--------CC----CCCCEEECCSCEEEEEEETTTCCEEEEEEESCTTC
T ss_pred --CCEEEEEEEEEEEEEecCCccccccccccccccC----CCCceEEccCCEEEEEEECCCCeEEEEEEeCCCCC
Confidence 5799999999999999999999999998544321 22468999999999999999999999999999975
|
| >1sng_A COG4826: serine protease inhibitor; serine protease inhibitor (serpin), native state., hydrolase inhibitor; 1.76A {Thermobifida fusca} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-80 Score=596.85 Aligned_cols=358 Identities=23% Similarity=0.431 Sum_probs=306.1
Q ss_pred CchhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHH
Q 016311 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVV 80 (391)
Q Consensus 1 ~~~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l 80 (391)
|+...+..++++||++||+++. ...+++|++|||+||+.+|+|+++||+|+|++||.++|| ++++..++.+ ..+
T Consensus 5 ~~~~~l~~~~~~Fa~~l~~~l~-~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~----~~~~~~~~~l-~~l 78 (370)
T 1sng_A 5 MSGGFLRDDHLEFALHLHRRLA-EAVPDGEVIWSPYSVAXALGVLAAGARATTRTELTTLLG----TDPAPLLAAL-DRA 78 (370)
T ss_dssp SSCCCCCHHHHHHHHHHHHHHH-HTSTTCCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHT----SCHHHHHHHH-HHT
T ss_pred ccHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEEccHHHHHHHHHHHhhccchHHHHHHHHHH----HHHHHHHHHH-HHH
Confidence 4556677899999999999998 456789999999999999999999999999999999999 4677788888 555
Q ss_pred hhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCC
Q 016311 81 FADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVD 160 (391)
Q Consensus 81 ~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~ 160 (391)
. ..+..++++|+||+++++.+.++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|++++++++++
T Consensus 79 ~-----~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~g~I~~l~~~~~l~ 153 (370)
T 1sng_A 79 V-----TDSPDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRTNPEGVRATVNADIADATRGMIRELLPQGAVT 153 (370)
T ss_dssp T-----TTCTTEEEEEEEEEETTSCCCHHHHHHHHTSTTEEEEEECTTTCHHHHHHHHHHHHHHHTTTSSCCSSCTTSCC
T ss_pred h-----CCCceEEEeeeeeeeCCCcccHHHHHHHHhhhCCeEEEecCcCCHHHHHHHHHHHHHHHhcCchhhccCccccC
Confidence 3 34568999999999999999999999999999999999999866889999999999999999999999988999
Q ss_pred CcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC--CeEEEEeecCCCCCCceEEEEE
Q 016311 161 NSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGEDKRRFSMYF 238 (391)
Q Consensus 161 ~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLp~~~~~~~~~~sm~i 238 (391)
++|.++|+||+||+|.|+.+|++..|..++|+ .+|++++||||++.+.++|++.+ ++++|+| ++ ++||+|
T Consensus 154 ~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~-~~~~~~~V~mM~~~~~~~y~~~~~~~~~vleL---~~----~~sm~i 225 (370)
T 1sng_A 154 PDLRAILTNALWAKARWTTPFEAHLTRAGTFR-TPRGPKRVPFMHRTKTMPYATARGWRMVTLHA---HD----ELAVDV 225 (370)
T ss_dssp TTCCEEEEEEEEEECCBSSCCCGGGCEEEEEE-ETTEEEEEEEEEEEEEEEEEEETTEEEEEEEB---ST----TCEEEE
T ss_pred CcccEEEEEEEEEccccccCCCcccCeeeeEe-cCCeEEEeEEEEEeeeeeeEEeCCCCEEEEEE---CC----CEEEEE
Confidence 99999999999999999999999999999999 99999999999999888887766 5678999 44 699999
Q ss_pred EecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCC
Q 016311 239 FLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGK 318 (391)
Q Consensus 239 ilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~ 318 (391)
|||+ .+|.++++ + ...+.+|....+...++|.||||++++++||++.|++||++++|+. .|||++|++ ..
T Consensus 226 iLP~--~~L~~l~~--~--~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~---~~ 295 (370)
T 1sng_A 226 LLPP--GTNAAAVP--T--APLLTALHRRSASTSVELALPRFELTQPHQLVEVLAEAGVRTLFTA-SADLSGIST---VP 295 (370)
T ss_dssp EECC--GGGTTCCC--C--HHHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGST-TCCCTTTCS---SC
T ss_pred EecC--CCHHHHhh--C--HHHHHHHHHhCcceeEEEEcceEEEecccchHHHHHhcCcchhcCC-ccCcccCCC---CC
Confidence 9999 67887766 2 4556666666666778999999999999999999999999999995 899999988 35
Q ss_pred CeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhcc-CCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 319 NLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIV-LSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 319 ~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~-~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
++|++++|++.|+|||+|++|+|+|++.+..++.+ .+.+.+|+|||||+|+|+|+ |.|||+|||.+|.+
T Consensus 296 -l~vs~v~hka~ieV~E~GteAaAaT~~~~~~~~~~~~~~~~~f~~drPFlf~I~~~--~~iLF~G~v~~P~~ 365 (370)
T 1sng_A 296 -LYVDTVIHQARLRVDERGAEGAAATAAMMLLAGAMPPRRTIRFSVDRPFHIVVRRR--GAILFLGSIADPHD 365 (370)
T ss_dssp -CCCCEEEEEEEEEECSCC--------------------CCEEEECCSCEEEEEEET--TEEEEEEEESSCCC
T ss_pred -eEEEEEEEEEEEEEcCCCcccccccchhhccccccCCCCCCEEEeeCCEEEEEEEC--CEEEEEEEcCCCCC
Confidence 99999999999999999999999998655555543 12357899999999999998 89999999999975
|
| >2wxw_A Angiotensinogen, serpin A8; glycoprotein, hypertension, vasoconstrictor, renin, serpins, vasoactive, hormone; 3.30A {Homo sapiens} PDB: 2x0b_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-80 Score=605.44 Aligned_cols=363 Identities=15% Similarity=0.195 Sum_probs=312.4
Q ss_pred hhhhhhhhHHHHHHHHHhhhcCCCCCcE--EEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh----------hHHHH
Q 016311 4 RESISNQTDVALSLTKHVALTEAKDSNL--VFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN----------DQLNA 71 (391)
Q Consensus 4 ~~~~~~~~~fa~~L~~~l~~~~~~~~N~--v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~----------~~~~~ 71 (391)
..+..++++||++||+++. ...+++|+ ||||+||+.+|+|+++||+|+|++||.++||++.. .+++.
T Consensus 72 ~~l~~~~~~Fa~~L~k~l~-~~~~~~Nin~v~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~~~~~~~~~~~~~~~ 150 (453)
T 2wxw_A 72 AMVGMLANFLGFRIYGMHS-ELWGVVHGATVLSPTAVFGTLASLYLGALDHTADRLQAILGVPWKDKNCTSRLDAHKVLS 150 (453)
T ss_dssp HHHHHHHHHHHHHHGGGCS-CTTTSCSBSSEECHHHHHHHHHHHHHSCCTTHHHHHHHHHTCCCCTTCTTTSBCHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHh-hcCCCCCcCEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCCccccccccccHHHHHH
Confidence 3467789999999999997 44577899 99999999999999999999999999999999753 35777
Q ss_pred HHHHHHHHHhhCC--CCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCe-eEEecCCCChHHHHHHHHHHHHHHhCC
Q 016311 72 FASELVAVVFADG--SPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAA-SNQVDFQTKAAEVSREVNMWAEKETNG 148 (391)
Q Consensus 72 ~~~~l~~~l~~~~--~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~-~~~~df~~~~~~a~~~iN~wv~~~T~g 148 (391)
.++.+...+.... .+.....++++|+||+++++.+.++|++.++++|++. ++.+||.+ ++.+++.||+||+++|+|
T Consensus 151 ~~~~l~~~l~~~~~~~~~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~~vdF~~-~~~a~~~IN~WV~~~T~g 229 (453)
T 2wxw_A 151 ALQAVQGLLVAQGRADSQAQLLLSTVVGVFTAPGLHLKQPFVQGLALYTPVVLPRSLDFTE-LDVAAEKIDRFMQAVTGW 229 (453)
T ss_dssp HHHHHHHHHSCCTTTCSCCCEEEEEEEEEECCTTCCEEHHHHHHHHHHCSCEEECBCCTTS-HHHHHHHHHHHHHHHHCS
T ss_pred HHHHHHHHHhhcccccCCCccEEEEEEeEeEECCCccCHHHHHHHHHHhCccceeeeCCCC-HHHHHHHHHHHHHHHhcC
Confidence 7888887775311 1223457999999999999999999999999999995 99999964 788999999999999999
Q ss_pred cccccCCCCCCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC--CeEEEEeecC
Q 016311 149 LVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYK 226 (391)
Q Consensus 149 ~i~~~l~~~~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLp~~ 226 (391)
+|+++++ +++++|.++|+||+||+|.|+.+|++.. .++|+..+|++++||||++.+.++|+..+ ++++++|||+
T Consensus 230 kI~~ll~--~l~~~t~lvLvNaiyFKg~W~~~F~~~~--~~~F~~~~~~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~ 305 (453)
T 2wxw_A 230 KTGCSLM--GASVDSTLAFNTYVHFQGKMKGFSLLAE--PQEFWVDNSTSVSVPMLSGMGTFQHWSDIQDNFSVTQVPFT 305 (453)
T ss_dssp CCSCSST--TCCSSCCCEEEEEEEEEEEETTEEECSS--CCCBCSSSSCCBCCCCEEEEEEEEEECCTTTTEEEEECCBT
T ss_pred chhhhhc--CcCCCCeEEEEehhEEeccCCCCCCccc--CCCcEeCCCEEEEEEEEEEecccceEEecCCCeEEEEEecC
Confidence 9999996 5999999999999999999999999988 89999999999999999999877777644 8999999997
Q ss_pred CCCCCceEEEEEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCC
Q 016311 227 QGEDKRRFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGG 306 (391)
Q Consensus 227 ~~~~~~~~sm~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~a 306 (391)
+ ++||+||||+++.+|.+++++|+. ..+..|.+..+...++|.||||++++++||+++|++|||+++|+. .|
T Consensus 306 ~-----~~sm~iiLP~~~~~L~~le~~L~~--~~l~~~~~~l~~~~V~v~LPKFkie~~~dL~~~L~~lGi~~~F~~-~A 377 (453)
T 2wxw_A 306 E-----SACLLLIQPHYASDLDKVEGLTFQ--QNSLNWMKKLSPRTIHLTMPQLVLQGSYDLQDLLAQAELPAILHT-EL 377 (453)
T ss_dssp T-----TEEEEEEEESSCSCHHHHHHTTSC--TTHHHHCCCCCEEEEEEEECCCEEEEEEEHHHHSCTTSCHHHHHS-SS
T ss_pred C-----cEEEEEEeCCCCCCHHHHHHHhCH--HHHHHHHHhcccccceEecceEEecccccHHHHHHhcCchhhcCC-CC
Confidence 5 499999999999899999999984 346667766667788999999999999999999999999999985 89
Q ss_pred CCcCCCCCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEec
Q 016311 307 GLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVL 386 (391)
Q Consensus 307 dfs~is~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~ 386 (391)
|||+|++ .+++|++++|++.|+|||+|++|+|+|... . .+.+.+|++||||+|+|+|+.||.|||+|||.
T Consensus 378 dfsgis~----~~l~Vs~v~hka~ieVnEeGteAaAat~~~----~--~~~~~~f~~drPFlF~I~~~~t~~iLF~G~v~ 447 (453)
T 2wxw_A 378 NLQKLSN----DRIRVGEVLNSIFFELEADEREPTESTQQL----N--KPEVLEVTLNRPFLFAVYDQSATALHFLGRVA 447 (453)
T ss_dssp CCCSSCS----SCCCCSCCEEEEEEEEEECC------------------CCCEEEECCSCEEEEEEETTTTEECCEEEES
T ss_pred CCCcccC----CCceEeEEEEEEEEEecCCCcccccccccc----c--CCCCCeEEEeCCEEEEEEECCCCcEEEEEEeC
Confidence 9999988 349999999999999999999999888631 1 12357899999999999999999999999999
Q ss_pred CCCC
Q 016311 387 NPLA 390 (391)
Q Consensus 387 ~P~~ 390 (391)
+|..
T Consensus 448 ~P~~ 451 (453)
T 2wxw_A 448 NPLS 451 (453)
T ss_dssp CCC-
T ss_pred CCCC
Confidence 9975
|
| >2r9y_A Alpha-2-antiplasmin; inhibitory serpin, plasmin inhibitor, AC phase, glycoprotein, protease inhibitor, secreted, serine P inhibitor, sulfation; 2.65A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-78 Score=590.19 Aligned_cols=357 Identities=26% Similarity=0.409 Sum_probs=307.2
Q ss_pred chhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHHh
Q 016311 2 DVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVF 81 (391)
Q Consensus 2 ~~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l~ 81 (391)
++..+..++++||++||+++. ...+++|+||||+||+.+|+|+++||+|+|++||.++||++...+++..++.+...+
T Consensus 17 ~~~~l~~~~~~Fa~~L~k~l~-~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~eL~~~L~~~~~~~~~~~~~~l~~~~- 94 (430)
T 2r9y_A 17 ETRRLAQAMMAFTTDLFSLVA-QTSTSSNLVLSPLSVALALSHLALGAQNQTLHSLHRVLHMNTGSCLPHLLSHFYQNL- 94 (430)
T ss_dssp HHHHHHHHHHHHHHHHHHHHH-HHCCSSSEEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTCCTTSCHHHHHHHHHHTS-
T ss_pred HHHHHHHHHHHHHHHHHHHHH-hcCCCCCEEECHHHHHHHHHHHHhhcCcHHHHHHHHHhCCCcHHHHHHHHHHHHhhc-
Confidence 356677899999999999997 456789999999999999999999999999999999999986656666666665332
Q ss_pred hCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCC
Q 016311 82 ADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDN 161 (391)
Q Consensus 82 ~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~ 161 (391)
.+..++++|+||+++++.+.++|++.++++|++++..+||. ++.+++.||+||+++|+|+|+++++ ++++
T Consensus 95 ------~~~~L~~An~l~~~~~~~l~~~F~~~~~~~y~a~~~~~d~~--~~~a~~~IN~WV~~~T~gkI~~ll~--~l~~ 164 (430)
T 2r9y_A 95 ------GPGTIRLAARIYLQKGFPIKDDFLEQSERLFGAKPVKLTGK--QEEDLANINQWVKEATEGKIEDFLS--ELPD 164 (430)
T ss_dssp ------CSSSEEEEEEEEECTTCCCCHHHHHHHHHHHSSCCEECCSC--HHHHHHHHHHHHHHHTTTSCCCCCC--CCCS
T ss_pred ------cCceEEeeehhhhhCCCcccHHHHHHHHHHhCCceeecCCC--cHHHHHHHHHHHHHhcCCCccchhh--ccCc
Confidence 34679999999999999999999999999999999988864 5788999999999999999999995 6999
Q ss_pred cCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccc-cccc--cccCCeEEEEeecCCCCCCceEEEEE
Q 016311 162 STRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKK-NQFV--SAFDGFKVLGLPYKQGEDKRRFSMYF 238 (391)
Q Consensus 162 ~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~-~~~~--~~~~~~~vveLp~~~~~~~~~~sm~i 238 (391)
+|+++|+||+||+|.|+.+|++..|..++|+..+|+.++||||++.+ .++| .+..++++|+|||++ ++||+|
T Consensus 165 ~T~lvLvNAiyFKg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~~~~~~~~l~~~vleLPY~~-----~~SM~i 239 (430)
T 2r9y_A 165 STVLLLLNAIHFHGFWRTKFDPSLTQKDFFHLDERFTVSVDMMHAVSYPLRWFLLEQPEIQVAHFPFKN-----NMSFVV 239 (430)
T ss_dssp SCSEEEEEEEEEECCEEECCCGGGCEEEEEESSSSEEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSS-----SEEEEE
T ss_pred ccceeEeeeeEEecccCCCCCCCCcccceEEecCCeEEEEEeeeecccceeEEEecCCcEEEEEeecCC-----CEEEEE
Confidence 99999999999999999999999999999999999999999999875 3444 346699999999986 499999
Q ss_pred EecCCC-CChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCC
Q 016311 239 FLPDAK-DGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVG 317 (391)
Q Consensus 239 ilP~~~-~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~ 317 (391)
|||++. .+|.+++++|+ ...+..+ ..+...++|.||||++++++||+++|++|||+++|+. ||||+|++
T Consensus 240 iLP~~~~~~L~~le~~L~--~~~l~~~--~~~~~~v~v~LPKFkie~~~dL~~~L~~lGi~~~F~~--Adfsgis~---- 309 (430)
T 2r9y_A 240 VMPTYFEWNVSEVLANLT--WDTLYHP--SLQERPTKVWLPKLHLQQQLDLVATLSQLGLQELFQG--PDLRGISE---- 309 (430)
T ss_dssp EEESSSCCCHHHHHTTCC--HHHHSCC--CSCCEEEEEEEECEEEEEEEECHHHHHHHTTGGGGTC--CCCTTTCS----
T ss_pred EecCCCCCCHHHHHHhcC--HHHHHHh--cccCceEEEEeccEEEEeeecHHHHHHhcCccccccc--ccccccCC----
Confidence 999885 58999999997 3344443 2234567999999999999999999999999999974 99999987
Q ss_pred CCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 318 KNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 318 ~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
.+++|++++|++.|+|||+|++|+|+|++.+. ++. ...|+|||||+|+|+|+.||.|||+|+|.+|..
T Consensus 310 ~~l~Vs~v~Hka~ieVnEeGteAAAaT~~~~~-~~s----~~~f~adrPFlF~I~d~~t~~iLF~G~v~~P~~ 377 (430)
T 2r9y_A 310 QNLVVSSVQHQSTMELSEAGVEAAAATSVAMN-RMS----LSSFTVNRPFLFFIMEDTIGVPLFVGSVRNPNP 377 (430)
T ss_dssp SCCCEEEEEEEEEEEECSCEEECC----------CC----CEEEECCSCEEEEEEETTTCCEEEEEEESCSCT
T ss_pred CCeEeeccceEEEEEecCCCcccccccccccc-ccC----CceEEecCCEEEEEEECCCCcEEEEEEecCCCc
Confidence 47999999999999999999999999985443 221 247999999999999999999999999999974
|
| >2oay_A C1-inhibitor, plasma protease C1 inhibitor, C1 INH, C1INH; latent serpin, RCL insertion, immune system,hydrolase inhibi; HET: NAG; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-77 Score=575.26 Aligned_cols=352 Identities=24% Similarity=0.388 Sum_probs=298.5
Q ss_pred hhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh-hHHHHHHHHHHHHHhh
Q 016311 4 RESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN-DQLNAFASELVAVVFA 82 (391)
Q Consensus 4 ~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~-~~~~~~~~~l~~~l~~ 82 (391)
..+..++++||++||+++.....+++|++|||+||+.+|+|+++||+|+|++||.++||++.. .+++..++.+.
T Consensus 30 ~~l~~~~~~Fa~~L~~~l~~~~~~~~Niv~SP~SI~~aLaml~~GA~g~T~~el~~~L~~~~~~~~i~~~~~~l~----- 104 (390)
T 2oay_A 30 AVLGDALVDFSLKLYHAFSAMKKVETNMAFSPFSIASLLTQVLLGAGENTKTNLESILSYPKDFTCVHQALKGFT----- 104 (390)
T ss_dssp HHHHHHHHHHHHHHHHHHCC----CCCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHHTCCTTCTTHHHHHHTTC-----
T ss_pred HHHHHHHHHHHHHHHHHHHhccCCCCCEEECHHHHHHHHHHHHhhcccHHHHHHHHHhCCCCcHHHHHHHHHHHh-----
Confidence 456778999999999999632357899999999999999999999999999999999999764 45655554321
Q ss_pred CCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCc
Q 016311 83 DGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNS 162 (391)
Q Consensus 83 ~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~ 162 (391)
...+.++|+||+++++.+.++|++.++++|+++++.+|+. ++.+++.||+||+++|+|+|+++++ +++++
T Consensus 105 ------~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~~~~~--~~~a~~~IN~WV~~~T~gkI~~ll~--~l~~~ 174 (390)
T 2oay_A 105 ------TKGVTSVSQIFHSPDLAIRDTFVNASRTLYSSSPRVLSNN--SDANLELINTWVAKNTNNKISRLLD--SLPSD 174 (390)
T ss_dssp ------CSSEEEEEEEEECTTSCCCHHHHHHHHHHHSCCCEECCSC--HHHHHHHHHHHHHHTTTTSCSCSCS--CCCTT
T ss_pred ------hCchhhhhhHhHhcCCcccHHHHHHHHHHhCceeeeccCC--hHHHHHHHHHHHHHhhCCccccccc--ccCcc
Confidence 1248999999999999999999999999999999999853 6789999999999999999999995 79999
Q ss_pred CeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccc-cccccc--cCCeEEEEeecCCCCCCceEEEEEE
Q 016311 163 TRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKK-NQFVSA--FDGFKVLGLPYKQGEDKRRFSMYFF 239 (391)
Q Consensus 163 t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~-~~~~~~--~~~~~vveLp~~~~~~~~~~sm~ii 239 (391)
|+++|+||+||+|.|+.+|++..|..++|+.. +++++||||++.. .+.|.+ ..++++++|||.+ ++||+||
T Consensus 175 t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~-~~~v~V~mM~~~~~~~~~~~~~~l~~~vleLpy~~-----~~sm~ii 248 (390)
T 2oay_A 175 TRLVLLNAIYLSAKWKTTFDPKKTRMEPFHFK-NSVIKVPMMNSKKYPVAHFIDQTLKAKVGQLQLSH-----NLSLVIL 248 (390)
T ss_dssp CCEEEEEEEEEEEEBSSCCCTTSCEEEEECC---CCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBST-----TEEEEEE
T ss_pred cceEEEeeEEEecccCCCCCccccEEeeeEEC-CceEEEEEEEeCceeEEEEecccCceEEEEEecCC-----cEEEEEE
Confidence 99999999999999999999999999999985 5678999999764 233334 3479999999965 5999999
Q ss_pred ecCCC-CChHHHHHHhcCchHHHhhcC---CCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCC
Q 016311 240 LPDAK-DGLPTLLEKMGSESKFLDHHL---PSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSP 315 (391)
Q Consensus 240 lP~~~-~~l~~l~~~L~~~~~~l~~~~---~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~ 315 (391)
||++. .+|.+++++|+. ..+..|+ ...+...++|.||||++++++||+++|++||+.+ |+. .||||||++
T Consensus 249 LP~~~~~~L~~le~~L~~--~~l~~~~~~l~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~-f~~-~Adfsgis~-- 322 (390)
T 2oay_A 249 VPQNLKHRLEDMEQALSP--SVFKAIMEKLEMSKFQPTLLTLPRIKVTTSQDMLSIMEKLEFFD-FSY-DLNLCGLTE-- 322 (390)
T ss_dssp EESSTTSCHHHHHHHCCH--HHHHHHHHHHHTCCEEEEEEEEECCEEEEEEEHHHHHGGGSSSC-GGG-GCCCTTTCS--
T ss_pred eCCccCCCHHHHHHHhCH--HHHHHHHHhCcccccceeEEecceEEEeccccHHHHHhhcCccc-ccc-cCCccccCC--
Confidence 99985 589999999973 3343332 2333345799999999999999999999999999 875 799999998
Q ss_pred CCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCC
Q 016311 316 VGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPL 389 (391)
Q Consensus 316 ~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~ 389 (391)
..+++|++++||+.|+|||+|++|+|+|++.+ .++ ...|++||||+|+|+|+.||.|||+|+|.+|.
T Consensus 323 -~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~-~~~-----~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~ 389 (390)
T 2oay_A 323 -DPDLQVSAMQHQTVLELTETGVEAAAASAISV-ART-----LLVFEVQQPFLFMLWDQQHKFPVFMGRVYDPR 389 (390)
T ss_dssp -CCCCCCCCEEEEEEEEECSSEEEEEEEEEESC-CCC-----EEECCCCSCEEEEEEETTTTEEEEEEEECCC-
T ss_pred -CCCeEEcchhhcceEEECCCCccccccccccc-cCC-----CCeEEecCCEEEEEEECCCCCEEEEEEecCCC
Confidence 46899999999999999999999999998533 221 35799999999999999999999999999996
|
| >1hle_A Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-74 Score=546.70 Aligned_cols=331 Identities=30% Similarity=0.453 Sum_probs=301.1
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHHhh
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFA 82 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l~~ 82 (391)
|.++..++++||++||+++. ...+++|+||||+||+.+|+|+++||+|+|++||.++||++..++++..++.+...+.+
T Consensus 2 ~~~l~~~~~~Fa~~l~~~l~-~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~l~~~l~~ 80 (345)
T 1hle_A 2 MEQLSTANTHFAVDLFRALN-ESDPTGNIFISPLSISSALAMIFLGTRGNTAAQVSKALYFDTVEDIHSRFQSLNADINK 80 (345)
T ss_dssp CHHHHHHHHHHHHHHHHHHH-HHCSSSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHHTGGGSTTHHHHHHHHHHHHTC
T ss_pred hHHHHHHHHHHHHHHHHHHh-hcCCCCCEEEchHHHHHHHHHHHHhccChHHHHHHHHhCCCCHHHHHHHHHHHHHHHhC
Confidence 34677899999999999998 44678999999999999999999999999999999999998666788899999888753
Q ss_pred CCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCc
Q 016311 83 DGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNS 162 (391)
Q Consensus 83 ~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~ 162 (391)
+..+..++++|+||+++++.+.++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|++++++++++++
T Consensus 81 ---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~~~ 157 (345)
T 1hle_A 81 ---PGAPYILKLANRLYGEKTYNFLADFLASTQKMYGAELASVDFQQAPEDARKEINEWVKGQTEGKIPELLVKGMVDNM 157 (345)
T ss_dssp ---SSCSSEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTTCHHHHHHHHHHHHHHHTTTSSSCSSCTTSSCTT
T ss_pred ---CCCCcEEEEEEEeeecCCCchhHHHHHHHHHHhCCeEEEecCCCCHHHHHHHHHHHHHHHhcCchhhhcCCcCCCCc
Confidence 33567899999999999999999999999999999999999976688999999999999999999999998899999
Q ss_pred CeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccc--cCCeEEEEeecCCCCCCceEEEEEEe
Q 016311 163 TRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSA--FDGFKVLGLPYKQGEDKRRFSMYFFL 240 (391)
Q Consensus 163 t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLp~~~~~~~~~~sm~iil 240 (391)
|+++|+||+||+|.|+.||++..|.+++|+..+|+.++||||++.+.++|.. ..++++|+|||+++ ++||+|||
T Consensus 158 t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~vleLPy~~~----~~sm~iiL 233 (345)
T 1hle_A 158 TKLVLVNAIYFKGNWQQKFMKEATRDAPFRLNKKDTKTVKMMYQKKKFPYNYIEDLKCRVLELPYQGK----ELSMIILL 233 (345)
T ss_dssp EEEEEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEGGGTEEEEEEEBTTS----SEEEEEEE
T ss_pred ceEEEEEeeEecccccCCCCcccCcceeEEeCCCeEEEEEEEEeeceEeeEEeCCCCeEEEEecCCCC----eEEEEEEe
Confidence 9999999999999999999999999999999999999999999988766554 55899999999987 79999999
Q ss_pred cCCC----CChHHHHHHhcCchHHHhhcCC--CCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCC
Q 016311 241 PDAK----DGLPTLLEKMGSESKFLDHHLP--SQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDS 314 (391)
Q Consensus 241 P~~~----~~l~~l~~~L~~~~~~l~~~~~--~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~ 314 (391)
|++. .+|.+++++|+ ...+..|.. ..+...++|.||||++++++||+++|++||++++|++..|||++|++
T Consensus 234 P~~~~~~~~~l~~l~~~L~--~~~l~~~~~~~~~~~~~v~v~lPKF~i~~~~~L~~~L~~lGi~~~F~~~~Adfs~is~- 310 (345)
T 1hle_A 234 PDDIEDESTGLEKIEKQLT--LDKLREWTKPENLYLAEVNVHLPRFKLEESYDLTSHLARLGVQDLFNRGKADLSGMSG- 310 (345)
T ss_dssp ESSCCSSSSSCHHHHHTCC--HHHHHHHHCGGGCEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGCTTTCCCHHHHS-
T ss_pred cCCCcccCcCHHHHHHHhC--HHHHHHHhhhhccccceEEEEcceEeeecccchHHHHHhcChhhcCCCCCCCcccCCC-
Confidence 9998 89999999997 345666655 34556789999999999999999999999999999965799999987
Q ss_pred CCCCCeeEeeeeeeeEEEEcCCCchhhhhhhh
Q 016311 315 PVGKNLYVSSIFQKSFIEVNEEGTEAAAASAA 346 (391)
Q Consensus 315 ~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~ 346 (391)
..+++|++++|++.|+|||+|++|+|+|++
T Consensus 311 --~~~l~vs~v~hka~ieV~E~GteAaAaT~~ 340 (345)
T 1hle_A 311 --ARDLFVSKIIHKSFVDLNEEGTEAAAATAG 340 (345)
T ss_dssp --SSCEEEEEEEEEEEEEECSSEEEEEEEEEE
T ss_pred --CCCeEEeeEEEEEEEEECCCCeeeccccce
Confidence 468999999999999999999999999974
|
| >3f02_A Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 3fgq_A 1jjo_C 1jjo_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-74 Score=551.90 Aligned_cols=330 Identities=28% Similarity=0.501 Sum_probs=289.0
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh--hHHHHHHHHHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN--DQLNAFASELVAVV 80 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~--~~~~~~~~~l~~~l 80 (391)
+..+.+++++||++||+++. ...+++|+||||+||+.+|+|+++||+|+|++||.++||++.. .+++..++.+...+
T Consensus 16 ~~~l~~~~~~Fa~~L~~~l~-~~~~~~Niv~SP~Si~~aLaml~~GA~G~T~~ql~~~L~~~~~~~~~~~~~~~~l~~~l 94 (359)
T 3f02_A 16 ATFPEEAIADLSVNMYNRLR-ATGEDENILFSPLSIALAMGMMELGAQGSTQKEIRHSMGYDSLKNGEEFSFLKEFSNMV 94 (359)
T ss_dssp -----CHHHHHHHHHHHHHH-HHSTTCCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTCCC----CHHHHHHCC----
T ss_pred cHHHHHHHHHHHHHHHHHHh-hcCCCCCEEEcHHHHHHHHHHHHhhcCChHHHHHHHHhCCCCCCHHHHHHHHHHHHHHH
Confidence 45677899999999999998 4567899999999999999999999999999999999999864 46778888877666
Q ss_pred hhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCC
Q 016311 81 FADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVD 160 (391)
Q Consensus 81 ~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~ 160 (391)
.+ +..+..+.++|+||+++++++.++|++.++++|+++++.+||. +++.+++.||+||+++|+|+|++++++++++
T Consensus 95 ~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~-~~~~a~~~IN~WV~~~T~gkI~~ll~~~~l~ 170 (359)
T 3f02_A 95 TA---KESQYVMKIANSLFVQNGFHVNEEFLQMMKKYFNAAVNHVDFS-QNVAVANYINKWVENNTNNLVKDLVSPRDFD 170 (359)
T ss_dssp ---------CEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTT-SHHHHHHHHHHHHHHTTTTCSCCSSCGGGCS
T ss_pred hc---CCCCcEEEEEEEEEEeCCCccchHHHHHHHHHhcCceEEcCCC-CHHHHHHHHHHHHHhhhCCcccccCCcccCC
Confidence 42 2456789999999999999999999999999999999999999 4789999999999999999999999988999
Q ss_pred CcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC--Ce------EEEEeecCCCCCCc
Q 016311 161 NSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--GF------KVLGLPYKQGEDKR 232 (391)
Q Consensus 161 ~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~------~vveLp~~~~~~~~ 232 (391)
++|+++|+||+||+|.|+.||++..|..++|+..+|++++||||++.+.++|++.+ ++ ++|+|||+++
T Consensus 171 ~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~~~y~~~~~l~a~~~~~~~vleLPY~~~---- 246 (359)
T 3f02_A 171 AATYLALINAVYFKGNWKSQFRPENTRTFSFTKDDESEVQIPMMYQQGEFYYGEFSDGSNEAGGIYQVLEIPYEGD---- 246 (359)
T ss_dssp TTEEEEEEEEEEEEEEBSSCCCGGGCEEEEEECTTSCEEEEEEEEEEEEEEEEEEECCC---CCEEEEEEEEBTTS----
T ss_pred CCceEEEEeHHHHhHHhhccCCcccceeeeeEecCCcEEEccceEeeceEeEEEccCcCcccccccEEEEeEcCCC----
Confidence 99999999999999999999999999999999999999999999999888776643 44 9999999987
Q ss_pred eEEEEEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCC
Q 016311 233 RFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMV 312 (391)
Q Consensus 233 ~~sm~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is 312 (391)
++||+||||+++.+|.+++++|+ ...+..|....+...++|.||||++++++||+++|++||++++|+. .||||+|+
T Consensus 247 ~~sm~iiLP~~~~~L~~l~~~L~--~~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfsgis 323 (359)
T 3f02_A 247 EISMMLVLSRQEVPLATLEPLVK--AQLVEEWANSVKKQKVEVYLPRFTVEQEIDLKDVLKALGITEIFIK-DANLTGLS 323 (359)
T ss_dssp SEEEEEEECCTTSCHHHHGGGCC--HHHHHHHHHHCEEEEEEEEEECEEEEEEEEHHHHHHHHTCCGGGST-TCCCTTTC
T ss_pred cEEEEEEEcCCCCCHHHHHHHhC--HHHHHHHHHhCcceEEEEEeeeeEeEeeechHHHHHHcCchhhcCC-CCCccccC
Confidence 79999999999999999999997 3345556555566778999999999999999999999999999996 89999998
Q ss_pred CCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhh
Q 016311 313 DSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAAT 347 (391)
Q Consensus 313 ~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~ 347 (391)
+ ..+++|++++|++.|||||+|++|+|+|++.
T Consensus 324 ~---~~~l~vs~v~hka~ieVnE~GteAaAaT~~~ 355 (359)
T 3f02_A 324 D---NKEIFLSKAIHKSFLEVNEEGSEAAAVSGMI 355 (359)
T ss_dssp S---CTTEEEEEEEEEEEEEECSSEEEEEEEEEEE
T ss_pred C---CCCeeEEEEEEEEEEEECCCCchhhhhheee
Confidence 7 4789999999999999999999999999853
|
| >3ndd_A Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 3ndf_A 7api_A* 8api_A* 9api_A* 1d5s_A 1ezx_A 3t1p_A 2d26_A 1qmb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-73 Score=539.75 Aligned_cols=326 Identities=26% Similarity=0.450 Sum_probs=295.8
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC----hhHHHHHHHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS----NDQLNAFASELVA 78 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~----~~~~~~~~~~l~~ 78 (391)
...+..++++||++||+++. ...+++|++|||+||+.+|+|+++||+|+|++||.++||++. .++++..++.+..
T Consensus 8 ~~~l~~~~~~Fa~~l~~~l~-~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~~l~~ 86 (343)
T 3ndd_A 8 FNKITPNLAEFAFSLYRQLA-HQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLR 86 (343)
T ss_dssp -CTTHHHHHHHHHHHHHHHH-HHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHH
T ss_pred HHHHHHHHhHHHHHHHHHHh-hcCCCCCEEEChHHHHHHHHHHHhhccchHHHHHHHHhCCCCCCCCHHHHHHHHHHHHH
Confidence 45677899999999999998 456789999999999999999999999999999999999974 2578889999988
Q ss_pred HHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCC
Q 016311 79 VVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGS 158 (391)
Q Consensus 79 ~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~ 158 (391)
.+.+ +..+..+.++|+||+++++.+.++|++.++++|+++++.+||.+ |+.+++.||+||+++|+|+|+++++ +
T Consensus 87 ~l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~wV~~~T~g~I~~ll~--~ 160 (343)
T 3ndd_A 87 TLNQ---PDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGD-TEEAKKQINDYVEKGTQGKIVDLVK--E 160 (343)
T ss_dssp HHTS---CCTTCEEEEEEEEEEETTCCCCHHHHHHHHHHHCEEEEEECTTS-HHHHHHHHHHHHHHHTTTSSCSCCS--C
T ss_pred HHhC---CCCCceEEeehhhHhhCCCChhHHHHHHHHHHhccccEeecCCC-HHHHHHHHHHHHHHhhcCchhhhhh--c
Confidence 8753 34567899999999999999999999999999999999999995 7899999999999999999999997 7
Q ss_pred CCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc--CCeEEEEeecCCCCCCceEEE
Q 016311 159 VDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF--DGFKVLGLPYKQGEDKRRFSM 236 (391)
Q Consensus 159 ~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLp~~~~~~~~~~sm 236 (391)
++++|+++|+||+||+|.|+.+|++..|..++|+..+|+.++||||++.+.++|... .++++|+|||+++ ++|
T Consensus 161 l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~~~~~~~~~l~~~vleLPY~~~-----~sm 235 (343)
T 3ndd_A 161 LDRDTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHAKKLSSWVLLMKYLGN-----ATA 235 (343)
T ss_dssp CCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEEGGGTEEEEEEEBSSS-----EEE
T ss_pred CCCCceEEEEeHHHHhHHHhcccCCccccCcceecCCCcEEEEEEEEEEeeEEEEEeccCCeEEEEEecCCC-----eEE
Confidence 999999999999999999999999999999999999999999999999987776554 4899999999974 899
Q ss_pred EEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCC
Q 016311 237 YFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPV 316 (391)
Q Consensus 237 ~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~ 316 (391)
+||||++ .+|.+++++|+ ...+.+|.+..+...++|.||||++++++||+++|++||++++|++ .||||+|++
T Consensus 236 ~iiLP~~-~~l~~le~~L~--~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfsgis~--- 308 (343)
T 3ndd_A 236 IFFLPDE-GKLQHLENELT--HDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSN-GADLSGVTE--- 308 (343)
T ss_dssp EEEEECT-TCHHHHHHHCC--HHHHHHHHHCCCCEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCTTTCS---
T ss_pred EEEEeCc-cCHHHHHHHhC--HHHHHHHHHhCCcceEEEecccEEEeeccchHHHHHhCCcHhhcCC-CCCCcccCC---
Confidence 9999998 58999999997 3455666555556678999999999999999999999999999998 899999998
Q ss_pred CCCeeEeeeeeeeEEEEcCCCchhhhhhhhh
Q 016311 317 GKNLYVSSIFQKSFIEVNEEGTEAAAASAAT 347 (391)
Q Consensus 317 ~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~ 347 (391)
..+++|++++|++.|||||+|++|+|+|++.
T Consensus 309 ~~~l~vs~v~hka~ieV~E~GteAaAaT~~~ 339 (343)
T 3ndd_A 309 EAPLKLSKAVHKAVLTIDEKGTEAAPDDDDE 339 (343)
T ss_dssp SSCEEEEEEEEEEEEEECSSEEEEEEEEEEE
T ss_pred CCCeeEEEEEEEEEEEECCCCcceeccccee
Confidence 4789999999999999999999999999753
|
| >2h4p_A MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-73 Score=548.42 Aligned_cols=330 Identities=29% Similarity=0.488 Sum_probs=298.8
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh----------------
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN---------------- 66 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~---------------- 66 (391)
+..+..++++||++||+++. ...+++|+||||+||+.+|+|+++||+|+|++||.++||++..
T Consensus 26 ~~~l~~~~~~Fa~~L~k~l~-~~~~~~Niv~SP~SI~~aLaml~~GA~G~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~ 104 (394)
T 2h4p_A 26 MEQVSASIGNFTVDLFNKLN-ETNRDKNIFFSPWSISSALALTYLAAKGSTAREMAEVLHFTEAVRAESSSVARPSRGRP 104 (394)
T ss_dssp HHHHHHHHHHHHHHHHHHHH-HHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTSSCC----------------
T ss_pred HHHHHHHHHHHHHHHHHHHh-ccCCCCCEEEChHHHHHHHHHHHHhccChHHHHHHHHhCCCcccccccccccccccccc
Confidence 45677899999999999998 4467899999999999999999999999999999999999752
Q ss_pred ------------hHHHHHHHHHHHHHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHH
Q 016311 67 ------------DQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEV 134 (391)
Q Consensus 67 ------------~~~~~~~~~l~~~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a 134 (391)
++++..++.+...+.+ ...+..++++|+||+++++.+.++|++.++++|+++++.+||.++++.+
T Consensus 105 ~~~~~~~~~~~~~~i~~~~~~l~~~l~~---~~~~~~l~~an~l~~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~~~~~a 181 (394)
T 2h4p_A 105 KRRRMDPEHEQAENIHSGFKELLTAFNK---PRNNYSLRSANRIYVEKTYALLPTYLQLSKKYYKAEPQKVNFKTAPEQS 181 (394)
T ss_dssp --------CCCCHHHHHHHHHHHHHHTC---CCSSSEEEEEEEEEEETTSCCCHHHHHHHHHHHCCEEEEECTTTCHHHH
T ss_pred cccccccccccHHHHHHHHHHHHHHhhc---CCCCcEEEEEEEEEEeCCCCccHHHHHHHHHHhCCeeEEecCcCCHHHH
Confidence 5778888888887753 3356789999999999999999999999999999999999997668899
Q ss_pred HHHHHHHHHHHhCCcccccCCCCCCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccc
Q 016311 135 SREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSA 214 (391)
Q Consensus 135 ~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~ 214 (391)
++.||+||+++|+|+|++++++++++++|+++|+||+||+|.|+.+|++..|.+++|+..+|+.++||||++.+.++|..
T Consensus 182 ~~~IN~WV~~~T~gkI~~ll~~~~l~~~T~lvLvNAiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~f~~~~ 261 (394)
T 2h4p_A 182 RKEINTWVEKQTESKIKNLLSSDDVKATTRLILVNAIYFKAEWEVKFQAEKTSIQPFRLSKNKSKPVKMMYMRDTFPVLI 261 (394)
T ss_dssp HHHHHHHHHHHTTTCC-CCSCTTTSCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEE
T ss_pred HHHHHHHHHHhhCCchhhccCccccCCccceeeeeeeeEEceeCCCCCcccccceEEEecCCeEEECceEeccCceeeEE
Confidence 99999999999999999999988999999999999999999999999999999999999999999999999988766544
Q ss_pred --cCCeEEEEeecCCCCCCceEEEEEEecCCC----CChHHHHHHhcCchHHHhhcCC--CCceeeeeeeceeeeeeccC
Q 016311 215 --FDGFKVLGLPYKQGEDKRRFSMYFFLPDAK----DGLPTLLEKMGSESKFLDHHLP--SQRVEVGDFRIPRFKISFGI 286 (391)
Q Consensus 215 --~~~~~vveLp~~~~~~~~~~sm~iilP~~~----~~l~~l~~~L~~~~~~l~~~~~--~~~~~~v~l~lPkf~i~~~~ 286 (391)
..++++|+|||+++ ++||+||||++. .+|.+++++|+ ...+..|.. ..+...++|.||||++++++
T Consensus 262 ~~~l~~~vleLPY~~~----~~sM~iiLP~~~~~~~~~L~~le~~L~--~~~l~~~~~~~~~~~~~v~v~lPKFkie~~~ 335 (394)
T 2h4p_A 262 MEKMNFKMIELPYVKR----ELSMFILLPDDIKDGTTGLEQLERELT--YERLSEWADSKMMTETLVDLHLPKFSLEDRI 335 (394)
T ss_dssp ETTTTEEEEEEEBGGG----SEEEEEEEESSCCSSSSSCHHHHHSCC--HHHHHHHHTCTTCEEEEEEEEEECEEEEEEE
T ss_pred eCCCCEEEEEeecCCC----cEEEEEEecCCCcccCccHHHHHHHhC--HHHHHHHhhhhccccceEEEecceEEEeeee
Confidence 56899999999987 799999999998 89999999997 345666655 35556789999999999999
Q ss_pred CcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhh
Q 016311 287 EVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAA 346 (391)
Q Consensus 287 dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~ 346 (391)
||+++|++|||+++|+. .|||++|++ ..+++|++++|++.|+|||+|++|+|+|++
T Consensus 336 dL~~~L~~lGi~~~F~~-~Adfsgis~---~~~l~vs~v~hka~ieVnE~GteAaAaT~~ 391 (394)
T 2h4p_A 336 DLRDTLRNMGMTTAFTT-NADFRGMTD---KKDLAISKVIHQSFVAVDEKGTEAAAATAV 391 (394)
T ss_dssp ECHHHHHHHTCCGGGST-TCCCTTSCS---SSCCCEEEEEEEEEEEECSSEEEEEEEEEE
T ss_pred chHHHHHhcCCccccCC-ccCcccccC---CCCeEEeeeEEEEEEEECCCCchhhcceee
Confidence 99999999999999995 899999997 468999999999999999999999999974
|
| >3dy0_A N-terminus plasma serine protease inhibitor; serpin, blood clotting, hydrolase inhibitor; HET: IDS SGN; 1.55A {Homo sapiens} PDB: 1lq8_A* 2hi9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-73 Score=535.90 Aligned_cols=321 Identities=26% Similarity=0.451 Sum_probs=289.2
Q ss_pred hhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh----hHHHHHHHHHHHHHhh
Q 016311 7 ISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN----DQLNAFASELVAVVFA 82 (391)
Q Consensus 7 ~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~----~~~~~~~~~l~~~l~~ 82 (391)
..++++||++||+++. ...+++|++|||+||+.+|+|+++||+|+|++||.++||++.. .+++..++.+...+.+
T Consensus 6 ~~~~~~Fa~~l~~~l~-~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~~~l~~~l~~ 84 (336)
T 3dy0_A 6 PSSRRDFTFDLYRALA-SAAPSQNIFFSPVSISMSLAMLSLGAGSSTKMQILEGLGLNLQKSSEKELHRGFQQLLQELNQ 84 (336)
T ss_dssp ----CCHHHHHHHHHH-HHSTTSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCSCHHHHHHHHHHHHHHHHHTTS
T ss_pred cchhhHHHHHHHHHHh-hhCCCCCEEEchHHHHHHHHHHHhHCcHHHHHHHHHHhCCCCCcCCHHHHHHHHHHHHHHHhC
Confidence 3578899999999998 4567899999999999999999999999999999999999863 4788889998887753
Q ss_pred CCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCc
Q 016311 83 DGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNS 162 (391)
Q Consensus 83 ~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~ 162 (391)
+..+..+.++|+||+++++++.++|++.++++|+++++.+||.+ |+.+++.||+||+++|+|+|+++++ +++++
T Consensus 85 ---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~wV~~~T~g~I~~l~~--~l~~~ 158 (336)
T 3dy0_A 85 ---PRDGFQLSLGNALFTDLVVDLQDTFVSAMKTLYLADTFPTNFRD-SAGAMKQINDYVAKQTKGKIVDLLK--NLDSN 158 (336)
T ss_dssp ---CCSSSEEEEEEEEEECTTCCBCHHHHHHHHHHHCCEEEECCTTS-HHHHHHHHHHHHHHHTTTSSCCCCC--SCCSC
T ss_pred ---CCCCcEEEEeehhhhCCCCCccHHHHHHHHHHhCCeeEEECCCC-hHHHHHHHHHHHHHhhcCcHhHhhc--CCCCC
Confidence 34567899999999999999999999999999999999999995 7899999999999999999999997 79999
Q ss_pred CeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc--CCeEEEEeecCCCCCCceEEEEEEe
Q 016311 163 TRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF--DGFKVLGLPYKQGEDKRRFSMYFFL 240 (391)
Q Consensus 163 t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLp~~~~~~~~~~sm~iil 240 (391)
|+++|+||+||+|.|+.||++..|..++|+..+|++++||||++.+.++|... .++++|+|||+++ ++|+|||
T Consensus 159 t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~v~V~mM~~~~~f~~~~~~~l~~~vleLPy~~~-----~sm~iiL 233 (336)
T 3dy0_A 159 AVVIMVNYIFFKAKWETSFNHKGTQEQDFYVTSETVVRVPMMSREDQYHYLLDRNLSCRVVGVPYQGN-----ATALFIL 233 (336)
T ss_dssp EEEEEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-----CEEEEEE
T ss_pred CeEEeEehheeeeeccCCCCcccccccceeccCCcEEEEeeEEEEeEEEEEEecCCCeEEEEeecCCC-----eEEEEEe
Confidence 99999999999999999999999999999999999999999999987776554 4899999999874 8999999
Q ss_pred cCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCe
Q 016311 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNL 320 (391)
Q Consensus 241 P~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l 320 (391)
|++ .+|.+++++|+ ...+.+|.+..+...++|.||||++++++||+++|++||++++|++ .||||+|++ ..++
T Consensus 234 P~~-~~l~~le~~L~--~~~l~~~~~~l~~~~v~v~lPKF~i~~~~~L~~~L~~lGi~~~F~~-~Adfsgis~---~~~l 306 (336)
T 3dy0_A 234 PSE-GKMQQVENGLS--EKTLRKWLKMFKKRQLELYLPKFSIEGSYQLEKVLPSLGISNVFTS-HADLSGISN---HSNI 306 (336)
T ss_dssp ECT-TCHHHHHHHCC--HHHHHHHHHHCEEEEEEEEEECEEEEEEEEGGGTGGGGTCCGGGST-TCCCTTTBC---STTC
T ss_pred cCC-CCHHHHHHHhC--HHHHHHHHHhCCcceEEEEcCcEEEEeccchHHHHHhCChhhhhCC-CCCcccccC---CCCc
Confidence 988 68999999997 3445555555556678999999999999999999999999999998 899999987 4789
Q ss_pred eEeeeeeeeEEEEcCCCchhhhhhhh
Q 016311 321 YVSSIFQKSFIEVNEEGTEAAAASAA 346 (391)
Q Consensus 321 ~v~~~~q~~~l~v~E~G~~a~a~t~~ 346 (391)
+|++++|++.|||||+|++|+|+|++
T Consensus 307 ~vs~v~hka~ieV~E~GteAaAaT~~ 332 (336)
T 3dy0_A 307 QVSEMVHKAVVEVDESGTRAAAATGT 332 (336)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEEEE
T ss_pred eeeeeEEEEEEEECCCcchhhhheee
Confidence 99999999999999999999999974
|
| >2xn6_A Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn7_A* 2xn5_A* 2riv_A 2xn3_A* 2riw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-72 Score=536.15 Aligned_cols=331 Identities=24% Similarity=0.361 Sum_probs=296.4
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh----hHHHHHHHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN----DQLNAFASELVA 78 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~----~~~~~~~~~l~~ 78 (391)
+..+..++++||++||+++. ...+++|+||||+||+.+|+|+++||+|+|++||.++||++.. ++++..++.+..
T Consensus 8 ~~~l~~~~~~Fa~~l~~~l~-~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~ 86 (350)
T 2xn6_A 8 LYKMSSINADFAFNLYRRFT-VETPDKNIFFSPVSISAALVMLSFGACCSTQTEIVETLGFNLTDTPMVEIQHGFQHLIC 86 (350)
T ss_dssp CHHHHHHHHHHHHHHHHHHH-HHSTTSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHH-hcCCCCCEEEchHHHHHHHHHHHhhccChHHHHHHHHhCCCccCCCHHHHHHHHHHHHH
Confidence 45677899999999999997 4567899999999999999999999999999999999999742 578889999988
Q ss_pred HHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCC
Q 016311 79 VVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGS 158 (391)
Q Consensus 79 ~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~ 158 (391)
.+.. ...+..++++|+||+++++.+.++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ +
T Consensus 87 ~l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~--~ 160 (350)
T 2xn6_A 87 SLNF---PKKELELQIGNALFIGKHLKPLAKFLNDVKTLYETEVFSTDFSN-ISAAKQEINSHVEMQTKGKVVGLIQ--D 160 (350)
T ss_dssp HHHS---CBTTEEEEEEEEEEEETTCCBCHHHHHHHHHHSCEEEEEECTTS-HHHHHHHHHHHHHHHTTTCSCCCCS--C
T ss_pred HhhC---CCCCcEEEEEEeehhhCCCcHHHHHHHHHHHHhCCEEEeeCCCC-HHHHHHHHHHHHHHhhCCchhhhhc--c
Confidence 8763 23557899999999999999999999999999999999999985 7889999999999999999999996 5
Q ss_pred CCCcCeEEEEEeeeeccccccccccCCCcccC-eEeCCCceEeeccccccccccccccC--CeEEEEeecCCCCCCceEE
Q 016311 159 VDNSTRLIFANALYFKGAWNETFDSSKTKDYD-FHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGEDKRRFS 235 (391)
Q Consensus 159 ~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~-F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLp~~~~~~~~~~s 235 (391)
++++|+++|+||+||+|.|+.+|++..|..++ |+..+|+.++||||++.+.++|...+ ++++|+|||+++ .+
T Consensus 161 l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~l~~~vleLPy~~~-----~s 235 (350)
T 2xn6_A 161 LKPNTIMVLVNYIHFKAQWANPFDPSKTEDSSSFLIDKTTTVQVPMMHQMDQYYHLVDMELNCTVLQMDYSKN-----AL 235 (350)
T ss_dssp CCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-----EE
T ss_pred cCCCceeeeeeHHHHhhHhhccCChhhCccCCceEeCCCcEEEEEEEEEeeeEeEEEeCCCCeEEEEeecCCC-----eE
Confidence 99999999999999999999999999999999 99999999999999999877776644 799999999986 59
Q ss_pred EEEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCC
Q 016311 236 MYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSP 315 (391)
Q Consensus 236 m~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~ 315 (391)
|+||||++ .+|.+++++|+ ...+..|....+...++|.||||++++++||+++|++|||+++|+. .||||+|++
T Consensus 236 m~iiLP~~-~~l~~le~~L~--~~~l~~~~~~~~~~~v~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~-- 309 (350)
T 2xn6_A 236 ALFVLPKE-GQMESVEAAMS--SKTLKKWNRLLQKGWVDLFVPKFSISATYDLGATLLKMGIQHAYSE-NADFSGLTE-- 309 (350)
T ss_dssp EEEEEECT-TCHHHHHHHCS--HHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGST-TCCCTTTBT--
T ss_pred EEEEecCC-CCHHHHHHHhC--HHHHHHHHHhhhcccceeeeeEEEEEeeecHHHHHHhcCchhhccC-cCCcccccC--
Confidence 99999998 68999999997 3445555555556678999999999999999999999999999985 899999997
Q ss_pred CCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhh
Q 016311 316 VGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRS 352 (391)
Q Consensus 316 ~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~ 352 (391)
..+++|++++|++.|+|||+|++|+|+|++.+..++
T Consensus 310 -~~~l~vs~v~hka~ieVnE~GteAaAaT~~~~~~~s 345 (350)
T 2xn6_A 310 -DNGLKLSNAAHKAVLHIGEKGTEAAGAMFLEAIPRS 345 (350)
T ss_dssp -TCCEEEEEEEEEEEEEECSSEEEEEEEEEEEEEEC-
T ss_pred -CCCceeeeeeEEEEEEECCCceeeccccceeecccC
Confidence 468999999999999999999999999986544333
|
| >4afx_A Protein Z dependent protease inhibitor; hydrolase inhibitor, serpin, protein Z dependent inhibitor, coagulation; 2.09A {Homo sapiens} PDB: 4aju_A 3h5c_A* 3f1s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-72 Score=538.53 Aligned_cols=327 Identities=24% Similarity=0.387 Sum_probs=295.4
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC-----hhHHHHHHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS-----NDQLNAFASELV 77 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~-----~~~~~~~~~~l~ 77 (391)
...+..++++||++||+++. ...++ |+||||+||+.+|+|+++||+|+|++||.++||++. .++++..++.+.
T Consensus 51 ~~~l~~~~~~Fa~~L~~~l~-~~~~~-Niv~SP~SI~~aLaml~~GA~G~T~~ql~~~L~~~~~~~~~~~~~~~~~~~l~ 128 (387)
T 4afx_A 51 RQQLAKETSNFGFSLLRKIS-MRHDG-NMVFSPFGMSLAMTGLMLGATGPTETQIKRGLHLQALKPTKPGLLPSLFKGLR 128 (387)
T ss_dssp HHHHHHHHHHHHHHHHHHHH-HHCCS-CEEECHHHHHHHHHHHHTTCCTHHHHHHHHHTTCTTCSCCCTTHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHh-hcCCC-CEEEChHHHHHHHHHHHhhccchHHHHHHHHhCCCccccCCHHHHHHHHHHHH
Confidence 46677899999999999998 34556 999999999999999999999999999999999985 267888999988
Q ss_pred HHHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCC
Q 016311 78 AVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPG 157 (391)
Q Consensus 78 ~~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~ 157 (391)
..+.. ..+..+.++|+||+++++.+.+.|++.++++|++++..+||.+ +..+++.||+||+++|+|+|++++ +
T Consensus 129 ~~l~~----~~~~~l~~an~lf~~~~~~l~~~F~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll--~ 201 (387)
T 4afx_A 129 ETLSR----NLELGLTQGSFAFIHKDFDVKETFFNLSKRYFDTECVPMNFRN-ASQAKRLMNHYINKETRGKIPKLF--D 201 (387)
T ss_dssp HHHHH----CGGGCEEEEEEEEEETTCCBCHHHHHHHHHHHCCEEEEECTTS-HHHHHHHHHHHHHHHTTTSSSCSC--C
T ss_pred HHhcc----CCCceEEEEEEEeecCCCchhHHHHHHHHHHhccceEecCCCC-hHHHHHHHHHHHHHhcCCCccccc--c
Confidence 87752 3456799999999999999999999999999999999999986 677999999999999999999999 6
Q ss_pred CCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc--CCeEEEEeecCCCCCCceEE
Q 016311 158 SVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF--DGFKVLGLPYKQGEDKRRFS 235 (391)
Q Consensus 158 ~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLp~~~~~~~~~~s 235 (391)
+++++|+++|+||+||+|.|+.+|++..|..++|+..+|+.++||||++.+.++|+.. .++++|+|||.+. +|
T Consensus 202 ~l~~~t~lvLvNAiyFKg~W~~~F~~~~T~~~~F~~~~g~~v~V~mM~~~~~f~y~~~~~l~~~vleLPY~~~-----~s 276 (387)
T 4afx_A 202 EINPETKLILVDYILFKGKWLTPFDPVFTEVDTFHLDKYKTIKVPMMYGAGKFASTFDKNFRCHVLKLPYQGN-----AT 276 (387)
T ss_dssp CCCTTEEEEEEEEEEEEEEBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEBTTS-----EE
T ss_pred CCCCCceEEEEeeeEEEeecccCCCcccceeeeeecCCCcEEEEEEEEeeeeEeEEEecCCceEEEEEEcCCc-----EE
Confidence 8999999999999999999999999999999999999999999999999987776654 5899999999984 99
Q ss_pred EEEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCC
Q 016311 236 MYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSP 315 (391)
Q Consensus 236 m~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~ 315 (391)
|+||||++..+|.+++++|+ ...+..|....+...++|.||||++++++||+++|++|||+++|++ .||||+|++.
T Consensus 277 M~iiLP~~~~~L~~le~~L~--~~~l~~~~~~l~~~~v~v~LPKFki~~~~dL~~~L~~lGi~~~F~~-~ADfsgis~~- 352 (387)
T 4afx_A 277 MLVVLMEKMGDHLALEDYLT--TDLVETWLRNMKTRNMEVFFPKFKLDQKYEMHELLRQMGIRRIFSP-FADLSELSAT- 352 (387)
T ss_dssp EEEEEESCCSSCCCGGGTCC--HHHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCTTTBSS-
T ss_pred EEEEecCCCCCHHHHHHHhC--HHHHHHHHHhCceeEEEEecCcEEEEeeccHHHHHHhcChhhhhCC-CCCcccccCC-
Confidence 99999999889999999997 3455666555666778999999999999999999999999999998 8999999872
Q ss_pred CCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhh
Q 016311 316 VGKNLYVSSIFQKSFIEVNEEGTEAAAASAATV 348 (391)
Q Consensus 316 ~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~ 348 (391)
..+++|++++|++.|+|||+|++|+|+|++.+
T Consensus 353 -~~~l~Vs~v~Hka~ieVnEeGteAAAaT~~~~ 384 (387)
T 4afx_A 353 -GRNLQVSRVLQRTVIEVDERGTEAVAGILSEI 384 (387)
T ss_dssp -CCCCEEEEEEEEEEEEECSSEEEEEEEEEEEE
T ss_pred -CCCceeeeEEEEEEEEECCCcccccccceeee
Confidence 26899999999999999999999999998543
|
| >1as4_A Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_A* 4caa_A 3caa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-72 Score=531.43 Aligned_cols=325 Identities=27% Similarity=0.415 Sum_probs=292.9
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh----hHHHHHHHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN----DQLNAFASELVA 78 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~----~~~~~~~~~l~~ 78 (391)
+..+..++++||++||+++. ...+++|+||||+||+.+|+|+++||+|+|++||.++||++.. ++++..++.+..
T Consensus 4 ~~~l~~~~~~Fa~~l~~~l~-~~~~~~Niv~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~ 82 (341)
T 1as4_A 4 DLGLASANVDFAFSLYKQLV-LKAPDKNVIFSPLSISTALAFLSLGAHNTTLTEILKGLKFNLTETSEAEIHQSFQHLLR 82 (341)
T ss_dssp --CHHHHHHHHHHHHHHHHH-HHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHHHh-ccCCCCcEEEchHHHHHHHHHHHhhccChHHHHHHHHhCCCCcCCCHHHHHHHHHHHHH
Confidence 45677899999999999997 4567899999999999999999999999999999999999742 578889999988
Q ss_pred HHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCC
Q 016311 79 VVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGS 158 (391)
Q Consensus 79 ~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~ 158 (391)
.+.. +..+..++++|+||+++++++.++|++.++++|+++++.+||.+ ++.+++.||+||+++|+|+|+++++ +
T Consensus 83 ~l~~---~~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~-~~~a~~~IN~WV~~~T~gkI~~ll~--~ 156 (341)
T 1as4_A 83 TLNQ---SSDELQLSMGNAMFVKEQLSLLDRFTEDAKRLYGSEAFATDFQD-SAAAKKLINDYVKNGTRGKITDLIK--D 156 (341)
T ss_dssp HHCE---ECSSCEEEEEEEEEEETTCCCCHHHHHHHHHHHCCEEEEECTTS-HHHHHHHHHHHHHHHTTTSCCCSCC--C
T ss_pred HHhc---cCCCcEEEeeehhHHhCCCchhHHHHHHHHHHhCCceEecCCCC-HHHHHHHHHHHHHHhhcCchhhHhh--c
Confidence 8753 23567899999999999999999999999999999999999985 7889999999999999999999996 5
Q ss_pred CCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccc-ccccccC--CeEEEEeecCCCCCCceEE
Q 016311 159 VDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKN-QFVSAFD--GFKVLGLPYKQGEDKRRFS 235 (391)
Q Consensus 159 ~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~-~~~~~~~--~~~vveLp~~~~~~~~~~s 235 (391)
++++|+++|+||+||+|.|+.||++..|.+++|+..+|++++||||++.+. ++|+..+ ++++++|||+++ .+
T Consensus 157 l~~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~l~~~vleLPY~~~-----~s 231 (341)
T 1as4_A 157 LDSQTMMVLVNYIFFKAKWEMPFDPQDTHQSRFYLSKKKWVMVPMMSLHHLTIPYFRDEELSCTVVELKYTGN-----AS 231 (341)
T ss_dssp CCTTEEEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEEETTTTEEEEEEEBSSS-----EE
T ss_pred cCCCceEEEEEhHhhcchhcCCCCccccccceeEeCCCeEEEEEEEEecCceEEEEEecCCCeEEEEecCCCC-----cE
Confidence 999999999999999999999999999999999999999999999999987 7776644 899999999986 59
Q ss_pred EEEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeee-eeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCC
Q 016311 236 MYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVG-DFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDS 314 (391)
Q Consensus 236 m~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v-~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~ 314 (391)
|+||||++ .+|.+++++|+ ...+..|.+..+...+ +|.||||++++++||+++|++||++++|+. .||||+|++
T Consensus 232 m~iiLP~~-~~l~~le~~L~--~~~l~~~~~~~~~~~v~~v~lPKFki~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~- 306 (341)
T 1as4_A 232 ALFILPDQ-DKMEEVEAMLL--PETLKRWRDSLEFREIGELYLPKFSISRDYNLNDILLQLGIEEAFTS-KADLSGITG- 306 (341)
T ss_dssp EEEEEECT-TCHHHHHHTCC--HHHHHHHHHHCEEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCHHHHS-
T ss_pred EEEEeeCC-CCHHHHHHHhC--HHHHHHHHHhccccccceEeeeEEEEeeecchHHHHHHcCchhhccC-CCCcccccC-
Confidence 99999998 58999999997 3455555555556678 999999999999999999999999999985 899999997
Q ss_pred CCCCCeeEeeeeeeeEEEEcCCCchhhhhhhh
Q 016311 315 PVGKNLYVSSIFQKSFIEVNEEGTEAAAASAA 346 (391)
Q Consensus 315 ~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~ 346 (391)
..+++|++++|++.|+|||+|++|+|+|++
T Consensus 307 --~~~l~vs~v~hka~ieVnE~GteAaAaT~~ 336 (341)
T 1as4_A 307 --ARNLAVSQVVHKAVLDVFEEGTEASRATAV 336 (341)
T ss_dssp --SSCEEEEEEEEEEEEEECSSEEEEEEEEEE
T ss_pred --CCCEEEeeEEEEEEEEECCCccccccccce
Confidence 468999999999999999999999999974
|
| >1mtp_A Serine proteinase inhibitor (serpin), chain A; structural genomics, protease inhibitor; 1.50A {Thermobifida fusca} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-70 Score=517.61 Aligned_cols=316 Identities=23% Similarity=0.411 Sum_probs=284.1
Q ss_pred CchhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHH
Q 016311 1 MDVRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVV 80 (391)
Q Consensus 1 ~~~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l 80 (391)
||...+..++++||++||+++. ...+++|+||||+||+.+|+|+++||+|+|++||.++|| ++++..++.+ ..+
T Consensus 1 ~~~~~l~~~~~~Fa~~l~~~l~-~~~~~~N~v~SP~Si~~aLaml~~GA~g~T~~el~~~L~----~~~~~~~~~l-~~l 74 (323)
T 1mtp_A 1 MSGGFLRDDHLEFALHLHRRLA-EAVPDGEVIWSPYSVACALGVLAAGARATTRTELTTLLG----TDPAPLLAAL-DRA 74 (323)
T ss_dssp --CCSSCHHHHHHHHHHHHHHH-HHSTTCCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHHT----SCHHHHHHHH-HHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHh-ccCCCCCEEEchHHHHHHHHHHHhhcCchHHHHHHHHHH----HHHHHHHHHH-HHH
Confidence 7788888999999999999998 446789999999999999999999999999999999999 4677788888 666
Q ss_pred hhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCC
Q 016311 81 FADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVD 160 (391)
Q Consensus 81 ~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~ 160 (391)
. ..+..+.++|+||+++++.+.++|++.++++|+++++.+||.++++.+++.||+||+++|+|+|++++++++++
T Consensus 75 ~-----~~~~~l~~an~l~~~~~~~l~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~WV~~~T~g~I~~l~~~~~l~ 149 (323)
T 1mtp_A 75 V-----TDSPDLASRTVLWVSADVPVRSSFRATMHDRPDSDVRTADFRTNPEGVRATVNADIADATRGMIRELLPQGAVT 149 (323)
T ss_dssp T-----CSCTTEEEEEEEEECTTSCBCHHHHHHHHHSTTCEEEECCTTTCHHHHHHHHHHHHHHHTTTSCSCSSCTTCSC
T ss_pred h-----CCCcEEeeeeeeeeECCcEecHHHHHHHHHHhCCEEEEEcCCCCHHHHHHHHHHHHHHHhcCcccccCCcCCCC
Confidence 3 34568999999999999999999999999999999999999866889999999999999999999999988999
Q ss_pred CcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC--CeEEEEeecCCCCCCceEEEEE
Q 016311 161 NSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGEDKRRFSMYF 238 (391)
Q Consensus 161 ~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~--~~~vveLp~~~~~~~~~~sm~i 238 (391)
++|+++|+||+||+|.|+.||++..|.+++|+ .+|++++||||++.+.++|++.+ ++++|+| ++ ++||+|
T Consensus 150 ~~t~lvLvNaiyFkg~W~~~F~~~~T~~~~F~-~~~~~~~V~mM~~~~~~~y~~~~~~~~~vleL---~~----~~sm~i 221 (323)
T 1mtp_A 150 PDLRAILTNALWAKARWTTPFEAHLTREGTFR-TPRGPKRVPFMHRTKTMPYATARGWRMVTLHA---HD----ELAVDV 221 (323)
T ss_dssp TTEEEEEEEEEEEEEEBSSCCCGGGCEEEEEE-ETTEEEEEEEEEEEEEEEEEEETTEEEEEEEB---ST----TEEEEE
T ss_pred cccceeeeeeeeeeccccCCCCcccCeeeeee-cCCeEEEeeEEEeeeeEeeEEeCCCCEEEEEE---CC----cEEEEE
Confidence 99999999999999999999999999999999 99999999999999888877766 5678999 44 699999
Q ss_pred EecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCC
Q 016311 239 FLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGK 318 (391)
Q Consensus 239 ilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~ 318 (391)
|||+ .+|.++++ + ...+.+|.+..+...++|.||||++++++||+++|++||++++|+. .||||+|++ ..
T Consensus 222 iLP~--~~l~~l~~--~--~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~---~~ 291 (323)
T 1mtp_A 222 LLPP--GTNAAAVP--T--APLLTALHRRSASTSVELALPRFELTQPHQLVEVLAEAGVRTLFTA-SADLSGIST---VP 291 (323)
T ss_dssp EECC--GGGTTCCC--C--HHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGST-TCCCTTTBS---SC
T ss_pred EecC--CCHHHHHh--C--HHHHHHHHHhCcceeEEEEeeEEEEecccchHHHHHhCChhhhcCC-CCCcccCCC---CC
Confidence 9998 67887766 2 4456666555566778999999999999999999999999999995 899999988 35
Q ss_pred CeeEeeeeeeeEEEEcCCCchhhhhhhh
Q 016311 319 NLYVSSIFQKSFIEVNEEGTEAAAASAA 346 (391)
Q Consensus 319 ~l~v~~~~q~~~l~v~E~G~~a~a~t~~ 346 (391)
++|++++|++.|+|||+|++|+|+|++
T Consensus 292 -l~vs~v~hka~ieV~E~GteAaAaT~~ 318 (323)
T 1mtp_A 292 -LYVDTVIHQARLRVDERGAEGAAATAA 318 (323)
T ss_dssp -CEEEEEEEEEEEEEETTEEEEEEEEEE
T ss_pred -ceeeeeEEEEEEEECCCccccccccce
Confidence 999999999999999999999999974
|
| >1f0c_A ICE inhibitor; apoptosis, caspase inhibitor, protease inhibitor, serpin, viral protein; 2.26A {Cowpox virus} SCOP: e.1.1.1 PDB: 1c8o_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-67 Score=492.30 Aligned_cols=294 Identities=27% Similarity=0.436 Sum_probs=259.1
Q ss_pred HHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHHhhCCCCCCCCeeee
Q 016311 15 LSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFADGSPSGGPRLSV 94 (391)
Q Consensus 15 ~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~~~~~~~l~~ 94 (391)
++||++++ ...+++|++|||+||+.+|+|+++||+|+|++||.++||++..+++ ....+.+
T Consensus 1 ~~l~~~l~-~~~~~~N~~~SP~Si~~aLaml~~GA~g~T~~el~~~L~~~~~~~~------------------~~l~l~~ 61 (305)
T 1f0c_A 1 MDIFREIA-SSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEADKNK------------------DDISFKS 61 (305)
T ss_dssp CHHHHHHH-HTTTTSCEEECHHHHHHHHHHHHHHCCTHHHHHHHTTC---------------------------CCSEEE
T ss_pred ChHHHHHh-ccCCCCCEEEchHHHHHHHHHHHHhcCChHHHHHHHHhCCCCcccc------------------chhhhhh
Confidence 37999998 4578899999999999999999999999999999999998753221 1124699
Q ss_pred eeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCeEEEEEeeeec
Q 016311 95 ANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFK 174 (391)
Q Consensus 95 ~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~l~lvna~~f~ 174 (391)
+|+||+++++.+.++|++.++++| +.+||.+ + .+++.||+||+++|+|+|+++++ ..++.+|+++|+||+||+
T Consensus 62 an~l~~~~~~~l~~~f~~~~~~~y----~~vdF~~-~-~a~~~IN~WV~~~T~g~I~~l~~-~~~~~~t~lvLvNaiyFk 134 (305)
T 1f0c_A 62 MNKVYGRYSAVFKDSFLRKIGDNF----QTVDFTD-C-RTVDAINKCVDIFTEGKINPLLD-EPLSPDTCLLAISAVYFK 134 (305)
T ss_dssp EEEEEEETTSCBCHHHHHHHGGGE----EEECSSS-T-HHHHHHHHHHHHHTTTSSCCSCC-SCCCTTEEEEEEEEEEEE
T ss_pred eeeEEEeCCCcHHHHHHHHHHHHh----hccCCCC-H-HHHHHHHHHHHHHhCCCcccccc-CCCCCCceeeeeehHhhh
Confidence 999999999999999999999999 7899986 5 89999999999999999999993 235566999999999999
Q ss_pred cccccccccCCCcccCeEeCCCceEeeccccccc-cccccc--cC--CeEEEEeecCCCCCCceEEEEEEecCCCCChHH
Q 016311 175 GAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKK-NQFVSA--FD--GFKVLGLPYKQGEDKRRFSMYFFLPDAKDGLPT 249 (391)
Q Consensus 175 ~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~-~~~~~~--~~--~~~vveLp~~~~~~~~~~sm~iilP~~~~~l~~ 249 (391)
|.|+.||++..|..++|+..+|++++||||++.+ .++|++ .. ++++++|||+++ +||+||||+++.+|.+
T Consensus 135 g~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~y~~~~~~~~~~~vleLPy~~~-----~sm~iiLP~~~~~l~~ 209 (305)
T 1f0c_A 135 AKWLMPFEKEFTSDYPFYVSPTEMVDVSMMSMYGEAFNHASVKESFGNFSIIELPYVGD-----TSMVVILPDNIDGLES 209 (305)
T ss_dssp EEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEEECCTTCCEEEEEEEBSSS-----EEEEEEEESSTTCHHH
T ss_pred hhhhccCCcccCeecEEEECCCEEEEEEEEEecCcceeeEEcccccCCCEEEEEeCCCC-----EEEEEEeCCCCCCHHH
Confidence 9999999999999999999999999999999988 777754 44 889999999874 9999999999999999
Q ss_pred HHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCeeEeeeeeee
Q 016311 250 LLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKS 329 (391)
Q Consensus 250 l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~v~~~~q~~ 329 (391)
++++|+ ...+.+|.+..+...++|.||||++++++||+++|++||++++|++ .||||+|++ .+++|++++|++
T Consensus 210 l~~~L~--~~~l~~~~~~~~~~~v~v~lPKF~i~~~~dL~~~L~~lGi~~~F~~-~Adfs~is~----~~l~vs~v~hka 282 (305)
T 1f0c_A 210 IEQNLT--DTNFKKWCDSMDAMFIDVHIPKFKVTGSYNLVDALVKLGLTEVFGS-TGDYSNMCN----SDVSVDAMIHKT 282 (305)
T ss_dssp HHTTCC--HHHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHTTCCSSSST-TCCCTTTBS----SCCEEEEEEEEE
T ss_pred HHHHhC--HHHHHHHHhhCceeEEEEecceEEEEeeechHHHHHhcCCCcCCCC-ccccccCCC----CCcEeeeEEEEE
Confidence 999997 3456666666667778999999999999999999999999999997 899999985 579999999999
Q ss_pred EEEEcCCCchhhhhhhh
Q 016311 330 FIEVNEEGTEAAAASAA 346 (391)
Q Consensus 330 ~l~v~E~G~~a~a~t~~ 346 (391)
.|+|||+|++|+|+|++
T Consensus 283 ~ieV~E~GteAaAaT~~ 299 (305)
T 1f0c_A 283 YIDVNEEYTEAAAATCA 299 (305)
T ss_dssp EEEECSSEEEEEEEEEE
T ss_pred EEEECCCceecccccee
Confidence 99999999999999975
|
| >1m93_B Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-56 Score=401.36 Aligned_cols=237 Identities=27% Similarity=0.421 Sum_probs=216.3
Q ss_pred CeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCeEEEEE
Q 016311 90 PRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFAN 169 (391)
Q Consensus 90 ~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~l~lvn 169 (391)
..++++|+||+++++.++++|++.+++.|. .+||.+ +.+++.||+||+++|+|+|+++++++ ++++|+++|+|
T Consensus 2 ~~l~~an~l~~~~~~~l~~~f~~~~~~~~~----~vdF~~--~~a~~~IN~WV~~~T~gkI~~ll~~~-l~~~t~lvLvN 74 (245)
T 1m93_B 2 ISFKSMNKVYGRYSAVFKDSFLRKIGDNFQ----TVDFTD--SRTVDAINKSVDIFTEGKINPLLDEP-LSPDTSLLAIS 74 (245)
T ss_dssp CSEEEEEEEEEETTSCBCHHHHHHHCSCEE----EECTTS--THHHHHHHHHHHHHTTTSSCCSCCSC-CCTTCCEEEEE
T ss_pred cEEEeEeeeeeeCCCCcCHHHHHHHHHHHH----hcCCCC--HHHHHHHHHHHHHHhcCchhhhcCCC-CCCCceEEEEE
Confidence 358999999999999999999999999874 799986 68999999999999999999999765 99999999999
Q ss_pred eeeeccccccccccCCCcccCeEeCCCceEeecccc-ccccccccc--cC--CeEEEEeecCCCCCCceEEEEEEecCCC
Q 016311 170 ALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMT-SKKNQFVSA--FD--GFKVLGLPYKQGEDKRRFSMYFFLPDAK 244 (391)
Q Consensus 170 a~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~-~~~~~~~~~--~~--~~~vveLp~~~~~~~~~~sm~iilP~~~ 244 (391)
|+||+|.|+.||++..|..++|+..+|+.++||||+ +.+.++|.. .. ++++++|||+++ +||+||||++.
T Consensus 75 aiyFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~l~~~~~vleLPy~~~-----~sm~iiLP~~~ 149 (245)
T 1m93_B 75 AVYFKAKWLMPFEKEFTSDYPFYVSPTEMVDVSMMSMYGEAFNHASVKESFGNFSIIELPYVGD-----TSMVVILPDNI 149 (245)
T ss_dssp EEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEECSCEEEEEEECCTTCCEEEEEEEBSSS-----EEEEEEEESST
T ss_pred eeeeechhcCCCCcccCceeeEEecCCcEEEEeeeeeccCceeEEEecccccCCEEEEEecCCC-----eEEEEEecCCC
Confidence 999999999999999999999999999999999999 887766654 34 899999999985 99999999999
Q ss_pred CChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCeeEee
Q 016311 245 DGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVSS 324 (391)
Q Consensus 245 ~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~v~~ 324 (391)
.+|.+++++|+ ...+..+....+...++|.||||++++++||+++|++||++++|++ .||||+|++ . +++|++
T Consensus 150 ~~l~~l~~~L~--~~~l~~~~~~~~~~~v~v~lPKF~i~~~~~L~~~L~~lGi~~~F~~-~Adfs~is~---~-~l~vs~ 222 (245)
T 1m93_B 150 DGLESIEQNLT--DTNFKKWSDSMDAMFIDVHIPKFKVTGSYNLVDALVKLGLTEVFGS-TGDYSNMSN---S-DVSVDA 222 (245)
T ss_dssp TCHHHHHTTCC--HHHHHHHHHTCEEEECEEEEECEEEEEEEEHHHHHHHTTCTTSSST-TCCCTTTBS---S-CCCCCC
T ss_pred CCHHHHHHHhC--HHHHHHHHHhCccceEEEECCeEEEeeeeccHHHHHhcCccccCCC-ccCcccccC---C-CceEee
Confidence 99999999997 3446666555666778999999999999999999999999999998 899999988 4 899999
Q ss_pred eeeeeEEEEcCCCchhhhhhh
Q 016311 325 IFQKSFIEVNEEGTEAAAASA 345 (391)
Q Consensus 325 ~~q~~~l~v~E~G~~a~a~t~ 345 (391)
++|++.|+|||+|++|+|+|+
T Consensus 223 v~hka~ieV~E~GteAaAaT~ 243 (245)
T 1m93_B 223 MIHKTYIDVNEEYTEAAAATS 243 (245)
T ss_dssp EEEEEEEEECSSEEEEEEEEE
T ss_pred EEEEeEEEECCCccccccccc
Confidence 999999999999999999986
|
| >1m93_A Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=99.45 E-value=5.5e-14 Score=95.05 Aligned_cols=51 Identities=25% Similarity=0.554 Sum_probs=42.6
Q ss_pred HHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh
Q 016311 15 LSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN 66 (391)
Q Consensus 15 ~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~ 66 (391)
++||+++. ...+++|++|||+||+.+|+|+++||+|+|+.||.++|+++..
T Consensus 1 ~~L~~~l~-~~~~~~Ni~~SP~Si~~aLaml~~GA~g~T~~ql~~~L~~~~~ 51 (55)
T 1m93_A 1 MDIFREIA-SSMKGENVFISPPSISSVLTILYYGANGSTAEQLSKYVEKEAD 51 (55)
T ss_dssp CHHHHHHH-HHTTTSCEEECHHHHHHHHHHHHHHCCHHHHHHHHTTC-----
T ss_pred ChHHHHHH-hcCCCCCEEECHHHHHHHHHHHHhhccchHHHHHHHHhCCCcc
Confidence 37899997 4567899999999999999999999999999999999999754
|
| >3ndd_B Alpha-1-antitrypsin; serpin, hydrolase inhibitor; 1.50A {Homo sapiens} PDB: 1ezx_B 3ndf_B 7api_B* 8api_B* 9api_B* 2d26_B | Back alignment and structure |
|---|
Probab=99.39 E-value=5.5e-13 Score=81.43 Aligned_cols=33 Identities=33% Similarity=0.582 Sum_probs=30.8
Q ss_pred CeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 358 KIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 358 ~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
+..|++||||+|+|+|+.|+.+||+|+|.+|.+
T Consensus 3 p~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 35 (36)
T 3ndd_B 3 PPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQ 35 (36)
T ss_dssp CCEEECCSCEEEEEEETTTCCEEEEEEESSCCC
T ss_pred CCEEEeeCCEEEEEEECCCCcEEEEEEecCCCC
Confidence 357999999999999999999999999999985
|
| >2riv_B Thyroxine-binding globulin; TBG, serpin, cleaved, mutation, glycoprotein, secreted, signaling protein; 1.50A {Homo sapiens} PDB: 2riw_B* 2xn3_B* | Back alignment and structure |
|---|
Probab=99.38 E-value=5.4e-13 Score=83.51 Aligned_cols=33 Identities=30% Similarity=0.498 Sum_probs=31.0
Q ss_pred CeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 358 KIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 358 ~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
+..|++||||+|+|+|+.|+.|||+|+|.+|.+
T Consensus 7 p~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 39 (40)
T 2riv_B 7 HPIIQIDRSFMLLILERSTRSILFLGKVVNPTE 39 (40)
T ss_dssp CCEEECCBCEEEEEEETTTTEEEEEEEESCTTC
T ss_pred CCEEEecCCEEEEEEeCCCCcEEEEEEecCCCC
Confidence 468999999999999999999999999999975
|
| >2xn6_B Thyroxine-binding globulin; transport, cleaved protein; HET: F6Y T44; 1.29A {Homo sapiens} PDB: 2xn5_B* 2xn7_B* | Back alignment and structure |
|---|
Probab=99.38 E-value=5.9e-13 Score=80.80 Aligned_cols=32 Identities=31% Similarity=0.507 Sum_probs=30.2
Q ss_pred eEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 359 IDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 359 ~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
..|.+||||+|+|+|+.|+.|||+|+|.+|.+
T Consensus 3 ~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 34 (35)
T 2xn6_B 3 PIIQIDRSFMLLILERSTRSILFLGKVVNPTE 34 (35)
T ss_dssp CEEECCBCEEEEEEETTTTEEEEEEEESCTTC
T ss_pred CEEEecCCEEEEEEECCCCcEEEEEEeCCcCC
Confidence 47999999999999999999999999999975
|
| >1hle_B Horse leukocyte elastase inhibitor; hydrolase inhibitor(serine proteinase); 1.95A {Equus caballus} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=99.37 E-value=6.2e-13 Score=78.49 Aligned_cols=30 Identities=40% Similarity=0.854 Sum_probs=28.6
Q ss_pred eEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 359 IDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 359 ~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
.+|++||||+|+|+|+.|+.|||+|+|.+|
T Consensus 2 ~~f~~drPFlf~I~~~~t~~iLF~G~v~~P 31 (31)
T 1hle_B 2 ENFNADHPFIFFIRHNPSANILFLGRFSSP 31 (31)
T ss_dssp EEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred CEEEEeCCEEEEEEECCCCcEEEEEEecCC
Confidence 479999999999999999999999999998
|
| >4afx_B Protein Z dependent protease inhibitor; hydrolase inhibitor, serpin, protein Z dependent inhibitor, coagulation; 2.09A {Homo sapiens} PDB: 4aju_B | Back alignment and structure |
|---|
Probab=99.37 E-value=6.6e-13 Score=81.07 Aligned_cols=32 Identities=41% Similarity=0.756 Sum_probs=30.4
Q ss_pred eEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 359 IDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 359 ~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
..|++||||+|+|+|+.|+.+||+|+|.+|.+
T Consensus 4 ~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 35 (36)
T 4afx_B 4 PVIKIDRPFHFMIYEETSGMLLFLGRVVNPTL 35 (36)
T ss_dssp CEEECCSCEEEEEEETTTTEEEEEEEESCTTC
T ss_pred CEEEeeCCEEEEEEECCCCcEEEEEEecCCCC
Confidence 47999999999999999999999999999986
|
| >2h4p_B MENT, heterochromatin-associated protein MENT; serine protease inhibitor, serpin, hydrolase inhibitor; 1.70A {Gallus gallus} PDB: 2h4q_B | Back alignment and structure |
|---|
Probab=99.36 E-value=8.1e-13 Score=79.77 Aligned_cols=32 Identities=34% Similarity=0.768 Sum_probs=29.7
Q ss_pred eEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 359 IDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 359 ~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
..|.+||||+|+|+|+.|+.|||+|+|.+|..
T Consensus 3 ~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 34 (34)
T 2h4p_B 3 LKFKVDHPFHFFIRHNKSKTILFFGRFCCPVE 34 (34)
T ss_dssp EEEECCSCEEEEEEETTTTEEEEEEEECSCC-
T ss_pred CEEEecCCEEEEEEECCCCeEEEEEEeCCCCC
Confidence 57999999999999999999999999999973
|
| >1as4_B Antichymotrypsin, ACT; serpin, serine protease inhibitor; 2.10A {Homo sapiens} SCOP: e.1.1.1 PDB: 2ach_B* 3caa_B 4caa_B | Back alignment and structure |
|---|
Probab=99.36 E-value=5.6e-13 Score=81.90 Aligned_cols=33 Identities=24% Similarity=0.344 Sum_probs=31.0
Q ss_pred CeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 358 KIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 358 ~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
+..|.+||||+|+|+|+.|+.|||+|+|.+|.+
T Consensus 4 p~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 36 (37)
T 1as4_B 4 GTIVRFNRPFLMIIVPTDTQNIFFMSKVTNPKQ 36 (37)
T ss_dssp CEEEECCSCEEEEEEETTSSCCSEEEEESCTTC
T ss_pred CCEEEecCCEEEEEEeCCCCcEEEEEEeCCCCC
Confidence 468999999999999999999999999999975
|
| >1m93_C Serine proteinase inhibitor 2; serpin, CRMA, apoptosis, ICE inhibitor, viral protein; 1.65A {Cowpox virus} SCOP: e.1.1.1 PDB: 1c8o_B 1f0c_B | Back alignment and structure |
|---|
Probab=99.24 E-value=9.5e-12 Score=78.18 Aligned_cols=32 Identities=38% Similarity=0.790 Sum_probs=29.2
Q ss_pred CeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 358 KIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 358 ~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
+.+|++||||+|+|+|+. +.|||+|+|.+|.+
T Consensus 9 p~~f~~drPFlf~I~~~~-~~iLF~G~v~~P~~ 40 (41)
T 1m93_C 9 TNEFSADHPFIYVIRHVD-GKILFVGRYSSPTT 40 (41)
T ss_dssp CCEEECCSCEEEEEEETT-SCEEEEEEECSCC-
T ss_pred CCEEEeeCCEEEEEEECC-CCEEEEEEeCCcCC
Confidence 468999999999999998 99999999999985
|
| >3f02_C Neuroserpin; cleaved form, fenib, human, disease MUT glycoprotein, protease inhibitor, secreted, serine protease inhibitor, hydrolase inhibitor; 1.80A {Homo sapiens} PDB: 1jjo_E | Back alignment and structure |
|---|
Probab=99.24 E-value=1.3e-11 Score=80.25 Aligned_cols=33 Identities=39% Similarity=0.832 Sum_probs=30.5
Q ss_pred CeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 358 KIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 358 ~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
+..|++||||+|+|+|+.|+.|||+|+|.+|..
T Consensus 5 ~~~f~~drPFlf~I~~~~t~~iLF~G~v~~P~~ 37 (48)
T 3f02_C 5 YPQVIVDHPFFFLIRNRRTGTILFMGRVMHPET 37 (48)
T ss_dssp CCEEECCSCEEEEEEETTTCCEEEEEEESCCCC
T ss_pred CCEEEeeCCEEEEEEECCCCcEEEEEEeCCCCc
Confidence 358999999999999999999999999999963
|
| >1mtp_B Serine proteinase inhibitor (serpin), chain B; structural genomics, protease inhibitor; 1.50A {Thermobifida fusca} SCOP: e.1.1.1 | Back alignment and structure |
|---|
Probab=99.18 E-value=2.9e-11 Score=76.57 Aligned_cols=31 Identities=32% Similarity=0.765 Sum_probs=28.6
Q ss_pred CeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 358 KIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 358 ~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
+..|++||||+|+|+|+ +.|||+|+|.+|..
T Consensus 8 p~~f~~drPFlf~I~~~--~~iLF~G~v~~P~~ 38 (43)
T 1mtp_B 8 TIRFSVDRPFHIVVRRR--GAILFLGSIADPHD 38 (43)
T ss_dssp CEEEECCSCEEEEEEET--TEEEEEEEESSCCC
T ss_pred CCEEEeeCCEEEEEEEC--CEEEEEEEeCCccc
Confidence 56899999999999998 89999999999974
|
| >3dy0_B C-terminus plasma serine protease inhibitor; serpin, blood clotting, hydrolase inhibitor; HET: IDS SGN; 1.55A {Homo sapiens} PDB: 1lq8_B* | Back alignment and structure |
|---|
Probab=99.10 E-value=8.9e-11 Score=67.77 Aligned_cols=27 Identities=30% Similarity=0.671 Sum_probs=25.3
Q ss_pred eEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 359 IDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 359 ~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
..|++||||+|+|+|+ ++||+|+|.+|
T Consensus 3 ~~f~~drPFlf~I~~~---~iLF~G~v~~P 29 (29)
T 3dy0_B 3 QRLVFNRPFLMFIVDN---NILFLGKVNRP 29 (29)
T ss_dssp EEEECCSCEEEEEESS---SEEEEEEESCC
T ss_pred CEEEecCCEEEEEEcC---ceEEEEEecCC
Confidence 4799999999999987 89999999998
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 391 | ||||
| d2b5ti1 | 426 | e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapien | 4e-89 | |
| d1uhga_ | 385 | e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId | 1e-82 | |
| d1by7a_ | 381 | e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Hu | 7e-82 | |
| d1lj5a_ | 379 | e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Hu | 1e-81 | |
| d1k9oi_ | 376 | e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornwor | 7e-81 | |
| g1hle.1 | 375 | e.1.1.1 (A:,B:) Elastase inhibitor {Horse (Equus c | 3e-79 | |
| d1xqga_ | 378 | e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId: | 1e-78 | |
| g1as4.1 | 369 | e.1.1.1 (A:,B:) Antichymotrypsin, alpha-1 {Human ( | 4e-76 | |
| g1jjo.1 | 334 | e.1.1.1 (A:,C:,E:) Neuroserpin {Mouse (Mus musculu | 8e-76 | |
| g1mtp.1 | 355 | e.1.1.1 (A:,B:) Thermopin {Thermobifida fusca [Tax | 2e-74 | |
| d1jmja_ | 420 | e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin | 7e-74 | |
| d1qlpa_ | 372 | e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sap | 1e-71 | |
| g1lq8.1 | 358 | e.1.1.1 (A:,B:) Protein C inhibitor {Human (Homo s | 1e-68 | |
| d1imva_ | 383 | e.1.1.1 (A:) Pigment epithelium-derived factor, PE | 5e-68 | |
| g1m93.1 | 322 | e.1.1.1 (A:,B:,C:) Viral serpin crmA (cytokine res | 5e-66 |
| >d2b5ti1 e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapiens) [TaxId: 9606]} Length = 426 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Antithrombin species: Human (Homo sapiens) [TaxId: 9606]
Score = 273 bits (699), Expect = 4e-89
Identities = 111/385 (28%), Positives = 193/385 (50%), Gaps = 16/385 (4%)
Query: 11 TDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK-----SKS 65
+ A + +H+A ++ + N+ SP SI ++ G+ TL QL+ K K+
Sbjct: 51 SRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKT 110
Query: 66 NDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQV 125
+DQ++ F ++L ++ + +L AN ++ D+SL+ T++ + + VY A +
Sbjct: 111 SDQIHFFFAKLNCRLYRK--ANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPL 168
Query: 126 DFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSK 185
DF+ A + +N W +T G + +V+P +++ T L+ N +YFKG W F
Sbjct: 169 DFKENAEQSRAAINKWVSNKTEGRITDVIPSEAINELTVLVLVNTIYFKGLWKSKFSPEN 228
Query: 186 TKDYDFHLLNGGSIKVPFMTSKKN-QFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPDAK 244
T+ F+ +G S M + ++ +G +VL LP+K + +M LP +
Sbjct: 229 TRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGDD----ITMVLILPKPE 284
Query: 245 DGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGE 304
L + +++ E L L + +PRF+I G + + L+ +GLV FS E
Sbjct: 285 KSLAKVEKELTPE--VLQEWLDELEEMMLCVHMPRFRIEDGFSLKEQLQDMGLVDLFSPE 342
Query: 305 GGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVAD 364
L +V +LYVS F K+F+EVNEEG+EAAA++A + RS+ +++ F A+
Sbjct: 343 KSKLPGIVAEG-RDDLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSLN-PNRVCFKAN 400
Query: 365 HPFVFMIREDMTGLVMFTGHVLNPL 389
PF+ IRE ++F G V NP
Sbjct: 401 RPFLVFIREVPLNTIIFMGRVANPC 425
|
| >d1uhga_ e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]} Length = 385 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Ovalbumin species: Hen (Gallus gallus) [TaxId: 9031]
Score = 255 bits (652), Expect = 1e-82
Identities = 93/394 (23%), Positives = 161/394 (40%), Gaps = 26/394 (6%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK----- 62
+ + + K + + N+ + P +I L+++ G+K T Q+ ++
Sbjct: 5 AASMEFCFDVFKELK-VHHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLP 63
Query: 63 ------SKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDN 116
S L ++ P+ S+A+ ++ +E + + Q V
Sbjct: 64 GFGDSIEAQCGTSVNVHSSLRDILNQITKPNDVYSFSLASRLYAEERYPILPEYLQCVKE 123
Query: 117 VYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGA 176
+Y+ ++FQT A + +N W E +TNG+++ VL P SVD+ T ++ NA+ FKG
Sbjct: 124 LYRGGLEPINFQTAADQARELINSWVESQTNGIIRNVLQPSSVDSQTAMVLVNAIVFKGL 183
Query: 177 WNETFDSSKTKDYDFHLLNGGSIKVP--FMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRF 234
W + F T+ F + S V + A + K+L LP+ G
Sbjct: 184 WEKAFKDEDTQAMPFRVTEQESKPVQMMYQIGLFRVASMASEKMKILELPFASG----TM 239
Query: 235 SMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKG 294
SM LPD GL L + E +PR K+ ++ VL
Sbjct: 240 SMLVLLPDEVSGLEQLESIINFEKLTEWTSSNVMEERKIKVYLPRMKMEEKYNLTSVLMA 299
Query: 295 LGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIV 354
+G+ FS A + ++L +S + E+NE G E ++ A V S+
Sbjct: 300 MGITDVFSSS----ANLSGISSAESLKISQAVHAAHAEINEAGREVVGSAEAGVDAASVS 355
Query: 355 LSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
+F ADHPF+F I+ T V+F G ++P
Sbjct: 356 ----EEFRADHPFLFCIKHIATNAVLFFGRCVSP 385
|
| >d1by7a_ e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Human (Homo sapiens) [TaxId: 9606]} Length = 381 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Plasminogen activator inhibitor-2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 253 bits (647), Expect = 7e-82
Identities = 109/394 (27%), Positives = 188/394 (47%), Gaps = 27/394 (6%)
Query: 6 SISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK--- 62
++N T AL+L KH+A + NL SP SI ++++ GS+G T DQ+ L+
Sbjct: 4 CVAN-TLFALNLFKHLA-KASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMAKVLQFNE 61
Query: 63 -SKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAA 121
+ D++++ L + + + +G L N ++ ++S S + + ++ Y +
Sbjct: 62 VGAAADKIHSSFRSLSSAIN---ASTGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSE 118
Query: 122 SNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETF 181
VDF A E +++N W + +T G + +LP GSVD TR++ NA+YFKG W F
Sbjct: 119 PQAVDFLECAEEARKKINSWVKTQTKGKIPNLLPEGSVDGDTRMVLVNAVYFKGKWKTPF 178
Query: 182 DSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLP 241
+ Y F + + V M ++ + + K L SM+ LP
Sbjct: 179 EKKLNGLYPFRVNSAQRTPVQMMYLREKLNIGYIEDLKAQILELPYAG---DVSMFLLLP 235
Query: 242 DAKDGLPTLLEKMGSESKF-------LDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKG 294
D + T LE + SE + + VEV IP+FK+ E+ +L+
Sbjct: 236 DEIADVSTGLELLESEITYDKLNKWTSKDKMAEDEVEV---YIPQFKLEEHYELRSILRS 292
Query: 295 LGLVLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIV 354
+G+ F+ + M + +L++S +F ++ ++VNEEGTEAAA + + R+
Sbjct: 293 MGMEDAFNKGRANFSGMSERN---DLFLSEVFHQAMVDVNEEGTEAAAGTGGVMTGRT-- 347
Query: 355 LSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
FVADHPF+F+I +T ++F G +P
Sbjct: 348 GHGGPQFVADHPFLFLIMHKITNCILFFGRFSSP 381
|
| >d1lj5a_ e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 379 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Plasminogen activator inhibitor-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 252 bits (645), Expect = 1e-81
Identities = 101/386 (26%), Positives = 172/386 (44%), Gaps = 21/386 (5%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSND 67
+D + + + VA +KD N+VFSP + +L+++ + G T Q+ + + K +D
Sbjct: 10 HLASDFGVRVFQQVA-QASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDD 68
Query: 68 QLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDF 127
A L + P +S + +++ L L F ++++ QVDF
Sbjct: 69 --KGMAPALRHLYKELMGPWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDF 126
Query: 128 QTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTK 187
+ +N W + T G++ +L G+VD TRL+ NALYF G W F S T
Sbjct: 127 S-EVERARFIINDWVKTHTKGMISNLLGKGAVDQLTRLVLVNALYFNGQWKTPFPDSSTH 185
Query: 188 DYDFHLLNGGSIKVPFMTSKKNQFVSAF-----DGFKVLGLPYKQGEDKRRFSMYFFLPD 242
FH +G ++ VP M + F + +L LPY SM+ P
Sbjct: 186 RRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYH----GDTLSMFIAAPY 241
Query: 243 AKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFS 302
K+ + L + S + + H + +P+F + +++ K L+ LG+ F
Sbjct: 242 EKEVPLSALTNILSA-QLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFR 300
Query: 303 GEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFV 362
+ D + L+V+ QK IEVNE GT A++++A V R + +
Sbjct: 301 QFQADFTSLSDQ---EPLHVAQALQKVKIEVNESGTVASSSTAVIVSAR----MAPEEII 353
Query: 363 ADHPFVFMIREDMTGLVMFTGHVLNP 388
D PF+F++R + TG V+F G V+ P
Sbjct: 354 MDRPFLFVVRHNPTGTVLFMGQVMEP 379
|
| >d1k9oi_ e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornworm (Manduca sexta) [TaxId: 7130]} Length = 376 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Alaserpin (serpin 1) species: Tobacco hornworm (Manduca sexta) [TaxId: 7130]
Score = 250 bits (640), Expect = 7e-81
Identities = 108/388 (27%), Positives = 183/388 (47%), Gaps = 16/388 (4%)
Query: 2 DVRESISN-QTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSF 60
D+++ + + V N+V S S+ L ++ S G + D+LL
Sbjct: 4 DLQKILRESNDQFTAQMFSEVV-KANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRA 62
Query: 61 LKSKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKA 120
L +++ ++L V G L +A+ +++ + L L + F V +V+ +
Sbjct: 63 LALPNDNVTKDVFADLNRGV----RAVKGVDLKMASKIYVAKGLELNDDFAAVSRDVFGS 118
Query: 121 ASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNET 180
VDF K+ E + +N W E +TN +K ++ P ++D +TR + NA+YFKG+W +
Sbjct: 119 EVQNVDFV-KSVEAAGAINKWVEDQTNNRIKNLVDPDALDETTRSVLVNAIYFKGSWKDK 177
Query: 181 FDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFL 240
F +T D DFH+ +IKVP M KK+ + + D + SM L
Sbjct: 178 FVKERTMDRDFHVSKDKTIKVPTMIGKKDVRYADVPELDAKMIEMSYEGD--QASMIIIL 235
Query: 241 PDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLP 300
P+ DG+ L +K+ EV + +P+FKI ++ +VL + +
Sbjct: 236 PNQVDGITALEQKLKDPKALSRAEERLYNTEV-EITLPKFKIETTTDLKEVLSNMNIKKL 294
Query: 301 FSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKID 360
F+ L ++ + ++L V + QK+FIEVNEEG EAAAA+A +V +S L +
Sbjct: 295 FTPGAARLENLLKTK--ESLTVDAAIQKAFIEVNEEGAEAAAANAFGIVPKS--LILYPE 350
Query: 361 FVADHPFVFMIREDMTGLVMFTGHVLNP 388
D PF F ++ G+ MF G V+ P
Sbjct: 351 VHIDRPFYFELKI--DGIPMFNGKVIEP 376
|
| >d1xqga_ e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId: 9606]} Length = 378 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Maspin species: Human (Homo sapiens) [TaxId: 9606]
Score = 245 bits (625), Expect = 1e-78
Identities = 95/389 (24%), Positives = 178/389 (45%), Gaps = 24/389 (6%)
Query: 6 SISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS 65
++N + A+ L K ++ + N++FSP ++ LSL G+KG T +++ L ++
Sbjct: 8 QLAN-SAFAVDLFKQLS-EKEPLGNVLFSPIALSTSLSLAQVGAKGDTANEIGQVLHFEN 65
Query: 66 NDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQV 125
+ + + V S L + +++D+SL+L F Y V
Sbjct: 66 VKDVPFGFQTVTSDV---NKLSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETV 122
Query: 126 DFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSK 185
DF+ K E ++N + T+G + +L SV++ T+++ NA YF G W + F S+
Sbjct: 123 DFKDKLEETKGQINNSIKDLTDGHFENILADNSVNDQTKILVVNAAYFVGKWMKKFSESE 182
Query: 186 TKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGEDKRRFSMYFFLP-- 241
TK+ F + + V M + + D K++ LP++ SM+ LP
Sbjct: 183 TKESPFRVNKTDTKPVQMMNMEATFSMGNIDSINSKIIELPFQNK----HLSMFILLPKD 238
Query: 242 --DAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVL 299
D GL + +++ SES + + IP+FK+ I+ L+ LGL
Sbjct: 239 VEDESTGLEKIEKQLNSESLSQWTNPSTMANAKVKLSIPKFKVEKMIDPKASLENLGLKH 298
Query: 300 PFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKI 359
FS + + M ++ K + +S++ K +E+ E+G ++ A ++ K
Sbjct: 299 IFSEDTSDFSGMSET---KGVALSNVIHKVSLEITEDGGDSIEVPGARIL------QHKD 349
Query: 360 DFVADHPFVFMIREDMTGLVMFTGHVLNP 388
+ ADHPF+++IR + T ++F G +P
Sbjct: 350 ELNADHPFIYIIRHNKTRNIIFFGKFSSP 378
|
| >d1jmja_ e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin 2) {Human (Homo sapiens) [TaxId: 9606]} Length = 420 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Heparin cofactor II (Hc-II, leuserpin 2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (597), Expect = 7e-74
Identities = 96/391 (24%), Positives = 165/391 (42%), Gaps = 29/391 (7%)
Query: 6 SISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK--- 62
+I N A +L + + N+ +P I + +IS G KG T +Q+ S L
Sbjct: 48 NILN-AKFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKD 106
Query: 63 ---SKSNDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYK 119
+ S ++ + + + G L N ++I + + FK V Y
Sbjct: 107 FVNASSKYEITTIHNLFRKLTHRLFRRNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYF 166
Query: 120 AASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNE 179
A + DF A + N K T GL+K+ L +D +T+++ N +YFKG+W
Sbjct: 167 AEAQIADFSDPAFI--SKTNNHIMKLTKGLIKDALEN--IDPATQMMILNCIYFKGSWVN 222
Query: 180 TFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD--GFKVLGLPYKQGEDKRRFSMY 237
F T +++F L +KV M +K N + +L L Y G SM
Sbjct: 223 KFPVEMTHNHNFRLNEREVVKVSMMQTKGNFLAANDQELDCDILQLEYVGG-----ISML 277
Query: 238 FFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGL 297
+P G+ TL ++ + ++ S + +P+FK+ + + LK +G+
Sbjct: 278 IVVPHKMSGMKTLEAQL--TPRVVERWQKSMTNRTREVLLPKFKLEKNYNLVESLKLMGI 335
Query: 298 VLPFSGEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSD 357
+ F + G +A + D + + + I VNEEGT+A + + S
Sbjct: 336 RMLFD-KNGNMAGISDQR----IAIDLFKHQGTITVNEEGTQATTVTTVGFMPLS----T 386
Query: 358 KIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388
++ F D PF+F+I E T ++F G V NP
Sbjct: 387 QVRFTVDRPFLFLIYEHRTSCLLFMGRVANP 417
|
| >d1qlpa_ e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 372 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Antitrypsin, alpha-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 226 bits (577), Expect = 1e-71
Identities = 96/382 (25%), Positives = 170/382 (44%), Gaps = 19/382 (4%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSND 67
N + A SL + +A ++ +N+ FSP SI +++S G+K T D++L L +
Sbjct: 6 PNLAEFAFSLYRQLA-HQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTE 64
Query: 68 QLNAFASELVAVVFADGS-PSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVD 126
A E + + P +L+ NG+++ E L L + F + V +Y + + V+
Sbjct: 65 IPEAQIHEGFQELLRTLNQPDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVN 124
Query: 127 FQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKT 186
F E +++N + EK T G + +++ +D T N ++FKG W F+ T
Sbjct: 125 FGDTE-EAKKQINDYVEKGTQGKIVDLVK--ELDRDTVFALVNYIFFKGKWERPFEVKDT 181
Query: 187 KDYDFHLLNGGSIKVPFMTSKKNQFVSAFDGFKVLGLPYKQGEDKRRFSMYFFLPDAKDG 246
++ DFH+ ++KVP M + L K + FFLPD +
Sbjct: 182 EEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGNAT---AIFFLPD-EGK 237
Query: 247 LPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGG 306
L L ++ + + L ++ +P+ I+ ++ VL LG+ FS
Sbjct: 238 LQHLENELTHD--IITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSNG-- 293
Query: 307 GLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHP 366
A++ L +S K+ + ++E+GTEAA A + SI + + P
Sbjct: 294 --ADLSGVTEEAPLKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSI----PPEVKFNKP 347
Query: 367 FVFMIREDMTGLVMFTGHVLNP 388
FVF++ E T +F G V+NP
Sbjct: 348 FVFLMIEQNTKSPLFMGKVVNP 369
|
| >d1imva_ e.1.1.1 (A:) Pigment epithelium-derived factor, PEDF {Human (Homo sapiens) [TaxId: 9606]} Length = 383 | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Pigment epithelium-derived factor, PEDF species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 5e-68
Identities = 81/386 (20%), Positives = 165/386 (42%), Gaps = 31/386 (8%)
Query: 8 SNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLK--SKS 65
+ ++ L + + + + +N++ SP S+ LS +S G+ T + L S
Sbjct: 21 AAVSNFGYDLYRVRS-SMSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDLIS 79
Query: 66 NDQLNAFASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQV 125
+ ++ EL+ D + L A+ + ++ L +K++F ++ Y +
Sbjct: 80 SPDIHGTYKELL-----DTVTAPQKNLKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVL 134
Query: 126 DFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRLIFANALYFKGAWNETFDSSK 185
+ +E+N W + + G + + + ++ +FKG W FDS K
Sbjct: 135 TGNPRLD--LQEINNWVQAQMKGKLAR--STKEIPDEISILLLGVAHFKGQWVTKFDSRK 190
Query: 186 TKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD---GFKVLGLPYKQGEDKRRFSMYFFLPD 242
T DF+L +++VP M+ K D K+ LP S+ FFLP
Sbjct: 191 TSLEDFYLDEERTVRVPMMSDPKAVLRYGLDSDLSCKIAQLPLT-----GSMSIIFFLPL 245
Query: 243 AKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFS 302
TL+E+ + S+F+ + +P+ K+S+ EV+K L+ + L F
Sbjct: 246 KVTQNLTLIEESLT-SEFIHDIDRELKTVQAVLTVPKLKLSYEGEVTKSLQEMKLQSLF- 303
Query: 303 GEGGGLAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFV 362
+ +++ GK + ++ + ++ E NE+G + + +D+
Sbjct: 304 -DSPDFSKIT----GKPIKLTQVEHRAGFEWNEDGAGTTPSPGLQPAHLT----FPLDYH 354
Query: 363 ADHPFVFMIREDMTGLVMFTGHVLNP 388
+ PF+F++R+ TG ++F G +L+P
Sbjct: 355 LNQPFIFVLRDTDTGALLFIGKILDP 380
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 391 | |||
| d2b5ti1 | 426 | Antithrombin {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jmja_ | 420 | Heparin cofactor II (Hc-II, leuserpin 2) {Human (H | 100.0 | |
| g1hle.1 | 375 | Elastase inhibitor {Horse (Equus caballus) [TaxId: | 100.0 | |
| d1uhga_ | 385 | Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]} | 100.0 | |
| d1by7a_ | 381 | Plasminogen activator inhibitor-2 {Human (Homo sap | 100.0 | |
| d1lj5a_ | 379 | Plasminogen activator inhibitor-1 {Human (Homo sap | 100.0 | |
| d1k9oi_ | 376 | Alaserpin (serpin 1) {Tobacco hornworm (Manduca se | 100.0 | |
| d1xqga_ | 378 | Maspin {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1imva_ | 383 | Pigment epithelium-derived factor, PEDF {Human (Ho | 100.0 | |
| d1qlpa_ | 372 | Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| g1as4.1 | 369 | Antichymotrypsin, alpha-1 {Human (Homo sapiens) [T | 100.0 | |
| g1mtp.1 | 355 | Thermopin {Thermobifida fusca [TaxId: 2021]} | 100.0 | |
| g1jjo.1 | 334 | Neuroserpin {Mouse (Mus musculus) [TaxId: 10090]} | 100.0 | |
| g1lq8.1 | 358 | Protein C inhibitor {Human (Homo sapiens) [TaxId: | 100.0 | |
| g1m93.1 | 322 | Viral serpin crmA (cytokine response modifier prot | 100.0 |
| >d2b5ti1 e.1.1.1 (I:6-431) Antithrombin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Antithrombin species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-82 Score=618.86 Aligned_cols=376 Identities=29% Similarity=0.508 Sum_probs=338.4
Q ss_pred hhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh-----hHHHHHHHHHHHH
Q 016311 5 ESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN-----DQLNAFASELVAV 79 (391)
Q Consensus 5 ~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~-----~~~~~~~~~l~~~ 79 (391)
++..++++||++||++++...++++|+||||+||+.+|+||++||+|+|++||.++||++.. ++++..++.+...
T Consensus 45 ~l~~~~~~Fa~~l~~~l~~~~~~~~N~v~SP~si~~aLa~l~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~l~~~ 124 (426)
T d2b5ti1 45 ELSKANSRFATTFYQHLADSKNDNDNIFLSPLSISTAFAMTKLGACNDTLQQLMEVFKFDTISEKTSDQIHFFFAKLNCR 124 (426)
T ss_dssp HHHHHHHHHHHHHHHHHHHTSCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTGGGSCHHHHHTHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCEEEECHHHHHHHHHHHHHhCchHHHHHHHHhcCCCCCCcchHHHHHHHHHHHHHH
Confidence 47789999999999999754578899999999999999999999999999999999998742 4578888888877
Q ss_pred HhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCC
Q 016311 80 VFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSV 159 (391)
Q Consensus 80 l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~ 159 (391)
+... ...+..+.++|++|+++++.++++|++.++++|+++++.+||.++++.+++.||+|++++|+|+|+++++++++
T Consensus 125 l~~~--~~~~~~l~~an~l~v~~~~~~~~~f~~~~~~~y~a~~~~vdF~~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~l 202 (426)
T d2b5ti1 125 LYRK--ANKASKLVSANRLFGDKSLTFNETYQDISELVYGAKLQPLDFKENAEQSRAAINKWVSNKTEGRITDVIPSEAI 202 (426)
T ss_dssp HTSC--CCSSEEEEEEEEEEEETTSCCCHHHHHHHHHHHSSCCEEECTTTCHHHHHHHHHHHHHHHTTTSCSCSSCTTCS
T ss_pred Hhcc--CCCCcEEeeeehhhhcccccchHHHHHHHHHhcCCeEEEecccccHHHHHHHHHHHHHHhcCCCccCCCCccCC
Confidence 6532 23456899999999999999999999999999999999999998888899999999999999999999998999
Q ss_pred CCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccccC-CeEEEEeecCCCCCCceEEEEE
Q 016311 160 DNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAFD-GFKVLGLPYKQGEDKRRFSMYF 238 (391)
Q Consensus 160 ~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~~-~~~vveLp~~~~~~~~~~sm~i 238 (391)
+++|.++|+||+||+|.|+.+|++..|..++|+..+|+.+.|+||++.+.++|++.+ ++++|+|||+++ +++|+|
T Consensus 203 ~~~t~l~Lvna~yFkg~W~~~F~~~~T~~~~F~~~~~~~v~v~mM~~~~~~~~~~~~~~~~vveLPy~~~----~~sm~i 278 (426)
T d2b5ti1 203 NELTVLVLVNTIYFKGLWKSKFSPENTRKELFYKADGESCSASMMYQEGKFRYRRVAEGTQVLELPFKGD----DITMVL 278 (426)
T ss_dssp CTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEECCSSSCCEEEEEEEEEEEEEEEECGGGCEEEEEEBTTS----SEEEEE
T ss_pred CchhHHHHHhhhhhccccccCccccccccceeecCCCeEEEeecceeecceeeEEccCCeEEEEeecCCC----ceEEEE
Confidence 999999999999999999999999999999999999999999999999888776543 799999999987 899999
Q ss_pred EecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCC
Q 016311 239 FLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGK 318 (391)
Q Consensus 239 ilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~ 318 (391)
+||++..++.+++++|. ...+..+....+...++|.||||++++++||+++|++||++++|++..|||++|+.++ .+
T Consensus 279 iLP~~~~~l~~le~~L~--~~~l~~~~~~l~~~~v~l~lPkF~i~~~~dL~~~L~~lGi~~~F~~~~Adfs~i~~~~-~~ 355 (426)
T d2b5ti1 279 ILPKPEKSLAKVEKELT--PEVLQEWLDELEEMMLCVHMPRFRIEDGFSLKEQLQDMGLVDLFSPEKSKLPGIVAEG-RD 355 (426)
T ss_dssp EECCSSSCHHHHHHHCC--HHHHHHHHHHCEEEEEEEEEECEEEECCSCHHHHHHTTTCCGGGCTTTCCCTTTSCSS-SS
T ss_pred EecCCCCCHHHHHHhhh--HHHHHHHHHhhhhccceEeeeeEEEEEeecHHHHHHHcCChhhcCCccccCccccccC-CC
Confidence 99999999999999997 4456666666667778999999999999999999999999999997679999998642 46
Q ss_pred CeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 319 NLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 319 ~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
+++|++++|++.|+|||+|++|+|+|.+.+..++. .++++.|++||||+|+|+|+.||.|||||||.||+.
T Consensus 356 ~l~vs~v~hka~ieVdE~GteAaa~T~~~~~~~s~-~~~~~~f~~drPFlF~I~d~~t~~iLF~G~v~~Pt~ 426 (426)
T d2b5ti1 356 DLYVSDAFHKAFLEVNEEGSEAAASTAVVIAGRSL-NPNRVCFKANRPFLVFIREVPLNTIIFMGRVANPCV 426 (426)
T ss_dssp CCCCCEEEEEEEEEECSSEESCCCCCCCCCSCCCC-CTTCCCEECCSCEEEEEEETTTCCEEEEEEESCCCC
T ss_pred CcEEEeEEEEEEEEECCCceeccccceeeeccccC-CCCCcEEEecCCEEEEEEECCCCCEEEEEEecCCCC
Confidence 89999999999999999999999999865555444 344678999999999999999999999999999973
|
| >d1jmja_ e.1.1.1 (A:) Heparin cofactor II (Hc-II, leuserpin 2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Heparin cofactor II (Hc-II, leuserpin 2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-79 Score=592.08 Aligned_cols=365 Identities=26% Similarity=0.433 Sum_probs=327.0
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC---------hhHHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS---------NDQLNAFA 73 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~---------~~~~~~~~ 73 (391)
++.+...+++||++||+++++..++++|+|+||+||+.+|+||++||+|+|++||.++||++. ..+++..+
T Consensus 44 ~~~l~~~n~~F~~~ly~~l~~~~~~~~Niv~SP~si~~aLaml~~GA~g~T~~ql~~~L~~~~~~~~~~~~~~~~i~~~~ 123 (420)
T d1jmja_ 44 IQRLNILNAKFAFNLYRVLKDQVNTFDNIFIAPVGISTAMGMISLGLKGETHEQVHSILHFKDFVNASSKYEITTIHNLF 123 (420)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTSCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTHHHHHHHCTTCCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHHhhcCCCCcEEECHHHHHHHHHHHHhhcchhHHHHHHHHcCCCCcCCcccchhHHHHHHHH
Confidence 345566788999999999985446789999999999999999999999999999999999863 14678888
Q ss_pred HHHHHHHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCccccc
Q 016311 74 SELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEV 153 (391)
Q Consensus 74 ~~l~~~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~ 153 (391)
+.+.+.+.. ...+..+.++|++|+++++++.++|++.++++|+++++.+||.+ + .+++.||+||+++|+|+|+++
T Consensus 124 ~~l~~~l~~---~~~~~~l~~an~l~v~~~~~~~~~f~~~~~~~y~a~~~~~df~~-~-~~~~~IN~wv~~~T~g~I~~~ 198 (420)
T d1jmja_ 124 RKLTHRLFR---RNFGYTLRSVNDLYIQKQFPILLDFKTKVREYYFAEAQIADFSD-P-AFISKTNNHIMKLTKGLIKDA 198 (420)
T ss_dssp HHHHHHHHS---CCSSEEEEEEEEEEEETTSCCCHHHHHHHHHHSSCCEEEECTTC-H-HHHHHHHHHHHHHTTTSCCCT
T ss_pred HHHHHHHhc---CCCCcEehhhHHHHhhCCccccHHHHHHHHHhhCceeeccccch-H-HHHHHHhHhHHhccCCcccch
Confidence 888888763 34567899999999999999999999999999999999999987 3 466789999999999999999
Q ss_pred CCCCCCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc--CCeEEEEeecCCCCCC
Q 016311 154 LPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF--DGFKVLGLPYKQGEDK 231 (391)
Q Consensus 154 l~~~~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLp~~~~~~~ 231 (391)
++ +++++|.++|+||+||+|.|+.||++..|..++|+..+|+++.|+||++.+.++|+.. .++++++|||+++
T Consensus 199 l~--~i~~~t~lvLvNa~yFkg~W~~~F~~~~T~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~l~~~vl~Lpy~~~--- 273 (420)
T d1jmja_ 199 LE--NIDPATQMMILNCIYFKGSWVNKFPVEMTHNHNFRLNEREVVKVSMMQTKGNFLAANDQELDCDILQLEYVGG--- 273 (420)
T ss_dssp TS--SCCTTCCEEEEEEEEEEEEBSSCCCGGGCEEEEEEEETTEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTT---
T ss_pred hc--ccCCccHHHHHHHHHHHhhhhccCCcccccccceecCCCceeeeeeeeeeccEEEeeccCCCEEEEEEeecCC---
Confidence 95 5899999999999999999999999999999999999999999999999987776654 4899999999874
Q ss_pred ceEEEEEEecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCC
Q 016311 232 RRFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEM 311 (391)
Q Consensus 232 ~~~sm~iilP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~i 311 (391)
++|+||||++..+|.+++++|+ ...+..+.+..+...++|.||||++++++||+++|++||++++|++ .|||++|
T Consensus 274 --~sm~iiLP~~~~~l~~l~~~l~--~~~l~~~~~~~~~~~v~v~lPkF~i~~~~dL~~~L~~lGi~~~F~~-~ad~s~i 348 (420)
T d1jmja_ 274 --ISMLIVVPHKMSGMKTLEAQLT--PRVVERWQKSMTNRTREVLLPKFKLEKNYNLVESLKLMGIRMLFDK-NGNMAGI 348 (420)
T ss_dssp --EEEEEEEESSTTHHHHHHHHCC--HHHHHHHHHTCEEEEEEEEEECEEEEEEEECHHHHHHHTCCGGGST-TSCCTTT
T ss_pred --eeEEEEecCCCCchhHHHHhhC--HHHHHHHHhhCccceEEEEEEEEEEEeEechHHHHHHcCchhhcCC-CCccccc
Confidence 9999999999889999999997 4566777777777888999999999999999999999999999997 7999999
Q ss_pred CCCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 312 VDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 312 s~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
++ .+++|++++|++.|+|||+|++|+|+|.+.... .+.++.|++||||+|+|+|+.||.|||+|||.+|++
T Consensus 349 s~----~~l~vs~v~hka~ieVdE~GteAaa~T~~~~~~----~~~~~~f~~drPFlF~I~d~~t~~iLF~G~v~~Ptk 419 (420)
T d1jmja_ 349 SD----QRIAIDLFKHQGTITVNEEGTQATTVTTVGFMP----LSTQVRFTVDRPFLFLIYEHRTSCLLFMGRVANPSR 419 (420)
T ss_dssp CS----SCCCCSEEEEEEEEEECSSEESCCCCCCSCCCC----SCCSEEEECCSCEEEEEEETTTTEEEEEEEESCTTC
T ss_pred CC----CCceeeeEEEEEEEEEcCCceeecccceeeecc----CCCCcEEEecCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 87 579999999999999999999999999854432 233679999999999999999999999999999986
|
| >d1uhga_ e.1.1.1 (A:) Ovalbumin {Hen (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Ovalbumin species: Hen (Gallus gallus) [TaxId: 9031]
Probab=100.00 E-value=1.1e-77 Score=580.13 Aligned_cols=365 Identities=25% Similarity=0.442 Sum_probs=326.1
Q ss_pred hhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh--------------hHHHH
Q 016311 6 SISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN--------------DQLNA 71 (391)
Q Consensus 6 ~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~--------------~~~~~ 71 (391)
+..++++||++||+.+. ..++++|+|+||++|+.+|+||++||+|+|++||.++||++.. .+++.
T Consensus 3 l~~~~~~Fa~~l~~~l~-~~~~~~N~v~SP~si~~~Laml~~GA~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~ 81 (385)
T d1uhga_ 3 IGAASMEFCFDVFKELK-VHHANENIFYCPIAIMSALAMVYLGAKDSTRTQINKVVRFDKLPGFGDSIEAQCGTSVNVHS 81 (385)
T ss_dssp HHHHHHHHHHHHHHHHH-HHCTTSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHHTCTTCTTCSHHHHTTTTSCTTTTH
T ss_pred HHHHHHHHHHHHHHHHh-ccCcCCcEEECHHHHHHHHHHHHHhCChHHHHHHHHHhCCCCCccccchhhhhcccHHHHHH
Confidence 45789999999999997 4678999999999999999999999999999999999998641 34677
Q ss_pred HHHHHHHHHhhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCccc
Q 016311 72 FASELVAVVFADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVK 151 (391)
Q Consensus 72 ~~~~l~~~l~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~ 151 (391)
.++.+.+.+.+ +..+..++++|++|++++++++++|++.++++|+++++.+||...++.+++.||+|++++|+|+|.
T Consensus 82 ~~~~~~~~~~~---~~~~~~l~~~~~l~v~~~~~~~~~f~~~~~~~y~~~~~~~df~~~~~~a~~~IN~wv~~~T~g~i~ 158 (385)
T d1uhga_ 82 SLRDILNQITK---PNDVYSFSLASRLYAEERYPILPEYLQCVKELYRGGLEPINFQTAADQARELINSWVESQTNGIIR 158 (385)
T ss_dssp HHHHHHHHHTS---CCSSEEEEEEEEEEEETTSCBCHHHHHHHHHHCSSCEEEECCTTTHHHHHHHHHHHHHHHTTTCSC
T ss_pred HHHHHHHHhhC---CCCCceEEEEEEEEEecCccccHHHHHHHHHHhCCcccccccccHHHHHHHHHHHHHHHHccCCcc
Confidence 88888877753 345568999999999999999999999999999999999999987788899999999999999999
Q ss_pred ccCCCCCCCCcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccc--ccCCeEEEEeecCCCC
Q 016311 152 EVLPPGSVDNSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVS--AFDGFKVLGLPYKQGE 229 (391)
Q Consensus 152 ~~l~~~~~~~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~--~~~~~~vveLp~~~~~ 229 (391)
+++++.+++++++++++||+||+|.|+.+|++..|.+++|+..+|+++.|+||+.++.++|. +..++++|+|||+++
T Consensus 159 ~~v~~~~l~~~t~l~lina~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~v~~m~~~~~~~~~~~~~~~~~~v~Lpy~~~- 237 (385)
T d1uhga_ 159 NVLQPSSVDSQTAMVLVNAIVFKGLWEKAFKDEDTQAMPFRVTEQESKPVQMMYQIGLFRVASMASEKMKILELPFASG- 237 (385)
T ss_dssp CCSCTTSSCTTCCEEEEEEEEEEECEEECCCGGGCEEEEECCCC--CEEEEEEEEEEEEEEEEEGGGTEEEEEEEBTTS-
T ss_pred ccCCccCCCcccceeeeeeEEEecccccccccccccccccccCCCceeeehhheeccccccccccccCcEEEEccccCC-
Confidence 99998999999999999999999999999999999999999999999999999998876655 456999999999987
Q ss_pred CCceEEEEEEecCCCCChHHHHHHhcCchHHHhhcCC--CCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCC
Q 016311 230 DKRRFSMYFFLPDAKDGLPTLLEKMGSESKFLDHHLP--SQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGG 307 (391)
Q Consensus 230 ~~~~~sm~iilP~~~~~l~~l~~~L~~~~~~l~~~~~--~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~ad 307 (391)
+++|+||||++..++.++++.|. ...+..+.. ..+...++|+||||++++++||+++|++||++++|++ .||
T Consensus 238 ---~~sm~iilP~~~~~l~~~~~~l~--~~~l~~~~~~~~~~~~~v~l~lPkF~i~~~~dl~~~L~~lGl~~~F~~-~ad 311 (385)
T d1uhga_ 238 ---TMSMLVLLPDEVSGLEQLESIIN--FEKLTEWTSSNVMEERKIKVYLPRMKMEEKYNLTSVLMAMGITDVFSS-SAN 311 (385)
T ss_dssp ---SEEEEEEEESSTTCHHHHHHHCC--HHHHHHHTSTTTCEEEEEEEEEECEEEEEEEEHHHHHHHHTCCGGGST-TCC
T ss_pred ---CeEEEEEECCccCchhhhhhhcc--hhhHHHHhhhhcccceEEEEEeeeEEeecceeHHHHHHhcCCchhhcC-CCC
Confidence 89999999999999999999997 334545443 4456678999999999999999999999999999998 799
Q ss_pred CcCCCCCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecC
Q 016311 308 LAEMVDSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLN 387 (391)
Q Consensus 308 fs~is~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~ 387 (391)
|++|++ .++++|++++|++.|+|||+|++|+++|.+....++. +.+|++||||+|+|+|+.||.|||+|||.|
T Consensus 312 fs~is~---~~~l~vs~i~q~~~i~v~E~Gt~a~a~t~~~~~~~~~----~~~f~~drPF~f~I~~~~t~~~lf~G~v~~ 384 (385)
T d1uhga_ 312 LSGISS---AESLKISQAVHAAHAEINEAGREVVGSAEAGVDAASV----SEEFRADHPFLFCIKHIATNAVLFFGRCVS 384 (385)
T ss_dssp CTTTBC---STTCCEEEEEEEEEEEECSCEEECCCHHHHHHHHTTC----CCEEECCSCEEEEEEETTTCCEEEEEEESC
T ss_pred cccCCC---CCCceeeeEEEEEEEEECCCCcccccccccccccCCC----CCEEEecCCEEEEEEECCCCcEEEEEEecC
Confidence 999988 5789999999999999999999999999854443322 468999999999999999999999999999
Q ss_pred C
Q 016311 388 P 388 (391)
Q Consensus 388 P 388 (391)
|
T Consensus 385 P 385 (385)
T d1uhga_ 385 P 385 (385)
T ss_dssp C
T ss_pred C
Confidence 9
|
| >d1by7a_ e.1.1.1 (A:) Plasminogen activator inhibitor-2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Plasminogen activator inhibitor-2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-77 Score=575.67 Aligned_cols=368 Identities=29% Similarity=0.507 Sum_probs=308.8
Q ss_pred hhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh----hHHHHHHHHHHHHH
Q 016311 5 ESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN----DQLNAFASELVAVV 80 (391)
Q Consensus 5 ~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~----~~~~~~~~~l~~~l 80 (391)
.+..++++||++||++++ ...+++|+||||+||+.+|+||++||+|+|++||.++||++.. ++++..++.+...+
T Consensus 2 ~l~~~~~~Fa~~L~~~l~-~~~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~l~~~l 80 (381)
T d1by7a_ 2 DLCVANTLFALNLFKHLA-KASPTQNLFLSPWSISSTMAMVYMGSRGSTEDQMAKVLQFNEVGAAADKIHSSFRSLSSAI 80 (381)
T ss_dssp CHHHHHHHHHHHHHHHHH-HHSSSSCEEECHHHHHHHHHHHHHTCCHHHHHHHHHHTTTTTTCCG-GGHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHH-hcCCCCcEEECHHHHHHHHHHHHHhcchHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHH
Confidence 456789999999999998 4578999999999999999999999999999999999999753 57888888888776
Q ss_pred hhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCC
Q 016311 81 FADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVD 160 (391)
Q Consensus 81 ~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~ 160 (391)
.. ...+..+.++|++|++++++++++|++.+++.|++++..+||.+.++.+++.||+|++++|+|+|.+++++.+++
T Consensus 81 ~~---~~~~~~~~~~~~l~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~IN~wv~~~T~g~I~~~~~~~~l~ 157 (381)
T d1by7a_ 81 NA---STGNYLLESVNKLFGEKSASFREEYIRLCQKYYSSEPQAVDFLECAEEARKKINSWVKTQTKGKIPNLLPEGSVD 157 (381)
T ss_dssp C---------CEEEEEEEEEETTSCBCHHHHHHHHHHHCCCCEEECHHHHHHHHHHHHHHHHHHHTTTSCTTSSCTTSCC
T ss_pred hc---CCCCcEEeeccchhcccCCccCHHHHHHHHHhhCCceeccccccchHHHHHHHHHHHHHhhcCCccccCCcccCC
Confidence 42 345667999999999999999999999999999999999999876678899999999999999999999988999
Q ss_pred CcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccccccccc--cCCeEEEEeecCCCCCCceEEEEE
Q 016311 161 NSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSA--FDGFKVLGLPYKQGEDKRRFSMYF 238 (391)
Q Consensus 161 ~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~--~~~~~vveLp~~~~~~~~~~sm~i 238 (391)
++|+++++||+||+|.|+.||++..|..++|+..+|+++.|+||++.+.++|+. ..++++|+|||+++ .+|++
T Consensus 158 ~~t~~~lvna~~fk~~W~~~F~~~~t~~~~F~~~~~~~~~V~mm~~~~~~~~~~~~~~~~~~v~lp~~~~-----~~m~i 232 (381)
T d1by7a_ 158 GDTRMVLVNAVYFKGKWKTPFEKKLNGLYPFRVNSAQRTPVQMMYLREKLNIGYIEDLKAQILELPYAGD-----VSMFL 232 (381)
T ss_dssp TTCCEEEEEEEEECCCBSSCCEECC---EEEEEETTEEEEECEEEEEEEEEEEEETTTTEEEEEEEETTT-----EEEEE
T ss_pred CccHhhhhheeEEeecccCCCccccccccccccCCCeeEEEeeeeeccccccccccCcCeEEEEeccCCC-----eEEEE
Confidence 999999999999999999999999999999999999999999999998776654 45899999999874 89999
Q ss_pred EecCCCC----ChHHHHHHhcCchHHHhhcCC--CCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCC
Q 016311 239 FLPDAKD----GLPTLLEKMGSESKFLDHHLP--SQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMV 312 (391)
Q Consensus 239 ilP~~~~----~l~~l~~~L~~~~~~l~~~~~--~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is 312 (391)
+||+... .+..+++.+. ...+..+.. ..+...++|+||||++++++||+++|++||++++|++..|||++|+
T Consensus 233 ilp~~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~~~v~v~lPkF~i~~~~dl~~~L~~lGi~~~F~~~~Adfs~is 310 (381)
T d1by7a_ 233 LLPDEIADVSTGLELLESEIT--YDKLNKWTSKDKMAEDEVEVYIPQFKLEEHYELRSILRSMGMEDAFNKGRANFSGMS 310 (381)
T ss_dssp EEESSCCSSSSSCHHHHHHCC--HHHHHHHTSTTTEEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTB
T ss_pred EecCCccchhhhhHHhhhhcc--HHHHHHHhhhhcccceeEEEecccEEEEeeechHHHHHhcCchhhhccccccccccC
Confidence 9998754 3666777765 344555543 2345678999999999999999999999999999998789999999
Q ss_pred CCCCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 313 DSPVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 313 ~~~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
+ ..+++|++++|++.|+|||+|++|+|+|......++. +++++|++||||+|+|+|+.|+.|||+|||.+|
T Consensus 311 ~---~~~l~vs~i~q~~~ieVdE~Gt~aaa~t~~~~~~~~~--~~~~~f~~nrPF~f~I~d~~t~~iLF~G~v~~P 381 (381)
T d1by7a_ 311 E---RNDLFLSEVFHQAMVDVNEEGTEAAAGTGGVMTGRTG--HGGPQFVADHPFLFLIMHKITNCILFFGRFSSP 381 (381)
T ss_dssp S---CSCCCCCEEEEEEEEEECSCBC-------------------CCEEECCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred C---CCCceEeeEEEEEEEEECCCccccccccceeeecccC--CCCCEEEecCCEEEEEEECCCCCEEEEEEecCC
Confidence 8 4789999999999999999999999999866555444 335689999999999999999999999999999
|
| >d1lj5a_ e.1.1.1 (A:) Plasminogen activator inhibitor-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Plasminogen activator inhibitor-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-77 Score=578.28 Aligned_cols=365 Identities=27% Similarity=0.481 Sum_probs=324.8
Q ss_pred hhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh-hHHHHHHHHHHHHHhhCC
Q 016311 6 SISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN-DQLNAFASELVAVVFADG 84 (391)
Q Consensus 6 ~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~-~~~~~~~~~l~~~l~~~~ 84 (391)
++++.++||++||+++. ...+++|+||||++|+.+|+||++||+|+|++||.++||++.. .+++..++.+...+..
T Consensus 8 ~~~~~~~F~~~l~~~l~-~~~~~~N~v~SP~si~~~La~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~l~~-- 84 (379)
T d1lj5a_ 8 VAHLASDFGVRVFQQVA-QASKDRNVVFSPYGVASVLAMLQLTTGGETQQQIQAAMGFKIDDKGMAPALRHLYKELMG-- 84 (379)
T ss_dssp HHHHHHHHHHHHHHHHH-HHSTTBCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHHTSCTTSTTHHHHHHHHHHHHHC--
T ss_pred HHHHHhHHHHHHHHHHH-hhCcCCcEEECHHHHHHHHHHHHHhCCcHHHHHHHHHhCCCCChHHHHHHHHHHHHHhhC--
Confidence 45789999999999998 4578899999999999999999999999999999999999855 4566777777777653
Q ss_pred CCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCe
Q 016311 85 SPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTR 164 (391)
Q Consensus 85 ~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~ 164 (391)
..++..++++|++|+++++.+.++|++.+++.|+++++.+||.+ +..+++.||+|++++|+|+|.+++++.++++++.
T Consensus 85 -~~~~~~l~~an~l~v~~~~~~~~~f~~~~~~~y~~~~~~vdF~~-~~~a~~~IN~wv~~~T~g~I~~~~~~~~l~~~t~ 162 (379)
T d1lj5a_ 85 -PWNKDEISTTDAIFVQRDLKLVQGFMPHFFRLFRSTVKQVDFSE-VERARFIINDWVKTHTKGMISNLLGKGAVDQLTR 162 (379)
T ss_dssp -GGGSSEEEEEEEEEEETTSCCCTTHHHHHHHHHSCCCEEECTTS-HHHHHHHHHHHHHHTTTTSCCCSSCTTSSCTTCC
T ss_pred -cccccchhhhhHHHHhccCcccHHHHHHHHHhhcceeccccccc-hHHHHHHHHHHHHhhcCCccccccCccCCCccce
Confidence 23567899999999999999999999999999999999999986 7899999999999999999999999889999999
Q ss_pred EEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc-----CCeEEEEeecCCCCCCceEEEEEE
Q 016311 165 LIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF-----DGFKVLGLPYKQGEDKRRFSMYFF 239 (391)
Q Consensus 165 l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~-----~~~~vveLp~~~~~~~~~~sm~ii 239 (391)
++++||+||+|.|+.+|++..|..++|+..+|+++.|+||++.+.++|++. .++++|+|||+++ ++||+||
T Consensus 163 ~~lvna~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~V~~M~~~~~~~~~~~~~~~~~~~~vv~Lp~~~~----~~sm~ii 238 (379)
T d1lj5a_ 163 LVLVNALYFNGQWKTPFPDSSTHRRLFHKSDGSTVSVPMMAQTNKFNYTEFTTPDGHYYDILELPYHGD----TLSMFIA 238 (379)
T ss_dssp EEEEEEEEEEEEBSSCCCCCTTCEEEEECTTSCEEEEEEEEEEEEEEEEEEECTTSCEEEEEEEEBTTS----SEEEEEE
T ss_pred eeeEeeEEEeeeecCcCCccccccccccccCCceEeecceeeccceeeEEeeccccceeEEEEeecCCC----cEEEEEe
Confidence 999999999999999999999999999999999999999999987766542 3589999999988 8999999
Q ss_pred ecCCC-CChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCC
Q 016311 240 LPDAK-DGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGK 318 (391)
Q Consensus 240 lP~~~-~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~ 318 (391)
||++. .++..+++.|. ...+..+....+...++|.||||++++++||+++|++||++++|++..|||++|++ +.
T Consensus 239 lP~~~~~~l~~l~~~l~--~~~~~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~---~~ 313 (379)
T d1lj5a_ 239 APYEKEVPLSALTNILS--AQLISHWKGNMTRLPRLLVLPKFSLETEVDLRKPLENLGMTDMFRQFQADFTSLSD---QE 313 (379)
T ss_dssp EESSTTSCTHHHHTTCC--HHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHHTTCCGGGCTTTCCCTTTCS---SS
T ss_pred cCCccccchHHHhhhcc--HHHHHHHHhhccccccEEEEEEEEEeeeecHHHHHHhCCChhhcCcccccccccCC---CC
Confidence 99775 47999998886 33444444445556679999999999999999999999999999987899999988 47
Q ss_pred CeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 319 NLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 319 ~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
+++|++++|++.|+|||+|++|+|+|.+....++. +.+|++||||+|+|+|+.||.|||||||.||
T Consensus 314 ~l~vs~v~hk~~iev~E~G~~a~a~t~~~~~~~~~----~~~f~~drPF~f~I~~~~t~~~lf~G~v~~P 379 (379)
T d1lj5a_ 314 PLHVAQALQKVKIEVNESGTVASSSTAVIVSARMA----PEEIIMDRPFLFVVRHNPTGTVLFMGQVMEP 379 (379)
T ss_dssp CCCEEEEEEEEEEEECSSEEEEEEEEEEEESSCCC----CCCCCBCCEEEEEEEETTTTEEEEEEEEECC
T ss_pred CcEEeeeEEEEEEEECCCceeecccceeeeccCCC----CCEEEeeCCEEEEEEECCCCcEEEEEEecCC
Confidence 89999999999999999999999999865443332 4579999999999999999999999999999
|
| >d1k9oi_ e.1.1.1 (I:) Alaserpin (serpin 1) {Tobacco hornworm (Manduca sexta) [TaxId: 7130]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Alaserpin (serpin 1) species: Tobacco hornworm (Manduca sexta) [TaxId: 7130]
Probab=100.00 E-value=1.8e-77 Score=576.86 Aligned_cols=366 Identities=29% Similarity=0.482 Sum_probs=326.8
Q ss_pred hhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHHhhCCC
Q 016311 6 SISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFADGS 85 (391)
Q Consensus 6 ~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l~~~~~ 85 (391)
+.+++++||++||+++. ..++++|+|+||++|+.+|+||++||+|+|++||.++||++..+..+..++.+.+.+.
T Consensus 9 l~~~~~~F~~~l~~~~~-~~~~~~N~v~SP~si~~~La~l~~ga~g~T~~el~~~L~~~~~~~~~~~~~~l~~~~~---- 83 (376)
T d1k9oi_ 9 LRESNDQFTAQMFSEVV-KANPGQNVVLSAFSVLPPLGQLALASVGESHDELLRALALPNDNVTKDVFADLNRGVR---- 83 (376)
T ss_dssp HHHHHHHHHHHHHHHHH-TTSTTSCEEECSGGGHHHHHHHTTTBCTHHHHHHHHHTTCSCTTHHHHHHHHHTSSCS----
T ss_pred HHHHHHHHHHHHHHHHH-hhCCCCeEEECHHHHHHHHHHHHHhcChHHHHHHHHHcCCCCcchHHHHHHHHHHHHh----
Confidence 45788999999999998 5677899999999999999999999999999999999999877666666666654332
Q ss_pred CCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCcCeE
Q 016311 86 PSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNSTRL 165 (391)
Q Consensus 86 ~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~t~l 165 (391)
...+..++++|++|++++++++++|.+.++++|+++++.+||.+ +..+++.||+|++++|+|+|++++++.++++++++
T Consensus 84 ~~~~~~~~~~~~i~~~~~~~~~~~f~~~~~~~y~~~~~~vdf~~-~~~a~~~IN~wv~~~T~g~I~~~~~~~~l~~~~~~ 162 (376)
T d1k9oi_ 84 AVKGVDLKMASKIYVAKGLELNDDFAAVSRDVFGSEVQNVDFVK-SVEAAGAINKWVEDQTNNRIKNLVDPDALDETTRS 162 (376)
T ss_dssp CCSSBCCEEEEEEEEESSCCBCSGGGSTTTSSSCCCEEEECTTS-HHHHHHHHHHHHHHHTTTSSCCCSCGGGCCTTCCE
T ss_pred hcCCCcEEEeeehhhhcCCCcchHHHHHHHhhcCceeecccccc-cHHHHHHHHHHHHHhhCCceeeccCCCCCCcchhh
Confidence 24556799999999999999999999999999999999999997 56789999999999999999999998899999999
Q ss_pred EEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc--CCeEEEEeecCCCCCCceEEEEEEecCC
Q 016311 166 IFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF--DGFKVLGLPYKQGEDKRRFSMYFFLPDA 243 (391)
Q Consensus 166 ~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLp~~~~~~~~~~sm~iilP~~ 243 (391)
+++||+||+|.|+.+|++..|..++|+..+|+.+.|+||++.+.++|++. .++++|+|||+++ +++|+||||++
T Consensus 163 ~lvna~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~v~~m~~~~~~~~~~~~~l~~~vveLP~~~~----~~sm~iilP~~ 238 (376)
T d1k9oi_ 163 VLVNAIYFKGSWKDKFVKERTMDRDFHVSKDKTIKVPTMIGKKDVRYADVPELDAKMIEMSYEGD----QASMIIILPNQ 238 (376)
T ss_dssp EEEEEEEEEBCBSSCCCGGGCEEEEECSSSSCCEEEEEEEEEEEEEEEEETTTTEEEEEEEBGGG----SEEEEEEEESS
T ss_pred hhhhhhhhhhhhcCCCCccccccceeecCCCceEEEEeeeecccEEEEeeCCCCEEEEEeecCCC----ceEEEEEecCC
Confidence 99999999999999999999999999999999999999999987777664 4899999999987 89999999999
Q ss_pred CCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCCeeEe
Q 016311 244 KDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKNLYVS 323 (391)
Q Consensus 244 ~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~l~v~ 323 (391)
..++.+++++|.. ...+..+....+...++|.||||++++.+||+++|++||++++|++..|||++|++. ..+++|+
T Consensus 239 ~~~l~~~~~~l~~-~~~~~~~~~~~~~~~v~v~lPkF~i~~~~~l~~~L~~lGl~~~F~~~~ad~s~~~~~--~~~l~vs 315 (376)
T d1k9oi_ 239 VDGITALEQKLKD-PKALSRAEERLYNTEVEITLPKFKIETTTDLKEVLSNMNIKKLFTPGAARLENLLKT--KESLTVD 315 (376)
T ss_dssp TTTHHHHHHHTTS-TTTTTTTTTSCEEEEEEEEEECEEEEEEEEHHHHHHTTTCCSTTSTTTSCBTTTBSS--CCCCCCS
T ss_pred CcchhHHHhhhcc-hhhHHHHHhhccceEEEEEeeeEEEeeeecHHHHhhhcCCccccCccccccccccCC--CCCEEEE
Confidence 9999999999973 234566666667778899999999999999999999999999999877999999874 3689999
Q ss_pred eeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 324 SIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 324 ~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
+++|++.|+|||+|++|+|+|.+....++.+ ...+|++||||+|+|++ +++|||+|||.+|
T Consensus 316 ~v~q~~~ievdE~G~~a~a~t~~~~~~~~~~--~~~~f~~drPF~f~I~~--~~~~lf~G~v~~P 376 (376)
T d1k9oi_ 316 AAIQKAFIEVNEEGAEAAAANAFGIVPKSLI--LYPEVHIDRPFYFELKI--DGIPMFNGKVIEP 376 (376)
T ss_dssp EEEEEEEEEECSCBSSCSSSCCSSSEESCCC--CCCEEECCSCEEEEEEE--SSSEEEEEEESCC
T ss_pred eeEEEEEEEECCCceeeecccceeeeccCCC--CCCeEEeeCCEEEEEEE--CCeEEEEEEecCC
Confidence 9999999999999999999998655544442 34589999999999997 4799999999999
|
| >d1xqga_ e.1.1.1 (A:) Maspin {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Maspin species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-77 Score=574.62 Aligned_cols=367 Identities=25% Similarity=0.415 Sum_probs=326.5
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCChhHHHHHHHHHHHHHhh
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSNDQLNAFASELVAVVFA 82 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~~~~~~~~~~l~~~l~~ 82 (391)
|-.+..++++||++||+.+. ..++++|+|+||++|+.+|+||++||+|+|++||.++||+++..+++..++.+...+.+
T Consensus 4 ~~~l~~a~~~Fa~~L~~~l~-~~~~~~N~v~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~ 82 (378)
T d1xqga_ 4 MDALQLANSAFAVDLFKQLS-EKEPLGNVLFSPIALSTSLSLAQVGAKGDTANEIGQVLHFENVKDVPFGFQTVTSDVNK 82 (378)
T ss_dssp THHHHHHHHHHHHHHHHHHH-HHSTTSCEEECHHHHHHHHHHHHHHCCHHHHHHHHHHTTGGGCSSHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHH-hhCCCCcEEECHHHHHHHHHHHHHhCChHHHHHHHHHhCCCChHHHHHHHHHHHHHHhc
Confidence 33456789999999999998 45789999999999999999999999999999999999997666777778877776653
Q ss_pred CCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCCc
Q 016311 83 DGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDNS 162 (391)
Q Consensus 83 ~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~~ 162 (391)
......++++|++|+++++.++++|++.++++|+++++.+||.++++.++..||+|++++|+|+|++++++.+++++
T Consensus 83 ---~~~~~~l~~~~~l~~~~~~~~~~~f~~~~~~~y~~~v~~~dF~~~~~~~~~~IN~wv~~~T~g~i~~~~~~~~~~~~ 159 (378)
T d1xqga_ 83 ---LSSFYSLKLIKRLYVDKSLNLSTEFISSTKRPYAKELETVDFKDKLEETKGQINNSIKDLTDGHFENILADNSVNDQ 159 (378)
T ss_dssp ---HTTTSSEEEEEEEEEETTSCCCHHHHHHTTTTTTTCEEEECHHHHHHHHHHHHHHHHHHHTTTSCSCCSCTTSCCTT
T ss_pred ---ccCCceEEEeechhhcccccccHHHHHHhhhhccceeEeccccchhhHHHHHHHHHHHHhccCCcccccCCCCCCCC
Confidence 23556899999999999999999999999999999999999987667888999999999999999999998899999
Q ss_pred CeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc--CCeEEEEeecCCCCCCceEEEEEEe
Q 016311 163 TRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF--DGFKVLGLPYKQGEDKRRFSMYFFL 240 (391)
Q Consensus 163 t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLp~~~~~~~~~~sm~iil 240 (391)
|+++++||+||+|.|+.+|++..|...+|+..+++++.|+||++++.++|+.. .++++|+|||+++ +++|+|||
T Consensus 160 t~~~l~na~~f~~~W~~~F~~~~T~~~~F~~~~~~~~~v~mm~~~~~~~~~~~~~l~~~vv~Lp~~~~----~~sm~iil 235 (378)
T d1xqga_ 160 TKILVVNAAYFVGKWMKKFSESETKESPFRVNKTDTKPVQMMNMEATFSMGNIDSINSKIIELPFQNK----HLSMFILL 235 (378)
T ss_dssp CCEEEEEEEEEECCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEGGGTEEEEEEEBGGG----SSEEEEEE
T ss_pred ceEEEEEEeEEeeeecCCCccccceecceecCCCceEecccccccceeeeeeccCCCeEEEEeecCCC----cEEEEEEe
Confidence 99999999999999999999999999999999999999999999987666554 4899999999987 89999999
Q ss_pred cCCC----CChHHHHHHhcCchHHHhhcCC--CCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCC
Q 016311 241 PDAK----DGLPTLLEKMGSESKFLDHHLP--SQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDS 314 (391)
Q Consensus 241 P~~~----~~l~~l~~~L~~~~~~l~~~~~--~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~ 314 (391)
|++. .+|.+++++|. ...+..++. ..+...++|+||||++++++||+++|++||++++|++..|||++|++
T Consensus 236 P~~~~~~~~~L~~l~~~l~--~~~l~~~~~~~~~~~~~v~l~lPkF~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~- 312 (378)
T d1xqga_ 236 PKDVEDESTGLEKIEKQLN--SESLSQWTNPSTMANAKVKLSIPKFKVEKMIDPKASLENLGLKHIFSEDTSDFSGMSE- 312 (378)
T ss_dssp ESSCCSSSSSCHHHHHSCS--HHHHHHHTCGGGCEEEEEEEEEECEEEEEEECTHHHHHHHTCCGGGCTTTCCCTTTCS-
T ss_pred cCccccccchHHHHHHhcC--HHHHHHHhhhhhceeEEEEEEeeeEEEEEeechHHHHHhcCchhccCCCCCccccCCC-
Confidence 9853 57999999997 344555553 34455689999999999999999999999999999987799999998
Q ss_pred CCCCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCC
Q 016311 315 PVGKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNP 388 (391)
Q Consensus 315 ~~~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P 388 (391)
.++++|++++|++.|+|||+|++|+++|.... .+.+.+|+|||||+|+|+|+.||.|||+|+|.+|
T Consensus 313 --~~~l~vs~i~qk~~i~vdE~G~~a~~~t~~~~------~~~~~~f~~drPFlf~I~d~~t~~~Lf~G~v~~P 378 (378)
T d1xqga_ 313 --TKGVALSNVIHKVSLEITEDGGDSIEVPGARI------LQHKDELNADHPFIYIIRHNKTRNIIFFGKFSSP 378 (378)
T ss_dssp --CSSCCEEEEEEEEEEEECSCBCCCCCCTTTTT------SSCCCCCBCCSCEEEEEEETTTTEEEEEEEECCC
T ss_pred --CCCceEEEeEEEEEEEEccCcccccccccccc------CCCCCEEEccCCEEEEEEECCCCCEEEEEEecCC
Confidence 47899999999999999999999998886422 2234589999999999999999999999999999
|
| >d1imva_ e.1.1.1 (A:) Pigment epithelium-derived factor, PEDF {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Pigment epithelium-derived factor, PEDF species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-75 Score=562.38 Aligned_cols=361 Identities=22% Similarity=0.360 Sum_probs=313.5
Q ss_pred hhhhhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCC--hhHHHHHHHHHHHHH
Q 016311 3 VRESISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKS--NDQLNAFASELVAVV 80 (391)
Q Consensus 3 ~~~~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~--~~~~~~~~~~l~~~l 80 (391)
+..+..+.++||++||++++ ..++++|+||||+||+.+|+||++||+|+|++||.++|+++. ..+++..++++...+
T Consensus 16 ~~~~~~~~~~F~~~L~~~l~-~~~~~~Niv~SP~si~~~L~~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~l~~~~ 94 (383)
T d1imva_ 16 VNKLAAAVSNFGYDLYRVRS-SMSPTTNVLLSPLSVATALSALSLGADERTESIIHRALYYDLISSPDIHGTYKELLDTV 94 (383)
T ss_dssp HHHHHHHHHHHHHHHHHHHH-HHCTTSCEEECHHHHHHHHHHHGGGCCHHHHHHHHHHTTGGGCCCSCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHh-ccCcCCcEEECHHHHHHHHHHHHHhcChHHHHHHHHHhCCCCCChHHHHHHHHHHHHhh
Confidence 34567899999999999998 567899999999999999999999999999999999999863 357888899988877
Q ss_pred hhCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCC
Q 016311 81 FADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVD 160 (391)
Q Consensus 81 ~~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~ 160 (391)
. ..+..++++|+||+++++.++++|++.++++|++.++.+||. +..+++.||+|++++|+|+|.+++. +++
T Consensus 95 ~-----~~~~~l~~~n~i~v~~~~~~~~~f~~~~~~~y~~~~~~~~~~--~~~~~~~IN~wv~~~T~g~I~~~~~--~~~ 165 (383)
T d1imva_ 95 T-----APQKNLKSASRIVFEKKLRIKSSFVAPLEKSYGTRPRVLTGN--PRLDLQEINNWVQAQMKGKLARSTK--EIP 165 (383)
T ss_dssp T-----STTSCEEEEEEEEECTTCCCCHHHHHHHHHHHCCCCEECCSC--HHHHHHHHHHHHHHHTTTCSCCCCS--CCC
T ss_pred h-----cCCcchHHHHHHHhccCCccchHHHHHHHhhcCceeeecccc--HHHHHHHHHHHHHhhCccccccccc--ccC
Confidence 4 244579999999999999999999999999999999999984 5788999999999999999999874 689
Q ss_pred CcCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeeccccccc-ccccc--ccCCeEEEEeecCCCCCCceEEEE
Q 016311 161 NSTRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKK-NQFVS--AFDGFKVLGLPYKQGEDKRRFSMY 237 (391)
Q Consensus 161 ~~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~-~~~~~--~~~~~~vveLp~~~~~~~~~~sm~ 237 (391)
+++.++++||+||+|.|+.+|++..|..++|+..+|+++.|+||++.+ .++|+ +..++++++|||+++ ++|+
T Consensus 166 ~~t~~~lvna~~fk~~W~~~F~~~~t~~~~F~~~~~~~~~V~mM~~~~~~~~~~~~~~~~~~vv~lp~~~~-----~sm~ 240 (383)
T d1imva_ 166 DEISILLLGVAHFKGQWVTKFDSRKTSLEDFYLDEERTVRVPMMSDPKAVLRYGLDSDLSCKIAQLPLTGS-----MSII 240 (383)
T ss_dssp SSCSEEEEEEEEEECCEEECCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTT-----EEEE
T ss_pred ccceeeeecceeeecccccccccccccccccccCCCeEEEeecccccccceeeeeccccceEEEEeecCCC-----eEEE
Confidence 999999999999999999999999999999999999999999999864 45554 456899999999874 9999
Q ss_pred EEecCCC-CChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCC
Q 016311 238 FFLPDAK-DGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPV 316 (391)
Q Consensus 238 iilP~~~-~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~ 316 (391)
||||++. .++..+++.+. ...+..+....+...++|.||||++++++||+++|++||++++|+. |||++|++
T Consensus 241 iiLP~~~~~~l~~l~~~l~--~~~l~~~~~~~~~~~v~v~lPkF~i~~~~dL~~~L~~lGl~~~F~~--adfs~is~--- 313 (383)
T d1imva_ 241 FFLPLKVTQNLTLIEESLT--SEFIHDIDRELKTVQAVLTVPKLKLSYEGEVTKSLQEMKLQSLFDS--PDFSKITG--- 313 (383)
T ss_dssp EEEESSCCSCCHHHHTTCC--HHHHHHHHHHCEEEEEEEEEECEEEEEEEECHHHHHTTTTTHHHHS--CCCTTTCS---
T ss_pred EEEecccCCChHHHhhhcc--HHHHHHHHhhccceEEEEeeceEEEeeecchhHhhhhcchhhhccc--cCccccCC---
Confidence 9999875 47888888886 3455555555566678999999999999999999999999999974 99999987
Q ss_pred CCCeeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 317 GKNLYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 317 ~~~l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
++++|++++|++.|+|||+|++|+++|.+....+ ..+++|++||||+|+|+|+.||.|||+|||.||..
T Consensus 314 -~~l~vs~v~hka~ieVdE~G~~a~a~t~~~~~~~----~~~~~f~~drPF~f~I~~~~t~~iLF~G~v~~P~~ 382 (383)
T d1imva_ 314 -KPIKLTQVEHRAGFEWNEDGAGTTPSPGLQPAHL----TFPLDYHLNQPFIFVLRDTDTGALLFIGKILDPRG 382 (383)
T ss_dssp -SCCCEEEEEEEEEEEECSCEEECC--------CC----CCCCEEECCSCEEEEEEETTTCCEEEEEEESCTTC
T ss_pred -CCcEeeeEEEEEEEEECCCccccccccceecccC----CCCcEEEecCCEEEEEEECCCCcEEEEEEecCCCC
Confidence 5799999999999999999999999887433222 22579999999999999999999999999999985
|
| >d1qlpa_ e.1.1.1 (A:) Antitrypsin, alpha-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Multi-domain proteins (alpha and beta) fold: Serpins superfamily: Serpins family: Serpins domain: Antitrypsin, alpha-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-74 Score=551.57 Aligned_cols=362 Identities=26% Similarity=0.449 Sum_probs=321.0
Q ss_pred hhhhhhHHHHHHHHHhhhcCCCCCcEEEChHHHHHHHHHHHhcCChhhHHHHHhhcCCCCh----hHHHHHHHHHHHHHh
Q 016311 6 SISNQTDVALSLTKHVALTEAKDSNLVFSPSSIHVLLSLISAGSKGPTLDQLLSFLKSKSN----DQLNAFASELVAVVF 81 (391)
Q Consensus 6 ~~~~~~~fa~~L~~~l~~~~~~~~N~v~SP~si~~~L~~l~~ga~g~t~~el~~~L~~~~~----~~~~~~~~~l~~~l~ 81 (391)
+..+.++||++||+.+. ...+++|+||||++|+.+|+||++||+|+|++||.++||++.. .+++..++.+.+.+.
T Consensus 4 ~~~~~~~Fa~~l~~~l~-~~~~~~N~v~SP~si~~~La~l~~Ga~g~T~~el~~~L~~~~~~~~~~~~~~~~~~~~~~~~ 82 (372)
T d1qlpa_ 4 ITPNLAEFAFSLYRQLA-HQSNSTNIFFSPVSIATAFAMLSLGTKADTHDEILEGLNFNLTEIPEAQIHEGFQELLRTLN 82 (372)
T ss_dssp THHHHHHHHHHHHHHHH-HHCSSSCEEECHHHHHHHHHHHHTTCCHHHHHHHHHHTTCCTTTSCHHHHHHHHHHHHHHHS
T ss_pred hhHhHHHHHHHHHHHHh-hhCCCCcEEECHHHHHHHHHHHHHhccHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHHhh
Confidence 45688999999999997 4578899999999999999999999999999999999999743 567778888877764
Q ss_pred hCCCCCCCCeeeeeeeeeecCCCccchHHHHHHHcccCCeeEEecCCCChHHHHHHHHHHHHHHhCCcccccCCCCCCCC
Q 016311 82 ADGSPSGGPRLSVANGVWIDESLSLKNTFKQVVDNVYKAASNQVDFQTKAAEVSREVNMWAEKETNGLVKEVLPPGSVDN 161 (391)
Q Consensus 82 ~~~~~~~~~~l~~~n~i~~~~~~~~~~~f~~~~~~~~~~~~~~~df~~~~~~a~~~iN~wv~~~T~g~i~~~l~~~~~~~ 161 (391)
. +..+..+.++|++|+++++++.++|++.++++|+++++.+||.+ +..+++.||+|++++|+|+|+++++ ++++
T Consensus 83 ~---~~~~~~l~~~n~i~~~~~~~l~~~f~~~~~~~f~~~~~~~df~~-~~~~~~~iN~wv~~~T~g~i~~~~~--~~~~ 156 (372)
T d1qlpa_ 83 Q---PDSQLQLTTGNGLFLSEGLKLVDKFLEDVKKLYHSEAFTVNFGD-TEEAKKQINDYVEKGTQGKIVDLVK--ELDR 156 (372)
T ss_dssp C---SSCCCCEEEEEEEEEETTCCBCHHHHHHHHHTSCCEEEEECTTS-HHHHHHHHHHHHHHHTTTSSCSCCC--CCCT
T ss_pred c---cCcchhhhhheeeeeccCCccCHHHHHHHHHHhCceeecccccc-hHHHHHHHHHHHHHHhCCCCccccc--CCCC
Confidence 2 34567899999999999999999999999999999999999986 6889999999999999999999996 6899
Q ss_pred cCeEEEEEeeeeccccccccccCCCcccCeEeCCCceEeecccccccccccccc--CCeEEEEeecCCCCCCceEEEEEE
Q 016311 162 STRLIFANALYFKGAWNETFDSSKTKDYDFHLLNGGSIKVPFMTSKKNQFVSAF--DGFKVLGLPYKQGEDKRRFSMYFF 239 (391)
Q Consensus 162 ~t~l~lvna~~f~~~W~~~F~~~~t~~~~F~~~~g~~~~v~mM~~~~~~~~~~~--~~~~vveLp~~~~~~~~~~sm~ii 239 (391)
++.++++||+||+|.|..+|++..|...+|+..+|..+.|+||++.+.++|++. .++++++|||+++ .++|+++
T Consensus 157 ~t~l~lina~~f~~~W~~~F~~~~t~~~~F~~~~~~~~~V~mm~~~~~f~~~~~~~l~~~~~~lp~~~~----~~~~il~ 232 (372)
T d1qlpa_ 157 DTVFALVNYIFFKGKWERPFEVKDTEEEDFHVDQVTTVKVPMMKRLGMFNIQHCKKLSSWVLLMKYLGN----ATAIFFL 232 (372)
T ss_dssp TCCEEEEEEEEECCCBSSCCCGGGCEEEEEESSSSCEEEEEEEEEEEEEEEEEETTTTEEEEEEEETTT----EEEEEEE
T ss_pred cchhhhhhhheeecccccccchhccccccccccCCceEEEeeeecccceeeeccccCCeEEEecccCCC----ceEEEEE
Confidence 999999999999999999999999999999999999999999999987766654 4899999999987 5665555
Q ss_pred ecCCCCChHHHHHHhcCchHHHhhcCCCCceeeeeeeceeeeeeccCCcHHHhhcCCCCCCCCCCCCCCcCCCCCCCCCC
Q 016311 240 LPDAKDGLPTLLEKMGSESKFLDHHLPSQRVEVGDFRIPRFKISFGIEVSKVLKGLGLVLPFSGEGGGLAEMVDSPVGKN 319 (391)
Q Consensus 240 lP~~~~~l~~l~~~L~~~~~~l~~~~~~~~~~~v~l~lPkf~i~~~~dl~~~L~~lGl~~~F~~~~adfs~is~~~~~~~ 319 (391)
.|+ .+|.++++.|. ...+..+....+...++|+||||++++++||+++|++||++++|++ .+||++|++ +.+
T Consensus 233 ~~~--~~l~~l~~~L~--~~~l~~~~~~~~~~~v~v~lPkF~i~~~~dl~~~L~~lGl~~~F~~-~ad~~~i~~---~~~ 304 (372)
T d1qlpa_ 233 PDE--GKLQHLENELT--HDIITKFLENEDRRSASLHLPKLSITGTYDLKSVLGQLGITKVFSN-GADLSGVTE---EAP 304 (372)
T ss_dssp ECT--TCHHHHHHHCC--HHHHHHHHHCCCCEEEEEEEECEEEEEEEEHHHHTGGGTCCGGGST-TCCCTTTBS---SSC
T ss_pred CCc--CCHHHHHHhhh--HHHHHHHHHhccceEEEEEEEEEEEeeeccHHHHHHhcCchhhhcc-hhhhcCcCC---CCC
Confidence 443 47999999997 3456666666667788999999999999999999999999999998 799999998 578
Q ss_pred eeEeeeeeeeEEEEcCCCchhhhhhhhhhhhhhccCCCCeEEEeecCeeEEEEECCCCcEEEEEEecCCCC
Q 016311 320 LYVSSIFQKSFIEVNEEGTEAAAASAATVVLRSIVLSDKIDFVADHPFVFMIREDMTGLVMFTGHVLNPLA 390 (391)
Q Consensus 320 l~v~~~~q~~~l~v~E~G~~a~a~t~~~~~~~~~~~~~~~~f~~drPF~f~I~~~~t~~ilf~G~v~~P~~ 390 (391)
++|++++|++.|+|||+|++|+++|.+....++. +.+|++||||+|+|+|+.||.|||+|||.||++
T Consensus 305 l~vs~v~q~~~i~v~E~Gteaaa~t~~~~~~~s~----~~~f~~drPFlf~I~~~~t~~iLf~G~v~~Pt~ 371 (372)
T d1qlpa_ 305 LKLSKAVHKAVLTIDEKGTEAAGAMFLEAIPMSI----PPEVKFNKPFVFLMIEQNTKSPLFMGKVVNPTQ 371 (372)
T ss_dssp CCCCEEEEEEEEEECSCSSSSCCCCCCCCCCSSC----CCEEECCSCEEEEEEETTTCCEEEEEEESCTTC
T ss_pred ceeeeEEEEEEEEECCCccchhhhheeecccCCC----CCeEEecCCEEEEEEECCCCcEEEEEEeCCCCC
Confidence 9999999999999999999999988754443332 468999999999999999999999999999986
|